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Abstract 
Background and aim 
Despite consensus on what optimal diabetes care should look like, this is not always 
achieved in ‘real world’ practice. Attention has shifted from solely testing the 
effectiveness of interventions to improve diabetes care, to also trying to uncover the 
influences, the how and why they work. Integrated care, organising care delivery 
within and between services, is a strategy to improve the quality of diabetes care; 
however, few studies have examined its implementation and whether quality 
improvements can be sustained. This thesis aims to understand whether and how 
integrated diabetes care can improve and sustain the quality of care in a real world 
community context using two approaches to integrated care in the Irish health 
system, a bottom-up locally-driven (structured primary care) initiative and recent 
top-down nationally-led reforms (a new model of integrated care supported by 
diabetes nurse specialists (DNS)).    
 
Methods 
A systematic review comprising a narrative synthesis and meta-analysis was 
conducted to identify the evidence on physician and practice factors associated with 
the quality of diabetes primary care management.  Trends in process of care 
recording and intermediate patient clinical outcomes (i.e. risk factors; blood 
pressure, cholesterol, HbA1c, creatinine) were examined over time using a series of 
cross-sections (1998, 2003, 2008, and 2016) from an existing structured primary care 
initiative. Data from the original cohort enrolled in this programme in 1999, were 
used to examine all-cause mortality and survival among people with diabetes, 
comparing mortality to the general population using Standardised Mortality Ratios 
(SMR). Excess mortality was compared with international estimates. The intended 
role of both hospital and community DNS is to support integrated care by managing 
patients with complicated type 2 diabetes, liaise with other professionals, deliver 
professional and patient education, and clinics. A national survey of DNS was 
conducted to examine their role. Interviews and focus groups were conducted with 
DNS, purposively sampled by region and type (hospital or community-based), to 
understand how they support the implementation of integrated care, including what 
factors influence their behaviours. 
 
Results 
Physician factors (female gender, younger age, and a higher volume of patients with 
diabetes), and practice factors (Electronic Health Record (EHR) and low deprivation) 
were associated with higher quality of care.  Process of care recording delivered by 
the structured care programme improved significantly over time (p < 0.001), 
although there was levelling-off in later years. Mortality among the original cohort 
was greater than the background population (overall SMR = 1.20 (95% Confidence 
Interval: 1.01-1.42)) though lower than some international estimates. Most DNS 
preformed their intended role. However, nurse-led clinics had variable support from 
xii 
 
other specialities, and access to the community DNS service was not available to all 
GPs. From qualitative analysis there was evidence that community DNS had to adapt 
and use initiative to make integrated care ‘workable’:  responding to the lack of an 
integrated EHR between primary and secondary care by using workarounds, adapting 
to the lack of multidisciplinary team “safety net” in the community by working more 
autonomously, linking in with professional networks as an alternative ‘safety net’, 
managing role misconceptions by colleagues and managers, and adapting their 
service to “blend in” with differences in diabetes care organisation and experience at 
practices. 
 
Conclusions  
Integrated diabetes care within primary care is feasible in a real world community 
setting, achieving improvements over time, and integrated care across services is 
‘workable’ through innovation and adaptation in a complex healthcare context.  To 
scale up integrated care nationally, making this model available to all patients, 
practices may need targeted support, based on physician practice profile or other 
factors (e.g. information systems, deprivation, experience) to improve and organise 
diabetes care delivery. To embed and sustain integrated care requires system-level 
investment in building a supportive culture (e.g. acceptance of new roles, supporting 
professional networks) and infrastructure (e.g. integrated EHRs, access to specialists 
in the community or across boundaries). Integrated care should continue to be 
evaluated as services are delivered, recognising the local and system-level context 
(e.g. physician factors, EHRs, role understanding, available community resources) can 
challenge efforts to improve care. There is a need to learn from service delivery as it 
is implemented and consider how to guide adaptations to ensure integrated care in 
the real world is both ‘workable’ and effective. 
 
1 
 
So there has been an epidemic of type 2 diabetes as everybody knows and hospitals 
are not equipped to provide the care that all patients with diabetes need all the time 
when it could be provided much more efficiently and effectively by the patient’s GP. 
So GP's like it, patients like it, consultants like it too, other allied health professional 
like it and the government likes it, it’s good policy, so how do you actually implement 
that?  
- National stakeholder participating in an evaluation study on the National 
Clinical Programme for Diabetes) [1]. 
 
1 Introduction  
1.1 Introduction 
The number of people affected by type 2 diabetes  is growing rapidly worldwide [2, 
3], the result of an aging population and increasing levels of obesity [3, 4]. The co-
morbidities and rate of complications [5, 6] associated with diabetes place a 
significant financial burden on health systems [7]. People with diabetes also have 
higher mortality compared to people without the condition [8-12]. 
 
Integrated care is seen as an effective way to deliver high-quality care for people with 
chronic diseases like type 2 diabetes [7, 13, 14]. Integrated care involves organising 
and co-ordinating management  between and within care settings [15].  Diabetes 
affects multiple organ systems, requiring the involvement of healthcare 
professionals from different disciplines and settings to achieve effective 
management [16]. This makes diabetes the exemplar chronic condition to study 
integrated care as a strategy to improve the quality of care. 
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Internationally, integrated care for chronic conditions, including diabetes, has 
involved structuring care to deliver routine care for uncomplicated diabetes,  
enhancing specialist support in primary care, and co-ordinating management across 
primary and secondary care [17-19]. This change in care delivery has required 
investment in primary care to better support chronic disease management in the 
community [20, 21]. The specialist nurse has become central to supporting chronic 
disease management in primary care and facilitating integration between settings 
[22], with the role increasingly moving into community settings [22]. 
 
While integrated diabetes care has been shown to improve quality in the short term 
as part of trials or evaluative studies [17, 23-25], we do not know whether quality 
improvements are sustained over time in everyday practice. Moreover, effectiveness 
is not always achieved in different healthcare or policy contexts [26].  There is 
consensus on the core aspects of optimal diabetes management, however, a gap 
remains between ideal and actual practice [21]. In short, while we may know what 
integrated diabetes care should look like, the question is whether it can be 
successfully implemented and sustained in a real world community setting.   
 
Approaches to improve and integrate diabetes care in Ireland include both long-
standing, locally driven, and more recent, nationally led changes, which build on local 
efforts.  Local primary care initiatives provide more structured care within general 
practice for people with diabetes [27]. A number of national reforms have been 
introduced to support routine management in primary care and better integration of 
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care between primary and secondary care, including a model of integrated care 
supported by new ‘integrated’ diabetes nurse specialists (DNS) [28]. 
 
As the Irish health system embodies many real world challenges for integrated care, 
studying these approaches presents a way to learn whether and how integrated care 
improves quality in a complex service context. There is an opportunity to learn from 
existing initiatives; how they perform over time, and how enrolled patients fare with 
respect to intermediate and long-term outcomes. DNS are central to the national 
strategy to improve and integrate diabetes care, yet unlike other countries [29-31] 
there is a dearth of information on how the DNS service currently operates in Ireland. 
Understanding the role DNS perform is important to inform how it can be best 
utilised within the specific health system to support integrated diabetes care, and to 
determine whether there are aspects of service delivery which need to be addressed. 
Previous work highlighted potential challenges to implementing integrated care in 
Ireland from the GP perspective [32]. Now that integrated care has been introduced, 
there is a need to understand its delivery, whether it is working as intended, and 
whether and how this model should be better supported.  
 
1.2 Aim 
 
This thesis aims to examine whether and how integrated diabetes care (structuring 
primary care management and improving coordination across primary and secondary 
care settings) can improve and sustain quality of care in a real world community 
context. 
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1.3 Objectives 
 
1. What physician and practice factors (contextual influences) have been 
associated with the quality of care in ‘real-life’ primary care? 
• Systematically review the evidence on the relationship between 
physician- and practice- level factors and the quality of diabetes care 
(type 1 or type 2)  in primary care (Paper 1/Chapter 3) 
 
2. Does a structured care programme to integrate and improve diabetes 
management in primary care, implemented in ‘real-life’ practices over a long 
period, deliver improvements in the quality of care and outcomes for 
patients? 
• Examine trends in the quality of care (processes of care) performed 
for people with type 2 diabetes and benchmark the programme 
against international standards over time. (Paper 2/Chapter 4) 
• Examine all-cause mortality (type 1 or type 2 diabetes) compared with 
the general population and conduct a survival analysis to examine 
predictors of mortality (Paper 3/Chapter 5) 
 
3. How do DNS support and implement integrated care between primary and 
secondary care? 
• Examine current DNS service provision, specifically aspects of the DNS 
role which are important in the integration of care and compare these 
5 
 
by type of DNS (hospital or community-based) and region (Paper 
4/Chapter 6) 
• Explore how they support the implementation of integrated care in a 
complex health system and respond to challenges and opportunities 
working within and between settings.  (Paper 5/Chapter 7) 
 
The research questions and corresponding studies are summarised in Figure 1.
6 
 
 
Figure 1 Overview of thesis including research questions and corresponding studies 
Abbreviations: DNS, diabetes nurse specialist
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1.4 Thesis outline 
This thesis contains eight chapters. Five are studies which address the aims and 
objectives outlined above, with chapters 3-7 corresponding to individual research 
(Figure 1). Chapter 2 introduces diabetes as an exemplar for studying quality 
improvement (QI). The chapter provides an overview of QI, introduces integrated 
care as an ‘organising principle’ to improve the quality of chronic disease 
management, and reviews its effectiveness as an intervention to improve the quality 
of diabetes care. The challenges of implementing integrated care are mentioned.  
Lastly, the chapter provides an overview of integrated diabetes care in Ireland.  
Chapter 8 provides a discussion of the main findings, the strengths and limitations of 
the thesis and makes recommendations for future research.
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1.5 Authors contribution 
I was the lead author of each research paper presented in Chapters 3, 4, 5, 6 and 7. 
This involved formulation of the research question for each chapter, literature 
screening, data collection and analysis, and drafting each manuscript. My 
supervisors, Prof. Patricia Kearney and Dr Sheena McHugh guided me on the study 
design, data analysis and interpretation for all research papers. Chapters 4 and 5 
involve data from the Midland Structured Diabetes Care Programme. The audit data 
for this work were collected in 1999, 2003, 2008 and 2016 by nurse specialists 
working with the programme. Together with my supervisors I collaborated with Dr 
Velma Harkins and Paul Marsden to plan data collection for the 2016 audit. Data 
entry was carried out by Paul Marsden, Public Health Researcher at the time.  Before 
analysis I performed data checks and corresponded with Paul Marsden to resolve any 
errors and discrepancies.  For the analysis conducted in Chapter 5, I collected 
additional data on cause and date of death from national death certificates stored at 
the General Registrar Office. Together with my supervisors, Dr Anthony Fitzgerald 
advised on the statistical analysis for this work. Chapter 6 involves a national survey 
of diabetes nurse specialists.  The survey was drafted by Dr Sheena McHugh before I 
began my PhD. I finalised the survey, constructed the sampling frame, administered 
and coordinated the survey, cleaned and analysed the data.  Katie Murphy, Diabetes 
Nurse Facilitator was co-author on this paper. She advised on interpretation and 
reviewed the final draft. Prof. Sean Dinneen, Clinical Lead for the National Clinical 
Programme for Diabetes, was co-author on the work in Chapter 7. Prof. Dinneen 
reviewed and advised on the paper. Julie Barrett and Niamh McGrath were second 
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coders for the qualitative data in Chapters 6 and 7 respectively, and reviewed drafts 
of these papers. Clodagh O’Donovan and Mavis Nomsa Mtshede were second 
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2 Background 
 
2.1 Diabetes as the exemplar chronic condition 
Diabetes is often used as an exemplar to study improvements in the management 
and coordination of care for complex chronic conditions. It is characterised by high 
prevalence which places a substantial burden on global health systems. The condition 
is associated with a number of co-morbidities and requires on-going management by 
primary care with input from a variety of specialist care providers. While there is 
consensus on what good quality diabetes care should look like, this is not always 
achieved in real world practice [21, 33].  
 
Diabetes is a chronic disease characterised by hyperglycaemia resulting from defects 
in insulin secretion, use, or both [34].  While type 1 diabetes arises from a problem 
with insulin production, type 2 diabetes results from ineffective use of the insulin 
produced [34]. The rise in global prevalence [2, 35-37], which has almost doubled in 
the past 30 years [36], together with the demand management places on health 
systems, has led diabetes to be called one of the greatest challenges of the 21st 
century[38]. In Europe, the overall prevalence in 2013 was 8.5% [21].  In Ireland, the 
prevalence of diagnosed diabetes among adults has increased from 2.2% in 1998 to 
5.2% in 2015 representing a mean increase of 0.17% per annum [37].   
 
Diabetes is associated with a number of serious microvascular (diabetic retinopathy 
[39-41], neuropathy, and nephropathy, including kidney failure [42, 43]) and 
11 
 
macrovascular (Coronary Heart Disease (CHD), stroke, and peripheral vascular 
disease) complications [5, 6, 44]. People with diabetes have up to a threefold 
increase in all-cause mortality compared to those without diabetes [8-12, 45]. This 
excess mortality is substantially higher with worsening glycaemic control [46, 47], 
renal function [47], and among those with lower socio-economic status (SES) [48], 
younger age [11, 46-50], and women [9, 48].  Complications are largely preventable 
if the condition is well-managed and risk factors (glucose levels, lipids, blood pressure 
(BP)) are well-controlled [51-55]. Declining rates of complications [56, 57] may reflect 
improvements in care, including, but not limited to, a greater focus on delivering 
more structured chronic disease management, increased opportunistic screening, 
improvements in medication and treatments over time, and better management of 
risk factors. The declining complication rates are against the backdrop of other 
population-level changes, including declines in smoking and CHD [58-60].  There is 
also evidence to suggest that excess mortality has declined in recent years, for 
example, in Denmark [61], Sweden [62], UK [49, 63], and US [64]. However, there is 
variability in the extent of excess mortality and its decline across countries [57, 65].  
 
The core elements of good diabetes management are well-established: 1) focus on 
managing blood glucose levels, BP, and lipids, and; 2) carrying out regular screening 
for complications. These processes are facilitated through patient registration, recall 
and regular review, the provision of protected time and commitment to following a 
standard protocol [66-68].  Individuals with diabetes often have other chronic 
diseases and medical problems [69], making management more challenging.  
Diabetes requires on-going monitoring and treatment of risk factors which can be 
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largely delivered in primary care. However, the range of complications of diabetes 
means that good management requires input from several specialities, including 
podiatry, dietetics, cardiology, vascular surgery, ophthalmology and endocrinology. 
This necessitates effective coordination of care across multiple health care 
professionals, making it a good condition to explore efforts to improve the quality of 
chronic disease management.  
 
2.2 Quality improvement 
Improving the quality of care is a goal of health systems worldwide, gaining 
substantial attention since the release of the seminal report, “Crossing the Quality 
Chasm”, in 2001[70]. QI can be described as “systematic, data-guided activities 
designed to bring about immediate, positive changes in the delivery of health care” 
[71].  A key part of QI is measurement [72, 73]. However, quality can be defined in 
different ways and may consist of many different dimensions. According to the 
Donabedian model, quality can be assessed in terms of structure (organisational 
aspects of the health system in which care is delivered), process (the delivery and 
receipt of care), or outcomes of care (consequences of care) [74, 75]. For individual 
patients, Campbell et al. reduce these to two all-encompassing dimensions of quality 
of care: access (availability, affordability) and effectiveness (clinical, interpersonal). 
For populations, they suggest three additional factors play a part; equity, efficiency 
and cost [74].  
 
Suitable quality indicators need to be measurable and supported by existing evidence 
or expert consensus; ideally they should be acceptable, feasible, reliable, sensitive to 
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change, and have predictive validity [73]. Developing and choosing quality measures 
will depend on the level at which improvements are envisioned (population vs. 
individual patient), the perspective one wants to reflect (e.g. patients or  
professionals), and the aspect of care deemed most important for the QI 
intervention; is the end goal to improve processes or outcomes [72], keeping in mind 
that an improvement in processes does not guarantee that outcomes will improve 
also [76, 77].  Balance also needs to be struck between using acceptable indicators 
and those which are feasible; measures of quality can be driven by data availability 
rather than other considerations (epidemiological, clinical) [78].  The quality of 
diabetes care delivery is often measured in line with the Donabedian dimensions. 
 
2.2.1 Achieving quality improvements in practice 
Achieving QI in a complex health care system is far from easy, and delivering change 
in the care of chronic diseases is cited as particularly challenging [79]. ‘System 
inertia’, whereby systems tend to continue to do what they already do despite 
change, is a central problem of improvements in healthcare [80]. This inertia includes 
clinical inertia or ‘satsificing’ at the physician level, making a ‘good enough’ decision 
under the strain of competing demands or multiple goals, and organisational inertia 
where static or inflexible organisational structures struggle to achieve change on a 
larger scale.  Healthcare systems are complex, and, as such, unpredictable, adaptive 
and self-organising [81], a challenge when introducing change. Coiera suggests 
system inertia is “natural emergent behaviour” of a complex system and the 
competing priorities therein, and/or may simply reflect a lack of resources [81]. That 
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is, a reform may be a good idea in principle but the behavioural changes necessary 
to deliver it will not be achieved in an over-constrained system.    
 
Given this challenge of introducing change, attention has shifted from solely testing 
the effectiveness of QI interventions, to also trying to uncover the influences, the how 
and why of interventions work [82]. There has been a shift from a passive translation 
of evidence into practice (e.g. diffusion of innovations theory) to more engaged 
approaches [83], with research in recent years focusing on the development of 
strategies to guide and support implementation to bridge the ‘second translational 
gap’ or ‘evidence to practice’ gap [84, 85] between knowing what works in 
interventional studies and trials, and making that work in real life [83].  
 
As such, QI operates on a continuum from finding out what works, to understanding 
how and why it worked or not [86]. The ultimate aim is to be able to translate 
research evidence into everyday practice, improving the quality of care through 
embedded and sustained change.  QI interventions which are effective in one setting 
need to be delivered in a way that they bring about similar improvements in a 
different setting[86-88].  For this reason, understanding the role of context, 
described as a ’poorly understood mediator of change’ [89], is essential in QI.   
 
There are many dimensions to context [89-91] which can be categorised as the  outer 
context (e.g. the extent to which organisations are networked, external polices and 
incentives) and the  inner context (e.g. social architecture, intra-organisational 
networks and communications, culture) [92].  Examining how models of care work 
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within the specific context provides insight into how to implement, embed and 
sustain them [93].  The context into which a QI intervention was originally introduced 
can change over time; therefore it has been suggested that efforts to study QI 
interventions should consider testing effectiveness in a variety of contexts and under 
different conditions, and use repeated measurements over time [94]. Contexts are 
‘dynamic’, and a context which supports implementation of an intervention in one 
area may, in another, act as a barrier [93]. As such, there is value in going beyond 
identifying contextual barriers and facilitators, to understanding how, and the 
mechanism by which, they act to influence implementation, understanding the 
interplay between context and intervention, and how the intervention achieves 
outcomes [95].  Summarised by Ovretveit [87, 96], the key questions in QI are: 
• Does it work? 
• Will it work here? 
• What conditions do we need to implement and sustain it? 
• Can we adapt it? 
 
The Consolidated Framework For Implementation Research (CFIR) was developed by 
Damshroder et al., in an effort to combine the existing implementation theories, 
elements of which often overlap.. Although it is not used as an overarching guide for 
the studies in this thesis, the framework provides a structure for describing the 
contextual factors identified in the qualitative work (Chapter 7).  It was considered a 
good choice to conceptualise the context for implementation given that it takes 
account of older theories.  The questions proposed by Ovretveit, rather than a 
specific theoretical framework, act as a guide for the pieces of work conducted as 
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part of this thesis. The findings from each study are brought together in Chapter 8 to 
help address these questions as they relate to integrated care as an intervention to 
improve the quality of diabetes care in a real world context. 
 
2.2.2 Integrated care as an intervention to improve quality 
In response to the converging issues of aging populations and the growing prevalence 
of chronic disease, health systems have focused on integrated care as an ‘organising 
principle’ [97-99] to deliver better quality and more cost-effective chronic disease 
management.  Referred to as the “international health care buzzword” [100], in 
essence, the aim of integrated care is to organise and coordinate care delivery within 
and between healthcare settings, guided by an overarching principle that patients 
receive the “right services” in the “right place” appropriate to their needs [15].  There 
are several different ways of classifying integrated care, according to level, 
orientation, type, and focus [98, 101]. Definitions of the terms used in this thesis are 
provided in  
Table 1. Ideally, both horizontal integration (integration or coordination within one 
organisation or setting) and vertical integration (integration or coordination of care 
across  settings) are required to achieve a true coordination and organisation of care 
for patients [102].  The definition of integrated care adopted by the recent 
Slaintecare report focuses on quality, patient access, and services being well-
organised [103].  
 
Integrated care is: “Healthcare delivered at the lowest appropriate level of 
complexity through a health service that is well organised and managed to enable 
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comprehensive care pathways that patients can easily access and service providers 
can easily deliver.”
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Table 1 Definitions relating to integrated care 
Term Definition 
Integrated care An organising principle’ for how care is delivered [97-99]. 
Integration Methods and strategies used to integrate care [97-99]. 
Integrated care – level [101].  
Micro Integrating care at the clinical level e.g. coordinating care for individual patients or conditions, considered to 
be more disease-focused integration. 
Meso Integrating care at the organisational level e.g. promoting collective action of organisations, and the different 
professionals within those organisations, across the care continuum for a patient group. 
Macro Integrating care at the systems level e.g. to meet the needs of populations. 
Integrated care – orientation [101].  
Horizontal Strategies to link or integrate professionals or organisations at the same level of care, for example integration 
or coordination within one organisation or setting (e.g. primary care).  
Vertical Strategies to integrate professionals or organisations at different levels, for example integration or 
coordination of care across settings (e.g. between primary and secondary care). 
Integrated care – types [100, 101].  
System  Rules and policies within a system. 
Organisational Coordination across different organisations. 
19 
 
Professional Coordination of care across different professional disciplines. 
Service or clinical Coordination of services. 
Functional Integration of support or infrastructure e.g. financing, information technology. 
Normative Alignment of values, shared vision, culture and attitudes. 
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2.2.3 Integrated diabetes care 
To integrate chronic disease management health systems have focused on 
strengthening primary care in terms of accessibility, resources, and capacity, and 
improving the co-ordination and integration of care between different settings: the 
community, out-patient/ambulatory and in-patient settings [20, 21]. Efforts to 
integrate diabetes care typically focus on improving primary care management [18, 
104-107] (e.g. establishing disease management programmes), and/or care 
coordination between primary care and specialist services [17-19, 108] (e.g. 
developing intermediary care settings or roles), strategies which represent the 
horizontal and vertical orientation of integration respectively.  Specific approaches 
used also represent different types of integration (Table 2).  
 
Table 2 Types of integration used in strategies to improve diabetes care 
Type of integration        Examples 
Functional  • Shared budgets, financial incentives [104, 106, 109, 110]. 
• Integrated information systems [18, 104, 111]. 
Professional  • Intermediary care teams and/or individual clinicians 
working at the interface of community and secondary care 
[17-21, 107, 112, 113]. 
• Establishment of multi-disciplinary teams [109, 114]. 
• Joint care planning or shared communication [105, 108, 
109]. 
• Task delegation [115, 116] or role expansion [117-119]. 
Service or clinical  • Coordination of care processes through agreed clinical 
care standards and guidelines [18, 104-107].    
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Some of these align with QI strategies classified using the taxonomy developed by 
the Cochrane Effective Practice and Organisation of Care (EPOC) group [120] 
(Appendix 1 Table 14). This taxonomy groups interventions by whether they relate 
to healthcare delivery, financial, or governance arrangements. 
 
Different interventions are sometimes considered synonymous with integrated care, 
including ‘disease management’, ‘case management’ ‘managed care’, ‘coordinated 
care’, ‘shared care’, ‘structured care’, ‘comprehensive care’, ‘multidisciplinary care’, 
‘organised and coordinated care’, ‘team care’, ‘managed care cooperation’ and 
‘chronic care models’ [98, 100, 121-123]. Some definitions are included in Appendix 
1 Table 15. What these definitions all have in common is that they align with the 
broad goal of integrated care, to better organise and coordinate care to improve 
outcomes.  The focus of this thesis is integrated care in the community, comprising: 
1) horizontal integration within one service through a multifaceted structured 
diabetes management programme and; 2) vertical integration, co-ordinating 
management across primary and secondary care through role expansion and task 
shifting of the DNS role.  
 
This approach to integrated care has elements of disease management (i.e. taking a 
systematic approach to care), structured care (i.e. multifaceted interventions 
focused on structuring and organising care in general practice), and shared care (i.e. 
which can involve clinics run by specialists in primary care; liaison between specialists 
and primary care professionals) (Appendix 1 Table 15). As such, the next sections 
focus on improvements in the quality of diabetes care, and the existing evidence of 
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the effectiveness of interventions to specifically organise care delivery in primary 
care, and coordinate management across settings.  
 
2.2.4 Quality of diabetes care 
The quality of diabetes care delivery is often measured in line with the Donabedian 
dimensions (Section 2.2), focusing on 1) structure, resources, infrastructure, 
staffing); 2) processes; recording of clinical tests performed, intermediate clinical 
outcomes or risk factors (e.g. BP, HbA1c, cholesterol), or screening  for 
complications, and; 3) outcomes e.g. mortality, complications, quality of life, 
patient satisfaction. As mentioned in Section 2.2.1, delivering change in chronic 
disease management is particularly challenging, and indeed interventions to 
improve the quality of diabetes management are not always successful, sometimes 
with limited impact on risk factors [23, 124]. Changes achieved by these 
interventions also may not be clinically significant. For example, in their review of 
diabetes management programmes, Egginton et al. reported a statistically 
significant, albeit minimal, change in HbA1c (weighted difference in means -0.21%, 
95% CI -0.40 to -0.03, p < 0.03) and LDL-cholesterol (weighted difference in means -
3.38 mg/dL, 95% CI -6.27 to -0.49, p < 0.02) [125].  Internationally, risk factor 
control among people with diabetes continues to be suboptimal and variable [126-
130].  
 
For this reason, there is interest in understanding what factors might influence the 
quality of diabetes care. Existing research has synthesised the qualitative evidence 
on barriers and facilitators to effective management of diabetes [131-133], 
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highlighting the role of factors at different levels:  the clinician, i.e. lack of time and 
workload [132], communication style [131], competencies and knowledge [131, 
132], and attitudes [131], and challenges managing co-morbidities [132]; 
organisation, i.e. information technology [132], protocols to structure care [132], 
division of labour ambiguities within the team [132, 133], and; patient knowledge, 
i.e. language, finances, social support and co-morbidities [131]. While a number of 
quantitative studies have investigated whether specific physician and/or practice 
factors are associated with measured quality of care [134-151], these studies have 
not been formally synthesised.   
 
2.2.5 Interventions to organise care delivery in primary care 
Given that primary care provides first-contact, continuous, comprehensive and 
coordinated care [152] it serves as “a starting point from where to improve and 
integrate care” [101, 153].  Over the past few years, health systems have moved away 
from reactive, episodic management in the acute setting and shifted management of 
chronic disease to the community where patients can be managed at the lowest level 
of complexity [29].  
 
Strategies to structure and improve the quality of diabetes care within general 
practice can include a mix of different elements, registration systems [110, 154], 
audit and feedback [155], clinician reminders [154, 156], and patient [110, 155, 156] 
and professional education[110, 155]. There appears to be consensus that multi-
component interventions do better than single component interventions for 
improving diabetes management [157, 158].  However, their multifaceted nature 
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means it is difficult to determine which specific elements have led to improvements 
in the quality of care and patient outcomes. Some studies have categorised 
interventions and tried to elucidate the key components [23, 158-161]. A review 
conducted in 2008 determined that studies specifically involving delivery system 
design and/or self-management support had the greatest impact on clinical 
outcomes i.e. HbA1c, BP and total cholesterol [160]. Both reviews and primary 
studies, indicate that components at the level of health system organisation have 
delivered improvements in clinical outcomes [17, 23-25, 158, 161-163], processes 
[163], reduced referrals to secondary care [112] and preventable hospitalisations for 
diabetes-related complications [164]. These components included team changes 
[158, 161], for example, access to a multidisciplinary team [17, 25, 164]; case 
management [23, 158] (particularly case managers who can make some medication 
changes without waiting for approval from physicians), including provision of care in 
general practice by specialists [24, 112, 165] or the partial replacement of physicians 
by nurses in organising care [162, 163]; patient education and self-management 
[161]; interventions to prompt recall and review of patients, including electronic 
registries and tracking systems [161, 163] and; relay to improve patient-provider 
communication [161]. 
 
Reviews of the evidence on multifaceted interventions to improve and organise 
diabetes management [23, 124, 125, 157-161, 163, 166-172] suggest these 
approaches can improve quality, both clinical outcomes [23, 125, 158, 160, 161, 168-
171], and receipt of care processes [23, 167, 168, 171].  Specifically, these approaches 
have improved HbA1c levels [125, 158, 160, 161, 168-171], with pooled mean 
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reductions of 0.46% [173] to 0.22% [125], blood pressure [23, 160, 161, 168], with a 
mean differences of 2.2mmHg [173]to 3.1mmHg [23],  and blood lipid concentrations 
[23, 125, 160, 161], with pooled mean differences in LDL of 0.1 mmol/L [23, 161]. 
These approaches have also improved the receipt of care processes: increased the 
proportion receiving HbA1c test by 15.6% [167]; the likelihood of eye tests[23, 167, 
168, 171], with relative risk (RR) of 1.22 [23] to 1.88 [168];  foot exams [23, 167, 168, 
171], with RR of 1.27 [23] to 2.11 [168], and renal function checks (RR = 1.28) [23].  
 
However, not all studies included in these systematic reviews reported 
improvements in clinical outcomes. Baptista et al. found only 6 of 12 included 
studies identified an improvement [172]. In a review of professional, organisational 
and patient-centred interventions in primary care categorised according to the 
EPOC taxonomy, Seitz et al. found only 17 of 45 included studies reported a 
significant improvement in glycated haemoglobin (HbA1c), and 11 of 32 reported a 
significant improvement in systolic BP and/or diastolic BP [166]. Norris et al. 
reported insufficient evidence of the effect of case management interventions on 
lipid concentrations and BP[167]. Lastly, a review of interventions found little 
impact for people with prevalent type 2 diabetes, only identifying improvements in 
those with screen-detected newly diagnosed diabetes [124]  
 
Review authors highlighted some issues with the  quality of the existing evidence.  A 
review of interventions involving components of chronic care model, reported just 
59% of included randomised controlled trials (RCT) were of high quality [173], while 
a more recent review of care models in the US, reported the quality of most RCT as 
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fair [125]. Other reviews highlighted specific issues; the inability to blind participants 
[125, 161], contamination [125, 161], poor reporting of allocation concealment [23, 
125, 161], and inadequate (poor reporting or incomplete) follow-up [125, 158, 161]. 
Pimouguet et al. also considered the likelihood that findings may be underestimated 
given that usual care in control groups in RCTs can be better than that provided in 
everyday clinical practice [170].  A further issue with the existing evidence is the 
range of different methodologies and outcomes across studies which makes it 
challenging to come to conclusions about effectiveness [168]. The effectiveness of 
strategies may also depend on baseline control; a review by Tricco et al. found team 
changes, case management and self-management promotion were most effective 
strategies where patients had baseline HbA1c of over 8%, while facilitated relay, 
team changes, patient reminders and electronic registers of patients were more 
effective where baseline HbA1c was 8% or less [174].  
 
Mortality has been infrequently used as an outcome measure in studies of 
interventions to improve management of diabetes [98, 159, 166, 175] and few 
studies have examined mortality using data from patients enrolled in structured 
primary care programmes [119, 175, 176].  While these have examined predictors of 
all-cause mortality [119, 176], they have not compared mortality with the general 
population. One Danish study which conducted six years follow-up of a randomised 
trial of a structured programme involving a number of changes to improve primary 
care organisation, did demonstrate an improvement in intermediate clinical 
outcomes. However, it was underpowered to detect a difference in complications 
and all-cause mortality between intervention and control groups [175].  
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2.2.6 Effectiveness of interventions to improve coordination 
Some reviews have focused on specific interventions to improve coordination across 
settings[108, 116]. A Cochrane review of shared care interventions involving one or 
more of the following, liaison meetings, shared care record cards and computer-
assisted shared care [177], and excluding those without ongoing joint management 
between settings, was inconclusive regarding effectiveness, with the authors 
suggesting this could be due to the short follow-up time of the included studies [108]. 
A review of 15 trials, reported that ‘transmural care’ (a Dutch approach to care 
coordination characterised by agreements between GPs and hospital specialists on 
the nature of collaboration, clarity on clinical roles and responsibilities and retention 
of sub-responsibilities) can be effective, albeit more so for process rather than clinical 
outcomes [116]. This review included studies of DNS working transmurally at the 
interface of primary and secondary care. The evidence was less conclusive for 
interventions involving task delegation or allocation to a professional with a lower 
level of training [116], for example, a review of task allocation from specialists to 
diabetes nurses, demonstrated only short-term effects on HbA1c [178].  
 
Internationally, the nurse specialist has become an increasingly important part of 
interventions to integrate care across the continuum for chronic disease [22, 106, 
179-185], evolving from its original focus on patient education to a more specialised 
and autonomous role [31, 186-188]. By engaging in liaison with other services and 
coordinating care between different specialties and providers [24, 107, 189, 190], the 
nurse specialist has a central part to play in the delivery of integrated care. The role 
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of the nurse specialist in the community has expanded [19, 22, 107, 112, 115]. 
Models of ‘vertical substitution’ involving task shifting between professionals at 
different levels of expertise (e.g. GPs to nurses (practice nurse, nurse specialists, 
nurse practitioner specialised in diabetes) [24, 112, 115, 162, 191-193]), or 
intermediary care provided by multidisciplinary teams including DNS [112, 115], have 
delivered favourable results in terms of clinical outcomes [24, 115, 162], 
inappropriate referrals to secondary care [112], and outpatient attendance [193].   
 
2.3  Challenges of implementing integrated care in complex real world settings 
While there may be growing interest in integrated care as way to achieve quality and 
efficiency in care delivery, it can be difficult to achieve in practice [106, 194]. Gaps in 
the quality and provision of diabetes care remain despite a consensus on optimal 
management [21, 33]. The effectiveness of chronic care models is not always 
demonstrated [108, 124]  and may be variable [168].    
 
One reason why it can be challenging is that models of integrated care for chronic 
diseases are introduced into systems which are configured for the delivery of acute 
and episodic care. In short, the real world health care context is complex, often 
characterised by fragmented services, with divisions between primary and secondary 
care services [109, 195], not only in terms of funding and delivery models [106, 195], 
but with respect to how information is shared and managed [106, 195-198]. 
Moreover, QI interventions which integrate and structure care for chronic conditions 
like diabetes, can often be multifaceted, creating added complexity when trying to 
implement change [124].   For this reason, the transferability of effective integrated 
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care models across settings or contexts, ‘scaling out’, is a challenge. Models of 
integrated care for long term conditions which are successful in one setting may not 
achieve the same outcomes when transferred to a different healthcare and policy 
contexts [26].   
 
2.3.1 Sustaining quality of care delivery over time 
A second issue is that while improvements may be achieved over a short time period¸ 
they may not be maintained over longer periods [168]; sustaining effectiveness over 
time can be difficult.  The end goal of integrated care is to achieve a system-wide 
reconfiguration which can be sustained as part of ‘everyday’ practice. However, most 
studies examining integrated diabetes management in primary care have a relatively 
short follow-up [108, 117, 118]. Few can demonstrate sustainability of structured 
care models in everyday practice [199] particularly over a longer period, of 10 years 
or more [119, 200, 201].  In their review of study heterogeneity in chronic care 
management programmes, Elissen et al. identified variation in the length of follow 
up. They suggest this is a particularly important given that delivery of these models 
require changes to behaviour, organisation and culture (e.g. self-management 
promotion) which must be embedded over time [168]. These types of changes may 
be effective [169, 174], but are potentially difficult to sustain over longer time 
periods. In general, few studies examine sustainability [93]; this is generally beyond 
the remit of most interventional studies and services research [202], and it is a topic 
that has only recently gained more traction [202, 203]. 
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2.3.2 Barriers and facilitators to integrated care 
Given these challenges, there is interest in understanding which factors can hinder 
or support integrated care delivery. Broad principles for successful integrated care 
have been outlined by Suter et al. (Table 3). These were consistent with a recent 
review of integrated models of care, which also cited workforce stability, professional 
identity, role boundaries and hierarchies, staff training, and patient engagement, as 
key factors influencing the implementation of integrated care [204].  Internationally, 
integration has been supported by: 1) shared values between organisations and 
individuals [198], a culture of interdisciplinary work [198, 205], willing and motivated 
providers [32, 206] or senior leaders ‘champions’ [206]; 2) a focus on local, rather 
than top down planning [207], affording flexibility to identify [206], meet local 
population needs [208], and to be able to capitalise on local professional (GP) 
networks to implement service developments [207], and; 3) funding models which 
remove competition between individual providers [207] incentivise guideline 
adherence [18]  or reduce the burden of out of pocket expenditures for patient 
attending general practice [209]. 
 
In contrast, factors hindering integration include: 1) a culture of ‘silo-working’ [198, 
205] tension between primary and secondary care settings and building new 
relationships [32, 210], and no tradition of interdisciplinary work [206]; 2) limited 
financial support available to GPs [206]; 3) unlinked information systems across 
settings [18, 196, 198, 210-212], and; 4) the complexity of the intervention and 
burden of administrative work to deliver it [206, 210].  
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Few of these studies specifically looked at barriers and facilitators to implementation, 
and the part context plays in the delivery of integrated diabetes care [18, 32, 206, 
210, 213]. Existing studies suggest there are system [187, 214-218] and 
organisational level [185, 214, 216, 218] barriers to the nurse specialist role. 
However, none have focused on understanding how the nurse specialist role 
operates within the health system to support delivery of integrated care [192], and 
what challenges might be inherent in a new way of working to integrate  care through 
provision of intermediary care and role expansion.  
 
In short, we have a sense of what high-quality integrated diabetes care should look 
like, that it can be an effective improvement strategy, at least in short-term 
evaluative studies. However, the critical question is can we successfully implement 
and sustain this intervention to improve quality in a real world setting.  
 
Table 3 Principles for successful integrated care 
1. A shared patient-centred focus and philosophy 
2. Providing comprehensive services across the care continuum 
3. Ensuring geographic coverage i.e. system responsibility for an identified 
population 
4. Facilitating standardised delivery of care irrespective of where or by which 
professional a patient is cared for (e.g. through clinical guidelines and pathways) 
5. Monitoring performance (e.g. examining processes and outcomes at different 
levels) 
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6. Information systems that can improve communication and collect and track data 
and activity 
7. Shared organisational culture, vision and leadership committed to integrated 
care 
8. Integrate physicians such that they have a role in the implementation and 
reforms 
9. Governance and organisational structures that promote integration 
10. Funding that provides enough resources to sustain integration and service 
reform, and funding mechanisms that promote integration and inter-
professional teamwork 
 
2.4 Integrated diabetes care in Ireland 
Delivering integrated care, shifting care from the hospital to community and 
providing care at a lower level of complexity in an appropriate setting as close to 
home as possible, has long been on the reform agenda in Ireland [103, 219-223]. 
Recent national reforms to support integrated diabetes care have been preceded by 
locally driven and long-standing initiatives to structure management in primary care. 
The structure of the health system in Ireland embodies many of the challenges facing 
integrated care: primary and secondary care services are funded and resourced 
separately, chronic disease management is often not well integrated between 
hospitals and general practice, and there is variation in the provision of diabetes 
management in primary care [224, 225]. Studying the delivery of integrated care in 
Ireland presents an opportunity for transferrable learning about whether and how 
integrated care can successfully improve quality of diabetes care in a complex real 
world service context. 
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2.4.1 Primary care  
In Ireland, most GPs are independent, self-employed practitioners, funded by a mix 
of state capitation payments for individuals who hold a means-tested General 
Medical Services (GMS) card, and fees paid by private patients. Some GPs choose to 
work on a fully private practitioner basis [226].  GMS cardholders who are eligible for 
free GP care currently make up just over 40% of the population [227]. Free access to 
GP care has expanded and been made available to anyone over 70 (independent of 
income) and all children under six [228]. Like other countries, GPs often act as a 
gateway to services in the hospital.  However, as is the case internationally, Irish 
general practice is facing a workforce shortage [229-231], which challenges efforts to 
build capacity. GPs experienced financial cuts in the wake of the economic recession 
and the Financial Emergency Measures in the Public Interest Act, 2009 [232] and 
there are on-going issues with GP recruitment and retention [231]. 
 
2.4.1.1 Diabetes management in primary care 
Type 2 diabetes care in Ireland was traditionally delivered in secondary care, that is, 
once people were diagnosed they were referred to specialist endocrinology services 
after which their management was largely carried out in this setting [233].  However, 
management in primary care has changed in the past few years. Primary care 
initiatives developed out of a local response to the lack of secondary care diabetes 
services and the need to improve care [107, 234-237]. As such, management 
between primary and secondary care settings is not consistent across the country. In 
some regions GPs deliver care opportunistically while others are engaged in 
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structured care delivery as part of initiatives [224].  There are currently 10 initiatives 
across Ireland. While these have demonstrated quality (process and outcomes of 
care) [234-237] they continue to be the exception rather than the rule, often driven 
by what McHugh and colleagues refer to as ‘vocational’ rather than financial 
incentives [32].  
 
Financial remuneration does form part of the Health Service Executive Midland 
Structured Diabetes Care programme. This programme is the longest established 
primary care-based diabetes care programme in Ireland, established in 1997/1998 as 
a ‘ground up’ effort to improve the quality of care for people with diabetes in the 
counties of Longford, Westmeath, Laois and Offaly (Appendix 10.1.1). The 
programme incorporates several strategies to integrate and coordinate diabetes 
management which align with elements shown to be effective in the international 
literature and map to QI approaches (EPOC categories) (Appendix 1 Table 16). 
 
2.4.2 National reforms  
At a national level there have been several reforms to support integrated care. 
Similar to other countries, building capacity in primary care has been the focus of a 
number of strategies and policy documents in the past few years [103, 220, 223, 238], 
including resourcing and structuring management for chronic disease [122, 220]. Part 
of the vision  of strengthening primary care was to bring together different services 
(e.g. public health nurses, occupational therapy)  through establishing primary care 
teams [220, 238, 239]. More recently, Slaintecare  envisions primary care centres as 
resource centre hubs for health and social care services [103].  Until recently GPs 
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were not incentivised to deliver chronic disease management. As part of the phased 
introduction of free GP care [231] the Diabetes Cycle of Care initiative was introduced 
in 2015.  The Cycle of Care for the first time remunerates GPs on a national scale for 
structured management of patients with type 2 diabetes [28]. It entitles all patients 
with diabetes holding a GMS card to two free GP visits per annum. It aims to better 
structure and organise primary care management of diabetes through establishing 
formal requirements for registering, recording and reporting processes of care 
(clinical parameters, routine foot screening and referral, lifestyle review) [28].   
 
Established in 2010, the National Clinical Care Programmes brought together 
representatives from different clinical disciplines to improve access to services, 
quality, safety and cost effectiveness of care. Prior to their establishment there had 
been limited work to integrate primary and secondary care. These programmes were 
tasked with developing standardised patient pathways and evidence-based models 
of care [240] and formed part of the “supporting architecture” in the phased 
introduction of integrated care [241]. The National Clinical Care Programme for 
Diabetes was one of the earlier Clinical Care Programmes and “early implementers” 
[241] of integrated care models envisioned for Ireland.  The national model of 
integrated care developed by the National Clinical Care Programme for Diabetes 
aimed to establish stratified patient pathways and outline the role of professionals 
involved in care for people with diabetes: DNS, practice nurses and GPs. The model 
specified how patients should be managed according to the complexity of their 
diabetes (Table 4).  
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Table 4 National model of integrated care 
Patient type Care delivery 
Uncomplicated type 2 diabetes  To be managed by primary care (seen 3 times a year 
for structured review visits) and discharged 
accordingly from secondary care services. 
Complicated type 2 diabetes  To be managed between primary and secondary 
care. 
Other patient groups i.e. type 1 
diabetes  
To be cared for solely in secondary care.  
 
In Ireland, before these new changes were introduced, the DNS service was 
predominantly hospital-based. However, prior to the National Clinical Programme for 
Diabetes there were some community DNS in post, as some existing primary care 
initiatives had already introduced the role and found it to be successful [107]. To 
support the roll-out of the model of integrated care the National Clinical Programme 
for Diabetes oversaw the recruitment of additional ‘integrated’ community DNS to 
provide specialist support to primary and secondary care services and act as a link 
between settings.   
 
2.5 Summary   
A substantial body of work has determined which interventions to improve diabetes 
care work. However, a gap remains between the effect reported in these trials and 
that achieved in actual practice. Existing studies are typically not conducted in ‘real-
life’ conditions, are short and do not provide insight into the long-term (>10 years) 
sustainability of interventions within a changing context. Evidence on factors 
(physician and practice level) associated with the quality of primary care diabetes 
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management, which has not been consolidated to date (Section 2.2.4), was 
synthesised in a systematic review and meta-analysis (Chapter 3).  Trends in the 
performance of a multifaceted structured primary care model delivered between 
1998 and 2016 were examined to determine whether this model works in everyday 
practice over a longer period (Chapter 4).  Although, monitoring excess mortality 
from diabetes can indicate improvements in the quality of diabetes care, it is not 
often used as an outcome measure in studies of interventions to improve 
management of diabetes. Chapter 5 examines excess mortality and predictors of 
survival among a cohort enrolled in a structured care programme.  
 
Few studies have examined the implementation of integrated diabetes care, 
including how models which involve a new way of working across care-boundaries, 
e.g. ‘integrated’ DNS, operate ‘on the ground’. Conducting research as a service 
evolves and develops may be beneficial. A national survey (Chapter 6), and a 
qualitative work following the roll-out of the new ‘integrated’ service (Chapter 7) 
were used to understand how DNS support and implement integrated care. 
 
In summary, this thesis contributes to an understanding of whether and how 
integrated diabetes care can improve and sustain quality of care in a real world 
community context by: 1) determining what factors may influence quality of care in 
primary care; examining trends in the performance of existing structured care model 
and long term outcomes among people receiving structured care, and; 2) exploring 
how integrated diabetes care involving the expansion of DNS role is implemented in 
practice. 
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4.1 Abstract  
Aim: Examine the quality of care delivered by a structured primary care-led 
programme for people with type 2 diabetes mellitus 1999-2016. 
 
Methods: The Midland Diabetes Structured Care Programme provides structured 
primary care-led management. Trends over time in care processes were examined 
(chi-squared trend test; age, gender adjusted logistic regression). Screening and 
annual review attendance were reviewed. A composite of eight National Institute for 
Clinical Excellence recommended processes was used as a quality indicator.  
Participants referred to DNS were compared to those not referred (Student’s t test; 
Pearson’s chi-squared test; Wilcoxon-Mann-Whitney test). Proportions achieving 
outcome targets (HbA1c ≤58mmol/mol (7.5%), blood pressure (BP) ≤140/80mmHg, 
cholesterol <5.0mmol/l) were calculated. 
 
Results: Data were available for people with diabetes ≥18 years: 1998/1999 (n = 336), 
2003 (n = 843), 2008 (n = 988), 2016 (n = 1,029). Recording of some processes 
improved significantly over time (HbA1c, cholesterol, BP, creatinine), in 2016 
exceeding 97%. Foot assessment and annual review attendance declined. In 2016, 
only 29% had all eight National Institute for Clinical Excellence processes recorded. A 
higher proportion of people with diabetes referred to a diabetes nurse specialist had 
poor glycaemic control compared to those not referred. The proportion meeting BP 
and lipid targets increased over time.  
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Conclusions: Structured primary care sustained improvements in the quality of care 
over time. Poorer recording of some processes, a decline in annual review 
attendance, and participants at high risk, suggest limits to what structured care alone 
can achieve. Engagement in continuous quality improvement to target other factors, 
including attendance and self-management, may deliver further improvements.  
 
Key words:  Primary Health Care, Quality of Health Care, Outcome and Process 
Assessment (Health Care), Standard of Care 
 
4.2 Introduction 
Diabetes Mellitus is a complex chronic condition requiring structured management, 
including a focus on treatment goals for BP,  glucose control and lipids, regular review 
and recall, screening for complications, and input from multidisciplinary 
professionals [366]. Primary care, as a first point of contact, and source of 
continuous, comprehensive, and coordinated care is often seen as a starting point 
for the delivery and organisation of diabetes care [152]. Evidence suggests that 
primary care management can be as effective as hospital-led care if well supported 
and organised [152]. Efforts to optimise care across different health systems have led 
disease management programmes to better organise management in primary care 
and improve co-ordination between the community, out-patient/ambulatory and in-
patient settings [104, 117, 367].  
 
Disease management programmes in primary care incorporate different 
components: multidisciplinary cooperation, registration systems, audit and 
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feedback, clinician reminders, patient and professional education, and/or the 
establishment of a specific communication system and ongoing collaboration 
between specialities and primary care (shared care). Structured approaches to 
diabetes care, combining some or all of these elements, demonstrate improvements 
in glycaemic control and cardiovascular risk factors [117, 118], albeit evidence for the 
effectiveness of shared care is less certain [23, 108]. Specific components delivering 
significant improvements in clinical outcomes [23, 118, 162] and care processes 
[118], include access to a multidisciplinary team [23], case management [23], partial 
replacement of physicians by nurses [162], self-management promotion[23], and 
interventions to prompt recall and review of patients, including electronic registries, 
reminders and tracking systems [118]. However, interventions operating at all levels 
of the health system (system, provider and patient) have demonstrated a greater 
effect on glycaemic control than interventions targeting a single level [23].  
 
Despite growing evidence on ways to improve the quality of diabetes care, some 
uncertainties remain, including whether the effects achieved by evaluative quality 
improvement studies can be replicated in ‘real life’ practice. Despite international 
consensus on optimal diabetes management, a gap persists between 
recommendations and actual practice [21]. With increasing pressure on primary care, 
growing patient numbers and workforce shortages [152, 199], demonstrating the 
long-term sustainability of structured primary care management is a challenge. 
Internationally, high quality service evaluations to address this evidence gap are 
lacking [199]. Most studies examining diabetes management in primary care have a 
relatively short follow-up [108, 117, 118],  cannot provide an insight into the 
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sustainability of these programmes over time, and may not be able to demonstrate 
effectiveness [108]. Few studies evaluate enhanced models of primary care 
management over a longer period, of 10 years or more [119, 200, 201].    
 
In Ireland [188], as elsewhere in Europe [367], national policy in recent years has 
focused on moving from hospital-led management to deliver care in the community. 
Diabetes care is historically unstructured, however, formal primary care initiatives 
developed across the country to improve the quality of care and service delivery at a 
local level. The longest running is the HSE Midland Diabetes Structured Care 
Programme, established in 1997/1998. We aimed to examine the quality of care 
delivered by the Midlands programme over a long follow-up period (1999–2016) 
through a series of cross-sections. We reviewed the delivery of the programme by 
examining trends in the processes of care performed for people with type 2 diabetes 
and benchmarked the programme against international standards [67, 244]. 
 
4.3 Methods 
 
4.3.1 Setting 
In Ireland, the national prevalence of doctor diagnosed diabetes among adults aged 
18 years and over is 5.2 %, an increase from 2.2 % in 1998 [37]. Over one third of 
adults (37%) are overweight and 23% are obese. The prevalence of smoking is 23% 
[368].  
 
115 
 
4.3.2 Midland Diabetes Structured Care Programme 
The Midlands programme, based in 4 counties in Ireland (Longford, Westmeath, 
Laois and Offaly), employs several evidence-based intervention components: 
adoption of clinical guidelines, patient register and recall and protected time for 
review (three 30-minute visits per year), organisation and coordination of care by 
practice nurses, structured multidisciplinary support, and professional and patient 
education [23, 162]. Practices are remunerated for patients’ visits through an existing 
chronic disease programme, Heartwatch, or reimbursed for practice nurse time. 
Practices receive clinical (DNS, podiatry/chiropody, dietetic), educational, and 
administrative support, which has changed since the programme was first 
established e.g. loss of dietetic support (Figure 8). Additional detail on the 
programme is available in Appendix 10.1.1.  
 
4.3.3 Data collection 
DNS extracted data from practice records on people with type 1 diabetes and type 2 
diabetes (≥18 years) enrolled at four time points: 1998/1999, 2003, 2008, and 2016.  
Owing to resources constraints, reliability checks at each timepoint were not 
performed by DNS on the extracted data. However, quality checks at data entry were 
carried out by PM. A census sample was selected in 1998/1999 and 2003 and a 
systematic sample in 2008 and 2016. In 2008, participants were sampled by sorting 
alphabetically first by name and selecting every third person. In 2016, all participants 
who were still alive and were part of the census sample in 1998/1999 were 
selected. After ordering randomly, every third person was sampled from these 
participants. The remainder of the participants in 2016 was sampled by sorting 
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alphabetically first by name then sampling every third person. This approach was 
taken to approximate a random sample overall in 2016. A flow chart is included in 
Appendix 3 Figure 19. 
 
Sample size was calculated based on precision of HbA1c estimates.  In 2003, mean 
HbA1c for the total sample was 60mmol/mol (7.6%) and the 95% CI was ± 
1mmol/mol (0.11%) which equates to ~1.5%.  Therefore, a confidence level of 95% 
and CI of 2% was chosen to calculate the sample size for 2008 and 2016. Based on 
the total population of 2,275 participants in 2008, the sample size was 1,168.  Based 
on the total population of participants in 2016 of 3,797, the sample size was 
1,471.  Only participants with type 2 diabetes are reported here. 
 
Data sources included clinical notes (electronic and paper), outpatient appointments 
letters and referrals to chiropody/podiatry, retinopathy and dietetics. Data were 
collected on demographics: age, gender, and GMS status (a means tested method of 
public health insurance; GMS cardholders have free access to general practitioner 
services and medications) [369].Data were also collected on diabetes type, duration, 
annual review attendance, use of diabetes-related services (retinopathy screening, 
specialist eye services (any service in community or hospital, private or public), 
diabetes nurse specialist or podiatrist/chiropodist), prescription of diabetes 
medications (oral hypoglycaemic agents (OHAs), insulin, injectables) and other 
medications (statins, angiotensin converting enzyme  inhibiters, aspirin). Data were 
collected on care processes carried out in the previous 12 months: foot assessment 
carried out by any healthcare professional (i.e. GP, practice nurse, DNS, consultant, 
117 
 
podiatrist), measurement of HbA1c, cholesterol, BP, creatinine, albumin creatinine 
ratio, body mass index (BMI), smoking status) and intermediate clinical outcomes (i.e. 
risk factors; HbA1c, cholesterol, triglycerides, BP, creatinine). Smoking status 
(yes/no) in the past 12 months was determined on the basis of participants’ response 
to a question about whether they smoke now.  Data on complications were also 
collected: retinopathy, macrovascular (heart attack (myocardial infarction), heart 
failure (congestive cardiac failure), stroke (cerebrovascular accident), and mini stroke 
(transient ischemic attack)), peripheral neuropathy, autonomic neuropathy, foot risk 
category, and ulcer. Both eyes are checked and people were classified as having 
retinopathy if it was recorded in at least one eye.  Both feet are checked and 
classification of foot risk (low / moderate/ high) was recorded on the basis of the 
highest risk in either foot. Ulcer was recorded as “yes” if the person had an ulcer in 
at least one foot. 
 
4.3.4 Analysis 
Practice addresses were mapped to Electoral Divisions and assigned a deprivation 
score and decile using the 2011 National Deprivation Index for Health and Health 
Services Research developed by the Small Area Health Research Unit [370]. Data 
were represented as means ± SD or median (interquartile range (IQR)) (continuous) 
or numbers and proportions (categorical data). Quality of care was defined using a  
composite of eight care processes recommended by the National Institute for Clinical 
Excellence (HbA1c, BP, cholesterol, smoking status, BMI, creatinine, albumin 
creatinine ratio, and foot examination) [371]. While recording of triglycerides was 
reported, this process was excluded from the composite. Trends over time in the 
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proportion with processes recorded were examined using chi-square test for trend, 
and logistic regression models adjusted for age and gender.  Trends in recording was 
examined for selected processes collected across all four years (HbA1c, BP, 
cholesterol, smoking status, BMI, and creatinine) across practices.  Differences in the 
proportion with processes recorded between participants aged <75 years and ≥75 
years were examined using Pearson’s chi-squared test. The proportion attending 
annual review and diabetes-related services were reported at different time-points. 
Differences in the demographic and clinical profile of participants referred and those 
not referred to a diabetes nurse specialist were tested using Student’s t test or 
Wilcoxon-Mann-Whitney test (continuous data), and Pearson’s chi squared test 
(categorical data).  
 
Guidelines recommend people with complicated type 2 diabetes  attend a DNS[68]. 
Complicated type 2 diabetes is defined as those requiring insulin, people with HbA1c 
>58mmol/mol (7.5%) on two or more glucose lowering agents (not insulin), and 
people with complications or graded as having a high risk foot[68]. Continuous 
outcome data were categorised according to international standards: BP 
≤140/80mmHg, triglycerides <2.0 mmol/l, cholesterol <5.0mmol/l, HbA1c 
≤58mmol/mol (7.5%) [67, 244, 372], and proportions of participants meeting clinical 
outcome targets were calculated.  All analysis was carried out in Stata v.12 for 
windows (StataCorp, College Station, TX, USA). 
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4.4 Results 
4.4.1 Profile of the sample population 
Data on 336 people with type 2 diabetes in 1998/1999 (10 practices), 843 in 2003 (20 
practices), 988 in 2008 (30 practices), and 1,029 (30 practices) in 2016, were available 
for analysis. Overall less than 10% of data were missing, with some exceptions 
depending on time-points: creatinine (1-31%), BMI (27-44%), smoking status (21-
32%), podiatrist/chiropodist attendance (0-17%) and dietician attendance (0-40%). 
Where missing data occurs, the figures represent the recorded data. Over 85% of GPs 
were based in practices within the lowest deprivation deciles, 9 (n = 14, 41%) or 10 
(n = 15, 44%). In 2016, the cohort was aged 68 (60-76) years. Most were men (n = 
603, 59%) and had a GMS card (n = 823, 80%). Median duration of diabetes was nine 
years. The profile of people with type 2 diabetes was similar across time-points (Table 
6).  
 
4.4.2 Process measures 
In 2016, recording for most care processes was >97%. Recording improved 
significantly since 1998/1999, with change more evident between earlier time-points 
(Figure 9). BMI and smoking status recording remained consistently lower than other 
processes. Although there was a significant improvement between 1998/1999 and 
2008 (BMI: 60% vs. 73%; smoking status: 68% vs. 77%) recording remained below 
80% from 2008 to 2016. The proportion of participants with a foot assessment in the 
past 12 months declined from 2008 to 2016 (77% vs. 53%). In 2016, only 29% (n = 
296) of participants had all eight National Institute for Clinical Excellence 
recommended processes recorded.   
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Trends in recording were similar when stratified by age (<75 years and ≥75 years) 
with the exception of smoking status and BP recording among participants <75 years 
(Appendix 3 Table 24). At individual time points certain processes were consistently 
less well recorded (p < 0.05) among participants ≥75 years: 1999 (BMI: 64% vs. 48%; 
triglycerides: 72% vs. 51%), 2003 (BMI: 58% vs. 48%; triglycerides: 93% vs. 87%), 2008 
(BMI: 75% vs. 67%; triglycerides: 99% vs. 96%; albumin creatinine ratio: 74% vs. 67%), 
and 2016 (albumin creatinine ratio: 85% vs. 75%) 
 
Consistent improvements in recording were seen across all practices for HbA1c, 
systolic BP, cholesterol, triglycerides and creatinine. There was some variation in 
proportions recorded in 1999 among the 10 originally enrolled practices (HbA1c 0-
100%; BP 69-100%; cholesterol 0-100%; triglycerides 0-100%; creatinine 0-97%). BMI 
and smoking status recording did not improve consistently, with some practices 
showing a decline in recording over time. Data for the 10 original practices are shown 
in Appendix 3 Table 25.  
 
4.4.3 Attendance at annual review and diabetes-related services 
Annual diabetes review attendance increased between 1998/1999 (18%, n = 46 /261) 
and 2008 (91%, n = 895 / 980), but dropped in 2016 (77%, n = 788 / 1,025). In 2016, 
clinical parameters were recorded for most participants who attended and did not 
attend annual review (HbA1c: 100% vs. 97%; BP: 99% vs. 93%; cholesterol: 100% vs. 
96%; creatinine: 100% vs. 95%). However, there were differences in foot assessment 
(57% vs. 38%), BMI (79% vs. 47%) and smoking status (86% vs. 56%) recording. A 
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similar pattern was observed in 2008. In 2008, 58% (n = 548 / 949) of participants 
had seen a chiropodist or podiatrist in the past 12 months, which declined further by 
2016 (51%, n = 439 / 863). In 2008, only 51% (n = 507 /988) had attended specialist 
eye services but in 2016, 80% (n = 800 /1006) of participants had attended either the 
national screening programme (RetinaScreen) or specialist eye services. The 
proportion who had seen a hospital or community dietician dropped from 50% (n = 
167 / 336) in 1998/1999 to 7.1% (n = 42 / 610) in 2016. However, recording quality 
also declined; 41% (n = 419 / 1029) were missing data in 2016 compared to 0.3% (n 
= 1 /336) in 1998/1999.   
 
Attendance at a DNS increased between 2008 and 2016 (11% vs. 15%). Participants 
who were referred had diabetes for longer and were younger than those who were 
not referred (Table 7). A greater proportion of people referred had poor glycaemic 
control (HbA1c >58mmol/mol [7.5%]) (50% vs. 20%, p<0.001), were on OHAs or 
injectables (98% vs. 81%, p<0.001), and had retinopathy (41% vs. 30%, p<0.01). 
However, a lower proportion were classified as having a high risk of foot disease 
(1.9% vs. 4.4%, p<0.05). 
 
4.4.4 Outcome targets  
Over time, the proportion meeting BP and lipid targets increased, whereas the 
proportion with HbA1c ≤58mmol/mol (7.5%) was similar (Table 6). Across time 
points, the proportion meeting all three outcome targets (HbA1c, BP and cholesterol) 
ranged from 12% (1999) to 39% (2016). Those at high risk, HbA1c >58mmol/mol 
(7.5%), had diabetes for longer. The proportion on OHA only was similar across high 
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and low risk groups. A greater proportion at low risk were on OHAs or injectables 
(Appendix 3 Table 26). 
 
4.5 Discussion 
We examined the quality of care delivered by a structured primary care management 
programme for people with type 2 diabetes. We found significant improvements in 
process of care recording. These are consistent with changes in recording [104, 118, 
200, 201] reported by multifaceted international programmes with similar 
components: registration [118, 200, 201], practice guidelines [104, 201], incentives 
[104], on-going professional education [118, 201], nurse case management [200], 
and structured multidisciplinary support [104]. Our findings suggest these changes 
can be sustained over time in a ‘real life’ setting. However, despite evidence of 
ongoing improvement there may be limits to what structured programmes can 
achieve in the long term.  BMI and smoking status were consistently less well 
recorded, performance of foot assessment, and attendance at dietetic and annual 
review declined in the later years of the programme, and some participants remained 
at high risk. 
 
Unlike QOF in the UK, payment as part of the Midlands programme is not based on 
process recording.  Smoking status and BMI recording remained lower than other 
processes, comparing poorly with the recent National Diabetes Audit [371], based on 
QOF data, and other European countries [126]. However, BMI and smoking status 
recording in the National Diabetes Audit was also lower than recording of other 
processes. While incentivising individual indicators can improve recording to a 
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degree, poor documentation of certain processes may persist. Some may be 
prioritised less than other clinical measurements during review visits. BMI recording, 
for example, may only occur if a general practitioner or practice nurse recognises the 
patient as overweight/obese, intends to offer management, or feels willing or able 
to engage in discussions about weight [373]. We found variation across practices in 
recording of BMI and smoking status, with some practices showing a decline in 
recording over time.  With the exception of 2016, BMI was consistently less well 
recorded among older participants (≥75 years). Foot assessments, also poorly 
recorded, have been more frequently performed among people with low income, 
poorer metabolic control, or complications, and less frequently by general 
practitioners compared to specialists [374]. Assessments may be time-consuming 
and unfeasible as part of regular review, or only prioritised when the general 
practitioner is aware of an increased risk of amputation. 
 
We found a significant, improving trend over time in recording of care processes. 
However, this was driven by more substantial improvements between earlier time-
points. There was minimal change between 2008 and 2016 once recording >97% had 
been achieved. However, a similar pattern was observed for BMI and smoking status, 
although these were less well-recorded. This suggests that recording may plateau 
irrespective whether near maximal recording has been achieved or not. A plateau 
was also observed in the UK a year after the introduction of QOF [375]  suggesting 
limits to what can be achieved through incentives, regardless of the reimbursement 
method. This raises the question of replacing QOF with a model to deliver more 
sustained improvements [376]. This has implications for the new Diabetes Cycle of 
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Care initiative introduced in Ireland in 2015, which remunerates general practitioners 
for care of people with stable type 2 diabetes holding a GMS card. Practices are paid 
on the basis of registering eligible people with diabetes, delivering two review visits 
per year, recording and reporting on care processes (clinical parameters, routine foot 
screening/referral, lifestyle review), not on the basis of meeting clinical targets. The 
initiative may improve the delivery of care processes, but only up until a point. 
Scotland have recently replaced QOF, establishing GP quality clusters, small groups 
of practices which engage in local, peer-led quality improvement activities[376]. 
While they may see an initial decline in care processes, there is scope for 
improvement beyond what is achievable through payments.  
 
Although we did not track clinical outcomes in a fixed population, by reviewing 
outcomes in separate cross-sections we gain some insight into the profile of people 
with diabetes receiving structured care.  In Ireland, 40% of older adults (≥55 years) 
are reported to have high BP (systolic BP ≥140 mmHg), and 41%  have cholesterol >5 
mmol/l [377]. Although recording of most processes in the Midlands programme was 
>97%, many participants were in high risk categories in terms of glycaemic control 
and their cardiovascular profile. Between 2003 and 2016 26-40% had HbA1c 
>58mmol/mol (7.5%), 41-52% had BP >140/80mmHg, and 15-42% had cholesterol 
>5mmol/l, consistent with research showing recording does not necessarily translate 
to better outcomes [76]. 
 
Recording clinical values is a quality measure in itself which may indicate the need to 
intensify treatment. However, achieving outcome targets requires appropriate 
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action by professionals and patients. Emphasising processes alone, as with the Cycle 
of Care, may not deliver improved outcomes. Patient motivation, adherence, and the 
efficacy of self-management, influence risk factor management [21], but are not 
captured in the current study. We found the proportion with HbA1c ≤58mmol/mol 
(7.5%) was similar across time points, which could reflect the long disease duration 
among participants or the declining effect of OHAs [378]. While treatment goals 
provide a benchmark for quality, Lipska et al have recently questioned the use of 
‘surrogate’ outcome targets like HbA1c as a quality indicator. They may not be 
appropriate for certain subgroups (e.g. the elderly, or those with co-morbidities) and 
should be individualised according to complication risk, preferences, and control 
strategy [361]. Greater emphasis has been placed on involving people with diabetes 
in the decision about their individual HbA1c target [67, 244]. Future monitoring of 
the Midlands programme should consider incorporating this information; i.e., 
recording whether a target has been agreed, documenting the agreed target, and 
using this as a basis for evaluating the quality of care. 
 
Although retinopathy screening attendance improved, in 2016, 20% had not 
attended specialist eye services or RetinaScreen, the new national screening and 
treatment programme introduced in 2013.  National guidelines recommend that 
people with complicated type 2 diabetes should attend a DNS including people 
requiring insulin, people with HbA1c >58mmol/mol (7.5%) on two or more glucose 
lowering agents (not insulin), or people with complications or graded as having a high 
risk foot [68]. In line with this recommendation, we found participants with more 
complicated diabetes were referred to a DNS. While the rate of non-attendance was 
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low overall, those who did not attend had a higher median HbA1c than attenders. 
Further work is necessary to understand barriers to attendance among these 
participants, ways to improve attendance, and facilitate risk management.  Although 
most participants attended for annual review, this declined between 2009 and 2016 
(91% vs.77%). Transport, work and family commitments, and lack of motivation have 
been cited as reasons for non-attendance at annual review [379]. However, practice-
level resource constraints could also account for this decline. An official annual 
review may not be performed at a single visit but instead components spread over 
several visits to lessen practice nurse workload. The increasing complexity of 
management may require longer reviews that cannot be incorporated into one visit 
[151]. Unlike clinical measurements, BMI, smoking status and foot assessment were 
less well recorded among those who did not attend annual review. These processes 
may not be a priority during regular visits, particularly for people with poor 
attendance.  
 
Ireland is moving towards the delivery of structured, integrated diabetes 
management in primary care, with the establishment of the National Clinical 
Programme for Diabetes, resourcing of community-based ‘integrated’ DNS to 
facilitate delivery of the new model of integrated care which manages people with 
diabetes according to their complexity, and the Cycle of Care [68]. However, as a 
multi-component programme with good specialist support, the Midlands 
programme provides an insight into the impact of providing structured care in the 
community that predates these national changes. As enhanced access to community-
based specialist resources does not form part of the Cycle of Care initiative, care may 
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be moved to the community in areas with less access to a well-resourced 
multidisciplinary team. Programmes like the Midlands programme may also be 
influenced by health service changes. We found a drop in dietetic screening alongside 
a loss of resources further indicating the importance of sustained resources to deliver 
care in the community.  
 
A strength of the current study is that it examines, over a long follow-up period, the 
impact of structured primary-care led service model delivered in routine practice 
rather than as part of a QI trial. However, participants were not the same at each 
time point (although some were represented at each). We also took different 
approaches to sampling at each time point. In 2008 and 2016, as the number enrolled 
in the programme exceeded 2,000, it was not feasible to manually collect data on 
every participant. Therefore, an appropriate random sample was taken. In 2016, as 
part of the larger sample taken at this time point, data were collected on all 
participants who had been enrolled in 1998/1999 and were still alive in 2016.  This 
was done in order to facilitate a separate analysis which examines survival in the 
original cohort enrolled in the programme since its initiation. We can judge the 
overall delivery of the programme, but not infer the impact on individual participants 
since enrolment.  Although different individuals were represented across different 
time points, it is encouraging that participants enrolled in this structured care 
programme were meeting outcome targets. However, we lack control practices to 
determine whether changes in clinical outcomes reflect overall improvements in 
medication (e.g. new OHAs) and management in the time-period, or the organisation 
and delivery of the programme. Most participants enrolled were on lipid-lowering or 
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BP medication. The programme is multifaceted therefore we cannot prove that one 
component was more effective than others. Data were extracted from GP records, 
and we depend on the reliability of data from this source.  As highlighted in Section 
3.6 a composite measure depends on the reliability of the underlying indicators. A 
composite was used in the current study comprised of eight National Institute for 
Clinical Excellence recommended processes. However, while certain processes, i.e. 
HbA1c test, BP check, may be automatically added to the patient file, others, for 
example, retinopathy screening obtained through an external provider, may be 
recorded manually in the patient notes. As such, the reliability of individual processes 
may have varied. 
 
4.6 Conclusion 
Our findings illustrate sustained improvements in the care delivered by practices in a 
multifaceted, primary-care led programme over time, suggesting this approach is 
feasible in ‘real-life’ primary care. However, our findings also identify limits to what 
can be achieved by structured care programmes, particularly when operating within 
the resource constraints of primary care and the wider health service context. We 
need to better understand general practitioner management decisions, patient 
attendance, adherence and self-management, and whether these factors moderate 
the impact of these programmes. Programmes like the Midlands programme should 
move beyond monitoring and engage in a continuous cycle of QI to respond to the 
challenges of delivering optimal primary care-led diabetes care in everyday practice. 
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Figure 8 National reforms, resources available to the programme, and 
participating GPs and people with diabetes enrolled 1999 – 2016 
Abbreviations: DNS, diabetes nurse specialist 
Information on numbers of resources (DNS and podiatrists/chiropodists) were unavailable 
at time points between data collection. 
 
Table 6 Characteristics and clinical profile of participants with type 2 diabetes 
1998/1999 – 2016* 
 1998/1999 
N = 336 
2003 
N = 843 
2008 
N = 988 
2016 
N = 1,029 
Age (years)      
Median (IQR) 65 (56-74) 65 (56-73) 66 (59-74) 68 (60-76) 
     
Male 168 (50) 438 (52) 562 (57) 603 (59) 
     
Diabetes duration (years) 
Median (IQR) 
 
NA 
 
NA 
 
6 (3-9) 
 
9 (5-12) 
     
GMS NA NA NA 823 (80) 
     
BMI (kg/m2)     
Mean (SD) 29.3 (4.7) 30.6 (4.8) 30.6 (4.8) 31.2 (5.9) 
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Table 6 Characteristics and clinical profile of participants with type 2 diabetes 
1998/1999 – 2016* 
 1998/1999 
N = 336 
2003 
N = 843 
2008 
N = 988 
2016 
N = 1,029 
N (%) <25 33 (16) 42 (9) 94 (13) 81 (11) 
     
Smokers, N (%) 58 (25) 123 (20) 146 (19) 121 (15) 
     
Diabetes Treatment  
N (%) 
    
Diet only 60 (18) 187 (22) 131 (13) 173 (17) 
OHA only 262 (80) 532 (70) 685 (70) 643 (63) 
Insulin + OHA 0 (0) 39 (4.6) 131 (13) 140 (14) 
Insulin only 10 (3.0) 25 (3.0) 38 (3.9) 21 (2.0) 
     
Statins, N (%) NA NA 799 (81) 854 (83) 
ACE inhibitor, N (%) NA NA 734 (74) 680 (67) 
Aspirin, N (%) NA NA 740 (75) 611 (59) 
     
HbA1c (mmol/mol [%])     
Mean (SD) 55 (18) 
[7.2 (1.7)] 
58 (18) 
[7.5 (1.6)] 
53 (13) 
[7.0 (1.2)] 
54 (14) 
[7.1 (1.3)] 
N (%) <48 (6.5) 104 (37) 229 (29) 351 (36) 364 (36) 
N (%) ≤53 (7.0) 156 (55) 382 (48) 589 (61) 607 (59) 
N (%) ≤58 (7.5) 191 (67) 481 (60) 720 (74) 770 (75) 
     
BP (mmHg)     
(systolic) Mean (SD) 144.4 
(19.9) 
140.5 
(18.7) 
135.9 
(16.3) 
135.1 (16.0) 
N (%) <130/80 25 (8.0) 96 (12) 212 (22) 212 (21) 
N (%) ≤140/80 112 (36) 405 (48) 560 (57) 597 (59) 
     
Cholesterol (mmol/l)     
Mean (SD) 5.3 (1.2) 4.9 (1.0) 4.1 (1.1) 4.1 (1.0) 
N (%) <4.5 60 (23) 268 (33) 647 (67) 711 (70) 
N (%) <5.0 102 (38) 450 (55) 785 (81) 846 (83) 
     
Triglycerides (mmol/l)     
Mean (SD) 2.4 (1.5) 2.1 (1.9) 1.8 (1.2) 1.7 (1.5) 
% <2.0 103 (46) 460 (60) 684 (71) 760 (75) 
     
Creatinine (µmol/l)     
Mean (SD) 86.5 (30.1) 84.8 
(20.7) 
87.8 (46.0) 86.5 (34.0) 
Abbreviations: NA, not available -data on this variable were not collected at this time point; 
ACE, angiotensin-converting-enzyme inhibitor; OHA, oral hypoglycaemic agent; SD, 
standard deviation; IQR, interquartile range; BMI, Body Mass Index; BP, blood pressure 
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*Based on available data: Age: 1999 (336), 2003 (842), 2008 (987), 2016 (1,028). Diabetes 
duration: 2008 (848), 2016 (1,005). GMS: 2016 (1,027).  BMI: 1999 (203), 2003 (470), 2008 
(725), 2016 (736). Smoking status: 1999 (230), 2003 (629), 2008 (759), 2016 (813). 
Diabetes treatment: 1999 (332), 2003 (843), 2008 (985), 2016 (1,026). Statins: 2008 (987), 
2016 (1,028). Aspirin: 2008 (986), 2016 (1,027). ACE inhibitor: 2008 (984), 2016 (1,017).  
HbA1c: 1999 (284), 2003 (799), 2008 (967), 2016 (1,021). BP: 1999 (311), 2003 (836), 2008 
(979), 2016 (1,008). Cholesterol: 1999 (267), 2003 (815), 2008 (973), 2016 (1,018). 
Triglycerides: 1999 (226), 2003 (771), 2008 (968), 2016 (1,012). Creatinine: 1999 (234), 
2003 (695), 2008 (971), 2016 (1,016).  
Continuous variables were represented as means and SD for the normally distributed 
values; median (IQR) for non-normal values, as indicated. 
Categorical variables were represented as numbers and proportions.
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Figure 9 Participants with nine care processes recorded 1999 – 2016  
Abbreviations: ACR, Albumin Creatinine Ratio; BMI, Body Mass Index 
*p < 0.05 
ACR was not recorded in 1999 and 2003; foot assessment was not recorded in 1999 
Proportions were analysed using chi squared test for trend and logistic regression adjusted for age and gender
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Table 7 Profile of participants who were referred to a DNSβ in 2016 
 Referred to DNS 
 Yes 
N = 153 
N (%) 
No 
N = 866 
N (%) 
Yes, but did not attend 
N = 9 
N (%) 
Age* 
Median (IQR) 
65 (56-71) 69 (61-76) 58 (53-63) 
    
Male 88 (58) 511 (59) 4 (44) 
    
Diabetes duration 
(years)* 
Median (IQR) 
 
10 (6-14) 
 
9 (5-12) 
 
9.5 (9-12) 
    
BMI (kg/m2) 
Mean (SD) 
 
32.1 (6.1) 
 
31.0 (5.9) 
 
32.6 (4.4) 
    
Smoker 21 (18) 99 (14) 1 (13) 
    
Diabetes control*    
Diet only 3 (2.0) 168 (19) 1 (11) 
OHA only 71 (47) 569 (66) 3 (33) 
Insulin only 5 (3.3) 15 (1.7) 1 (11) 
Insulin and OHA 57 (38) 81 (9.3) 2 (22) 
Injectables and OHA 16 (11) 31 (3.6) 2 (22) 
OHA or injectable*║ 149 (98) 696 (81) 8 (89) 
    
HbA1c (mmol/mol 
[%]) 
   
> 58 (7.5) 80 (50)  172 (20)  4 (50)  
Median (IQR)* 60 (50-69) 
[7.6 (6.7-8.5)] 
 
50 (44-57) 
[6.7 (6.2-7.4)] 
 
64 (52-69) 
[8.0 (6.9-8.5)] 
    
Systolic BP (mmHg)    
Mean (SD) 133.7 (14.2) 135.4 (16.3) 127.2 (12.2) 
    
Complications    
Retinopathy* 54 (41) 197 (30) 3 (50) 
Macrovascular 8 (5.2) 89 (10) 2 (22) 
Peripheral neuropathy 7 (4.6) 29 (3.4) 0 (0) 
Autonomic 
neuropathy 
5 (3.3) 28 (3.2) 0 (0) 
High risk foot* 2 (1.9) 14 (4.4) 1 (17) 
Ulcer  4 (2.7) 20 (2.3) 0 (0) 
Abbreviations: OHA, oral hypoglycaemic agent; IQR, interquartile range; SD, standard 
deviation; BMI, Body Mass Index; DNS, diabetes nurse specialist; BP, blood pressure 
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βPeople with complicated type 2 diabetes should attend a diabetes nurse specialist. This 
includes people requiring insulin, people with HbA1c >58mmol/mol (7.5%) on two or more 
glucose lowering agents (not insulin), and people with complications or graded as having a 
high risk foot[68]. 
*p < 0.05; difference in people attending and not attending DNS were analysed using 
Students t test or Wilcoxon-Mann-Whitney test for continuous data and Pearson’s chi 
squared for categorical data 
║OHA, insulin or other injectable 
Continuous variables were represented as means and SD for the normally distributed 
values; median (IQR) for non-normal values, as indicated 
 Categorical variables were represented as numbers and proportions 
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6.1 Abstract 
Objectives  
International evidence suggests the diabetes nurse specialist (DNS) has a key role in 
supporting integrated management of diabetes. We examine whether hospital and 
community DNS currently support the integration of care, examine regional variation 
in aspects of the service relevant to the delivery of integrated care, and identify 
barriers to service delivery and areas for improvement.  
 
Design 
A cross-sectional survey of hospital and community-based DNS in the Republic of 
Ireland. 
 
Methods  
Between September 2015 and April 2016, a 67-item online survey, comprising of 
closed and open questions on their clinical role, diabetes clinics, multidisciplinary 
working, and barriers and facilitators to service delivery, was administered to all 
eligible DNS (n = 152) in the Republic of Ireland. DNS were excluded if they were 
retired or on maternity leave or extended leave.  
 
Results  
The response rate was 66.4% (n = 101); 60.6% (n = 74) and 89.3% (n = 25) among 
hospital and community DNS respectively. Most DNS had patients with stable (81.8%) 
and complicated type 2 diabetes (89.9%) attending their service. Most were 
delivering nurse-led clinics (81.1%). Almost all DNS had a role liaising with (91%) and 
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providing support and education to (95%), other professionals. However, only a third 
reported that there was local agreement on how their service should operate 
between the hospital and primary care. Barriers to service delivery which were 
experienced by DNS, included deficits in the availability of specialist staff (allied 
health professionals, endocrinologists and DNS), insufficient space for clinics, 
structured education, and issues with integration. 
 
Conclusions 
Delivering integrated diabetes care through a nurse specialist-led approach requires 
that wider service issues, including regional disparities in access to specialist 
resources and formalising agreements and protocols on multidisciplinary working 
between settings, be explicitly addressed.  
 
Keywords: Clinical Nurse Specialist, Integrated Care, Diabetes and Endocrinology, 
Health Services Research 
 
6.2 Background 
In recent years, internationally and in Ireland, there has been increased interest in 
how to deliver integrated care for people with chronic diseases such as type 2 
diabetes [7, 13], co-ordinating management so that patients receive the ‘right 
services’ in the ‘right place’ [15]. The complex nature of diabetes necessitates the 
involvement of healthcare professionals from different disciplines and settings to 
achieve effective management [7]. Integrated diabetes management across 
community-based and specialist services has been shown to improve quality of care 
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[24, 25], and reduce preventable hospitalisations for diabetes-related complications, 
with patients in an integrated care group almost half as likely to be hospitalised 
(incidence rate ratio of 0.53, 95% CI 0.29, 0.96, 24 months after study initiation) 
[164]. 
 
International evidence suggests the nurse specialist has a key role in supporting the 
integrated management of chronic disease [179] through delivering nurse-led clinics 
in primary care [107, 115], liaising between care providers [24, 107, 189, 190], and 
providing specialist education and support to other professionals [24, 189], including 
those in primary care [19, 107, 112]. The shift towards primary-care management of 
type 2 diabetes, has meant the role has been increasingly moved into community 
settings [22]. The UK [112], and the Netherlands [24, 115], have seen the introduction 
of models of care where the diabetes nurse specialist (DNS) supports GPs or practice 
nurses in diabetes management [112, 115], (e.g. intermediate care clinics for 
diabetes which accept referrals of more complex patients to reduce the burden the 
hospital system [346]), or performs tasks previously conducted by the GP, including 
co-ordination and organisation of care (‘vertical task substitution’) [115]. These 
models have been found to improve clinical outcomes [24, 115]. In the Netherlands, 
among patients enrolled in shared care with task delegation to DNS, the proportion 
with BP ≤150/85 mmHg and cholesterol ≤5 mmol/mol increased by 12% over three 
years with no change in the usual care group. The proportion with HbA1c ≤7.0%  
remained stable while declining 8% the usual care group. These models  have also 
been associated with significant decreases in total (31%) and inappropriate (57%) 
referrals to secondary care [112]. They also may reduce outpatient attendances; 
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Nocon et al. documented a decline in mean monthly hospital attendance from 478.5 
to 361.8 (25% reduction) after the introduction of intermediate care clinics [193, 
346].   However, the role and work setting of DNS differs between countries [31, 392, 
393]. For example, in Sweden and the Netherlands, half or more of DNS may work in 
integrated or community, settings, and have prescribing rights [190, 392]. In contrast, 
most DNS in Ireland are hospital-based, and, although nurse prescribing has been 
introduced since 2008, not all nurses perform this role. Given these differences, it is 
important to establish how the DNS role works to inform how it can be best utilised 
within the specific health system to support an integrated and sustainable model of 
diabetes care.   
 
In Ireland, the importance of nurse specialists in chronic disease management and 
facilitating integrated care between settings has been recognised [32, 185, 394]. The 
National Clinical Programme for Diabetes, established in 2010 to improve care for 
people with diabetes in Ireland, is developing the DNS service by introducing more 
community-based DNS to facilitate the delivery of a new model of integrated 
diabetes care[395]. These changes are taking place within a traditionally hospital-
centric healthcare system where there is a disconnect between secondary and 
primary care services in how they are funded, managed and resourced. Diabetes 
services have historically been unstructured and characterised by pockets of good 
provision and a mix of care arrangements [32]. In some areas diabetes care is 
primarily hospital-led. In others, care is delivered in general practice on an 
opportunistic and ad-hoc basis. Chronic disease management in secondary care is 
also not well-integrated with general practice [394], not all areas have a local 
158 
 
diabetes service, and within general practice the delivery of diabetes care may be 
variable. There may be deficiencies in terms of access to specialist resources, 
including DNS [224, 225, 396]. This has driven the development of formal diabetes 
initiatives (10 nationally) which seek to improve the quality and organisation of care 
at a local level. These include models of structured or shared care with local clinical 
guidelines and support from a community DNS to  facilitate communication between 
these practices and the hospital [107], or enhanced access to specialist community 
resources, including  dietetics, podiatry and DNS [397].  
 
The purpose of the new integrated care model is to standardise management of 
patients with diabetes, ensure patients are cared for the most appropriate setting 
and by the most appropriate health care professionals according to the complexity 
of their condition. As outlined in the latest guidance on diabetes management[68]  
patients with uncomplicated type 2 diabetes are managed in primary care, patients 
with complicated type 2 diabetes are managed between primary and secondary care, 
and management of type 1 diabetes and gestational diabetes takes place in 
secondary care. Implementation of the new model could vary depending on local 
circumstances and context including the existing models of care. Newly introduced 
DNS have, in some areas, been linked to existing initiatives, whereas in other areas 
the service was entirely new. The current study may identify some of this regional 
variation, and forms part of a programme of work evaluating the implementation of 
the National Clinical Programme for Diabetes [1]. 
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The new reforms can be understood as evidence-based strategies to integrate care 
at the level of service organisation and delivery (e.g. promoting multi-disciplinary 
teamwork through establishing the DNS as a ‘link’ between services; providing 
dedicated support by nurse specialists to primary care professionals) and the clinical 
level (e.g. introduction of guidelines on practice management) [68]. Similar to 
intermediate care clinics for diabetes established in the UK, these new DNS will 
provide necessary intermediary specialist support in the community in the 
management of more complex patients. They provide education and support for GPs 
and practice nurses, and work between community (80%) and hospital settings (20%) 
facilitating integration between the two settings [68]. DNS may deliver clinics in 
general practice, independently, or in some cases initially jointly with the practice 
nurse or GP, to build capacity, confidence and skills in the management of more 
uncomplicated patients. 
 
Although DNS support for patients and health professionals is a pillar of our national 
strategy for delivering integrated diabetes care, unlike other countries [18, 24, 31, 
189, 190], there is a dearth of information on how DNS services are delivered in 
Ireland. Our aim is to examine the way, and extent to which, DNS services currently 
support the integration of care, and identify areas for improvement. We expect 
hospital and community DNS to differ in terms of the patients they provide care to, 
and the professionals they support and are supported by. Therefore, we describe the 
role of these DNS separately. Given the current variation in how diabetes services are 
delivered in Ireland, some aspects of the DNS role which are important in the 
integration of care (nurse-led clinics, agreements on working across primary and 
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secondary care, access to other professionals) may differ across the country. 
Therefore, we examine these aspects by region. Finally, we identify barriers and 
facilitators to delivering diabetes care from the DNS perspective. The study will 
provide an insight into how the DNS role works in the context of a traditionally 
fragmented health system characterised by regional variation and ongoing efforts to 
standardise and improve how diabetes care is delivered [395].  
 
6.3 Methods 
6.3.1 Participants 
The eligible study population comprised of all currently employed DNS (n=152), 
excluding retired DNS, those on maternity or extended leave. Registration with the 
Irish Diabetes Nurse Specialist Association is not mandatory, and there is no national 
register of DNS posts in Ireland. Therefore, we compiled a list through regional 
primary care initiatives, the Irish Diabetes Nurse Specialist Association, Diabetes 
Ireland, the national diabetes charity which funds the provision of some DNS posts, 
and the National Clinical Programme for Diabetes, who highlighted the survey at 
national and local conferences and meetings. The Irish Diabetes Nurse Specialist 
Association asked their members to register their details with the study researchers. 
 
6.3.2 Questionnaire 
Participants were invited by email to complete the self-administered, 67-item 
questionnaire electronically (Surveymonkey™) between September 2015 and April 
2016. The survey was based on a questionnaire developed by Diabetes UK and ABCD 
Specialist Services Study Group[31], modified for the Irish health system in 
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collaboration with a local nurse network, and piloted with two DNS, both of whom 
worked across hospital and community settings.  Adaptations related to the 
questionnaire are included in Appendix 10.5.1. The survey comprised of closed and 
open-ended questions addressing the DNS’ role in diabetes, clinic activity, links with 
other services, the nature of service agreements and their liaison role, and barriers 
and facilitators to service delivery (Appendix 10.10). Three reminders were sent, the 
final in conjunction with an email notification from the Irish Diabetes Nurse Specialist 
Association (Appendix 10.5.2). 
 
6.3.3 Data management and analysis 
Data were cleaned in Excel before importing into Stata v12 for windows (StataCorp, 
College Station, TX, USA) for analysis. Fisher’s exact tests were used to test 
differences in the role performed between hospital and community, and to examine 
service provision (clinics, referrals, local agreements) across the four regions defined 
according to Diabetes Services Implementation Groups, which are clinically-led 
regional networks responsible for local implementation of the national programme.  
A p value of <0.05 was considered statistically significant. The Bonferroni correction 
was used to adjust for multiple comparisons. Complete case analysis was used, and 
missing data is highlighted as applicable. NVivo (Version 11) was used to manage and 
categorise open-ended responses. FR conducted a thematic analysis of responses to 
the question on barriers and facilitators. The grouping of codes to generate 
overarching themes were reviewed by JB. 
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6.4 Results 
The response rate was 66.4% (n = 101), 60.6% (n = 74) of hospital and 89.3% (n = 25) 
of community DNS. This included six Advanced Nurse Practitioner (ANP) or Advanced 
Midwife Practitioner (AMP) grade nurses; two Clinical Nurse Managers and three 
diabetes nurses not graded as DNS but who were qualified and performing role of 
DNS. Two DNS in non-clinical roles were classified as ‘Other’. DNS from all four DSIGs, 
and all counties in the Republic of Ireland participated. Most were hospital-based 
(Table 11). Respondents were working as a DNS for an average of 11 years. Although 
most had completed a postgraduate diploma in diabetes, few (10.9%) had a Masters 
level qualification, and just over a third (36.6%) were nurse prescribers.  
 
6.4.1 DNS role 
Most DNS had a written job description (n = 89, 88.1%). All DNS were involved in 
some aspect of patient management (Table 12) but this differed by setting. More 
hospital than community DNS were involved in inpatient care, and specific elements 
of care for patients with type 1 diabetes (referrals, glucose monitoring, insulin 
initiation or education, checking injection sites) (p < 0.001) and provision of specialist 
clinics (non-significant) (Table 12). While most hospital and community DNS reported 
that patients with complicated type 2 diabetes attended their service, the majority 
also saw patients with stable type 2 diabetes (Figure 10).  In two regions a greater 
proportion of nurses reported seeing patients with stable type 2 diabetes (R1:95.7%; 
R2: 70.8%; R3: 88.9%; R4: 72%). Other patients seen were reported in open-ended 
comments (Appendix 10.5.3).  
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Of the 58 (59.2%) DNS who spent time on administrative work, mean hours per week 
were 4.8 ± 2.5, and 5.7 ± 2.8 among hospital and community DNS respectively. Few 
spent time on research or audit (n = 36, 35.6%); on average, hospital DNS spent 1.5 
± 0.8 hours per week while community DNS spent 2.3 ± 1.6 hours. Few DNS had a 
dedicated budget (n = 16, 16.3%) or protected time (n = 27, 27.5%) for CPD. 
6.4.2  Clinics 
Nurse-led clinics can be understood as clinics where DNS may work without 
immediate supervision and are responsible for case management. Overall, 81.1% (n 
= 82) of DNS delivered nurse-led clinics including generalised clinics (n = 31, 37.8%), 
specialised (n = 27, 32.9%) or both (n = 24, 29.3%).  
 
The greatest proportion of DNS provided ≥4 clinics per week (48.8%). While similar 
across most regions (R1: 55.6%; R2:61.9%; R3:54.6%; R4: 23.8%) frequency in R4 was 
consistently lower. This was true among both DNS types: overall 52% community DNS 
provided ≥4 clinics (R1: 57.1%; R2:50%; R3:80% R4: 28.6%); and 47.5% of hospital 
DNS provided ≥4 clinics (R1: 54.5%, R2: 64.7%, R3:47.1%, R4:21.4%) (Table 30). 
 
Some DNS were supported in clinics by other members of the multidisciplinary team 
(MDT) e.g. a podiatrist (n = 30, 36.6%) or dietician (n = 44, 53.7%). Most community 
DNS were supported in clinic by a practice nurse (73.9%). According to hospital and 
community DNS, patients generally saw a consultant (74.6%) or GP (56.5%) at a later 
date rather than on the day of the clinic.   
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Half reported a waiting list for their clinic service. Where reported (n = 41), the 
waiting time was commonly 1-3 months (n = 20), ranging from >1 month (n = 5), to a 
year or more (n = 4). The main reasons reported in open-ended comments (n = 51) 
were the referral volume (n = 24) and shortage of clinical staff (n=12). Of 24 
respondents who provided clinics in the community, 12 reported that GPs were 
eligible to access those clinics, and, in open-ended comments (n = 11), indicated the 
service was available to GPs who were enrolled in a shared or structured care scheme 
(n = 6), interested in diabetes care or willing to engage with the integrated care 
programme (n = 3), or practices employing a practice nurse (n = 2). Respondents 
reported that clinics were currently inaccessible where the service was at capacity or 
the catchment area was too large for the DNS to cover (n = 4). 
  
6.4.3 Links with other professionals 
Most DNS (n = 94, 95%) were educating other professionals, primarily hospital-based 
nursing staff by hospital DNS (81.2%), and practice nurses (92%) and GPs (88%) by 
community DNS. Community DNS were involved in education of allied health 
professionals (52%) and staff in nursing homes (21.6%) (Table 12). 
 
Most DNS liaised with other healthcare professionals (n = 92, 91.1%) (Table 12). As 
outlined in open-ended responses (n = 83), this role involved patient case discussion 
(n = 40) and follow-up (n = 8), referrals (advising but also being able to facilitate fast-
track into hospital) (n = 18), providing advice (n = 13) and education (n = 7) to other 
staff, seeking advice from consultants (n = 6), and being a coordinator or ‘link’ 
between services (n = 10).  
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Over one third of DNS, (n = 37, 36.6%) reported there was no discharge pathway to 
primary care for ward discharges (R1: 30.4%; R2: 40%; R3: 44.4%; R4: 30.8%), and a 
third (n=36, 36.7%), reported there was an agreement between the hospital and 
primary care outlining how their service operates (R1: 50%; R2: 16.7%; R3: 33.3%; R4: 
48%). As outlined in open-ended comments (n = 29) local agreements included 
following a shared care model (n = 6) or integrated model (regular GP review with 
annual secondary care review) (n = 5), working 80/20 between community/hospital 
(n = 5), rapid referral pathways from primary care into hospital (n = 3), or being able 
to discharge patients to primary care (n = 2). 
 
While almost all DNS reported referral access to other professionals (n = 92, 91.1%), 
there were regional differences in access to social workers (p = 0.01) and 
psychologists (p = 0.01) (Figure 11) (non-significant after adjustment). 
  
6.4.4  Barriers and facilitators to delivering diabetes care 
Most participants outlined barriers and facilitators to delivering their service in open-
ended comments (n = 89, 88%). DNS suggested it was not feasible to conduct audit, 
research and quality improvement (n = 14), citing time constraints (n = 7), and poor 
IT systems (n = 4) as the main reasons. They identified limited opportunities for 
professional development (n = 9), which was not supported by managers (n = 3) or 
allocated protected time (n = 3).   
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Being supported by the multidisciplinary team facilitated service delivery (n = 15), 
and DNS identified a shortage of specialist staff (allied health professionals, 
endocrinologists, DNS) as a main barrier to providing care (n = 48). Other barriers 
were a lack of clerical support (n = 19), poor ICT (n = 8), and space limitations (n = 
19), which affected clinic (n = 10) and structured education (n = 8) provision. Barriers 
to integration included inappropriate referrals of people with uncomplicated type 2 
diabetes to secondary care (n = 7), GP reluctance to engage with the new community 
DNS service (n = 7), and the lack of information communication technology (ICT) to 
facilitate information-sharing between primary and secondary care (n = 6). 
 
6.5 Discussion 
6.5.1 Main findings 
Our study indicates that most hospital and community DNS supported integrated 
care through management of complicated type 2 diabetes; liaising with, and 
educating, other professionals, and; working independently to deliver nurse-led 
clinics. The latter is consistent with the move towards greater autonomy in the role. 
In the UK, nurse-led clinics were identified as a new development in 2008, with 90% 
of DNS services providing this service [31]. However, we also identified specific areas 
for attention, in terms of the types of patients being managed by DNS, access to other 
professionals, the provision of clinics, and support for CPD, research and audit.    
 
Although the role of the DNS is to support management of complex patients, most 
reported that patients with stable type 2 diabetes attend their service. DNS also 
highlighted ongoing issues with inappropriate referrals to secondary care. Many 
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lacked a formal agreement on how their service operates between primary and 
secondary care, and a protocol to guide discharge from secondary to community 
care.  Although most DNS had a liaison role with other care providers, referral access 
to specialist staff varied regionally. Space limitations, a shortfall in specialist staff, and 
the lack of shared ICT between primary and secondary care were highlighted by DNS 
as barriers to service delivery.  Half of DNS reported a waiting list for clinics, and the 
frequency varied, as did the support available in clinics from multidisciplinary 
professionals. These differences in clinic delivery may reflect the availability of space 
and staff at a given hospital or GP practice.  Although most community DNS delivered 
community clinics, access to this service was not universal. In some areas it depended 
on GP willingness to engage with the integrated service, practice participation in an 
existing diabetes care scheme, practice nurse availability, or DNS service capacity.   
 
Research and audit is considered a key component of the nurse specialist role 
nationally [185, 398], and internationally [399]. However, as in the UK and Sweden 
[31, 392, 400], we found that few DNS spend time on research or audit, lacking 
opportunity or support to do so. Although DNS were highly trained and experienced, 
as in the UK, few (11%) had completed a masters qualification [187]. Lack of support 
for CPD, was identified as an issue in the UK [31, 187], and was also highlighted by 
the current survey.  
 
6.5.2 Strengths and limitations 
This study is the first to examine the provision of DNS services nationally in Ireland. 
One strength is the use of a comprehensive questionnaire employed in a previous UK 
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study [31], which was adapted for the Irish context.  Although there is no definitive 
list of all DNS in Ireland, we enlisted the support of the Irish Diabetes Nurse Specialist 
Association, and this increases the likelihood that all potential participants were 
aware of the study. All four Diabetes Service Implementation Group regions and 
counties were well-represented, and we are confident the results capture the 
national situation in terms of DNS services. The balance of hospital to community 
DNS in the study reflects the national profile of DNS. Due to the small number of 
nurses working in both roles, our results did not distinguish between DNS solely 
based in the community and those in new posts working between hospital and 
community. The latter group spend 80% of their time in the community and their role 
is likely to be very similar to community DNS.  Our question on patients who attend 
DNS services provides some insight into whether the role aligns with the national 
model. However, it does assume that DNS have the same understanding, of what is 
meant by complicated and uncomplicated (stable) type 2 diabetes. A further 
limitation is that this question does not capture why certain patients are being seen 
by the DNS. For example, we do not know whether there is a process by which DNS 
can discharge patients who become stable, given that patients may transition from 
complicated to stable and vice versa. While we are lacking routinely-collected, 
administrative data on the number and nature of referrals, community DNS have 
begun to collect data on their activity (number of complex/stable patients seen, 
practices visited, GPs interested in engaging, patients were discussed with the MDT, 
formal professional education sessions). This data may also be harnessed to further 
assess the implementation of the model.  
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6.5.3 Implications 
Our study has implications for the implementation of integrated care models which 
rely substantially on the role of the DNS.  First, the findings suggest the need for 
organisational and professional changes i.e. better resourcing of specialist staff, 
provision of dedicated space, and changes in the receptiveness to the DNS role, to 
better enable DNS to support the integration of care as intended. Specific barriers 
which affect DNS service delivery (space and staff resources, inappropriate referrals 
to secondary care) may also not be unique to Ireland, and their implications for 
integrated care may be relevant for the delivery of DNS services internationally.  
 
Secondly, DNS continued to manage stable type 2 diabetes, and mentioned the 
volume of inappropriate referrals in open-ended comments. This appears to suggest 
the model of care, where DNS primarily see complex patients, has not been fully 
realised.  Variation in diabetes services and the capacity of primary care may mean 
that moving to a scenario where DNS only see complicated patients will be a gradual 
process. There were also regional differences in terms of patients with stable type 2 
diabetes attending DNS services, which may reflect the structure of primary care 
locally, access to secondary care services and other specialists. 
 
Thirdly, while nurse-led community clinics have been implemented effectively in 
parts of the Netherlands as a strategy to integrate care[24, 115], our findings suggest 
that local arrangements and resourcing may affect delivery.  There were issues at a 
local level in terms of accessing DNS support through community-based clinics which 
have reached capacity or operate outside their catchment. Where GPs did have 
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access, other factors (e.g. being part of an existing initiative) affected eligibility. 
Although more work is required to fully understand how nurse-led clinics can operate 
effectively in this context, formal agreements and protocols to guide patient 
management across settings and healthcare providers are likely important[401]. 
Without a formal structure and adequate resourcing in place, as the DNS services 
become oversubscribed, they may contribute to, rather than address, any existing 
regional variation in diabetes care.  
 
Finally, discharge pathways to community care, and formal agreements on how DNS 
services operate between the hospital and primary care did not always appear to be 
in place; this may be one reason why existing arrangements continue to dictate 
patient management across the two settings. We show that the liaison role described 
by DNS in this study did align with elements of international models; i.e., patient case 
discussion [17, 19, 24]  and care planning [115], provision of advice, support [24, 112] 
and education [112, 189] to other care providers. However, without formal guidance 
in place, DNS availability for advice and support could vary nationally. This is 
something which needs to be further explored. 
 
Our study was carried out at a time of on-going policy reform. In 2015 a new funding 
initiative, known as the Diabetes Cycle of Care was introduced. This scheme will for 
the first time nationally, remunerate GPs for care of patients with stable type 2 
diabetes (two structured visits of per year) who hold a GMS card.  The initiative  will 
establish formal requirements for registering, recording and reporting processes of 
care (clinical parameters, routine foot screening and referral, lifestyle review)[28]. 
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Payment will be made on the basis of registering eligible patients and delivering two 
review visits, and data will be reported/collected as per a standard proforma. While 
this may translate to more appropriate referrals and structured patient 
management, enhanced access to community resources does not form part of the 
initiative, and it is likely to further stretch already limited specialist resources, and 
the demand for community DNS. Almost one fifth of DNS surveyed will be eligible to 
retire in the next 10 years or fewer, which may place an additional strain on services. 
Our survey respondents identified the lack of DNS as a barrier to providing care. The 
shortfall in nurses has also been highlighted as a concern in the UK where DNS posts 
are stagnating[402]. It is concerning that the shift of patient care to the community 
may continue in areas unsupported by a well-resourced multidisciplinary team. Such 
deficiencies will influence how successfully a DNS can coordinate care and support 
the delivery of an integrated service.  
 
6.6 Conclusion 
Our results suggest that hospital and community DNS, working in a traditionally 
fragmented health system and against a backdrop of service variation, perform key 
roles to support the integration of care. Yet our findings suggest there is some 
regional variation in terms of how the new model of care is being implemented; in 
terms of management of uncomplicated type 2 diabetes, clinic delivery, and available 
support from multidisciplinary professionals. There are areas for improvement if the 
DNS role is to be used to its full potential and if a standardised model of care is to be 
achieved. Changes to the wider service infrastructure (resourcing, space allocation, 
ICT, attitudes of professionals involved) are required to align the health system 
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towards the delivery of integrated care. Expanding the DNS service into the 
community to support primary care as an isolated strategy may be limited in its 
potential to fully integrate care on a national level. While this study provides a useful 
‘snapshot’ into DNS service delivery, future qualitative work is required to explore 
and understand how the role supports integration, and changing requirements of the 
service as reforms continue. 
 
Table 11 Characteristics of the sample population (n = 101) 
 N (%) 
Based  
Hospital 74 (73.3)* 
Community  25 (24.8)† 
Other 2 (2.0) 
  
Service area  
Adult 66 (65.4) 
Paediatric only 14 (13.9) 
Maternity only 5 (5.0) 
All 3 service areas 9 (8.9) 
Adult and Paediatrics 3 (3.0) 
Adult and Maternity 2 (2.0) 
Other 2 (2.0) 
  
Region  
1 23 (22.8) 
2 25 (24.8) 
3 27 (26.7) 
4 26 (25.7) 
  
Age  
25-34 9 (8.9) 
35-44 36 (35.6) 
45-54 38 (37.6) 
55-64 18 (17.8) 
  
Education  
Masters in Diabetes 11 (10.9) 
Diabetes counselling course 7 (6.9) 
PGDip in Diabetes Nursing 81 (80.2) 
Cert. in Diabetes Nursing (including e-learning) 22 (21.8) 
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Masters in Primary Care 1 (1.0) 
Registered Nurse Prescriber 37 (36.6) 
  
Employer║  
HSE 84 (83.1) 
Private 9 (8.9) 
Other 6 (5.9) 
  
Employment Mean (SD) 
Years working as a DNS¶ 11.2 (7.4) 
Years in current positionβ 8.1 (6.8) 
*includes 6 Advanced Nurse Practitioner or Advanced Midwife Practitioner grade 
nurses; 2 Clinical Nurse Managers; 3 diabetes nurses not graded as a DNS but qualified 
and performing the role of a DNS 
†includes 16 integrated care nurses recruited as part of the national programme 
║missing data for 2 respondents  
¶missing data for 3 respondents 
βmissing data for 1 respondent  
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Figure 10 Patient types seen by nurse type; hospital (n = 74) or community (n = 25) 
Abbreviations: GDM, gestational diabetes 
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Table 12 Specific roles performed by diabetes nurse specialists (DNS) 
 Overall (n = 99)
‡ Hospital (n = 74) Community (n = 25) 
 Type 1 Type 2 Type 1 Type 2 Type 1 Type 2 
 N (%) N (%) N (%) N (%) N (%) N (%) 
Core role       
Patient management * 88 (88.9) 90 (90.9) 73 (98.6) 67 (90.5) 15 (60.0) 23 (92.0) 
Medical review  54 (54.5) 57 (57.6) 46 (62.2) 44 (59.5) 8 (32.0) 13 (52) 
Telephone advice* 89 (89.9) 89 (89.9) 72 (97.3) 66 (89.2) 17 (68.0) 23 (92.0) 
Referrals* 73 (73.7) 74 (74.7) 62 (83.8) 57(77.0) 11 (44.0) 17 (68.0) 
Dose adjustment  73 (73.7) 72 (72.7) 58 (78.4) 51 (68.9) 15(60.0) 21 (84.0) 
Insulin/GLP initiation/education* 81 (81.8) 89 (89.9) 68 (91.9) 66 (89.2) 13 (52) 23 (92.0) 
Checking injection sites* 90 (90.9) 89 (89.9) 73 (98.6) 66 (89.2) 17 (68) 23 (92.0) 
Glucose monitoring* 89 (89.9) 91 (91.9) 73 (98.6) 67 (90.5) 16 (64.0) 24 (96.0) 
Inpatient care*† 77 (77.8) 71 (71.7) 69 (93.2) 61 (82.4) 8 (32) 10 (40.0) 
Hypo management* 89 (89.9) 90 (90.9) 73 (98.6) 67 (90.5) 16 (64) 23 (92.0) 
       
Specialist roles       
Hypertension clinics  5 (5.1) 6 (6.1) 5 (6.8) 5 (6.8) 0 (0) 1 (4.0) 
Renal clinics  10 (10.1) 13 (13.1) 10 (13.5) 12 (16.2) 0 (0) 1 (4.0) 
Assessment clinics prior to surgery  25 (25.3) 23 (23.2) 23 (31.1) 21 (28.4) 2 (8.0) 2 (8.0) 
Pre-conception discussion  52 (52.5) 48 (48.5) 41 (55.4) 36 (48.6) 11 (44.0) 12 (48.0) 
Prescribing  31 (31.3) 34 (34.3) 27 (36.5) 29 (39.4) 4 (16.0) 5 (20.0) 
       
Other        
Providing foot care 76 (76.7)  52 (70.3)  24 (96.0)  
RetinaScreen registration 62 (62.3)  43 (58.1)  19 (76.0)  
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Liaison        
Consultant 81 (81.8)  60 (81.1)  21 (84)  
Hospital DNS║ 43 (43.4)  22 (29.7)  21 (84)  
Community DNS 48 (48.5)  40 (54.1)  8 (32)  
GP║ 70 (70.7)  46 (62.2)  24 (96)  
Practice nurse║ 58 (58.6)  35 (47.3)  23 (92)  
 
Overall    
(n = 101) 
Hospital   
(n = 74) 
Community (n = 25) 
Professional education       
GP║ 48 (47.5)  25 (33.8)  22 (88.0)  
Practice nurse║ 60 (59.4)  35 (47.3)  23 (92.0)  
Nursing staff in hospitals║ 82 (81.2)  71 (95.9)  11(44.0)  
Medical staff in hospitals║ 49 (48.5)  47 (63.5)  2 (8.0)  
Allied health professionals 41(40.6)  27 (36.5)  13 (52)  
Medical staff in nursing homes║ 35 (34.7)  16 (21.6)  17 (68.0)  
Patient education 101 (100)  74 (100)  25 (100)  
‡2 respondents were excluded as they did not perform a clinical role 
*significant difference in role performed for patients with T1DM after adjustment for multiple comparisons (Bonferroni corrected p < 0.002) 
†significant difference in role performed for patients with T2DM after adjustment for multiple comparisons (Bonferroni corrected p < 0.002) 
║significant difference in role performed after adjustment for multiple comparisons (Bonferroni corrected p < 0.002) 
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Figure 11 Referral access by region 
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7.1 Abstract  
Background 
Expanding nurse specialist support in the community is a strategy to integrate and 
improve the quality and efficiency of chronic disease management; however, little is 
known about how to successfully implement this model in a health system designed 
for acute and episodic care. We examine how new diabetes nurse specialists (DNS) 
working across care boundaries, together with hospital-based DNS, support the 
implementation of integrated care, including determinants of their behaviours. 
 
Methods 
We purposively sampled DNS (n = 30) from national survey respondents by work 
setting (community, hospital) and four administrative health service regions.  We 
conducted focus groups and interviews using a semi-structured topic guide. 
Interviews were digitally recorded and transcribed verbatim. Analysis was data-
driven, using action coding. 
 
Results 
Facing a choice of ‘sink or swim’ when introduced with limited guidance, community 
DNS used initiative and adapted to the local context.  When first introduced, both 
community and hospital DNS actively managed role misconceptions. To establish 
clinics in general practices, community DNS capitalised on professional contacts and 
targeted GPs. They built GP trust by adopting practice norms and responding to 
individual needs. They adapted to the lack of multidisciplinary team ‘safety net’ in 
the community, by ‘practicing at a higher level’, working more autonomously. 
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Developing professional links and pursuing on-going education was a way to create 
an alternative ‘safety net’.  Workarounds facilitated information flow between 
settings in the absence of a shared electronic record.  
 
Conclusions 
A capacity for flexibility and innovation facilitates a new way of working across 
boundaries.  Successful implementation of integrated care supported by nurse 
specialists requires strategies to address elements in the inner context (e.g. 
differences in practice organisation, role acceptance) and outer context (e.g. 
information systems). context. 
 
Keywords 
Clinical Nurse Specialists, Integrated Care, Quality Improvement, Diabetes Mellitus 
 
7.2 Introduction 
Integrated care is seen as a way to improve both the quality and efficiency of 
healthcare delivery for people with chronic conditions [123]. Intermediary support 
by community-based multidisciplinary teams [17, 25, 164], or expanding nurse 
specialist roles in the community to support primary care [17-19, 24, 112] are 
strategies to integrate diabetes care both in Ireland and internationally. These 
models have delivered better clinical outcomes for patients [17, 23-25], reduced 
referrals to secondary care [112] and preventable hospitalisations [164]. However, 
models of integrated care do not always deliver improvements [163, 168, 172], in 
part because successful implementation in different healthcare or policy contexts is 
181 
 
challenging; health care systems are inherently complex, characterised by 
unpredictability and self-organising practices [81], making it difficult to introduce and 
embed change. Moreover, health systems are traditionally designed for delivery of 
acute or episodic care and not necessarily configured for integrated care.  
Interventions are often adapted during implementation to increase compatibility and 
‘fit’ with the given context [92].   
 
Integration can be supported by existing relationships and shared values between 
organisations and individuals[198] and a culture of interdisciplinary work [198, 205]. 
Professional networks can serve as a platform for engagement in  service 
development [207]. Lastly, integration can be supported by financing models which 
remove competition, placing emphasis on collective rather than individual 
performance [207].  In contrast, integration has been hindered by an organisational 
culture of ‘silo-working’ [198, 205], difficulties with data-sharing and communication 
caused by different or unlinked IT systems across settings [196, 198], and the failure 
to secure information-sharing agreements between services [198]. Existing 
frameworks [92] categorise these factors as implementation determinants. The CFIR, 
developed by Damschroder et al. consolidates existing theories, and provides a 
useful and comprehensive structure to describe contexts, whether they belong to 
the outer context (e.g. the extent to which organisations are networked; external 
polices and incentives) and inner context (e.g. social architecture, intra-
organisational networks and communications, culture) [92]. 
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The Irish health system is not necessarily suitable for integrated care; primary and 
secondary care services are funded and resourced separately, chronic disease 
management is often not well integrated between hospitals and general practice 
[394], and there is variation in the provision of diabetes management in primary care 
[32, 224]. Efforts to integrate care include a model of integrated care developed by 
the National Clinical Programme for Diabetes (2010) to improve the quality of care 
and ensure patients receive care in the most appropriate setting according to the 
complexity of their condition [68]. To support the delivery of this new model, 
community-based ‘integrated’ DNS, who work across primary-secondary care 
boundaries, were recruited from 2013 onwards to complement the predominantly 
hospital-based DNS service.  Nurse specialists are central to the integration of chronic 
disease management [17-19, 112]; running nurse-led clinics [115, 188], providing 
specialist education and support to other professionals [19, 24, 112, 188], and liaising 
with other care providers from multiple specialities and co-ordination of patient care 
[24, 106, 107, 188]. ‘Integrated’ DNS in particular reflect an international shift 
towards expanding nurse specialist support in the community [24, 107, 112, 115, 
188]. As a new way of working to support care in a system designed for episodic care, 
it is important to understand how context shapes the delivery of the role. Studies 
which have specifically explored the role of the DNS [186, 215, 216, 392, 403-406], 
have focused on role  perceptions [186, 215, 392, 400, 403, 404], and specific aspects, 
such as nurse prescribing [405, 406]. Previously reported barriers of service delivery, 
have included resource constraints [214, 215], inefficiencies in data-sharing and 
documentation [407],  understanding of the role by colleagues [185, 214, 216], and 
lack of funding for, or restrictions on, Continuing Professional Development (CPD) 
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[216, 217, 408].  However, few studies have explored the nurse specialist role as it 
pertains to the delivery of integrated care in practice [205], including how these 
models may be adapted during implementation [409].  Our aim therefore was to 
understand how DNS support the implementation of integrated care in a complex 
health system, including determinants of their behaviours.  
 
7.3 Methods 
7.3.1 Setting 
In Ireland, both hospital and community DNS support integrated care by managing 
complex patients with type 2 diabetes, liaising with other professionals, delivering 
professional and patient education, and nurse-led clinics [188]. While hospital DNS 
spent 100% of their Whole Time Equivalent (WTE) in hospital, new community DNS 
are distinct in that they split their WTE between the community (80%) and hospital 
(20%) to facilitate integration between the two settings[68]. At the end of 2016 when 
this study was carried out, there were 26 nurses in post. Community DNS include: 1) 
existing community DNS in place before 2013, in some areas attached to primary care 
initiatives; 2) additional new posts placed into areas with an existing community DNS; 
and 3) community DNS posts entirely new to an area (no previous community DNS) 
(Appendix 6 Figure 20). At the time of the study, community DNS reported to the 
Director of Nursing in the hospital they were attached to. 
7.3.2 Participants and sampling 
We carried out semi-structured focus groups and individual interviews with hospital 
and community DNS across Ireland. Participants were sampled from respondents to 
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a national DNS survey who indicated their willingness to be contacted about the 
follow-up qualitative study [188]. Participants were purposively sampled according 
to their main work setting (hospital or community) across the four administrative 
regions of the Health Service Executive, the national health system in Ireland (Table 
13). A greater proportion of community-based DNS were sampled to explore the new 
integrated care role. Participants were invited by email and were provided with an 
information sheet explaining the study aims and methodology.   
 
7.3.3 Data collection 
Interviews and focus groups were conducted between December 2016 and February 
2017. They took place in participants’ workplace (i.e. offices within hospitals or 
primary care centres) or in hotels when interviews were arranged to coincide with 
conferences or meetings. All interviews were conducted by a single researcher (FR) 
with a background in Public Health and Health Services Research and no experience 
of working within the health service. Participants knew the interviewer as an 
independent researcher conducting the study as part of her PhD training.   
 
Topic guides (Appendix 10.6.1) were developed based on the findings from the 
national survey and two pilot interviews (one community DNS; one hospital-based 
DNS). Topic guides included questions about the DNS experience delivering care, 
governance, working with other professionals in the community and hospital, 
strengths and weaknesses of the current service, and, in the case of new DNS, their 
approach to establishing the service.  Hospital DNS were also asked about the 
introduction of the new community DNS role. Some interviews were conducted as 
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part of a broader study on the implementation of the National Programme for 
Diabetes so some questions focused on particular aspects of that programme [1]. The 
topic guide was modified after an initial set of interviews to pursue emergent 
themes. For example, additional questions were included about the challenges of 
working between primary and secondary care, and how nurses worked with other 
professionals.   
 
Prompts and probes were used throughout the interviews to encourage discussion. 
Signed informed consent was obtained before each interview. All interviews were 
audio-taped and transcribed in full.  The average duration of individual interviews 
was 40 minutes, and 1.5 hours for focus groups.   
 
7.3.4 Data analysis 
Open-coding of transcripts was carried out with a broad aim of understanding the 
experiences of DNS in delivering care. Analysis was data-driven, drawing on some of 
the principles of grounded theory: coding actions or processes to stay closer to the 
data, and using In Vivo codes to preserve meaning [410]. Unlike classical grounded 
theory, the aim of the study was not to generate a hypothesis or theory. However, 
the purpose of grounded theory according to Noble and Michell [411], to uncover an 
understanding of behaviours, did align with the focus. The analysis approach has 
some but not all the features of grounded theory, for example, categories and 
analytic codes were developed from the data i.e. not pre-conceptualised. Two 
transcripts (one community DNS; one hospital DNS) were read and open-coded by 
two other members of the research team (SMH, NMG), and the analysis approach 
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and emerging themes were discussed. Subsequently, codes were organised and 
refined with a focus on DNS reported actions or behaviours (how they acted to 
support integrated diabetes care), the factors leading them to respond this way, and 
any consequences of those actions.  Actions were grouped according to conceptual 
similarity, and concepts were discussed with the research team. Memo writing was 
used throughout, particularly to establish conceptual links between the DNS actions, 
the conditions or causes, and the outcomes of these. Throughout the analysis the 
language and expressions of DNS were maintained to preserve meaning and context. 
NVivo (Version 11) was used for data management. The CFIR was not used as a 
framework to explicitly guide the analysis or reporting of the results. Instead this 
framework was used in the discussion as a means of classifying  and reflecting on the 
identified determinants. To assess the validity of the synthesized themes, we 
presented the findings to a sub-group of community-based diabetes nurse specialists 
to check whether they accurately represented their views. 
 
Ethical approval to carry out the study was obtained from the Clinical Research Ethics 
Committee of the Cork Teaching Hospitals. The consolidated criteria for reporting 
qualitative research statement (COREQ) was used to inform reporting of the findings. 
Participant quotations from community DNS (CDNS) and hospital DNS (HDNS) have 
been selected to illustrate findings. To assess the validity of the synthesized themes, 
findings were presented to a sub-group of community DNS. 
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7.4 Findings 
Response rate to the initial survey was 67% (n = 101). Most  (n = 96, 95%) indicated 
their willingness to be contacted about the follow-up qualitative study [188]. Of 40 
DNS invited, 30 took part in total, in two focus groups (n = 8) and individual interviews 
(n = 23). One DNS took part both in a focus group and a subsequent interview. Ten 
DNS did not take part, due to sick or maternity leave (n = 4), lack of time (n = 3), or 
non-response (n = 3). Characteristics of participating DNS (region and type) are 
shown in Table 13.  
 
7.4.1 Overview of themes 
Most themes were specific to the community DNS experience. Therefore, we present 
themes as they relate to community DNS, and, where appropriate, highlight 
similarities or differences with the hospital DNS experience within each theme. When 
establishing and delivering their new service, community DNS faced a choice of ‘sink 
or swim’. The decision to ‘swim’ comprised of two main behaviours; using initiative 
and adapting role delivery to the health service context (Figure 12).  
 
7.4.2 Establishing the service 
When first employed, DNS who were not linked to an existing initiative felt there was 
no one to oversee their role or organise logistical issues. At the time of their 
introduction the official Model of Integrated Care document was also not published. 
Community DNS’ options were to ‘sink or swim’ when setting up the service locally 
(CDNS5, CDNS4-FG1). They established the service by ‘doing a sales job’ (CDNS14) 
among local GPs and Practice Nurses to enrol practices. To reach GPs, they used 
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existing contacts or knowledge they had from previous positions or took advantage 
of practice visits made by pharmaceutical reps, study days or information events. In 
areas where the service was entirely new, nurses had to ‘start from scratch’ (CDNS1, 
CDNS5) in some cases generating contacts with GPs through cold calls: 
 
One [practice] rang and asked me to come for a meeting which I did, and 
started a clinic there. And no contact from anybody else. Had to start going 
around and making calls, and then, knocking on doors. (CDNS3-FG2). 
 
So it's a case of using my contacts that I previously had. It was hard at the 
start [laughs] but only because I had experience in [hospital] I would have…it 
was either sink or swim…there was nobody else to say right this the way you 
should do it, because nobody else had a clue? (CDNS5) 
 
7.4.3 ‘Well, no, that's not part of my role’ – managing role misconceptions  
When community DNS were first introduced, other staff lacked clarity about their 
role, and they had to manage misconceptions by 1) using initiative to clarify and 
explain the role and, 2) asserting role boundaries.  Some hospital DNS saw the 
community role as a different role to their own, while others saw it as part of the 
hospital team, ‘complementary to’ (HDNS13) or a version of their own role.  
It's a valuable service I think really and can help to keep people out [of 
hospital], but in terms of what it helps to secondary care I'm not sure really. 
It's more of us, it's an extension of what we were doing (HDNS4) 
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Where community DNS were perceived as separate to the hospital team, it was 
difficult to integrate care: 
I think it would have been much more helpful if the consultants and the 
hospital-based team were engaged, were aware of what the role was, and 
that you were part of that team… The idea is that we're meant to integrate 
care, but you can't integrate anything if your team aren't on board. (CDNS7) 
 
Community DNS managed misconceptions by explaining their role, educating other 
staff, and establishing role boundaries, justifying the need for flexibility in their role 
to managers (i.e. their working hours, how they spent their time, and tasks 
performed). Where community DNS had faced a lack of understanding from 
managers, managing misconceptions sometimes involved organising their own 
hours, forgoing explanation to save time. 
 
People are going to wonder what is your role, or what you can and cannot do, 
or maybe a public health nurse thinks that you can go in and give insulin every 
day, or...So, I think you just would need quite good interpersonal skills, and 
explain, 'Well, no, that's not part of my  role, or...' (CDNS#19) 
 
Although a much more established role, when first introduced, hospital DNS had 
faced a similar scenario; they also felt their role had not been appreciated or well 
understood. Other staff had not used the role appropriately, sometimes 
unnecessarily referring patients:  
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Maybe about 5 or 6 years ago, we were getting a phone call just because they 
had diabetes. It didn't matter really, they just saw 'diabetes' and they'd asked 
us, from the nurses on the wards, or from the doctors. But I think they're 
appropriate referrals now and they tend to know when to call us. they 
probably realise that... We're trying better. We've done a lot of guidelines, 
and a lot of input on how to manage somebody with diabetes when they 
come in for procedures. (HDNS23) 
 
Managing these misconceptions through ongoing education by hospital DNS, 
together with an increasing number in post, meant that understanding of the 
hospital-based role developed over time. There was an expectation that 
understanding of the newer community DNS service would develop in the same way. 
 
7.4.4 ‘Practicing at a higher level’ without a ‘safety net’ 
 
Community DNS had to adapt to ‘a whole different MDT’ in the community and work 
without the  ‘safety net’ (CDNS14) usually present in the hospital, that is, equipment 
and supplies ‘on tap’ (CDNS10), and other experts to check with who act as ‘backup’ 
(CDNS22) for one another.  
 
I’ll get in my car and I’ll drive off. You perhaps haven’t got the people around 
to bounce ideas off. You’ve got to be the one making some decisions. But also 
as well for your own planning and stuff, nobody comes to me and says, ‘Oh, 
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there’s your clinics.’ You are responsible for your own workload…..So it is a 
different role, you don’t have as much as a safety net of the team that you 
would do in a hospital, you are very much more… in some ways you can be 
more isolated but I prefer autonomous to isolated (CDNS14) 
 
They adapted to the lack of this traditional ‘safety net’ by ‘practicing at a higher level’ 
(CDNS22), which meant asserting themselves as autonomous practitioners, and 
assuming greater responsibility and ownership over their workload and service 
organisation, for example, using initiative to ‘look for services’ (CDNS21) in the 
community to refer to and link in with. It also involved exercising greater autonomy 
in clinical decision-making as the ‘diabetes expert’ (CDNS22) in GP practices, 
‘daunting’ (CDNS22, CDNS11) for some. To support themselves in this latter role they 
required confidence in their abilities and needed to maintain their skills and have a 
‘much broader knowledge’ (CDNS7) to deal with the patient mix and range of 
recommended medications.  
 
You are expected to make decisions and to be advising the GP I suppose 
technically on paper but I mean the GP is looking to you as a diabetes person 
to give the best advice on what we should do with particular patients. So, you 
are practising really at a higher level in primary care than you are within the 
hospital. (CDNS22). 
 
The dynamics [in community] are different. I wouldn't have been aware of 
the way things are done in primary care. It’s very different to the hospital. 
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You have everything at hand in the hospital really. It’s very different out in 
the community. You have to look for services. You have to see what’s 
available. It probably took me a good 12 months settling in period. That’s just 
to get to know the system. (CDNS21) 
 
Both community and hospital DNS recognised the need to further their specialist 
skills; however, a lack of protected time and resources meant they had to use their 
initiative to participate in their CPD on their ‘own time’ (HDNS8). As a result, 
undertaking some professional education was considered unfeasible, for example, 
becoming a nurse prescriber. This course required an extended period of study leave, 
with a lack of remuneration for a ‘very big responsibility’ (HDNS3). 
 
You have to be more up to date with all the medications and doses and side 
effects…Because you're advising the GP what to do, at the end of the day, 
whereas you would have always had somebody to run that off. But then, I'm 
in it now [ ] years, and I probably feel more au fait and on top of my drugs, 
than I did before. …. I think you have to be quite confident in your own 
practice, but if you are, then it's fine (CDNS19) 
 
7.4.5 Developing professional links 
Both community and hospital DNS used their initiative to reach out to other 
professionals, for support and guidance, to share information and standardise care, 
or to support patients.  
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Creating an alternative safety net 
To support themselves to practice ‘at a higher level’, community DNS, along with 
pursuing CPD, developed links with other professionals to create an alternative 
‘safety net’ (Figure 13). They did this by: 1) linking in with other community DNS for 
advice, to be ‘shown the ropes’ (CDNS21), to discuss concerns about patients, to 
compare service delivery with colleagues and learn from those in post longer, the 
‘biggest saving grace’ (CDNS10) and; 2) linking in with hospital colleagues for advice 
and to up-skill through case discussion. For some community DNS, the 80/20 WTE 
split between time spent in the community and hospital settings had been delayed, 
leaving DNS feeling ‘isolated’ (CDNS16).  
 
It was great to compare what you were doing with the other diabetes 
nurses, so at least then you knew you were somewhere on track. If you're 
going down a similar road, that at least you knew you were somewhere on 
track and that you were  doing the right things  (CNS#10) 
 
Developing links to support patients 
Both community and hospital DNS linked with Public Health Nurses (PHNs) to identify 
and support patients who needed their service, that is, those not attending a GP or 
hospital services who ‘can fall through the gaps’ (CDNS3-FG1). Community DNS 
considered the ‘bigger picture’ (CDNS5), liaising with PHNs and not restricting their 
contact to primary care professionals and the secondary care diabetes team (CDNS5). 
Both community and hospital DNS benefited from PHNs’ knowledge and the links 
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PHNs had, but also supported PHNs in their role, providing education and advice 
(Appendix 6 Table 31). 
 
I know we link in with the GP, ultimately but you have to think of the bigger 
picture. Fair enough you have to say grand you don’t refer to me, I don’t 
accept referrals through the PHN but I can listen to what she has to say and I 
can get her to link in with the GP and get the patient sorted instead of 
saying I don’t have anything to do with them (CDNS5) 
 
Developing links to standardise care 
A lack of national guidance meant hospital DNS were responsible for developing 
guidance on diabetes management at their individual hospitals.  Some hospital DNS 
could reach out to other hospital DNS to develop standard guidelines, harnessing 
existing nurse networks, to avoid ‘all reinventing different ones [guidelines]’ (HDNS4) 
or ‘starting from scratch’ (HDNS17).  
 
7.4.6 Blending in with practice norms and needs 
In contrast with the autonomy they had in establishing their service, community DNS 
relied on GPs to facilitate their service in general practice, they ‘couldn't go in solo 
and do our own thing’ (CDNS4-FG1). Although confident in their own abilities, 
community DNS were a ‘complete stranger’ (CDNS10) when they first started in a 
practice.  To build GPs’ trust in their service, community DNS needed to adapt and 
with how things were done in the practices and to be flexible and responsive to 
practice needs.  
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You can't be too dogmatic. You barely get in the door of a practice so you 
can't be dictating everything to them, you know. You're not going to muddy 
the waters. It takes a long time to build up trust with a GP practice so 
they've to trust you, you're a complete stranger walking in the door to 
them, they don't know you from Adam. (CDNS#10) 
 
I just can't emphasise enough how flexible you have to be when you're 
working in the community, and you have to acknowledge that you're going 
in to somebody's private business and that, it's very much defined by the 
personalities in it. And it's not all, the GP, it could be the nurse, you know. 
But you have to blend in with how things are done (CDNS2-FG2) 
 
 
Community DNS built trust by respecting the GP’s autonomy, remembering to ‘run 
everything by them’ (CDNS10), and including GPs in medication decisions where 
feasible. Community DNS involvement in nurse prescribing depended on their 
situation with the practice, that is, whether they were starting a new service or 
joining an existing primary care initiative. If community DNS felt they were ‘hardly 
inside the door’ (CDNS10) rather than somewhere they had ‘already built that trust 
and relationship’ (CDNS21), they saw nurse prescribing as a challenge to GP 
autonomy which would remove opportunities for relationship-building, and they did 
not pursue it.  
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Community DNS were flexible about the referrals they accepted, recognising that 
patients referred to their service varies: 
 
So, I ask them to send the newly diagnosed patients to me so that varies 
from practice to practice because some practices are maybe doing  diabetes 
20 years and some are new to it. So, then the ones that are new to it 
mightn't have a practice nurse so they send everything to me, and then ones 
who are doing it a while would send the complex type news to me. (CDNS5) 
 
They developed GPs’ skills and expertise, for example ensuring GPs were informed 
of, and understood, any treatment changes. They did this by being responsive to 
practice workflow, creating time to discuss their decisions with GPs, waiting until the 
‘doctor has the headspace’ (CDNS16) or developing workarounds, ‘leaving notes with 
the practice manager to pass on’ (CDNS20) to explain what they had done.  The type 
of service community DNS provide to practices, including the patients they see, was 
something felt to change over time, as practice experience builds. 
 
If you think a new drug is recommended or something like that, [to make 
sure] that they know why, and where, and when, and that they're not just 
following your word, that they understand why, and that they understand the 
drug, and that they have their own opinion on it as well. (CDNS16). 
 
I had to call out to them [the practice] a few times and show them how to set 
up a practice, show them how to educate patients, how to use the meter, 
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show them what literature to use, start from scratch and now he's [the GP] 
fine. They see the newly diagnosed, uncomplex, and now they send the 
complex to me. (CDNS5) 
 
7.4.7  Using workarounds to manage information gaps  
Working between primary and secondary care, community DNS adapted to a 
complex information environment, becoming ‘the only link [or] bit of integration 
between the hospital and GP’ (CDNS4-FG1), and using initiative to develop 
workarounds to address information gaps.  Community DNS provided information to 
secondary care to inform management decisions. However, patient follow-up after 
community DNS left GP practices, case discussion with consultants, and fast-track of 
patients to specialist services, were hindered by two elements: 1) the absence of a 
shared record between settings, and; 2) GP ownership over patient data with no 
standard for how DNS could safely share or transfer information out of the practice. 
As a result, DNS were not always aware of what had taken place during a patient’s 
hospital or GP appointment.  
 
They adapted by bringing back ‘basic’ data (CDNS14) to the hospital and entering 
that, or filling out information twice, once in practice, and again on the hospital 
system, a ‘time-consuming’ (CDNS21) and ‘frustrating’ (CDNS15) process, checking 
patient information, ringing the hospital or e-mailing colleagues. Others used 
initiative to manage the information deficit: establishing a patient passport or their 
own system to remember patients, using the clinic dates and patient visit order.  They 
recognised the risks inherent in relying on memory and notes. Sometimes, filling in 
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information gaps meant unnecessary appointments in secondary care could be 
avoided. These approaches contrasted with situations where community DNS were 
based in a primary care centre, arranged for referrals to be sent directly to them, and 
established their own system for recording patient data electronically, giving them 
ownership over that data. 
 
You have the issue of patient information belongs to the GP. But I might have 
to ring a particular person about their insulin, but I'm not supposed to have 
that information beside me. So if I have 20 people to ring, how am I supposed 
to remember exactly all of those people, and be safe in doing that? (CDNS7) 
 
7.5 Discussion 
We found that the capacity of DNS to adapt and innovate is important for 
implementation of their role. For community DNS in particular it enabled them to 
work with, and around, features of the outer and inner context as conceptualised by 
CFIR [92]. These features included inter-organisational networks and connectedness 
(i.e. general practice delivery by independent self-employed practitioners, absence 
of a shared record between primary and secondary care), and intra-organisational 
culture and norms (i.e. practice workflow, practice organisation and experience in 
diabetes management, the expectation to engage in CPD on their ‘own time’, and a 
lack of role understanding by peers and managers). These findings highlight the 
challenge of introducing boundary-spanning roles to facilitate integration and 
improve the quality of care when the wider system is not yet configured to support 
this model. The fact that both community and hospital DNS shared experiences of 
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role misconceptions indicates the persisting challenges of introducing new clinical 
roles, and the need for greater clarity on nurse specialist roles integral to integrated 
care, to ensure they are used appropriately and effectively.  
We identified inefficiencies in data-sharing and documentation and clinical 
information systems, also reported as barriers to other nurse-led services, regardless 
of the condition being managed [202, 407]. Poor coordination and information 
systems between secondary and primary care, in particular continue to pose a 
problem for integrated care [106, 195, 196].  The current study identified the specific 
consequences of this issue for implementation: curtailing aspects of the role such as 
case discussion and follow-up; placing additional demands on time, including liaison 
to address information gaps and duplication of data entry; missing opportunities to 
streamline services and appointment slots.   
Inter-professional relationships [198, 207] and understanding of new roles [205] are 
important in the delivery of integrated care. Role ambiguity is an international 
challenge in the establishment of advanced nursing roles [412, 413]. As evident in 
the current study, ambiguity can lead to inappropriate or ineffective use of the 
service [205], and hinder interdisciplinary collaboration [205]. While both community 
and hospital DNS in this study managed role ambiguity, it may be circumvented 
through advance planning. Preparation for this new service could include ensuring 
readiness in terms of infrastructure and resources [414], making policies and 
protocols which outline the role available [412, 415], formally designating an 
individual (e.g. local nurse administrator) to oversee implementation and facilitate 
systems entry [414, 415],  and engaging stakeholders [414], in particular influential 
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or senior professionals to ‘champion’ the role within the  organisation [415, 416]. 
Since this study was completed, the National Clinical Programme for Diabetes has 
developed a guidance document to help community DNS to explain their role and 
introduce their service in new practices.  
As nurse specialists have become more autonomous [31, 188] and move to the 
community to facilitate the integration of care [24, 115, 417], they may face 
professional isolation[418].  We found nurse specialists work without the usual 
‘safety net’ of other experts and a link to the hospital. Peer support [216, 217] and 
engagement in communities of practices [205], have been identified as facilitators of 
the nurse specialist role [216, 217]. In the current study, pursuing CPD, fostering links 
to secondary care professionals and other DNS were ways for nurses to create an 
alternative ‘safety net’. A blend of ‘formal and tacit knowledge’ is required in 
boundary-spanning roles [419].  Professional networks provide an avenue for sharing 
knowledge and developing specific skills (e.g. care coordination, promoting service 
engagement) which cannot be supported through formal training. Limited study 
leave, as reported in the current study, is not unique to Ireland [31, 205]. Adequate 
training for boundary-spanning roles created to support the integration of care [419] 
is increasingly important to ensure these roles are sustainable, do not rely wholly on 
‘exceptional’ and committed individuals with local links [419], and can be replicated 
in the event of staff turnover.  
Implementation will be affected by the degree to which the intervention is workable 
in, and can be integrated into, existing practice [420].   Our findings illustrate the 
creative, self-organising behaviours [421] inherent in complex systems, and how 
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providers make trade-offs between achieving intervention fidelity and sustaining the 
quality of care delivery. The adaptations made by community DNS to their role and 
the model of integrated care to make it ‘workable’ can be classified as intervention 
content modifications [422]: 1) adding elements consistent with the principles of 
integrated model (e.g. reaching out to, and educating PHNs); 2) refining the 
intervention to make it more appropriate (e.g. being flexible with referrals); 3) 
removing elements (e.g. nurse prescribing). However, this raises the question about 
which elements of community DNS role to support integration are ‘core’ and which 
belong to the ‘adaptable periphery’ [92].  Some variation is to be expected in complex 
systems; in Ireland, diabetes management in general practice ranges from ad hoc and 
opportunistic to structured approaches [32, 224]. We might expect variation in the 
service delivered by community DNS to GP practices according to GP experience and 
quality of the GP-DNS relationship. The community service is still in its infancy and 
some elements may be accorded some flexibility in the earlier stages of 
implementation. As the service develops however it will be important to support 
community DNS to navigate the ”dance between flexibility and consistency” [423], 
providing some specification, and clarity around which elements can continue to be 
adapted, and, if deemed essential, how these can be consistently implemented [81]. 
 
Interventions may be made ‘workable’ at a local level. However implementation will 
also be affected by the system capacity (social-structural resources available to those 
enacting implementation) and whether it enables professionals like community DNS 
to contribute to the implementation process [420]. Our findings illustrate their 
202 
 
ongoing contribution to embedding change by cultivating trust and building 
relationships with GPs and managing role misconceptions among peers and 
managers. The current study distinguishes between aspects of system capacity which 
will change over time e.g. social norms (role acceptance), cognitive resources 
(knowledge and experience of GPs), and those outside of the control of local actors 
e.g. material resources (information systems). The latter will continue to affect 
service delivery, and to constrain the role of the community DNS and its potential to 
support integration of care, and demand ongoing workarounds.   
 
We believe findings from our study are transferable to other countries facing similar 
health service constraints e.g. poor integration across service providers[106], 
incompatible information systems [196, 197], GPs working as independent 
practitioners. Moreover, the clinical responsibilities and core competencies of DNS 
are similar internationally [31, 188, 392]. That the researcher who conducted the 
interviews was not a clinician may be a limitation; when interviewing clinicians, peer 
researchers can enlist greater trust and may be able to elicit richer data on more 
sensitive topics [424]. However, the position of the researcher as a non-clinician 
‘outsider’ also meant they had no preconceptions or opinions about how the nurse 
specialist role works and may have been less susceptible to  ‘shared conceptual 
blindness’ [424]. The researcher also made her position as a non-clinician clear to 
participants at the outset of interviews. Almost all community-based DNS were 
sampled for this study. However, since a lower proportion of hospital DNS were 
invited to take part their perspectives may not be as well-represented. While using 
action coding allowed themes to be guided by DNS responses in line with the data-
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driven principle of grounded theory, core behaviours only became apparent during 
the later stages of analysis.  The study was not designed to specifically explore how 
interventions (including the DNS role) are adapted; a more nuanced understanding 
of the process of adaptation may have been achieved had this been the sole aim. The 
CFIR was used as a way to classify contextual determinants once they were identified 
but not as an explicit guide during the analysis. Had the aim been to elucidate DNS 
views on specific determinants, using the CFIR to structure the topic guide may have 
been beneficial. This may have prompted a discussion around other elements of the 
outer context, for example, financing and incentives, leading the researcher to probe 
whether and how this influenced the DNS role. As it stands, that these factors were 
not discussed suggests their impact may be less apparent or important to DNS when 
reflecting on their service delivery, as compared to other factors such as peer 
relationships.  Adopting a phenomenological approach to inquiry may have been 
appropriate, had the explicit sole purpose been to explore the DNS shared 
experience of establishing a new service.  The study is limited to the DNS perspective 
on their role. Future research should consider eliciting the views of other 
stakeholders on the service, specifically patients and primary care professionals. 
Evaluations of new integrated care service models in the UK and Australia have taken 
this approach [198, 210] A final strength is the fact that when we presented the 
findings to a sub-group of community-based DNS they expressed recognition of the 
behaviours identified.   
 
Our findings have implications for the implementation of integrated care 
internationally.  Strategies to avoid ambiguity when introducing new roles to support 
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integrated care are important to ensure their appropriate and effective use. To 
support greater autonomy specialist nurses should be facilitated to engage in 
education and training, and to link in with peer networks and other professionals. An 
ability to adapt, and a capacity for flexibility and innovation, can facilitate the 
implementation of integrated care delivery into existing practice and specific 
contexts. However, there is a need for clarity on core elements, to support 
standardisation of new care models. Successful implementation and spread of 
integrated care models supported by nurse specialists requires a combination of 
strategies to address determinants in the inner context (e.g. differences in practice 
organisation in diabetes management, role acceptance) and outer context (e.g. 
information systems). 
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Table 13 Participant matrix (n = 30)* 
 Region Population** Diabetes 
prevalence*** 
Community DNS 
N = 19 
Hospital DNS 
N = 11  
 
  N (% sampled) (% region) N (% sampled) (% region) 
South (n = 7) 1,162,112 5.0 5 (26) (83) 2 (18) (10) 
West (n = 9) 1,083,011 5.2 5 (26) (71) 4 (36) (22) 
DNE (n = 6) 1,022,184 4.5 4 (21) (80) 2 (18) (11) 
DML (n = 8) 1,320,945 4.4 5 (26) (71) 3 (27) (19) 
 Abbreviations: DNE, Dublin North East; DML, Dublin Mid-Leinster *1 DNS from focus group also participated in an interview 
 **2011 population (Public Health Information System Data Table) 
 ***Estimated prevalence; type 1 and type 2 combined [425]
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Figure 12 Examples of ‘sink or swim’; DNS using initiative or adapting their role to 
the health service context to establish and deliver their service 
Abbreviations: CPD, Continuing Professional Education 
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Figure 13 ‘Practicing at a higher level’ and linking in with other professionals  
Abbreviations: CPD, Continuing Professional Development; WTE, Whole Time Equivalent
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8 Discussion
209 
 
 
The overarching aim of this thesis was to understand whether and how integrated 
care can improve and sustain quality of care in a ‘real world’ community context.  This 
chapter summarises the main findings of the thesis and discusses the health services 
research and policy implications. Main strengths and limitations of the thesis are 
outlined.  Areas for future research are proposed and an overall conclusion is 
provided. 
 
 
8.1 Summary of main findings 
This thesis highlights that while structured care in a real world context may deliver 
benefits to patients in terms of their clinical profile and mortality, there continues to 
be variation in service delivery across general practice. Evidence from the 
international literature together with the qualitative work suggests that some 
practices, those in more deprived areas or with higher volume of patients with 
diabetes per physician,  may need additional support to deliver high-quality diabetes 
care. As evidenced from the work based on the Midland programme, even with 
structured management some patients have a  higher risk profile and may need more 
intensive support. The intended role of the DNS within integrated care is to focus on 
complicated, poorly controlled patients. However, the current work highlights how 
DNS continue to see patients with stable diabetes,  along with the challenges 
inherent in establishing and accessing the role in the community, and the lack of 
guidance on how the service should be delivered in practice. These issues necessitate 
innovation and adaptation at an individual level to make integrated care ‘workable’. 
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Overall, the thesis suggests that integrated diabetes care, comprised of structured 
management in general practice and specialists working across primary and 
secondary care settings, may be feasible and ‘workable’ in a real world community 
setting. However, there is a need to move beyond ‘workable’ to better understand if 
and how this model can be optimised to deliver effective care for all people with 
diabetes. This may be achieved through focusing on how best to measure the quality 
of integrated diabetes care, and engaging in further evaluation, in particular 
exploring the perspectives of multiple stakeholders.   
 
The systematic review (Chapter 3) found that there was substantial variation in the 
number and type of measures used individually to represent quality, or to construct 
composite measures, limiting comparability across studies. Based on the meta-
analysis and narrative synthesis, some physician (female gender, younger age, and 
higher volume of patients with diabetes), and practice (EHR, low deprivation) factors 
were associated with higher quality of care.   
 
The structured care programme in general practice achieved significant 
improvements in process of care recording over time (Chapter 4). However, 
improvements levelled off in later years. BMI and smoking status were less well 
recorded than other care processes and recording varied by GP practice. While 
sustainable improvements in the quality of care (processes) can be achieved these 
may be limited by resource constraints locally and in the wider service context.  
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Chapter 5 found mortality among people with diabetes enrolled in the programme 
when first initiated in 1999 was greater than the background population (overall SMR 
= 1.20 (95% CI: 1.01-1.42)), and lower than some other international studies [8-11, 
47, 48]. However, there has been a decline in excess mortality internationally in the 
past decade [61, 62, 64].  Improved clinical profile over time suggests cardiovascular 
risk factors are well-managed as part of the programme. This may explain the lower 
excess mortality. However, this is against the backdrop of declines in cardiovascular 
risk both internationally and nationally [59, 60]. Renal function (eGFR) and having 
experienced a macrovascular complication differed between decedents and 
survivors at baseline and these factors predicted mortality.  
 
The national survey (Chapter 6) found most DNS supported integration through 
management of complicated type 2 diabetes; liaising with, and educating, other 
professionals, and delivering nurse-led clinics [188]. However, a substantial 
proportion of DNS had people with uncomplicated type 2 diabetes attending their 
service. There was also variation in referral access to different specialities regionally, 
and space and availability of specialist staff were limited. Support from other 
specialities for nurse-led clinics was variable. Access to their service (community 
clinics) was not universal. In some areas it depended on GP willingness to engage 
with the service, or their participation in an existing diabetes care initiative.   
 
Chapter 7 found community DNS adapted to the lack of a shared record between 
primary and secondary care, lack of role understanding by peers and managers, and 
limited provision for CPD. They also adapted to differences in practice organisation 
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and experience, and the position of GPs as independent practitioners.  The study 
concluded DNS should be facilitated to link in with a ‘safety net’ of peer networks 
and other professionals. It highlighted the need for: 1) strategies to avoid ambiguity 
when introducing new roles (e.g. better initial communication and clearer role 
definitions [214], nurse administrators to oversee their introduction [414, 415], and 
senior professionals to promote the role [415, 416]), and; 2) EHR interoperability, at 
the very least ensuring specialists working across boundaries have access to patient 
data stored on multiple systems [212]. 
 
8.2 Implications for policy and practice 
Integrated care is often used as a buzzword, a catch-all term, and an overarching 
solution to all problems in the health system. Its importance is reiterated in 
numerous Irish policy documents and national strategies [103, 219-223].  However, 
in Chapter 2 we saw that integrated care can mean many different things. Often high-
level policy discussions and strategies fall short of outlining how, in practical terms, 
a model of integrated care should work in real world settings and everyday practice.  
 
Since the advent of the National Clinical Care Programmes, the priority has been 
standardising care and “implementing proven solutions to save lives, prevent 
complications, remove waiting lists and save money” [426].  On a national level there 
is recognition that the approach to integrated care studied in this thesis, structured 
management in primary care and nurse specialist support in the community, 
represents a ‘proven solution’.  Primary care services, identified “as a cornerstone” 
[427] of the response to population ageing and the rise in chronic disease, have been 
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better supported to deliver diabetes care through the Cycle of Care[28]. The most 
recent National Service Plan (2018) has prioritised the negotiation of the GP contract 
[428]. There is a plan for on-going investment in the specialist and advanced nursing 
infrastructure in the community [429]. 
 
As such, in Ireland we are interested in knowing, will this ‘proven solution’ work here, 
what conditions do we need to implement and sustain it, and can we adapt it. This 
brings us back to the questions posed at the start of this thesis (Section 2.2.1). The 
thesis provides insights into how integrated service delivery works within, is shaped 
by, and adapts to, the service context. These insights are encapsulated in the next 
sections as three key messages relevant to integrating and improving the quality of 
diabetes care in Ireland and internationally. 
 
8.2.1 Delivering integrated care ‘at scale’ while addressing access and equity 
Firstly, when considering ‘does it work?’ and ‘will it work here?’ in relation to 
structured primary care, the answer appears to be ‘yes’, suggesting this model should 
be rolled out to the whole population. Chapter 5 concluded it is essential that 
integrated structured management be made available to all patients, to identify and 
manage the early signs of preventable complications and reduce excess mortality as 
a result of diabetes. The most recent National Service Plan is focused on progression 
of the Integrated Care Programme for the Prevention and Management of Chronic 
Disease to deliver integrated care “at scale” [428].   As outlined in the framework 
developed by Campbell et al. [74],  effectiveness is only one dimension of quality; 
dimensions of equity and access are relevant for populations and individual patients 
214 
 
respectively. Improvements to diabetes care to date in Ireland have often been 
locally driven, accentuating variation in care provision and access to services. 
Chapters 6 and 7 found access to the DNS service (community clinics) was not 
universal, with evident challenges accessing and making contact with practices who 
were not previously engaged. These findings suggest there is a need to be mindful 
that efforts to scale up, address rather than contribute to, existing inequity in care 
delivery. New DNS in areas without initiatives had to “start from scratch”, resorting 
to “knocking on doors” to get their service up and running. Routinely collected 
activity data (care processes, including patients seen, type (uncomplicated vs. 
complicated), practices attended, and patients discussed with the multidisciplinary 
team) collected by new DNS (Appendix 7 10.7.1) suggests that, despite this, the 
majority are now at capacity. As suggested by the survey, part of the issue around 
capacity may be that DNS receive referrals of patients with relatively stable diabetes 
who may be more appropriately managed by practice nurses. Improving nurse skills 
and education may address this issue. While DNS play an important role in building 
practice team capacity and skills, time needed to engage with practice for structured 
development and education is not always available. This was evidenced by the 
workarounds used by DNS to communicate with busy GPs. With DNS resources 
limited, Ireland runs the risk of facing the same problem reported in the UK, referred 
to as the ‘black hole’ in diabetes care [430]. The NHS has been criticised for the 
stagnation in DNS posts, citing recruitment embargo and the failure to staff 
appropriately for the rising numbers with diabetes [430]. If numbers of community 
DNS remain limited in Ireland, patterns in how they are accessed and used may add 
to existing variation in diabetes care.  The Cycle of Care may also contribute to 
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inequity by making free structured review visits available only to people with GMS or 
GP visit cards. Future reforms to deliver care in the community also need to be 
cognisant of the fact not all patients attend their GP. As highlighted in this thesis, 
there is a “little cohort of patients in community who sees nobody”, patients who 
DNS felt can “fall through the gaps”.  Beyond the Cycle of Care, there needs to be 
some consideration of how to structure and standardise care delivery to this cohort, 
be it through formally expanding the remit of community nurse specialists or 
engaging in active efforts to build and support the education of PHNs in diabetes.  
 
Scaling up may not be as simple as rolling out a standard care delivery package across 
Ireland. Findings from this thesis, that some physician and practice factors were 
associated with higher quality of care, and that DNS adapted their role in response 
to practice experience, suggest some practices may need targeted support. For 
example, those lacking informational infrastructure, those with less experience in 
diabetes care, and/or based in more deprived areas. The audit indicated some 
patients had a  higher risk profile, despite structured management, suggesting some 
patients with poorer control may need more or different types of support [431]. 
While practice audits like that conducted in the Midlands regions could identify 
patients who are at  higher risk, further patient-level data is needed to fully 
understand who may require more support. At present, some activity data is 
manually collected by community DNS, namely the number of complicated and 
uncomplicated patient episodes. There may be some scope for this data, if collected 
and collated electronically, to highlight regional variation and indicate areas of 
greater need.  
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Internationally, there have been some promising interventions to improve diabetes 
care among socially disadvantaged populations [432]. Features include one-on-one 
interventions, feedback provision to patients, involving community or lay people in 
intervention delivery, cultural tailoring, and implementing high-intensity 
interventions over a long duration [432]. The issue of socio-economic deprivation 
and general practice has captured national media attention through GPs at the Deep 
End, a group of GPs working in disadvantaged areas of Ireland [433]. This group have 
highlighted the difficulties of treating patients with multiple health and social needs 
served by these practices, and the need for additional resourcing, better access to 
secondary care and diagnostics [433, 434]. Over 85% of GPs enrolled in the Midlands 
programme were based in practices within the lowest deprivation deciles suggesting 
good quality care can be provided to patients in these areas. However, this 
incentivised programme is more comprehensive and better resourced than the Cycle 
of Care and does not necessarily reflect service provision nationally.   
 
This thesis identified variation in the quality of primary care management (e.g. as 
part of the Midlands programme and international studies), which could reflect GP 
demographics, management decisions, their diabetes volume, along with patterns of 
patient attendance, adherence and self-management. Previous work conducted in 
the UK as part of the ‘Improving Quality in Diabetes’ (IQuad) study, tried to 
understand national variability in diabetes care through examining factors 
(organisational, team, individual) which influence professional behaviours [435, 436].  
Most variability was found to exist between clinicians within practices rather than 
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between practices [435]. Though variability in care quality may be due to patient 
characteristics and behaviour, these findings, together with the work in this thesis, 
suggest there is a need to better understand physician behaviour and consider 
theory-based interventions to target this in the Irish context, along with taking steps 
to address broader system-level challenges. 
 
8.2.2 Embedding and sustaining integrated care 
This brings us to the second key message arising from the work in this thesis. When 
considering ‘what conditions do we need to implement and sustain it [integrated 
care]?’, the findings suggest that “islands of excellence” [381] and central pillars of 
care delivery need to be supported by system-level changes in culture, training, 
infrastructure and resourcing for integrated care. This is essential to embed and 
sustain integrated care in the Irish health service. The aforementioned ‘islands of 
excellence’, the primary care initiatives, have led the way in terms of delivering high-
quality structured care in Ireland.  With the introduction of new DNS service we see 
again a somewhat isolated strategy to organise care, a good service which does 
perform functions to integrate care but which is challenging to implement within a 
resource-constrained and misaligned infrastructure. Chapters 6 and 7 found local 
arrangements for diabetes care delivery played part in how DNS services operate, be 
it where they deliver clinics in the community or the type of referral access they have.  
The findings indicate that at the time of the study the wider healthcare system was 
not completely ready to support this new way of integrating care involving 
professionals working across care boundaries. In short, integrated care is more than 
just putting the right professionals in the right place.  
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For the different parties involved in integrated care to work together there needs to 
be a shared vision, what Evans et al. refer to as a shared mental model [437].  We 
know that integrating care can require a cultural shift to facilitate interdisciplinary 
work and to counter silos of expertise, and the siloed thinking which is often 
ingrained in current healthcare delivery [198, 205, 210]. The stakeholder’ statement 
on integrated care introduced at the start of this thesis asserted that “patients like 
it”. Integrated chronic disease management, although challenging to implement, 
aligns with the national vision for patient-centred care. The Patient Narrative Project 
looks to patients and service users to guide the delivery of healthcare through the 
integrated care programmes [428]. Cost-effectiveness and the need to address the 
burden of chronic disease on health systems are cited as drivers of integrated care. 
However, organising services to ultimately make things easier and better for patients 
is a vision which can unite service providers in shaping a better health system. 
 
It was evident from the work in this thesis that a shared vision of integrated care may 
not yet have filtered through at a local level. Social norms (role acceptance) are 
aspects of system capacity which can change over time [420].  However, they may 
hinder integration in the interim.  Aptly put by one DNS: “you can't integrate anything 
if your team aren't on board”. With professionals, including new ‘integrated’ DNS, 
increasingly working across boundaries, issues around role understanding and 
acceptance, blurring of professional roles and clinical responsibility will likely 
continue to arise [438, 439]. A systematic review of barriers to primary care type 2 
diabetes management, found there was “uncertainty and unease” about clinical 
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responsibility when coordination across numerous professionals occurred [132].  A 
qualitative study of GP-led integrated care in Australia, found there was a need to 
build trust and change the “mindset” of specialists to recognise the benefits and 
quality of moving more complex diabetes care to the community, and to counter 
resistance from GPs who did not want to “deal with” more complex management 
[210].  A study of the integration of health and social care in mental health services 
in the UK, identified concerns about the “erosion” of professional roles and identities 
among individuals who worked across boundaries [440]. Future efforts to integrate 
care in Ireland will need to consider how to generate receptiveness to new roles and 
new ways of interdisciplinary working. A practical issue arising from this thesis was 
the lack of clarity on the role of the DNS. Although guidance on integrated care was 
published in 2016 after new DNS were in post, there was no formal agreed document 
in place from the outset to outline their role, particularly how it should operate in 
relation to the other key professionals involved.  
 
As mentioned, building the advanced nursing infrastructure in Ireland is central to 
delivering chronic disease management in the community [441].  Developing a 
workforce with the right competencies to facilitate integrated and coordinated care 
is important but needs to be part of a long-term plan involving wider service changes 
[442-444]. There is a need, not only for adequate training for boundary-spanning 
roles created to support the integration of care [419], but system-level changes in 
training of all professionals involved in the integrated care. This should include better 
support for additional training in diabetes in general practice, but also address the 
specialisation and “siloed nature of training” [419] of healthcare professionals, which 
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can challenge collaborative working across professions and settings.  Developing 
skills to support new ways of working may need to begin at the undergraduate and 
postgraduate level, and be further developed through on-going learning and CPD. 
However, as highlighted by Erens et al. there may be limited scope to change 
nationally set curriculums [444]. 
 
Restrictive information sharing across settings and poor information technology 
continues to challenge efforts to engage in QI and integrate care internationally [19, 
133, 212]. This thesis showed that practices without EHRs delivered lower quality 
care, and that un-linked information systems affected the delivery of the DNS service 
and required workarounds; a tangible example of how this presents a day-to-day 
problem and limits elements of what is otherwise a good model of care delivery. The 
between-service disconnect in information systems and the difficulty accessing and 
synthesising information across organisations is a key challenge in Ireland. 
Encouragingly, this is being addressed as part of the eHealth strategy, which recently 
began piloting of interoperable EHRs and making provisions for the operational use 
of the national Individual Health Identifier [445]. To support integrated care, Darker 
et al. [122] and the more recent Slaintecare report, have recommended  building the 
ICT infrastructure, along with changing governance structures, funding mechanisms, 
workforce planning and building networks and coordination between services [103].   
 
8.2.3 Learning from service delivery ‘on the ground’ 
This thesis not only indicates what ‘conditions’ may be important to embed and 
sustain integrated care but highlights how integrated care can be shaped by context. 
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Interestingly, changes in context of the Midlands programme appeared to have a 
knock-on effect on attendance at dietician services. GP demographics, diabetes 
caseload, and practice factors were associated with quality of primary care 
management as evidenced by the systematic review findings, while the qualitative 
study showed that practice experience and existing relationships shaped delivery of 
the DNS service in the community.  While the answer to ‘can we adapt it [integrated 
care]?’ appears to be ‘yes’, a third key message from this thesis is that integrated 
care should continue to be evaluated as it is rolled out to determine what adaptations 
occur, why and whether they influence effectiveness. However, in doing so we 
should take context, ‘conditions’, into consideration.  
 
Without learning from delivery on the ground to understand why things worked and 
why they did not, and why they were adapted, integrated care runs the risk of 
remaining an idealistic concept rather than a practical solution. Encouragingly, there 
is now on-going commitment to learning from the progress of pioneer and 
demonstrator sites of integrated care delivery across Ireland [428, 441]. While the 
DNS activity data goes some way towards demonstrating the contribution of the new 
posts, the Department of Health are moving towards developing key performance 
indicators for integrated nursing roles as part of demonstrator projects, to answer 
‘does it work’ [446].  Future evaluations can take a standardised approach to 
measurement, using acceptable indicators of quality, but need to be mindful of that: 
1) the delivery of new services can be shaped by context to account for local needs, 
and; 2) context can change over the course of an evaluation (e.g. resources available 
to structured programmes). In an effort to better capture the dynamic nature of 
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context some studies have used a longitudinal qualitative design [447, 448]. For 
example,  a study of the implementation of new infection control practices in 
hospitals representing ‘extremes’ (selected by whether or not they were most likely 
to succeed or face challenges in implementation) [447]. As a highly detailed 
approach, consisting of multiple non-participatory observations, it may be 
impractical for real world service evaluation and beyond the scope of many research 
grants. However, some effort should be made to record baseline differences and 
changes in context alongside evaluations. This, at the very least will mean that 
knowledge of what might affect implementation can be brought to new sites, to 
guide scale-up and anticipate issues.  
 
When implementing and evaluating new models of integrated care, as asserted by 
Foster et al. in their study of GP-led integrated care [210], there is a need to “balance 
the ‘ideal’ model with the realities of resourcing”. It is important to allow for 
interventions to be adapted to the local context, rather than insisting on rigid 
standardisation [449].  Some guidance is needed on how to suitably modify DNS 
service delivery, if necessary. In Ireland and internationally, the focus is often on 
developing interventions that work, but less so on how to guide delivery of services 
and interventions once already in place, or how to adapt them so they are still 
effective[450]. Continuing to monitor and adapt interventions during delivery can 
identify important influences on service delivery which may not have been 
prioritised, were missed, or simply not apparent before the implementation began 
[351]. 
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8.2.4 Summary of policy recommendations 
There are several key recommendations arising from this thesis: 
 
1. Extending coverage 
There is evidence from this thesis to indicate structured care is beneficial to people 
with diabetes, particularly in terms of ensuring they receive regular checks and 
screening. The Midland programme is not limited to people holding a GMS card.  The 
Cycle of Care should be extended to the whole population with diabetes. 
 
2. Embedding flexibility 
The Cycle of Care covers two visits in general practice annually to patients holding a 
GMS card. However, it was evident from this thesis that some patients and practices 
may need additional support.  Some flexibility may need to be built in to the initiative, 
for example, considering how to introduce additional visits for patients with poorly 
controlled diabetes or those who are newly diagnosed who may need more intensive 
follow-up in general practice for a period of time. 
 
3. Needs-based allocation  
Greater attention is needed to ensure limited access to resources like DNS does not 
accentuate disparities in care delivery. Policymakers should consider how these 
resources are allocated on a national level, and whether a systematic approach to 
documenting and allocating resources on  the basis of need, be it practice or patient-
level, can be implemented.   
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5. Protocol and guidance for introducing new roles 
Future efforts to integrate care in Ireland will need to consider how to generate 
receptiveness to new roles and new ways of interdisciplinary working. A practical 
issue arising from this thesis was the lack of clarity on the role of the DNS. Although 
guidance on integrated care was published in 2016 after new DNS were in post, there 
was no formal agreed document in place from the outset to outline their role, 
particularly how it should operate in relation to the other key professionals involved. 
 
6. Investment in education 
Wider system changes are necessary to support integrated care, the first being 
greater investment in education. Arguably skills and competencies for collaborative 
and cross-boundary working should be embedded in early training and could be built 
into existing curricula through engagement with the higher education authority. 
However, education could also be further supported in general practice by better 
structuring the role of the outreach specialist (e.g. DNS). One recommendation 
would be to resource not only the specialist role, but the time required for the 
practice to engage with DNS  and jointly identify education and support needs for the 
practice, developing practice plans for how these needs can be met by the DNS or 
external courses.  
 
7. Supporting integrated information sharing 
The second key change to support integrated care had already been recognised at a 
national level, namely the need to improve the informational infrastructure, and 
implement interoperable EHRs. 
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8. Incorporating adaptation in models of care 
A final recommendation would be to develop guidance for professionals who are 
working to deliver integrated care. This guidance should recognise the need for 
adaptation and indicate which aspects of the model of care in question are flexible 
and can be tailored to local settings and circumstances.   
 
8.3 Strengths and limitations 
This section provides an overview of the overall strengths and limitations of this 
thesis. The strengths and limitations of the five individual papers have been 
acknowledged in the previous chapters (3-7).  
 
‘Integrated care’ is a nebulous term. As such, deriving clear messages from research 
in this area is challenging. The thesis has tried to mitigate this issue by limiting its 
focus to well-articulated approaches to integrated diabetes care; 1) horizontal 
integration within one service through a multifaceted structured diabetes 
management programme and; 2) vertical integration, co-ordinating management 
across primary and secondary care through role expansion and task shifting of the 
diabetes nurse specialist role. This thesis addresses existing research gaps; i.e. 
whether quality improvements achieved by interventions to integrate care in primary 
care can be sustained within a changing real life context, what factors influence 
quality, and how models which involve a new way of working across care-boundaries 
operate ‘on the ground’). It does this by focusing on learning from the delivery of 
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primary care diabetes management internationally (Chapter 3) and real world efforts 
to integrate diabetes care in the Irish setting (Chapters 4, 5, 6 and 7). 
 
The results of this research are timely. The thesis was conducted while service 
provision was changing; a new service and integrated model of care were being rolled 
out nationally, and the Cycle of Care had been launched (2015).  Researchers and 
policy makers are interested in understanding whether integrated diabetes care can 
be sustained in everyday practice, and how to achieve this [428, 429].  The author 
has had the opportunity present the work at national and international conferences 
in the areas of primary care, integrated care and quality in healthcare (Appendix  
10.7.4) and to prepare the audit report on the Midland Structured Diabetes Care 
Programme [451]. Two of the included papers have been published. A policy brief 
was prepared for the National Clinical Programme for Diabetes on the work relating 
to DNS (Appendix 10.7.3). This brief outlined important factors which could lead to 
differences in the role of DNS nationally; i.e. practice experience in diabetes, GP-DNS 
relationship, links with other professionals and services. These issues may explain 
differences in activity data collected by new ‘integrated’ nurses; the author analysed 
and co-authored an annual report on this data published in draft format by the HSE 
(Appendix 10.7.1).  These issues highlight the challenges of improving the quality of 
diabetes care and standardising management within health systems that may have a 
legacy of long-standing ‘ground up’ primary care programmes. The pressure to 
maintain the structure of local services, together with the different baseline service 
delivery created by existing professional relationships and GP or nurse training may 
influence the implementation of new initiatives and reforms. 
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Although this thesis has shown that the intervention to structure diabetes 
management in primary care demonstrated improvement, the multifaceted nature 
of interventions like this means it is difficult to determine which specific elements led 
to improvements. To answer this question some studies have categorised 
interventions according to their components, and tried to elucidate the key 
components [23, 158-161, 169] or determine whether the number of components is 
important [157, 160, 168, 169].  While the existing literature does not demonstrate 
a clear association between the number of intervention components and clinical 
outcomes [160, 168, 169]; as outlined in Appendix 10.1.1, the components 
incorporated by the Midlands programme reflect those found to be effective, such 
as clinical guidelines, establishing a patient register and recall system, and protected 
time for review.  The causal link between the context (highlighted physician and 
practice factors) and quality outcome measures established in Chapter 3 is tentative, 
given this link was based largely on evidence from cross-sectional studies.   
 
The thesis is strengthened by using routinely collected data to examine long-term 
service performance. In Ireland, data to study primary care management of diabetes 
are limited. Harnessing existing data collected for service audits is an efficient way to 
obtain ‘added value’ from these data sources [452]  and study real world care 
delivery. However, this thesis was also limited by challenges relating to the use of 
routine data: substantial missing data, using sub-section of population, no 
appropriate comparison data to assess the performance of those participating in the 
structured care programme [452].  Within the structured programme it may have 
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been beneficial to examine patient-level factors and their relationship with 
outcomes, for example, relationship between patient demographic factors, 
medications, their risk profile and development of complications. However, data 
were not available on important factors, including duration of diabetes, and 
medications. Data on complications were also not recorded consistently across 
different audit years. This, together with the missing data in 2003 and 2008, meant 
it was not feasible to examine the development of complications over time.  To 
separate background trends in cardiovascular profile from the potential effect of the 
programme, and control for other practice features (e.g. location, team 
infrastructure, practice size) requires a more rigorous study design and additional 
resources to engage in primary care data collection. Comparison across practices 
delivering more or less structured care would also need to take account of patient 
case mix.  Electronic data capture by DNS on a routine basis could help highlight and 
explain some of the regional variation in how the service is used. For example, there 
may be scope to record more detailed patient information, treatment approaches, 
changes in risk factor profile over time, which would not only help understand the 
impact of the DNS, but potentially identify patients and practices required more 
support or highlight regions which may require more DNS resources. Currently 
activity data collected by DNS is done so manually; and comparing the volume of 
complicated versus uncomplicated patient episodes per DNS provides some limited 
insight into referral patterns.  
 
The availability of national data on patients would afford further scope to address 
some of these issues; i.e. gaps in data and the lack of comparison groups. Although 
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progress has been made, currently there is no national diabetes register and no 
unique health identifier to enable linkage of patient data from different sources e.g. 
general practice and hospital inpatients. The fact that mortality among people with 
diabetes had not been examined in Ireland before this thesis clearly indicates the 
need for change.  Future data from the Cycle of Care or the database established by 
the new national retinopathy screening service, RetinaScreen [453] may serve as a 
basis for a national diabetes register [13, 454]. National data on diabetes prevalence, 
complications and mortality are important to plan and organise health services. This 
data can also allow the health impacts of the disease to be monitored and serve as 
an indicator of improvements in the management of risk factors, or the quality and 
organisation of care.  The data would enable population-level risk factors and long-
term outcomes to be monitored following changes to care delivery (e.g. Cycle of 
Care).  Although the UK has struggled to establish acceptable consent processes for 
extraction and centralised storage of data from EHRs in primary care [455, 456], they 
have been able to reap the benefits of the General Practice Extraction Service, 
examining the quality of diabetes care nationally [457, 458]. They can do, on a large 
scale, what Ireland, as evidenced in this thesis, can only do on a very small scale with 
laborious efforts in data collection and collation [107, 234-237].   
 
Quality indicators used in the international literature on diabetes care varied 
substantially in terms of the individual indicators selected, and whether and how 
these are combined as a composite measure (Chapter 3). Measures of the quality of 
integrated care used by this thesis may have been too limited or should have been 
more closely aligned with international studies (e.g. measures based on QOF, 
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constructing a composite measure from individual measures) [140, 151, 257, 267].  
Although an important dimension for integrated care, culture was not specifically 
measured by this thesis. This is an aspect infrequently examined by existing 
studies[459]. Previous work in Ireland has indicated there may be openness to 
integrated care [32] but with new reforms occurring since then (model of integrated 
care, Cycle of Care, ‘integrated’ DNS) the current climate may be different. Although, 
user evaluation is one dimension of quality (consequences of care) [74], the patient 
perspective is also missing from this thesis. Measuring continuity of care [460] among 
people enrolled in primary care initiatives, or patient experience [461] may extend 
previous work in Ireland which has examined the quality of care from the patient 
point of view [462, 463]. 
 
8.3.1 Risk of bias 
Reporting guidelines were used for Chapter 3 (PRISMA) and Chapter 7 (COREQ). 
Joanna Briggs checklists (observational and cohort studies) were used to reflect on 
the other studies (Chapter 4, 5 and 6). Most consideration is given to the main 
source of bias, namely the processes by which data were measured and collected.  
A number of  issues may have undermined the reliability of measurement of the 
clinical outcome variables used in Chapter 4 and 5.  Firstly, there was no quality 
check performed on the data collected from EHRs. Given this process comprised 
manual data extraction from files onto paper-based audit proforma, there was 
potential for error.  A second concern is the repeatability of the clinical 
measurements. Recorded clinical values were based on the most recent 
measurement on the patient in the last 12 months. Given the variability in HbA1c 
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[464], for example, taking a value at one point in time could be viewed as a limited 
approach. With the introduction of the Cycle of Care, within a 12-month period 
people with diabetes should have at least two sets of blood results. In future audits, 
recording both rather than the most recent value may provide a more reliable 
measure. A final consideration is that certain items may have been less well 
recorded, for example, confirmation of attendance at screening services or 
diagnosis with complications. These were verified by the presence of a letter from 
outpatient services or external providers, or in notes on the patient file, and rely on 
the consistency of certain processes; i.e., updating files and coding complications, 
within each practice.  Poor recording of attendance at dietetic services in 2016 
could reflect a change in service provision or changes in how this was recorded.  
These considerations are also relevant for the follow-up study (Chapter 5). 
Additionally, in Chapter 5 certain important confounders, duration of diabetes, SES, 
were not available and could not be adjusted for and examined as predictors in the 
survival model. In terms of Chapter 6, limitations of the survey instrument should 
be taken into consideration. While the survey was based on one developed in the 
UK, validation appears to have been limited to a pilot of the questionnaire 
conducted among a group of DNS [31]. A similar approach was used for the Irish 
version. While this was valuable to check the clarity of wording and understanding, 
it is insufficient to fully test the validity of the instrument [465, 466]. For example, 
no tests were performed for repeatability. More comprehensive approaches could 
have been used, for example, cognitive interviewing. As part of the cognitive 
interview,  respondents who represent the study group of interest,  can be probed 
face-to-face as they answer questions to gain a better understanding their thinking 
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and whether they truly comprehend the items in the manner intended by the 
researchers [467].  
 
8.4 Future research recommendations 
Although this thesis found that the quality of structured primary care delivery can be 
sustained, this study was not designed to specifically examine and understand 
sustainability. Future qualitative work may be needed to understand what factors 
influence sustainability and why certain interventions, like the Midlands programme, 
are sustained while others are not [409].  
 
The thesis is unable to fully explain variation in quality of care (e.g. process of care 
recording across practices, or the fact there was levelling-off of improvements in 
some processes).  Further qualitative work with purposively sampled patients 
according to whether they received higher or lower quality care (e.g. high-risk 
category or not, care processes recorded or not) and their GPs could help better 
understand management decisions, patient attendance, adherence and self-
management.  
 
Variation in what measures constitute quality of diabetes care in primary suggests 
future work, at least in Ireland, may be needed to obtain consensus on core 
outcomes, including how to construct composites in order to standardise how the 
quality of diabetes care is evaluated.  Since composite measures continue to be 
favoured and used widely to study quality, agreement on a standardised measure 
may be beneficial.  As the data from the Cycle of Care is collected and reviewed, this 
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raises the question of whether fulfilling these care processes will truly constitute 
quality, or will this instead represent, as one DNS suggested, a “tick box”1, unable to 
indicate whether care delivery has really improved. Going forward there is a need for 
consideration of how quality of integrated care in primary care should be measured. 
Is the aim to monitor performance with respect to individual processes/indicators or 
overall? Should practices be considered to have achieved optimal quality of care on 
the basis of an ‘all or nothing’ approach with respect to individual processes, or 
should a quality score be derived from these? If the Cycle of Care is taken as the Irish 
equivalent of QOF then an approach could be modelled on existing studies which 
have constructed a score based on QOF indicators [140, 151, 257, 267], using this to 
examine changes in quality over time [468].  
 
This study of integrated care is limited to the DNS perspective on their role 
integrating management between primary and secondary care. Future research 
should consider eliciting the views of other stakeholders on the service, specifically 
patients and primary care professionals, in line with international approaches to 
evaluating integrated care [198, 210]. Given the apparent variation in how DNS the 
service works within different practices, it would be particularly valuable to explore 
GP or practice nurse perspectives. This would help elucidate whether the service 
meets their needs, and how the role might better support them and operate most 
effectively within general practice. 
 
                                                     
1 DNS participating in the qualitative study and national evaluation study 
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A final recommendation would be to consider exploring the role of practice nurses 
or PHNs in diabetes care, for example examining their education and training needs. 
The author has been involved in the development and administration of a national 
survey on practice nurse role in diabetes. This work is currently been prepared for 
submission. The value of PHNs as a link to reach patients was highlighted by DNS in 
this thesis. Existing work in Ireland has recognised the role of PHNs as “pivotal”, 
calling for greater focus on their role, CPD, and structures for how they communicate 
and work with secondary care [469]. Extending outpatient care to include a period of 
home-monitoring by PHNs has shown some success in terms of improving diabetes 
self-management and control [470, 471]. Inclusion of PHNs as part of the 
interprofessional primary care practice team to deliver stepped-care intervention for 
people with type 2 diabetes has been demonstrated to be feasible [472]. 
8.5 Conclusions 
The prevalence of chronic conditions like diabetes is growing worldwide. The burden 
this confers on health systems has led to a greater focus on integrated care as a way 
to deliver better quality, and more effective care.  This thesis suggests that integrated 
diabetes care may be feasible and sustainable in a real world community setting. 
Structured care can deliver quality improvements over time alongside policy and 
resource changes and integrated management between settings led by nurse 
specialists is made ‘workable’ through innovation and adaptation in a challenging 
context.  This thesis supports the national roll-out of structured care, making this 
accessible to all. However, with respect to integration between settings led by nurse 
specialists, there is a need to move beyond ‘workable’ and feasible, to better 
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10 Appendices  
10.1 Appendix 1 Supplementary files for Chapter 2 
 
 Table 14 EPOC Delivery arrangements 
Category: Changes in how, when and where healthcare is organized and delivered, and who delivers healthcare 
Sub category Definition 
Group versus individual care Comparisons of providing care to groups versus individual patients 
Queuing strategies A reduction or increase in time to access a healthcare intervention 
Coordination of care amongst different 
providers 
Organizing different providers and services to ensure timely and efficient delivery of healthcare. 
Quality and safety systems Essential standards for quality of healthcare, and reduction of poor outcomes related to unsafe healthcare. 
Triage Management of patients attending a healthcare facility, or contacting a healthcare professional by phone, 
and receiving advice or being referral to an appropriate service 
Category: Where care is provided and changes to the healthcare environment 
Sub category Definition 
Environment Changes to the physical or sensory healthcare environment, by adding or altering equipment or layout, 
providing music, art. 
Outreach services Visits by health workers to different locations, for example involving specialists, generalists, mobile units 
Site of service delivery Changes in where care is provided, for example home vs. healthcare facility 
Size of organizations Increasing or decreasing the size of health service provider units 
Transportation services Arrangements for transporting patients from one site to another 
Category: Who provides care and how the healthcare workforce is managed 
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Role expansion or task shifting Expanding tasks undertaken by a cadre of health workers or shifting tasks from one cadre to another, to 
include tasks not previously part of their scope of practice. 
Self-management Shifting or promoting the responsibility for healthcare or disease management to the patient and/or their 
family. 
Length of consultation Changes in the length of consultations 
Staffing models Interventions to achieve an appropriate level and mix of staff, recruitment and retention of staff, and 
transitioning of healthcare workers from one environment to another, for example interventions to 
increase the proportion of healthcare workers in underserved areas. 
Exit interviews A verbal exchange or written questionnaire between employees’ resignation and last working day 
Movement of health workers between 
public and private care 
Strategies for managing the movement of health workers between public and private organizations 
Pre-licensure education Changes in pre-licensure education of health professionals 
Recruitment and retention strategies for 
underserved areas 
Strategies for recruiting and retaining health workers in underserved areas 
Recruitment and retention strategies for 
district health managers - LMIC 
Interventions for hiring, retaining and training district health systems managers in LMIC 
Category: coordination of care and management of care processes 
Sub category Definition 
Care pathways Aim to link evidence to practice for specific health conditions and local arrangements for delivering care. 
Case management Introduction, modification or removal of strategies to improve the coordination and continuity of delivery 
of services i.e. improving the management of one “case” (patient) 
Communication between providers Systems or strategies for improving the communication between health care providers, for example 
systems to improve immunization coverage in LMIC 
Comprehensive geriatric assessment A multidimensional interdisciplinary diagnostic process focused on determining a frail older person’s 
medical, psychological and functional capability to ensure that problems are identified, quantified and 
managed appropriately 
Continuity of care Interventions to reduce fragmented care and undesirable consequences of fragmented care, for example 
by ensuring the responsibility of care is passed from one facility to another so the patient perceives their 
needs and circumstances are known to the provider 
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Discharge planning An individualized plan of discharge to facilitate the transfer of a patient from hospital to a post-discharge 
setting. 
Disease management Programs designed to manage or prevent a chronic condition using a systematic approach to care and 
potentially employing multiple ways of influencing patients, providers or the process of care 
Integration Consolidating the provision of different healthcare services to one (or simply fewer) facilities. 
Packages of care Introduction, modification, or removal of packages of services designed to be implemented together for a 
particular diagnosis/disease 
Patient-initiated appointment systems Systems that enable patients to make urgent appointments when they feel they cannot manage their 
condition or where something has changed unexpectedly 
Procurement and distribution of supplies Systems for procuring and distributing drugs or other supplies 
Referral systems Systems for managing referrals of patients between health care providers 
Shared care Continuing collaborative clinical care between primary and specialist care physicians 
Shared decision-making Sharing healthcare decision making responsibilities among different individuals, potentially including the 
patient. 
Teams Creating and delivering care through a multidisciplinary team of healthcare worker 
Transition of Care Interventions to improve transition from one care provider to another, for example adolescents moving 
from child to adult health services. 
Category: Information and communication technology (ICT) 
Subcategory Definition 
Health information systems Health record and health management systems to store and manage patient health information, for 
example electronic patient records, or systems for recalling patients for follow-up or prevention e.g., 
immunization. 
The use of information and communication 
technology 
Technology based methods to transfer healthcare information and support the delivery of care. 
Smart home technologies Electronic assistive technologies 
Telemedicine Exchange of healthcare information from one site to another via electronic communication 
 
266 
 
Table 15 Other terms used for integrated care 
Term Definition 
Disease management Broadly understood as “any intervention involving coordination of diagnosis, treatment, or other aspects of ongoing 
management by a person or multidisciplinary team in collaboration with or supplementary to the primary care 
provider”[83]. The EPOC definition states that disease management programmes are those “designed to manage or prevent 
a chronic condition using a systematic approach to care and potentially employing multiple ways of influencing patients, 
providers or the process of care”[120]. According to Norris et al. disease management should be ‘proactive’ and ‘multi-
component’ comprised of the following: (1) the identification of the population with diabetes or a subset with specific 
characteristics (2) guidelines or performance standards for care, (3) management of identified people, and (4) information 
systems for tracking and monitoring[167]. 
Shared care Sometimes considered a specific form of integrated care, is characterised by “joint participation” between primary care and 
secondary care to plan the delivery of care, including establishing a specific communication system between specialist 
services and primary care[108]. Shared care is distinct from structured care in that management can be structured and 
organised in primary care without enhancing communication with other services beyond usual referral systems, a feature 
which would distinguish the model as shared care according to the above definition. Approaches falling under the definition 
of shared care include clinics run by specialists in primary care, formal communication systems between primary and 
secondary care, liaison meetings both specialists and primary care professionals attend to discuss patient planning, a patient 
record card (e.g. patient passport), and shared IT systems with electronic communication system[177]. 
Structured care Used to describe primary care delivery as part of national chronic disease management programmes, but can also be used as 
a general term to describe multifaceted interventions outside of these programmes, which focus on structuring and 
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Table 15 Other terms used for integrated care 
Term Definition 
organising care in general practice with[105, 109, 117, 118, 473] or without[175] the provision of additional specialist 
support to GPs. 
Chronic care model Interventions are often guided by Wagner’s Chronic Care Model[474] which suggests organisation with respect to four 
components is important to achieve high-quality care for chronic disease patients: patient self-management support, 
delivery system design, decision support and clinical information systems. Health care organisation and community 
resources and policies are two further overarching components related to management of chronic disease[66, 366]. The 
Chronic Care Model has been used both to operationalise integrated care[213] and classify interventions[157, 160, 168, 169, 
172]. 
Case management Person other than physician has an active role in coordinating diagnosis, treatment and ongoing management[23]. 
Care coordination    “Care coordination is the deliberate organization of patient care activities between two or more participants (including the 
patient) involved in a patient’s care to facilitate the appropriate delivery of health care services. Organising care involves the 
marshalling of personnel and other resources needed to carry out all required patient care activities and is often managed 
by the exchange of information among participants responsible for different aspects of care.”[475] 
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10.1.1 Overview of the Midland Structured Diabetes Care programme 
Overall there is very little data available to evaluate the performance of primary care 
in Ireland[226].  Efforts to examine diabetes care models within the Irish health 
system often rely on data collected as part of primary care initiatives[234, 381]. This 
thesis uses data from the Midlands programme. To date there are 82 GPs and 63 
practice nurses across 30 GP practices, actively participating in the programme, with 
3,797 patients have enrolled since initiation.  Monitoring and audit are a core part of 
the programme; data have been collected by nurse specialists in 1998/1999, 2003, 
2008 and 2016, and four audit reports have been published to date. Practices 
participating in the Midlands programme receive clinical, educational and 
administrative support. The programme incorporates a number of strategies to 
integrate and coordinate diabetes management namely the use of evidence-based 
clinical guidelines, patient register and recall and protected time for review visits, 
ongoing organisation and coordination of care by practice nurses, structured 
multidisciplinary support and professional and patient education. The programme 
incorporates a number of strategies to integrate and coordinate diabetes 
management which align with elements shown to be effective in the international 
literature: team changes[158, 161], for example, access to a multidisciplinary 
team[17, 25, 164]; case management[23, 158], including provision of care in general 
practice by specialists[24, 112, 165] or the partial replacement of physicians by 
nurses in organising care[162, 163]; patient education and self-management[161]; 
interventions to prompt recall and review of patients, including electronic registries 
and tracking systems[161, 163] and; relay to improve patient-provider 
communication[161].
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Table 16 Approaches to quality improvement in diabetes management (EPOC categories) incorporated by the Midland Diabetes 
Structured Care Programme* 
Strategy Description Midlands 
Targeting health systems 
Case management 
 
 
Person other than physician has an active 
role in coordinating diagnosis, treatment 
and ongoing management. 
√ 
Practice nurse leads on organisation and coordination of care 
Team changes Adding a team member or ‘shared care’ i.e. 
routine visits with personnel other than 
primary care team; active participation of 
MDT; expansion or revision of professional 
roles. 
√ 
Enhanced access to multidisciplinary personnel: 
Practice level dietetic support (until 2013) 
Chiropody/podiatry practice support 
Electronic patient registry  √ 
Facilitated relay of clinical 
information to clinicians 
  
Continuous quality 
improvement 
  
Structured care  √ 
Shared care   
Targeting health-care provider  
Audit and feedback  √  
Research and audit is carried out under the Diabetes Structured Care Research 
and Audit Group 
Clinician education  √ 
Annual study days 
5-day Dublin City University accredited programme 
Clinician reminders   
Financial incentives  √ 
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Remuneration for practice nurse time or payment by review visit through 
Heartwatch programme 
Evidence-based guidelines  √ 
“A Practical Guide to Integrated Type 2 Diabetes Care” (2008, 2016) 
Specialist expertise  √ 
Community DNS support at practice level 
Targeting patients  
Patient education  √ 
Patient education programmes provided by DNS and dieticians 
Promotion of self-
management 
 √ 
Practice nurse and group education 
Patient reminder systems   
Abbreviations: MDT, multidisciplinary team; DNS, diabetes nurse specialist 
*Sub-components which are not specific to the EPOC categories are highlighted
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10.2 Appendix 2 Supplementary files for Chapter 3 
Section/topic  # Checklist item  
Reported 
on page #  
TITLE   
Title  1 Identify the report as a systematic review, meta-analysis, or both.  37 
ABSTRACT   
Structured summary  2 Provide a structured summary including, as applicable: background; objectives; data sources; study eligibility criteria, 
participants, and interventions; study appraisal and synthesis methods; results; limitations; conclusions and 
implications of key findings; systematic review registration number.  
38 
INTRODUCTION   
Rationale  3 Describe the rationale for the review in the context of what is already known.  40,41 
Objectives  4 Provide an explicit statement of questions being addressed with reference to participants, interventions, comparisons, 
outcomes, and study design (PICOS).  
41,42 
METHODS   
Protocol and registration  5 Indicate if a review protocol exists, if and where it can be accessed (e.g., Web address), and, if available, provide 
registration information including registration number.  
41 
Eligibility criteria  6 Specify study characteristics (e.g., PICOS, length of follow-up) and report characteristics (e.g., years considered, 
language, publication status) used as criteria for eligibility, giving rationale.  
41,42 
Information sources  7 Describe all information sources (e.g., databases with dates of coverage, contact with study authors to identify 
additional studies) in the search and date last searched.  
43 
Search  8 Present full electronic search strategy for at least one database, including any limits used, such that it could be 
repeated.  
228 
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Study selection  9 State the process for selecting studies (i.e., screening, eligibility, included in systematic review, and, if applicable, 
included in the meta-analysis).  
41,42 
Data collection process  10 Describe method of data extraction from reports (e.g., piloted forms, independently, in duplicate) and any processes 
for obtaining and confirming data from investigators.  
44 
Data items  11 List and define all variables for which data were sought (e.g., PICOS, funding sources) and any assumptions and 
simplifications made.  
44 
Risk of bias in individual 
studies  
12 Describe methods used for assessing risk of bias of individual studies (including specification of whether this was 
done at the study or outcome level), and how this information is to be used in any data synthesis.  
44 
Summary measures  13 State the principal summary measures (e.g., risk ratio, difference in means).  44 
Synthesis of results  14 Describe the methods of handling data and combining results of studies, if done, including measures of consistency 
(e.g., I2) for each meta-analysis.  
44,45 
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Table 17 EMBASE search strategy 
# Search type  Results 
1 diabet*:ti,ab    
 
2 'diabetes mellitus'/exp   
3 1 or 2 
 
924,551 
4 'primary medical care'/exp   
5 'general practitioner'/exp   
 
 
6 'general practice'/exp 
 
 
7 'primary health care'/exp 
 
 
8 'private practice'/exp 
 
 
9 (‘primary care’ or ‘primary health care’ or ‘primary medical care’ or 
‘family practice’ or ‘family doctor’ or ‘family physician’ or ‘family 
practitioner’ or ‘family medicine’ or ‘general practice’ or ‘general 
practitioner’ or GP or ‘private practice’ or ‘private 
practitioner’):ti,ab   
 
 
10 4 or 5 or 6 or 7 or 8 or 9  
 
369,548 
11 (practitioner* or doctor* or physician* or GP or GPs) NEAR/3 
(characteristic* or factor* or attribute* or feature* or pattern* or 
practice*)):ti,ab 
 
 
12 ((practitioner* or doctor* or physician* or GP or GPs) NEAR/2 (age 
or gender or experience or interest or training or knowledge or 
qualification* or education)):ti,ab  
 
13 'clinical education'/exp 
 
 
14 'work experience'/exp 
 
 
15 'working time'/exp  
 
 
16 (‘working hours’ or ‘work hours’ or ‘work experience’):ti,ab     
17 (physician* or practitioner* or doctor* or GP or GPs) NEXT/2 
location):ti,ab 
 
 
18 11 or 12 or 13 or 14 or 15 or 16 or 17 
 
87,160 
19 ((practice* or ‘primary care’ or ‘primary-care’) NEAR/2 
(characteristic* or attribute* or feature* or organi?ation or 
structure*)):ti,ab  
 
20 ((practice* or ‘primary care’ or ‘primary-care’) NEXT/2 (factor* or 
pattern*)):ti,ab  
 
 
21 (organi?ational NEXT/2 (characteristic* or attribute* or feature* or 
structure* or practice* or factor* or determinant*)):ti,ab 
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22 ((healthcare or health-care or ‘health care’) NEXT/2 
organi?ation):ti,ab 
 
 
23 ‘practice management’:ti,ab 
 
 
24 (patient* NEAR/3 (volume or number)):ti,ab 
 
 
25 caseload:ti,ab 
 
 
26 (‘solo practice’ or single-handed or ‘group practice’ or ‘practice 
size’ or ‘size of practice’ or ‘list size’ or ‘panel size’ or ‘diabetes 
prevalence’):ti,ab 
 
 
27 (‘practice type*’ or ‘type of practice*’):ti,ab  
28 ((physician or doctor or nurs* or practitioner) NEXT/1 patient 
NEXT/1 ratio):ti,ab 
 
 
29 'nurse patient ratio'/exp 
 
 
30 (practice* NEAR/2 (location or deprivation)):ti,ab 
 
 
31 ((rural or urban) NEXT/2 practice*):ti,ab 
 
 
32 ((physician* or doctor* or nurs* or administrat* or practitioner*) 
NEAR/3 (volume or number*)):ti,ab 
 
 
33 ((staff or staffing) NEAR/2 (volume or number)):ti,ab 
 
 
34 ((physician* or doctor* OR nurs* or practitioner*) NEAR/3 (training 
or education)):ti,ab 
 
 
35 'staff training'/exp 
 
 
36 (“patient registry” or register or ‘reminder system*’ or ‘recall 
system*’):ti,ab 
 
37 ‘reminder system'/exp 
 
 
38 (‘diabetes protocol’ or ‘diabetes guideline’ or ‘practice protocol’ or 
‘clinical protocol’ or ‘practice guideline’):ti,ab 
 
 
39 'practice guideline'/mj 
 
 
40 'clinical protocol'/mj 
 
 
41 19 or 20 or 21 or 22 or 23 or 24 or 25 or 26 or 27 or 28 or 29 or 30 
or 31 or 32 or 33 or 34 or 35 or 36 or 37 or 38 or 39 or 40 
 
385, 025 
 
42 'health care quality'/exp OR 'quality control'/exp 
 
 
43 ((guideline* OR protocol) NEAR/2 (adhere* OR uptake OR 
compliance)):ti,ab  
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44 (‘standards of care’ OR ‘standard of care’):ti,ab  
45 (quality NEAR/2 (healthcare OR health?care OR care OR indicator* 
OR measure* OR assess* OR  treatment OR score* OR 
metric*)):ti,ab 
 
 
46 ‘quality-of-care score’:ti,ab 
 
 
47 (quality NEAR/3 indicator* NEAR/5 health?care):ti,ab 
 
 
48 ‘optimal care’:ti,ab 
 
 
49 (quality NEAR/2 (assurance OR improvement* OR 
measurement*)):ti,ab 
 
 
50 ((quality OR practice) NEAR/2 (gap OR gaps)):ti,ab 
 
 
51 (variation NEAR/2 care):ti,ab 
 
 
52 (process* NEAR/3 care):ti,ab 
 
 
53 (outcome* NEAR/3 care):ti,ab 
 
 
54 42 or 43 or 44 or 45 or 46 or 47 or 48 or 49 or 50 or 51 or 52 or 53 
 
2,853,079 
55 3 and 10 and 18 and 54  863 
56 3 and 10 and 41 and 54  1679 
57 55 or 56  2228 
58 Limit 57 to English  2082 
59 Search dates 01-01-1990 – 01-07-2017 2071 
Search was conducted in EBSCO
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Table 18 Reasons for exclusion from meta-analysis 
Measure Study references Meta-analysis performed 
Gender[134, 256, 259-261, 263, 268-270, 272, 276, 280, 281, 311-313, 315-317] 
Composite [268, 272, 311-313, 
315, 317] 
No, five studies used continuous measures 
Group level (male/female) mean (SD) were unavailable for 4/5 studies to estimate SMD[268, 272, 311, 313, 
317] 
One study used binary outcome measure[313]  
HbA1c test [134, 260, 269, 270, 
272, 311, 313, 316] 
Yes, data available from at least two studies 
Data NA[260, 269, 311]  
Eye exam [134, 260, 269, 270, 
272, 280, 311, 313, 
316]  
Yes, data available from at least two studies 
Data NA[311]  
Foot check [260, 269, 272] Yes, data available from all studies 
Lipid test [134, 260, 269, 270, 
272, 280, 311, 313, 
316]  
Yes, data available from at least two studies 
Data NA.[134, 269, 311]  
Microalbuminuria 
test 
[134, 260, 269, 272, 
280]  
Yes, data available from at least two studies. 
Data NA[134, 269]  
HbA1c value [256, 260, 272, 276]  Yes, data available from two studies with similar targets (HbA1c <7.0%[260]; HbA1c <8.5%[272]) 
Data NA[276] 
Lipid value [256, 260, 272, 276]  Yes, data available from two studies with similar targets (LDL-C <130[260]; LDL-C <130[272]) 
Data NA[276] 
BP value 
 
[256, 260, 272, 276] Yes, data available from two studies with similar targets (BP >130/85mmHg[260]; systolic BP < 140[272]) 
Data NA[276] 
Age[134, 259, 263, 266, 268, 281, 311, 313, 317, 318] 
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Table 18 Reasons for exclusion from meta-analysis 
Measure Study references Meta-analysis performed 
Composite [268, 311, 313, 317] No, two had available data using same exposure (10 years)[311, 331]  
Measured composite as continuous outcome, but group level (male/female) mean (SD) unavailable to 
estimate SMD 
HbA1c test [134, 311, 313, 318]  No, data NA[311], age measured in different categories[134, 313]  
Lipid test [134, 311, 313, 318]  No, data NA[311], age measured in different categories[134, 313]  
Eye test [311, 313, 318] No, data NA[311], age measured in categories[313] or continuous variable[318] 
Urine albumin [134, 313] No, different age categories used 
Years since graduation[315, 318] or years in practice[256, 259, 261, 280, 316, 317] 
 
Composite [315, 317]  No, only one had data available. 
Eye test [280, 318] No, different exposure variables (>15 years in practice[280]; years since graduation[318]) 
Lipid test [280, 318] No, different exposure variables (>15 years in practice[280]; years since graduation[318]) 
HbA1c value [256, 318] Yes 
LDL-C value [256, 318] Yes 
Training[255, 266, 275, 306, 308, 312, 316, 317] 
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Table 18 Reasons for exclusion from meta-analysis 
Measure Study references Meta-analysis performed 
Composite [255, 312, 317]  No, data NA[312], different exposures (board certified physician or not board certified[317], patients of 
physicians in top quartile of MOC score vs. lowest quartile[255]) 
HbA1c test 
 
[275, 308, 316] No, different exposures (board certification[316] vs. total EBM score[275] vs. postgraduate training in 
diabetes[308]) 
HbA1c value [306, 308] No, different exposures (GP education: dichotomous measure, amount of accredited education less than 
50 hours per year or exactly/more than 50 hours[306],postgraduate training in diabetes[308]) 
BP value [306, 308] No, different exposures (GP education: dichotomous measure, amount of accredited education less than 
50 hours per year or exactly/more than 50 hours[306], postgraduate training in diabetes[308]) 
Panel size and workload[140, 252, 256, 261, 267, 268, 277, 281, 282, 284, 311-313, 317] 
 
Composite [140, 267, 277, 311, 
313, 317, 331] 
No, different exposure variables (panel in groups of 200 patients[311], categorised as ≥1500 vs. < 1500 
patients[313], number of patients[317], list size (effect by 100)[331], panel size above the mean (>2959) vs. 
those below mean[277], list size per FTE GP[140, 267] 
HbA1c test [282, 284, 311, 313] No, data NA[311], different exposure variables (≥1500 vs. < 1500[313]; volume per day <20, 20-35, 25-30, 
30-40,>40[284]; performance levels across panel size 1200, 1500, 1800, 2100, 2400[282]) 
Lipid test [282, 284, 311, 313] No, data NA[311], different exposure variables (≥1500 vs. < 1500[313]; volume per day <20, 20-35, 25-30, 
30-40,>40[284]; performance levels across panel size 1200, 1500, 1800, 2100, 2400[282]) 
Eye test [282, 284, 311, 313] No, data NA[311], different exposure variables (≥1500 vs. < 1500[313]; volume per day <20, 20-35, 25-30, 
30-40,>40[284]; performance levels across panel size 1200, 1500, 1800, 2100, 2400[282]) 
HbA1c value [140, 256] No, different exposure variables (number of patients seen in a typical month; list size per FTE GP[140]) 
BP value [140, 256] No, different exposure variables (number of patients seen in a typical month; list size per FTE GP[140]) 
Lipid value [140, 256] No, different exposure variables (number of patients seen in a typical month; list size per FTE GP[140]) 
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Table 18 Reasons for exclusion from meta-analysis 
Measure Study references Meta-analysis performed 
ACE/ARB 
prescribed 
[252, 282, 284]  No, different exposure variables (volume per day <20, 20-35, 25-30, 30-40,>40[284]; performance levels 
across panel size 1200, 1500, 1800, 2100, 2400[282], number of patients per GP in percentiles[252]) 
Diabetes volume[134, 261, 278-281, 284, 322] 
Lipid test [134, 278-280, 284, 
303] 
 
Yes[278, 280] 
Data NA[134], different exposures (diabetes-specific volume in increments of 100[284], number of patients 
with diabetes (<55, 56-70, 71-85,>85; <55 = reference)[134], volume in quintiles[278], per 10 patients with 
diabetes treated annually[279], number of patients with diabetes >20[280]; annual volume in 
quartiles[303] 
 
Reported predictive margins[284] 
HbA1c test [134, 278, 279, 284, 
303] 
Yes[134, 278, 279] 
Reported predictive margins[284]  
Eye test [134, 278-280, 284, 
303] 
 
Yes[278, 280] 
Reported predictive margins[284]  
Data NA[134, 279] 
Microalbuminuria 
test 
[134, 280, 303] No, data NA[134], different exposure variables (number of patients with diabetes >20[280]; annual volume 
in quartiles[303]) 
Credential (MD or DO)[288, 311, 318] 
Composite [288, 311] No, data NA[311] 
HbA1c test [311, 318] No, data NA[311] 
Nephropathy 
check 
[311, 318] No, data NA[311] 
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Table 18 Reasons for exclusion from meta-analysis 
Measure Study references Meta-analysis performed 
Eye test [311, 318] No, data NA[311] 
HbA1c value [288, 318] No, data NA[288] 
Cholesterol value [288, 318] No, data NA[288] 
Practice size[138, 140, 142, 144, 150, 259, 262, 267, 290, 301, 304, 312] 
 
Composite [140, 262, 267, 290, 
312] 
No, data NA[312]  
Studies with available data used different exposure variables (number of patients during a census 
period[290], size of service population <=500, 501-999 or >= 1000[262], number of patients[140, 267]) 
HbA1c test [138, 142, 150, 304] No, data NA[142], different exposure (number of patients[304], list size per 1000s[150]), or outcome 
(improvement in quality[138]) 
Lipid test [138, 142, 144] No, data NA[142], different outcome (improvement in quality[138]), did not carry out detailed statistical 
analysis.[144] 
BP test [138, 142, 144, 150] No, data NA[142], different outcome (improvement in quality[138]), did not carry out detailed statistical 
analysis[144] 
Eye test [142, 144, 150, 302] No, data NA[142, 150], did not carry out detailed statistical analysis[144] 
Foot check [142, 144, 150] No, data NA[142],did not carry out detailed statistical analysis[144] 
Microalbuminuria 
check 
[142, 144, 150] No, data NA[142],did not carry out detailed statistical analysis[144] 
HbA1c value [138, 140, 142, 144, 
150, 301, 304] 
No, data NA[142, 150, 301], different outcome (improvement in quality[138]), did not carry out detailed 
statistical analysis[144] 
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Table 18 Reasons for exclusion from meta-analysis 
Measure Study references Meta-analysis performed 
 
BP value [138, 140, 144, 301] No, data NA[301], different outcome (improvement in quality[138]), did not carry out detailed statistical 
analysis[144] 
Cholesterol value [138, 140, 144, 301] No, data NA[301], different outcome (improvement in quality[138]), did not carry out detailed statistical 
analysis[144] 
Practice location (urban compared to rural practices).[135, 253, 259, 286-288, 311-313, 317] 
Composite [135, 262, 286, 288, 
311-313, 317] 
Yes[135, 288, 311, 313, 317], three with binary outcome[135, 288, 313], two with continuous but group 
level (urban/rural) mean (SD) unavailable to estimate SMD 
HbA1c test [253, 287, 311, 313, 
318] 
No, data NA[311, 313], different exposure variable (uses region not urban v. rural[318]), reports adjusted 
proportions[253], analysis not adjusted for confounders[287] 
Lipid test [253, 287, 295, 311, 
313, 318] 
No, data NA[311, 313], different exposure variable (uses region not urban v. rural[318]), reports adjusted 
proportions[253], adjusted mean %[295], analysis not adjusted for confounders[287] 
Eye test [253, 287, 295, 311, 
313, 318] 
No, data NA[311, 313], different exposure variable (uses region not urban v. rural[318]), reports adjusted 
proportions[253], adjusted mean %[295], analysis not adjusted for confounders[287] 
Solo or single-handed to group practices[140, 252, 256-259, 267, 285, 289, 306, 313, 316, 318] 
Composite [140, 267, 285, 313] Yes, two with binary outcome measure[285, 313] 
HbA1c test [313, 316, 318]  Yes 
Lipid test [313, 318] Yes 
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Table 18 Reasons for exclusion from meta-analysis 
Measure Study references Meta-analysis performed 
Eye test [313, 316, 318] Yes 
HbA1c value [140, 289, 306, 318] No, different outcome variables (mean difference in % achievement between solo and group[289], HbA1c 
<7.4%[140], % HbA1c[306], HbA1c poorly controlled rate[318]) 
Lipid value  [140, 289, 306, 318] No, different outcome variables (mean difference in % achievement[289], total cholesterol ≤5mmol/l[140], 
total cholesterol[306],LDL-C poorly controlled rate[318]) 
BP value [140, 289, 306] 
 
No, different outcomes (mean difference in % achievement[289], BP ≤150/90 mmHg[140], total SBP (mm 
Hg)[306]) 
Practice deprivation[140, 144, 150, 151, 265, 267, 289, 293, 301, 312]   
Composite [140, 151, 267, 293, 
312] 
No, continuous outcome measure 
HbA1c test [150, 265] Reported as standardised beta coefficient.[265] 
Eye test [150, 265] Reported as standardised beta coefficient.[265] 
HbA1c value [140, 144, 150, 289, 
301]  
No, data NA[150], reported mean difference in % achievement[289], did not carry out detailed statistical 
analysis[144], different outcomes[140, 301] 
BP value [140, 144, 289, 301]  No, reported mean difference in % achievement[289], did not carry out detailed statistical analysis[144], 
different outcomes[140, 301] 
Lipid value [140, 144, 289, 301]  No, reported mean difference in % achievement[289], did not carry out detailed statistical analysis[144], 
different outcomes[140, 301] 
Practice prevalence of diabetes[140, 144, 150, 259, 263, 267, 268, 289, 293, 299, 301, 312]  
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Table 18 Reasons for exclusion from meta-analysis 
Measure Study references Meta-analysis performed 
Composite [140, 267, 268, 293, 
299, 312] 
No, continuous outcome measure 
HbA1c value [140, 144, 150, 289, 
301] 
No, reported mean difference in % achievement[289], did not carry out detailed statistical analysis[144], 
different outcomes[140, 301] 
Lipid value [140, 144, 150, 289, 
301] 
No, reported mean difference in % achievement[289], did not carry out detailed statistical analysis[144], 
different outcomes[140, 301] 
BP value [140, 144, 150, 289, 
301] 
No, reported mean difference in % achievement[289], did not carry out detailed statistical analysis[144], 
different outcomes[140, 301] 
EHRs at the practice[135, 254, 256, 285, 286, 294, 296-298, 302, 306, 307, 310, 311, 314, 316] 
Composite [254, 285, 286, 294, 
297, 298, 302, 310, 
311, 314] 
Yes, four studies using the same exposure (EHR vs. no EHR)[254, 285, 294, 311]  
HbA1c test [296, 307, 310, 311] No, data NA[296, 311], matched pairs[307], difference in means[310] 
Eye exam [296, 307, 310, 311] No, data NA[311], matched pairs[307], difference in means[310] 
HbA1c value [256, 306, 310] Yes[256, 306], adjusted difference in means[310] 
BP value [256, 306, 310] Yes[256, 306], adjusted difference in means.[310] 
Lipid value [256, 306, 310] Yes[256, 306], adjusted difference in means.[310] 
Number of GPs[135, 150, 151, 252, 268, 286, 290, 309, 312, 315] 
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Table 18 Reasons for exclusion from meta-analysis 
Measure Study references Meta-analysis performed 
Composite [151, 268, 286, 290, 
309, 312, 315] 
No, exposure unclear[151, 312], different exposures (i.e. categorised per session rather than per 
practice[290],  categorised as two or more GPs[135], as % of GP on the team[331]), did not adjust for 
confounders[319], examined the improvement in quality score[286] 
HbA1c test [150, 151, 286] No, did not conduct detailed statistical analysis[151], examined the improvement in quality score[286] 
Eye exam [150, 151, 286] No, did not conduct detailed statistical analysis[151], examined the improvement in quality score[286] 
Foot check [150, 151, 286] No, did not conduct detailed statistical analysis[151], examined the improvement in quality score[286] 
Microalbuminuria 
test 
[150, 151] No, did not conduct detailed statistical analysis[151] 
Nurse practitioner (NP) or physician assistant (PA) involvement[143, 256, 258, 259, 287, 292, 300, 304, 305] 
HbA1c test [143, 264, 287, 304, 
305] 
No, no adjustment for confounders[287], reports difference in proportions[264], different exposure 
variables (PA vs. physician only[143], PA/NP role type[304], care delivery by NP[305]) 
Lipid test [143, 264, 287, 305] No, no adjustment for confounders[287], reports difference in proportions[264], different exposure 
variables (PA vs. physician only[143], care delivery by NP[305]) 
ACE/ARB: [143, 305] 
 
No, different outcomes (microalbumin in urine >30 mg in 24 hr and on an ACE inhibitor or ARB[143], 
prescription of ACE/ARB[305]) 
Lipid-lowering 
drugs 
[136, 143, 305] 
 
No, different exposures (presence of diabetes assistant at practice[136], different outcomes 
(LDL-cholesterol ≤100 mg/dL, or >100 mg/dL and on a lipid lowering agent[143],: use of statin[305]) 
BP-lowering 
drugs 
[136, 143] 
 
No, different exposures (presence of diabetes assistant at practice[136], practices with NP vs. PA, NP vs. 
Physician only, PA vs. Physician only[143]) 
Glucose-lowering 
drugs 
[136, 143] No, different exposures (presence of diabetes assistant at practice[136], practices with NP vs. PA, NP vs. 
Physician only, PA vs. Physician only[143]) 
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Table 18 Reasons for exclusion from meta-analysis 
Measure Study references Meta-analysis performed 
HbA1c value [143, 256, 264, 300, 
304] 
No,  reports difference in proportions[264], no adjustment for confounders[300], different exposure 
variables (PA involvement[256], PA vs. physician only[143], PA/NP role type[304]) 
Cholesterol value [143, 256, 264] No,  reports difference in proportions[264], different exposure variables (PA involvement[256], PA vs. 
physician only[143] 
BP value [143, 256, 264] No,  reports difference in proportions[264], different exposure variables (PA involvement[256], PA vs. 
physician only[143] 
Composite [135, 140, 267, 290, 
312] 
No, data NA[312], different exposure variables (number of nurses at the practice[290], whether the 
practice had a nurse[135], list size per nurse[140, 267]) 
HbA1c value [140, 150, 306] No, different exposure variables (number of nurses at the practice[290],list size per nurse[140, 267, 306]), 
different outcomes (HbA1c <7.4%[140], HbA1c value[306]) 
BP value [140, 306] No, different outcomes (BP <145/85[140], total SBP[306]) 
Cholesterol value [140, 306] No, different outcomes (cholesterol <5mmol/l[140], total cholesterol[306]) 
Staff/clinician ratios[257, 285, 288] 
Composite [257, 285, 288] No, different exposure variable 
Team tenure[257, 288, 315] 
Composite [257, 288, 315] No, data NA[257], different exposure variables (“Team tenure” is defined as the number of years that each 
physician has worked with the majority of physicians currently constituting the team—a range of zero to 19 
years in the practices studied[315], clinician Associate years working in the current dyad (tenure)[288] 
Booking interval length[151, 257] 
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Table 18 Reasons for exclusion from meta-analysis 
Measure Study references Meta-analysis performed 
  No statistical test[151] 
Use of a register or recall system[141, 150, 256, 291, 306, 308, 312] 
Composite [141, 312] No, different outcomes (continuous score[312], optimal QoC score (binary)[141]) 
HbA1c test [150, 291, 308] No, different outcomes (difference in proportions[291], difference in means[308]), different exposures 
(register[291], recall[150], reminder or register[308]) 
BP test [150, 308] No, different outcomes (difference in means[308]), different exposures recall[150], reminder or 
register[308]) 
Eye exam [150, 308] No, different outcomes (difference in means[308]), different exposures recall[150], reminder or 
register[308]) 
HbA1c value [150, 256, 306, 308] No, different outcomes (difference in means[308], OR highest vs. lowest quartile[306]), different exposures 
(register[256], recall[150], reminder or register[308], recall or register[306]) 
BP value [256, 306, 308] No, different outcomes (difference in means[308], OR highest vs. lowest quartile[306]), different exposures 
(register[256], reminder or register[308], recall or register[306]) 
Cholesterol value [256, 306, 308] No, different outcomes (difference in means[308], OR highest vs. lowest quartile[306]), different exposures 
(register[256], reminder or register[308], recall or register[306]) 
Guidelines[141, 306, 314] 
Composite [141, 314] No, different outcomes (mean quality score[314], optimal quality score[141]) 
Education programmes[135, 141, 312] 
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Table 18 Reasons for exclusion from meta-analysis 
Measure Study references Meta-analysis performed 
Composite [135, 141, 312] No, different outcomes (binary[135, 141], continuous[312]) 
Nurse training[288, 300, 306, 308] 
Composite [288, 300, 306, 308] No, different exposures (CAs, RNs, LPNs), or MAs[288], nurse education (hours per year)[306], nurse with 
diabetic training[308]), no adjustment for confounders[300] 
Diabetes clinic[150, 306, 312] 
 
 
HbA1c value [150, 306] No, different outcomes (HbA1c ‘normal’ - Since normal ranges for glycated haemoglobin vary between 
different centres,1 the cut-off for the respective local laboratories was taken as normal[150]; OR in highest 
vs. lowest quartile for HbA1c[306]) 
Abbreviations: ACE, Angiotensin Converting Inhibitor; ARB, Angiotensin II Receptor Blockers; EHR, Electronic Health Record; NA, Not available; SMD, 
Standardised mean difference; EBM, Evidence-based medicine; MOC, Maintenance of Certification; BP, blood pressure; CAs, clinical associates; RNs 
registered nurses; LPNs, licensed practical nurses; MA, medical assistants; MD, doctor of medicine; DO, doctor of osteopathic medicine; OR, Odds Ratio;  
If they were not listed then all other individual outcomes were only examined by one study or by studies which did not conduct statistical analysis or 
adjust for confounders. 
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Table 19 Studies which used a composite measure of quality (n = 34).  
Reference Factors Composite Results 
Kern et 
al.[311] 
Physician 
Practice 
Continuous 
 
Number of eligible patients receiving four indicators of 
recommended care (HbA1c test, eye exam, LDL-C, 
nephropathy) divided by the total number of eligible 
patients for that measure. Compared each physician’s 
performance on each measure to NCQA’s 2008 national 
benchmark for that measure, and then expressed the 
physician’s performance as the number of standard 
deviations from that benchmark. 
 
Composite quality score for each physician = average 
of the standard deviations across measures.  
Lower performance among older physicians (10-year increase) (β = 
−0.238, p = 0.001), family medicine vs. internal medicine 
physicians (β = -0.640, p <0.001). 
 
Higher performance among female physicians (β = 0.422 (p 
=0.005), practice with EHR vs. paper (β = 0.373, p = 0.008). 
 
n.s. (non-significant) results for practice location, panel size and 
physician credentials. 
Alberti et 
al.[312]║ 
Physician 
Practice 
Continuous 
 
Non-weighted process-of-care score: assigning to each 
patient a score of 1 for each measurement undertaken 
(fasting glucose assessment, BP, weight, total 
cholesterol, creatinine, foot examination, cardiovascular 
examination, electrocardiogram, eye exam, HbA1c in 
last year) 
(maximum score: 10). 
 
Higher weighted process of care scores among physicians with 
higher motivation (β = 0.37, 95% CI: 0.22-1.68, p = 0.013), and 
higher affluence practices (β = 0.51, 95% CI: 0.12-0.53, p = 0.003). 
 
n.s. results for physician gender, training, workload, time 
commitment, practice interest, number of clinicians, location, 
practice size, frequency of medical clinics, distance from capital 
city, use of disease register, disease specific medical records, total 
patients, diabetes prevalence, equipment, patient education 
sessions, availability of medication, patient affluence. 
289 
 
Table 19 Studies which used a composite measure of quality (n = 34).  
Reference Factors Composite Results 
Weighted process-of-care score: Glucose and BP 
measurement given a weighted score of 4 rather than 1; 
other measurements remained with a score of 1 
(maximum score: 16). 
 
Four-variable outcome-of-care score:  calculated based 
on how many of the targets (BP <140/80 mmHg; fasting 
glucose ≤7.8mmol/l; total cholesterol ≤5mmol/l; BMI 
≤25 kg/m2) achieved. A score was assigned to each 
patient based on the proportion of targets achieved. 
 
Two-variable outcome-of-care score: calculated using 
fasting glucose and blood pressure levels only. Assigned 
score of 2 for good control, 1 for borderline control, and 
0 for poor control for both fasting glucose and blood 
pressure using a denominator of 2 (if only one variable 
recorded) or 4 (if both variables recorded). 
 
Reliability: The scores were assessed for normality, and 
the value of Cronbach’s alpha was calculated to 
measure the internal consistency of each score. 
Fantini et 
al.[313]║ 
Physician 
Practice 
Dichotomised 
 
Six indicators: receipt of HbA1c (at least 2), 
microalbuminuria (any test), creatinine (any test), lipid 
profile (at least 1), electrocardiogram, retinal eye 
examination by ophthalmologist or optometrist. 
Better management in group practices (vs. those with no 
organisational arrangement) (OR = 1.179, 95% CI: 1.010-1.376). 
 
Worse management among males (vs. females) (AOR = 0.81, 95% 
CI 0.71-0.93). 
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Table 19 Studies which used a composite measure of quality (n = 34).  
Reference Factors Composite Results 
 
Composite: % with good management. 
n.s. results for patients on roster (≥1500 vs. < 1500), location (rural 
vs. urban; mountain vs. urban), physician age. 
Keating et 
al.[314]*║¶β 
Physician 
Practice 
Continuous 
 
Quality of care score = six indicators for which care 
performed according to defined standards (HbA1c <8% 
(if none documented, defined as poor control); LDL 
<100mg/dl (none documented = poor control); BP 
<130/80mmHg; nephropathy, retinopathy, and foot 
disease assessment. 
n.s. results for physician satisfaction with career, % incomes from 
incentives, use of email for communication, use of EHR, use of 
guidelines for diabetes, flow sheets, type of practice payment. 
Parkerton et 
al.[315] β 
Physician 
Practice 
Continuous 
 
The rates for each physician’s patients across four 
indicators were averaged for the full year and their 
means computed to form the aggregate measures: 
microalbuminuria test (rates), HbA1c test (rates), 
(annual) retinal exam, and (annual) foot exam. 
Better management in shared practices (β = 0.248 p < 0.05), and 
larger medical clinics (β = 0.252 p < 0.05), with longer team tenure 
(β = 1.241 p <0.001). 
 
n.s. results for physician gender, administrative role, years since 
graduation, continuity. 
Vinker et 
al.[317] 
Physician 
Practice 
Continuous 
 
The performance of each physician on each indicator 
was ranked and then divided into quartiles. According 
to the quartile, the physicians’ performance was ranked 
as 1 for those with indicator performance score in the 
first quartile, 2 for the second, 3 for the third, and 4 for 
the fourth quartile. Total score was the total of new 
quartile ranks for all quality indicators. 
 
Greater diabetic care score in 2003 (β = 0.185, p < 0.05) and 
diabetic control score in 2003 (β = 0.196, p < 0.05) and 2005 (β = 
0.348, p < 0.05) among board certified physicians (vs. non-board 
certified physicians) 
  
n.s. results for physician age, gender, managerial position, years in 
practice, workload, practice location. 
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Table 19 Studies which used a composite measure of quality (n = 34).  
Reference Factors Composite Results 
Diabetic care score (six indicators): sum of quartile 
ranks for eye exam, HbA1c test, urine microalbumin, 
LDL, HbA1c <7%; LDL < 100mmol/mol. 
 
Diabetic control score (two indicators): sum of quartile 
ranks for HbA1c <7%; LDL < 100mmol/mol. 
Visca et 
al.[268]║ 
Physician 
Practice 
Continuous 
 
Composite of four indicators: adherence to guidelines: 
(at least one during year) GFR or serum creatinine, 
HbA1c test, lipid profile, eye exam 
(score ranged from 0 to 4). 
Lower adherence among older physicians (effect x 10 years) (β = - 
0.092 (95% CI: -0.123, -0.061)), greater number of patients 85+ (β 
= -0.004 (95% CI: -0.007, -0.001)). 
  
Greater adherence among female physicians (β = 0.058, 95% CI: 
0.022-0.094), practices with greater list size (effect x 100) (β = 
0.009, 95% CI: 0.004-0.014), greater number of patients with dx >4 
years (β = 0.003, 95% CI: 0.001-0.005), greater number of GPs on 
team (β = 0.016, 95% CI: 0.006-0.026), and financial incentives (β = 
0.085, 95% CI: 0.022-0.147). 
 
n.s. results for physician panel diabetes prevalence, practice types. 
Bower et 
al.[257] 
Practice Continuous 
 
18 indicators based on QOF 
• In past 14 months: HbA1c, foot check, 
creatinine, proteinuria, eye exam, weight, BP, 
hypo symptoms if patient taking sulphonylurea 
• In past 5 years: cholesterol, diabetes education, 
smoking status, smoking advice, weight advice 
Better management associated with higher number of staff (β = 
0.54, 95% CI: 0.12-0.96, p = 0.014), longer booking interval (β = 
9.70, 95% CI: 2.79-16.63, p = 0.007). 
 
n.s. results for practice type, deprivation practice payments, 
training status, length employment practice staff, skill-mix. 
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Table 19 Studies which used a composite measure of quality (n = 34).  
Reference Factors Composite Results 
• Offer BP treatment: <80 years if DBP>100 
mmHg, or BP >150/90 mmHg; > 80 years if DBP 
>110 mmHg, or BP >160/100mmHg  
• Treatment: prescribed ACEi inhibitor, creatinine 
and potassium (measured within one month of 
ACEi), taking ACEi (if hypertension and 
proteinuria), therapeutic intervention for 
glycaemic control ( <70, if HbA1c was >9; >70, if 
HbA1c was >10), referral to a specialist if serum 
creatinine is >200 mmol/l 
 
Composite: scored on a 0/1 basis; patient scores 
obtained for each condition from the rescaled residuals 
of the item response model and rescaled to range from 
0 to 100.  
Bredfelt et 
al.[283]¶β 
Practice Continuous 
 
In year of study performance of 10 indicators: foot 
exam, eye exam, nephropathy assessment, smoking 
assessment/counselling, value and proportion of values 
above or below the cut-off values for each physician: 
HbA1C, LDL, BP. 
 
Indicators combined to produce one overall score that 
ranges from 0 to 100. 
Improvement in scores among practice using out of office 
communication with patients: secure messaging (4.7, p < 0.01) or 
phone (1.3, p< 0.1), both (1.6-unit increase). 
Campbell et 
al.[151] 
Practice  Continuous 
 
Higher scores among larger (vs. smaller) practices (adjusted 
difference: 2.16, 95% CI: 0.22-4.10), p = 0.029), and practices with  
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Table 19 Studies which used a composite measure of quality (n = 34).  
Reference Factors Composite Results 
18 indicators based on QOF 
• In past 14 months: HbA1c, foot check, 
creatinine, proteinuria, eye exam, weight, BP, 
hypo symptoms if patient taking sulphonylurea 
• In past 5 years: cholesterol, diabetes education, 
smoking status, smoking advice, weight advice 
• Offer BP treatment: <80 years if DBP>100 
mmHg, or BP >150/90 mmHg; > 80 years if DBP 
>110 mmHg, or BP >160/100mmHg  
• Treatment: prescribed ACEi inhibitor, creatinine 
and potassium (measured within one month of 
ACEi), taking ACEi (if hypertension and 
proteinuria), therapeutic intervention for 
glycaemic control ( <70, if HbA1c was >9; >70, if 
HbA1c was >10), referral to a specialist if serum 
creatinine is >200 mmol/l 
 
Composite: calculated a score for each practice by using 
a random intercept constant only multilevel model 
(patients within practices). This is equivalent to 
calculating a mean score for each practice but adjusting 
for different pools of patients in different practices and 
the fact that many items were conditional variables that 
did not apply to all patients (for example, action to be 
taken if cholesterol exceeded a certain value). Only 
items that were applicable for individual patients were 
included in the score for the practice. 
Higher (10 minute) vs. lower (5 minute) booking intervals 
(adjusted difference 10.0, 95% CI: 1.06-18.95, p = 0.028). 
 
n.s. results for practice deprivation. 
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Table 19 Studies which used a composite measure of quality (n = 34).  
Reference Factors Composite Results 
Cebul et 
al.[310]║ 
Practice Dichotomised 
 
Care standards (all or none composite) based on four 
indicators: test for HbA1c value, urinary microalbumin 
or prescription of an angiotensin-converting–enzyme 
inhibitor or an angiotensin-receptor blocker, an eye 
examination to screen for diabetic retinopathy, 
pneumococcal vaccination.  
 
Intermediate outcome standards (all or none 
composite) based on five indicators: HbA1c < 8%, BP < 
140/80 mm Hg, LDL < 100 mg/dl or documented 
prescription for a statin medication, BMI < 30, and non-
smoking status. 
Higher performance among EHR (vs. paper-based) sites: adjusted 
difference 35.1 percentage points (95% CI: 28.3-41.9, p <0.001) 
across all practices. 
 
Higher performance among EHR (vs. paper-based) sites: adjusted 
difference 15.2 percentage points (95% CI: 4.5-25.9, p = 0.005). 
Crosson et 
al.[285]║ 
Practice  Dichotomised 
 
Five indicators: HbA1c (in last 6 mths), urine 
microalbumin (last 12 mths), smoking status (last 5 
mths), LDL (last 12 mths), BP record (at each of 3 
previous visits). 
 
Composite: scored 1 if 3 or more of the 5 criteria were 
met and 0 if fewer than 3 criteria were met. 
 
Three indicators: HbA1c ≤8% or >8% on hypoglycemic 
agent; LDL≤100mg/dl or >100mg/dl if on lipid-lowering 
Higher performance among EHR (vs. without) and physician-
owned practices, and lower performance among solo practices (vs. 
group practices). 
 
 
 
 
AOR = 2.25, 95% CI:1.42-3.57, p <0.001 [EHR].  
AOR = 0.38, 95% CI: 0.17-0.87, p = 0.02 [Solo]. 
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Reference Factors Composite Results 
agent; BP ≤130/85mmHg or >130/85 mmHg and on 
antihypertensive medication 
 
Composite 1: patients meeting all three outcome 
targets were given a score of 1, with all others scoring 0.  
 
Composite 2: patients were given a score of 1 for partial 
achievement (if 2 of 3 laboratory values were at or 
below the target value). 
 
Composite 3: patients were given a score of 1 for 
complete achievement (if all 3 laboratory values were at 
or below the target value). 
 
 
 
AOR = 1.67, 95% CI:1.07-2.60, p = 0.02 [EHR]. 
AOR = 0.63, 95% CI: 0.41-0.98, p = 0.04 [Solo]. 
 
AOR = 1.44, 95% CI: 1.05-1.18, p = 0.02 [physician-owned]. 
AOR = 1.67, 95% CI:1.25-2.24, p <0.001 [EHR]. 
 
 
AOR = 2.68, 95% CI:1.49-4.82, p = 0.001 [EHR] 
 
 
n.s. results for staff/clinician ratios 
Dickinson et 
al.[286]║  
Practice Continuous 
  
Nine indicators within the 12 months before the end of 
each audit period: HgA1c, foot exam, BP, eye exam, 
cholesterol, nephropathy screen, flu shot, nutrition 
counselling, self-management support. 
 
Composite score: ranging from 0 to 9. 
Greater improvement in rural practices among intervention arms 
(RAP: +0.70 p = 0.006, CQI: +2.44 p <0.001). 
 
Greater improvement in urban among control arm (SD: −0.75, p = 
0.004). 
 
Greater improvement in smaller practices among intervention 
arms (RAP: +0.56 p = 0.02; CQI: +1.96 p <0.001; SD n.s.). 
 
n.s. results for EHR, % Medicare patients. 
Erickson et 
al.[288] 
Practice Dichotomised 
 
Higher likelihood of quality goal with longer clinician tenure (p = 
.0319) [data not available], among practices with registered nurse 
(vs. licensed practical nurse) (AOR = 1.37, 95% CI: 1.01-1.84, 
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Table 19 Studies which used a composite measure of quality (n = 34).  
Reference Factors Composite Results 
Performance of five indicators: nontobacco use, daily 
aspirin use, BP < 130/80 mm Hg, LDL-C <100 mg/dL, 
HbA1c <7.0%. 
 
Composite: % patients with diabetes between the ages 
of 18 and 74 who met the goal in all 5 metrics defined 
by the health system at the time of the study. 
 
p<0.001), practices with MD/Doctor of Osteopathic medicine (vs. 
associate provider) (AOR = 2.33, 95% CI: 1.23-4.41, p = 0.022), 
rural practices (vs. urban) (AOR = 1.14, 95% CI: 0.82-1.57, p = 
0.78). 
 
Lower quality among practices with medical assistant (vs. licensed 
practical nurse) (AOR = 0.60, 95% CI: 0.44-0.81, p <0.001)). 
 
n.s. results for team tenure, allied health staff-to-clinician ratio. 
Esterman et 
al.[135] 
Practice Dichotomised 
 
Completion of Annual Cycle of Care based on nine 
indicators**:  HbA1c test (annual); eye examination 
(every two years); BMI measurement (twice yearly), 
blood pressure (twice yearly), feet check (twice yearly); 
total cholesterol (annual), triglyceride (annual), HDL 
cholesterol test (annual), microalbuminuria (annual). 
Greater likelihood of completion among practices with chronic 
disease-focused nurse (AOR = 2.01, 95% CI: 1.07-3.77, p = 0.036), 
practices with patient education events (AOR = 1.92, 95% CI: 1.21-
3.06, p= 0.004). 
 
n.s. number of GPs, chronic disease planning software, audit and 
feedback, metropolitan practice, presence of practice nurse, 
corporate practice, co-located allied health professionals, regular 
MDT meetings, staff education, shared EHR. 
Griffiths et al. 
2010[140] 
Practice Continuous 
 
Composite: overall population achievement for 18 QOF 
indicators for diabetes (see Campbell et al.. above). 
 
 
Greater performance associated with higher % female physicians 
(β = 0.394, SE = 0.112, p < 0.001), higher % trained in UK (β = 
0.613, SE = 0.130, p < 0.001), lower list size per FTE nurse (Q1: β = 
1.935 SE = 0.604, p <0.01; Q2: β = 1.777, SE = 0.618, p <0.05; Q3: β 
= 1.505, SE = 0.630, p <0.05; Q4: β = 1.430, SE = 0.627, p <0.05). 
 
n.s. results for diabetes prevalence, % patients ethnic minority, % 
≥65 years, practice population density, deprivation, practice size, 
% physicians ≥45 years. 
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Reference Factors Composite Results 
Griffiths et al. 
2011[267] 
Practice Continuous 
 
Composite: overall population achievement for 18 QOF 
indicators for diabetes (see Campbell et al.. above). 
 
Greater performance associated with higher % qualified in UK (β = 
0.694, SE = 0.080, p < 0.001), lower list size per FTE nurse 
associated with greater quality of care score (Q1: β = 1.227, SE = 
0.166, p <0.001; Q2: β = 1.603, SE = 0.287, p < 0.001; Q3: β = 
1.352, SE = 0.298, p < 0.001; Q4: β = 1.093, SE = 0.300, p < 0.001; 
Q5: β = 0.990, SE = 0.302, p < 0.01), clinical recording (β = 2.632, 
SE =0.235, p < 0.001) and education & training (β = 0.900, SE 
=0.144, p < 0.001). 
 
Lower performance associated with greater area density (β = -
0.317, SE = 0.082, p < 0.001), higher diabetes prevalence (β = -
0.571, SE = 0.081, p <0.001), higher % patients ≥65 years (β = -
0.372, SE = 0.123, p <0.01). 
 
n.s. results for % physicians ≥45 years, % female physician, % 
patients ethnic minority, practice type, deprivation, practice size, 
list size per full time equivalent (FTE) GP. 
Gulliford et 
al. 2001[290] 
║ 
Practice  Continuous  
 
Performance of 12 indicators. 
In last year: BP, blood glucose, foot exam, urine glucose, 
urine protein, fundoscopy, urea or creatinine, weight  
Ever: dietary advice, exercise advice, smoking, alcohol 
 
Composite: summing the responses using values of ‘1’ 
for item of care recorded and ‘0’ for item of care not 
recorded or not known if recorded (score range 0-12). 
Higher scores among practices with ≥2 GPs (β = 1.90, 95% CI: 0.73-
3.06), 2 nurses per session (β = 1.16, 95% CI: 0.032-2.00), and ≥ 3 
nurses (β = 1.18, 95% CI: 0.27-2.09), more equipment items (8-9 
items vs. 6-7 items: β = 0.72, 95% CI: -0.51-1.96); 10-11 items vs. 6-
7: β = 2.02, 95% CI: 0.56-3.47). 
 
Lower scores among practices with higher number of patients: 
practices in second quartile had lower mean score (β = -0.31, 95% 
CI: -2.01- -1.39), as did practices in highest quartile (β = -1.12, 95% 
CI: -3.22-0.99). 
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Reference Factors Composite Results 
 
Reliability: the score was approximately Normally 
distributed. The value of Cronbach’s alpha, as a 
measure of the internal consistency of the scale, 
indicated a moderate level of consistency for the overall 
scale (0.60). 
He et 
al.[254]║ 
Practice Dichotomised  
 
Diagnostic testing (four indicators): glucose, HbA1c, BP, 
cholesterol.  
Patient counselling (education on diet ⁄ nutrition and 
exercise). 
 
Composite:  two outcome variables were created; 
dichotomised as ‘yes’ – indicating the provision of 1 or 
more diagnostic testing and patient counselling vs. ‘no’. 
Higher likelihood of diagnostic testing among EHR practices (older 
men: AOR = 2.2, 95% CI: 1.38-3.58), practices with on-site 
laboratory tests (older men: AOR = 2.9, 95% CI: 1.99-4.42, older 
women: AOR = 5.1, 95% CI: 3.20–8.32). 
 
n.s. results for practice setting, whether physicians were 
employees or contractors vs. owners. 
Kontopantelis 
et al.[293]║ 
Practice Continuous  
 
17 QOF indicators: 
• In past 15 months: HbA1c, foot check, 
neuropathy testing, creatinine testing, 
proteinuria, eye exam, weight, BP, cholesterol, 
smoking status, smoking advice 
• In past 6 months: flu vaccination  
• Last BP ≤145/85 mm Hg 
• Last measured total cholesterol ≤5 mmol/l 
Patients attending practices from the most deprived quartile 
gained less from the QOF intervention; practices in higher quartile 
of diabetes prevalence gained more. 
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Reference Factors Composite Results 
• Treated with ACEi or A2 antagonists if 
hypertension and proteinuria,  
• Last HbA1C (or equivalent) is ≤7.4% 
• Last HbA1C (or equivalent) is ≤10% 
 
 
Composite score:  calculated for each patient and time 
point as the number of indicators achieved for that 
patient as % of number that applied to that patient; an 
indicator was deemed to be achieved if a relevant 
process event or outcome was identified in the required 
time period (usually 15 months prior to the end of the 
financial year) and a diagnosis of diabetes pre-dated the 
event. 
Matthews et 
al.[262]║ 
Practice Continuous and dichotomised  
 
15 indicators: ACR, eGFR, lipid profile, HbA1c, physical 
checks (weight, waist circumference, BMI, BP, visual 
acuity, dilated eye check, foot check), counselling for 
certain risk factors (nutrition, physical activity, tobacco 
and alcohol use).  
 
Process of care performance:  proportion of services 
received out of the 15 scheduled services. A mean 
adherence in a given health centre represented an 
overall performance score for the health centre in a 
given audit cycle. Each aggregate score was converted 
Increased odds of improvement with practice remoteness, and in 
practices with higher patient attendance (AOR = 1.40, 95% CI 1.22-
1.61, p <0.001). 
 
n.s. results for size of service population, and governance. 
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Reference Factors Composite Results 
into a binary outcome variable that categorised ‘higher’ 
performance as being within the top quartile of delivery 
across all health centres measured at baseline (greater 
than 76% service delivery). 
McCullough 
et al.[294] 
Practice Continuous  
 
Percentage of patients with diabetes (type I and type II) 
aged 18 to 75 years who reach 5 treatment goals:  
HbA1c < 8%, BP < 130/80 mmHg, LDL-C < 100 mg/dL, 
Daily aspirin use unless contraindicated (ages 41-75 
years only), Documented tobacco-free status. 
 
Composite: optimal diabetes care (ODC) scores = reach 
5 treatment goals. 
Increased quality score in EHR (vs. paper) practices (β = 0.028, SE = 
0.012, p < 0.05), and greater number of clinics in medical group (β 
= 0.004, SE = 0.000, p < 0.001). 
 
n.s. results for diabetes prevalence. 
Orzano et 
al.[297]║β 
Practice Dichotomised 
 
Assessment: at least 3 of the four items completed 
In past 6 months: HbA1c test 
In past 12 months: LDL-C, microalbumin, BP at every 
visit 
Ever: smoking status  
 
Treatment: acceptable = all four items adhered to 
HbA1c ≤8% or >8% and on a hypoglycemic agent; LDL-C 
≤100mmol/l or >100 mmol/l and on a lipid-lowering 
agent; BP ≤130/85mmHg or >130/85mmHg and on an 
Achievement of at least 2 of 3 outcome targets improved with the 
use of identification systems (AOR = 1.23, 95% CI: 1.06-1.44, p = 
0.007), as it did with the use of tracking systems (AOR = 1.32, 95% 
CI: 1.11-1.59, p = 0.002). 
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Reference Factors Composite Results 
antihypertensive; urine microalbumin >30 and on 
ACEi/ARB. 
 
Target:  acceptable = all three items achieved; partial = 
any two items achieved 
HbA1c ≤7%, LDL-C ≤100, BP ≤130/85mmHg. 
Poon et 
al.[298] ¶ 
Practice Continuous 
 
Four indicators: HbA1c, LDL-C, eye exam, nephropathy 
monitoring. 
 
Composite: sums of the numerators and denominators 
for each component measure. 
n.s. results for EHR use. 
Ricci-Cabello 
et al.[299] β 
Practice Continuous 
 
Arithmetic mean of the logit-transformed achievement 
rates of the corresponding indicators in each set. 
 
Process measure (eight indicators): BMI, neuropathy 
testing, microalbuminuria, ACEi, influenza 
immunization, retinal screening, renal function record 
(eGFR or serum creatinine), foot risk testing. 
 
Outcome measure (three indicators): cholesterol ≤5 
mmol/L, Diabetes control (HbA1c = 7.5%), BP ≤140/80 
mm Hg. 
Lower achievement of process measures associated with higher 
diabetes prevalence (β = - 31, 95% CI -0.41, -0.21). 
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Reference Factors Composite Results 
Spigt et 
al.[141] 
Practice Continuous 
 
Eight process indicators (1 per year): HbA1c test, LDL-C 
test, creatinine level, proteinuria, SBP, weight, foot 
exam, eye exam. 
 
Quality of care (QoC) index ranging from zero to eight. 
More likely to receive optimal quality of care if  yearly medical 
check-ups done by both the GP and nurse (AOR = 5.51, 95% CI: 
4.16–7.30, p <0.05), at practices with diabetes education 
programme (AOR = 4.29, 95% CI: 3.40–5.41, p <0.05), if after the 
patient visited the nurse practitioner the patient is discussed with 
the GP (AOR = 1.80, 95% CI: 1.62–2.00, p <0.05). 
 
n.s. results for practice protocol, registration, multidisciplinary 
collaboration, use of report cards. 
Wang et 
al.[309] 
Practice Continuous 
 
No details provided. 
Using data on the points attained under the QOF. 
n.s. results for practice size. 
Wencui et 
al.[302]║ 
Practice Dichotomised 
 
Lab testing: HbA1c, LDL-C, nephropathy test. 
Binary variable capturing whether the patients received 
all three types of tests or not. 
Likelihood of lab testing greater in practices using records for 
patient reminders (AOR = 1.26, 95% CI: 1.15-1.38, p <0.01), with 
increasing number of patients (AOR = 1.03, 95% CI: 1.02-1.04, p < 
0.01, per 100 patients). 
n.s. results for using registries for quality improvement. 
Angstman et 
al.[277]║ 
Physician Dichotomised 
 
Composite: % patients achieving the combined 
outcome of three indicators HbA1c <8.0%, BP <140/90 
mmHg, and LDL-C <100 mg/dL. Physicians placed in 
≤25th or ≥75th percentile of performance. 
More likely to have poor-quality ranking (≤225th percentile) in 
quality of care if physician panel size is above the mean (>2959) 
(AOR = 7.61, 95% CI: 1.13–51.46, p = 0.04). 
Holmboe et 
al. 
2006[278]║¶ 
Physician Dichotomised 
 
More likely to achieve all 3 processes with higher physician 
volume (group III AOR = 1.31, 95% CI: 1.07-1.61; group IV AOR = 
1.35, 95% CI: 1.10-1.64; group V AOR = 1.48, 95% CI: 1.22-1.81). 
303 
 
Table 19 Studies which used a composite measure of quality (n = 34).  
Reference Factors Composite Results 
HbA1c measurement (previous year), Lipid profile (in 
past 2 years), Eye exam (in past 2 years). 
 
Composite: proportion who received all three 
processes of care: “1” = achieved all; “0” = any other 
combination). 
Holmboe et 
al. 
2008[255]║¶ 
Physician Dichotomised 
 
HbA1c measurements (at least two in past year). 
Lipid test, eye examination (in past year). 
 
Composite measure:  value of “1” if all three measures 
had been performed and “0” if two or fewer measures 
had been performed. 
More likely to receive all 3 diabetes processes of care if physicians 
scored in top quartile vs. lowest quartile of American Board of 
Internal Medicine maintenance of certification examination (AOR 
= 1.17, 95% CI: 1.08-1.27). 
Kamien et 
al.[271] 
Physician Continuous 
• Blood tests (5 items): HbA1c (1 per annum), 
blood glucose (2 per annum), cholesterol, 
triglycerides, creatinine (3 yearly) 
• Annual physical exam (3 items): BP, eye exam 
(or referral to ophthalmologist), weight 
• Feet examined (4 items): pulses, sensation, 
nails, reflexes 
• Urinalysis (3 items): glucose, protein, nitrite 
• History (6 items): duration of known diabetes, 
alcohol intake enquiry and advice, dietary 
enquiry and advice, exercise enquiry and 
Mean total quality score of vocationally registered (VR) doctors 
was significantly higher than those of the non-vocationally 
registered (NVR) doctors. (VR mean (sd) = 6.07 (2.3), NVR = 5.5 
(2.2), p <0.05). 
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Table 19 Studies which used a composite measure of quality (n = 34).  
Reference Factors Composite Results 
advice, smoking enquiry and advice, 
impotence/vaginitis enquiry and advice 
 
Overall score: checklist of 12 main items with a value of 
one point each.   
Several items were sub-divided into several parts each 
receiving fractional scores resulting in a total of 21 
separate processes each of which was given a weighting 
ranging from 0.25 of a point to 1 point. 
Kim et 
al.[272] 
Physician Continuous 
 
In 12-month period: HbA1c, lipid, eye exam, urine 
microalbumin/protein testing, foot exam, 
recommendation to take aspirin or aspirin use, 
influenza vaccination (self-reported). 
 
Composite measure: un-weighted sum of these seven 
process measures as a continuous variable ranging from 
0 (no services delivered) to 7 (all services delivered). 
n.s. results for physician gender. 
Parkerton et 
al. 
2003[274]¶ 
Physician Continuous 
 
Rates of four process of care indicators: 
microalbuminuria, HbA1c testing, annual eye exam, 
annual foot exams. 
 
Composite: mean of process measures formed the 
diabetic management outcome measure. 
Lower physician appointment hours associated with higher quality 
score (favours part-time practice) (β = -0.107, 95% CI -1.86, -0.029, 
p = 0.008). 
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Table 19 Studies which used a composite measure of quality (n = 34).  
Reference Factors Composite Results 
Abbreviations: n.s. non-significant; OR, Odds Ratio;  AOR, Adjusted Odds Ratio; EHR, Electronic Health Record; CI, Confidence Interval; AHP, Allied Health 
Professionals; MOC, Maintenance of Certification examination; MDT, Multidisciplinary team; WTE, Whole Time Equivalent; GPs, General Practitioners; 
RAP, intervention arm receiving practice facilitation using reflective adaptive process change model based on complexity theory; CQI, Continuous quality 
improvement arm received practice facilitation based on the model for improvement; SD, Self-directed arm received limited feedback on their baseline 
practice culture and level of implementation of the Chronic Care Model based on practice; FTE, Full Time Equivalent;  
║Patient-level covariates adjusted for in multivariate analysis 
¶Physician-level covariates (additional to explanatory variables) adjusted for in multivariate analysis 
βPractice-level covariates (additional to explanatory variables) adjusted for in multivariate analysis 
*also examined LDL-C and BP but among patients with coronary artery disease and hypertension 
**excluded all newly diagnosed patients as they would not have had time to have a completed Annual Cycle of Care 
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Table 20 Main results for studies which examined physician factors only (n = 20) 
Reference N Factors Main results (multivariate analysis unless otherwise stated) 
Angstman et 
al.[277]*║ 
36 
physicians 
Patients 
not 
reported 
(NR) 
Panel size  Physician-adjusted panel size above the mean (>2959) were more likely to have 
poor-quality ranking (≤225th percentile) in quality of care (AOR = 7.61, 95% CI: 
1.13–51.46, p = 0.04). 
Berthold et 
al.[260]║ 
3096 
physicians 
51 053 
patients 
Gender Patients of female physicians more likely to have some processes of care 
performed: urine albuminin (AOR = 0.85, 95% CI: 0.75–0.96, p = 0.008), creatinine 
(AOR = 1.42, 95% CI: 1.04–1.94, p =0.027) and less likely to have lipid profile (AOR = 
0.84, 95% CI: 0.76–0.94, p = 0.002). 
n.s. for HbA1c, neurological exam, eye exam. 
 
Patients of female physicians less likely to have some OHAs (AOR = 0.88, 95% CI: 
0.82–0.95), p = 0.001) OHAs alone (AOR = 0.88, 95% CI: 0.77–0.999, p = 0.048), 
Biguanides (AOR = 0.88, 95% CI: 0.81–0.96, p = 0.003) prescribed. 
n.s. results for sulfonylureas, statins. 
 
Among patients of female physicians, mean HbA1c levels (AOR = 0.92, 95% CI: 0.87–
0.96, p <0.0001), and LDL levels (AOR = 0.16, 95% CI: 0.03–0.78, p = 0.024) were 
lower and patients were more likely to have HbA1c <6.5% (AOR = 1.14, 95% CI: 
1.05–1.24, p = 0.002) HbA1c <7.0% (AOR = 1.22, 95% CI: 1.13–1.32, p <0.001),  LDL-
C < 100 mg dL−1  (AOR = 1.16, 95% CI: 1.06–1.27, p = 0.002), LDL-C <130 mg dL−1 
(AOR = 1.12, 95% CI: 1.04–1.21, p = 0.005). 
n.s. for HDL-C, triglycerides and meeting all 3 lipid targets. 
Bralic Lang et 
al.[261]║ 
449 
physicians 
Gender Male physicians more likely to be clinically inert (AOR = 1.2, 95% CI 1.00-1.35) 
Years of work experience n.s. 
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Table 20 Main results for studies which examined physician factors only (n = 20) 
Reference N Factors Main results (multivariate analysis unless otherwise stated) 
10 275 
patients 
Total number of patients on panel  n.s. 
Total number of type 2 patients on 
panel 
n.s. 
Average daily visits  n.s. 
Working status (health care centre 
employee; private practice outside 
health care centres; private practice 
inside health care centres) 
Private practice outside health centre vs. health care centre employee: n.s. 
Physicians working in private practice inside health care centre vs. health centre 
employees less likely to be inert (AOR = 0.8, 95% CI 0.66-0.90). 
Brody et 
al.[269]║ 
26 
physicians 
924 
patients 
Gender Patients of female physicians more likely to receive eye exam (AOR = 1.59, 95% CI: 
1.09 to 2.33) and foot exam (AOR = 1.52, 95% CI: 1.03 to 2.22); n.s. for HbA1c, LDL-
C, microalbuminuria screening 
Specialty (family medicine; internal 
medicine) 
Patients of internal medicine physicians more likely to receive eye exam (AOR = 
1.85, 95% CI: 1.29-2.66), foot exam (AOR = 1.83, 95% CI: 1.26-2.68), HbA1c test 
(AOR = 2.48, 95% CI: 1.85-3.31) and microalbuminuria screening (AOR = 22.0, 95% 
CI: 2.96-163.52) than family medicine physicians. 
Dahrouge et 
al. 
2016[270]║¶ 
4195 
physicians 
837,778 
patients 
 
Gender Patients of female physicians more likely (p <0.05) to have eye exam (AOR = 1.07, 
95% CI: 1.04-1.10), lipid test (AOR = 1.14, 95% CI: 1.18-1.31), HbA1c test (AOR = 
1.10, 95% CI: 1.04-1.17), prescription of metformin (AOR = 1.18, 95% CI: 1.05-1.57), 
ARB/ACEi (AOR = 1.04, 95% CI: 1.01-1.08) and lipid-lowering agent (AOR = 1.10,95% 
CI: 1.06-1.15). 
Dahrouge et 
al. 
2016[282]║¶β 
4,195 
physicians 
8.3 mil. 
patients 
Physician panel size n.s. 
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Table 20 Main results for studies which examined physician factors only (n = 20) 
Reference N Factors Main results (multivariate analysis unless otherwise stated) 
Ferroni et 
al.[134]║β 
 
21 health 
units 
4660 
physicians 
139,935 
patients 
Age Among patients not attending a diabetes clinic (at least 1 specialist visit in the year) 
patients of younger physicians more likely to receive two HbA1c test: ≤50 years (RR 
= 1.15, 95% CI: 1.06–1.25); 51-55 years (RR = 1.07, 95% CI: 0.99-1.15, p =0.008); 56-
60 years (RR = 1.07, 95% CI: 1.00-1.14) compared to physician >60 years. 
 
Among patient attending a diabetes clinic n.s. 
 
Gender Among patients not attending a diabetes clinic those with female physicians more 
likely to receive two HbA1c tests (RR = 1.08, 95% CI: 1.02–1.14). 
 
Among patients attending a diabetes clinic n.s. 
 
Total number with diabetes on panel 
 
Among patients not attending a diabetes clinic, those whose physicians had >85 
diabetes patients (compared to ≤55) were more likely to receive tests (RR = 1.06, 
95% CI: 0.99-1.15) 
 
Among patients not attending a diabetes clinic n.s. 
Holmboe et 
al. 
2006[278]*║ 
1261 
physicians  
26,260 
patients 
Patient volume (in quintiles: 1-4; 5-
10; 11-18;19-31 and 32-166) 
Compared to physicians with lowest volume (1-4), those in higher volume groups 
were more likely to have a HbA1c test (group III AOR = 1.67, 95% CI: 1.27-2.19; 
group IV AOR =1.66, 95% CI: 1.28-2.15; group V AOR = 1.92, 95% CI: 1.48-2.49), a 
lipid test (group III AOR = 1.44, 95% CI: 1.13-1.84; group IV AOR =1.57, 95% CI: 1.24-
1.99; group V AOR = 1.63, 95% CI: 1.29-2.06), and eye exam (group III AOR = 1.25, 
95% CI: 1.05-1.49; group IV AOR =1.24, 95% CI: 1.05-1.47; group V AOR = 1.36, 95% 
CI: 1.15-1.60). 
 
309 
 
Table 20 Main results for studies which examined physician factors only (n = 20) 
Reference N Factors Main results (multivariate analysis unless otherwise stated) 
Those in higher volume groups were also more likely to achieve all 3 processes 
(group III AOR = 1.31, 95% CI: 1.07-1.61; group IV AOR = 1.35, 95% CI: 1.10-1.64; 
group V AOR = 1.48, 95% CI: 1.22-1.81). 
Holmboe et 
al. 
2008[255]*║¶ 
3602 
physicians  
52307 
patients 
MOC score - divided into 3 percentile 
groups (<25th, 25-75th, and >75th)  
Patients of physicians in top quartile vs. lowest quartile were more likely to receive 
all 3 diabetes processes of care (AOR = 1.17, 95% CI: 1.08-1.27). 
Kamien et 
al.[271]* 
110 
practices 
204 
physicians 
467 
patients 
Vocational registration With the exception of blood pressure and urinalysis, vocationally registered (VR) 
doctors recorded all items more frequently than did non-vocationally registered 
(NVR) doctors.  Mean total quality score of VR doctors was significantly higher than 
those of the NVR doctors. (VR mean (SD) 6.07 (2.3), NVR 5.5 (2.2), P <0.05). 
Kim et 
al.[272]*║¶ 
1686 
physicians 
3459 
patients 
Gender Patients of female physician more likely to have lipid (AOR = 1.09, 95% CI 1.02–
1.15), HbA1c (AOR = 1.02, 95% CI: 1.00–1.05) measurements and LDL <130 mg/dl 
(AOR = 1.05, 95% CI: 1.00–1.10).  
Female physicians and male physicians did not differ significantly on other 
processes of care, control of risk factors, or satisfaction. 
LeBlanc et 
al.[281]║ 
107 
physicians  
921 
patients  
 
Age n.s. 
Gender n.s. 
Duration of employment  n.s. 
Primary care training (internal 
medicine vs. family medicine) 
n.s. 
Education (MD vs. nurse 
practitioner/physician assistant) 
n.s. 
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Table 20 Main results for studies which examined physician factors only (n = 20) 
Reference N Factors Main results (multivariate analysis unless otherwise stated) 
Total number of patients on panel n.s. 
Percentage of patients with diabetes 
on panel 
n.s. 
Mean Charlson co-morbidity index of 
patients on panel 
n.s. 
Linder et 
al.[273]║¶ 
10 practices 
234 
physicians 
7000 
patients 
(coronary 
artery 
disease or 
diabetes) 
 
Physician documentation styles—
dictation, structured documentation, 
and free text - mutually exclusive 
groups by predominating 
documentation style. 
Greater adjusted % patients of structured documenters (53%) and free text (54%) 
had eye exam than dictators (39%) (p <0.001). 
Similarly for BP:  dictators (81%); structured documenters (98%); free text (89%) 
(p<0.001); BMI: dictators (28%); structured documenters (40%); free text (35%) 
(p<0.001); tobacco use documentation: dictators (22%); structured documenters 
(38%); free text (36%) (p <0.001) and flu vaccination: dictators (60%); structured 
documenters (64%); free text (68%) (p <0.001). 
Foot exam: dictators (11%); structured documenters (14%); free text (9%) (p<0.001) 
Parkerton et 
al. 
2003[274]*¶ 
25 clinics 
194 
physicians 
Patients NR 
Part-time status  Physician appointment hours (favours part-time practice) (β = -0.107; 95% CI -1.86, -
0.029; p = 0.008). 
Shuval et 
al.[275]¶ 
74 
physicians  
8334 
patients  
 
Total evidence-based medicine (EBM) 
knowledge score; continuous variable 
0–100  
 
Higher EBM score associated with performance of microalbumin tests (β = 0.33; p = 
0.001), eye exam referrals (β = 0.16; p = 0.021), HbA1c tests (β = 0.17; p = 0.036), 
and LDL tests (β = 0.13; p = 0.037). 
Quality of care was independently associated with the total EBM knowledge while 
controlling for covariates (F = 4.65; p = 0.004). 
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Table 20 Main results for studies which examined physician factors only (n = 20) 
Reference N Factors Main results (multivariate analysis unless otherwise stated) 
Component of EBM score: critical 
appraisal skills (a continuous variable 
of 0–53) 
Higher critical appraisal skills score associated with performance of microalbumin 
tests (β = 0.46; p = 0.002), and eye exam referrals (β = 0.20, p = 0.048) but not 
HbA1c and LDL-C tests. 
Component of EBM score: 
information retrieval skills (a 
continuous variable of 0–47) 
Higher score associated with HbA1c testing (β = 0.43; P = 0.004), not microalbumin, 
eye exam referrals or LDL tests. 
Streja et 
al.[280]║ 
22 
physicians  
524 
patients 
Physician gender n.s. 
Practice experience (less vs. more 
than 15 years in practice 
Having > 15 years in practice associated with greater odds of 
proteinuria testing (AOR = 2.62, 95% CI: 1.61-4.37, p = 0.001); n.s. for receipt of 
HDL-C test and ophthalmology referral. 
 
In sub-group analysis (removing 110 patients with eye disease; patients treated 
with diet and oral agents, or insulin) practice experience was associated with an 
ophthalmology referral (OR = 1.80, 95% CI: 1.16-3.43, p = 0.014). 
Specialty (internal medicine vs. family 
medicine or surgery) 
n.s. 
Practice style ("fast" and "slow." = 
count the number of claims for each 
physician for a minimum of 3 months 
and to divide it by the number of half 
days of work. "Fast" = above average; 
"slow" = below average) 
Practice style, "Fast" associated with lower odds of HDL-C test (AOR = 0.56, 95% CI: 
0.35-0.89, p = 0.001), proteinuria test (AOR = 0.42, 95% CI: 0.26-0.67, p = 0.001) but 
n.s. for ophthalmology referral. 
In sub-group analysis (removing 110 patients with eye disease; patients treated 
with diet and oral agents, or insulin) fast style was associated with a lower referral 
rate (AOR = 0.25; 95% CI: 0.07-0.85, p = 0.03). 
Size of diabetic practice (more vs. less 
than 20 patients) 
n.s. 
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Table 20 Main results for studies which examined physician factors only (n = 20) 
Reference N Factors Main results (multivariate analysis unless otherwise stated) 
Tabenkin et 
al.[276]║¶ 
30 practices 
55 
physicians 
4,195 
patients 
Gender Female physicians more likely to provide dietary and weight loss and physical 
activity advice than male physicians (AOR = 6.55, 95% CI: 2.01 - 21.33, p<0.05) but 
n.s. for other processes. 
Turchin et al. 
2007[279]║¶ 
368 
physicians 
7,120 
patients 
Diabetes volume  Number of diabetes patients (per 10 patients) treated by physician associated with 
decreased likelihood of HbA1c test (AOR = 0.96, 95% CI: 0.93-1.0, p = 0.05) but n.s. 
for receipt of LDL test, and BP, HbA1c, and LDL control. 
Frequency of encounters with 
patients with diabetes 
Increase in daily encounters with diabetes patients associated with lower odds of 
HbA1c test (AOR = 0.75, 95% CI: 0.58-0.97, p =0.03) and LDL test: (AOR = 0.80, 95% 
CI: 0.70-0.91, p<0.001), but n.s. for BP, HbA1c, and LDL control. 
Fraction of patients with diabetes 
among all of the physician's patients  
Fraction of diabetic patients associated with lower likelihood of LDL test (AOR = 
0.59, 95% CI: 0.39-0.88, p =0.01), but n.s for receipt of HbA1c test, and BP, HbA1c, 
and LDL control. 
Fraction of encounters with patients 
with diabetes among all of the 
physician's encounters 
Greater fraction of encounters associated with increased odds of patients having 
HbA1c <7.0% (AOR = 1.19, 95% CI: 1.05-1.36, p = 0.009) but n.s. for receipt of HbA1c 
test, LDL test, and BP, HbA1c, and LDL control. 
 
Turchin et al. 
2008[266]║ 
301 
physicians 
8127 
patients 
Physician age n.s. 
Number of years since last board 
certification  
Every decade since the physician’s last board certification was associated with a 
21.3% drop in the probability of treatment intensification (p = 0.0097). 
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Table 20 Main results for studies which examined physician factors only (n = 20) 
Reference N Factors Main results (multivariate analysis unless otherwise stated) 
Abbreviations: NR, Not Reported; OR, Odds Ratio; Adjusted Odds Ratio (AOR); OHAs, Oral Hypoglycaemic Agents; ARBi, Angiotensin II Receptor Blockers; 
ACE, Angiotensin Converting Inhibitor HER; Electronic Health Record; MDT, Multidisciplinary team; VR, Vocationally Registered; NVR, Non-Vocational 
Registered 
*Composite outcome 
║Patient-level covariates adjusted for in multivariate analysis 
¶Physician-level covariates (additional to explanatory variables) adjusted for in multivariate analysis 
βPractice-level covariates (additional to explanatory variables) adjusted for in multivariate analysis 
** Indicators grouped as ‘Records and information about patients (19), Patient communication’ (8), Education and training (9), Practice management (10), 
Medicines management (10). 
§also includes patients for breast cancer screening; chlamydia screening; colorectal cancer screening; appropriate medications for people with asthma; 
testing for children with pharyngitis; and treatment for children with upper respiratory infection. 
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Table 21 Main results for studies which examined practice factors only (n = 44) 
Reference N Factors Main results (multivariate analysis unless otherwise stated) 
Bower et 
al.[257]* 
42 
practices  
 
Patients 
not 
reported 
(NR) 
Practice type (solo or other) n.s. 
Team size (number of employed 
staff) 
Greater number of staff associated with better management: β = 0.54, 95% CI: 0.12-
0.96, p = 0.014. 
Existence of deprivation payments 
to the practice  
n.s. 
Training status of the practice  n.s. 
Mean length of employment of staff 
at the practice 
n.s. 
Routine booking intervals for 
patient consultations (5, 7.5, or 10 
minutes) 
Booking interval of 10 minutes compared to 5 minutes associated with better 
management: β = 9.70; 95% CI: 2.79-16.63, p = 0.007. 
Skill-mix: ratio of doctors to nurses, 
ratio of doctors to non-medical 
clinical staff, ratio of clinical to 
administrative staff 
n.s. 
Bredfelt et 
al.[283]*¶β 
174 
physicians  
Patients 
NR 
Use of out-of-office communication 
(phone, secure messaging) 
Physicians whose patient panels predominantly white or mixed race: n.s. 
 
Physicians whose patients predominantly black or Hispanic: on average, a 0.1 increase 
in the proportion of the patient panel that shared out-of-office communication 
(including both phone and secure messaging) with their primary care provider was 
associated with a 1.6 unit increase in quality scores. 
 
A 0.1 increase in the proportion of the patient panel that used secure messaging was 
associated with an increase in score of 4.7 (p < 0.01) 
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Table 21 Main results for studies which examined practice factors only (n = 44) 
Reference N Factors Main results (multivariate analysis unless otherwise stated) 
A 0.1 increase in the proportion of the patient panel that used phone to communicate 
was associated with an increase in scores of 1.3 (p < 0.1)   
Campbell et 
al.[151]* 
42 
practices 
Patients 
NR 
Practice size (number of GPs) Larger practices had higher scores for diabetes than smaller practices (adjusted 
difference: 2.16, 95% CI: 0.22-4.10, p = 0.029) 
Routine booking interval for 
consultations (5, 7.5, or 10 minutes) 
Compared to practice with 5 minutes interval, adjusted mean scores in practices with 
routine 10-minute booking intervals were higher (adjusted difference = 10.0, 95% CI: 
1.06-18.95, p = 0.028) 
Practice deprivation score n.s. 
Cebul et 
al.[310]║* 
46 
practices  
569 
providers  
27,207 
patients 
 
EHR  Process of care composite: adjusted difference between EHR and paper-based sites 
was 35.1 percentage points (95% CI: 28.3-41.9; p <0.001) across all practices and 29.8 
percentage points (95% CI: 24.0-35.7, p <0.001) at safety-net sites. 
 
Intermediate outcome composite: adjusted difference between EHR and paper-based 
sites was 15.2 percentage points (95% CI: 4.5-25.9, p = 0.005); for safety-net sites, the 
difference was 9.7 percentage points (95% CI: 3.4-16.1, p = 0.002. 
Cheung et 
al.[284]║¶β 
9014 
physicians 
1,018,647 
patients 
Overall ambulatory volume = 
number of outpatient visits of any 
type the physician had during the 3 
years preceding the index date 
divided by the number of days the 
physician worked during this period 
Compared to practices with lowest volume, patients of practices with highest volume 
had lower marginal rates (ptrend <0.001) of eye exam (≤20 patients/day = 72, 95% 
CI:71.7-72.4 vs. >40 patients/day = 67.1, 95% CI: 66.6-67.5), HbA1c testing (55.0, 95% 
CI: 54.1-55.8 vs.  50.1, 95% CI: 49.1-51.1), LDL cholesterol testing (85.5, 95% CI: 85.0-
85.9) vs. 84.4, 95% CI: 83.9-84.9), prescriptions for ACEIs /ARBs) 74.7, 95% CI: 74.2-
75.2) vs. 70.8, 95% CI: 70.2-71.4), prescriptions for statins (74.9, 95% CI: 74.3-75.5) vs. 
70.3, 95% CI: 69.6-71.1). 
Diabetes-specific volume = number 
of patients with diabetes for whom 
the physician was the usual primary 
Compared to practices with lowest volume (≤100 patients), patients of practices with 
highest volume (≥301 patients) had higher rates (ptrend <0.001) of eye exams (67.0, 
95% CI: 66.7-67.4) vs 69.8, 95% CI: 69.2-70.4), HbA1c testing (50.0, 95% CI: 49.3-50.8 
vs.  53.0, 95% CI: 51.6-54.4), LDL cholesterol testing (82.2, 95% CI: 81.7-82.6 vs.  87.5, 
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Table 21 Main results for studies which examined practice factors only (n = 44) 
Reference N Factors Main results (multivariate analysis unless otherwise stated) 
care provider (100, 150, 200, and 
300 patients) 
95% CI: 86.9-88.1), prescriptions for ACEIs /ARBs (70.6, 95% CI: 70.0-71.1 vs. 74.4, 95% 
CI: 73.9-75.6), prescriptions for statins (68.4, 95% CI: 67.6-69.0 vs. 76.1, 95% CI: 75.2-
77.1). 
Cho et 
al.[258]║ 
183 
practices 
24,628 
patients 
Practice type (solo or group) Patients in solo practice (vs. group) were less likely to receive treatment with lipid-
lowering drugs (OR = 0.86, 95% CI: 0.75-0.99); n.s. RAAS-blockers, glucose-lowering 
drug, BP-lowering drugs, lipid-lowering drugs. 
Number of diabetes patients  Increased number of patients associated with decreased odds of treatment with 
glucose-lowering drugs (OR = 0.99, 95% CI: 0.99-0.99), lipid-lowering drug (OR = 0.99, 
95% CI: 0.99-0.99), BP-lowering drugs (OR = 0.99, 95% CI: 0.99-0.99), RAAS-blockers 
(OR = 0.99, 95% CI: 0.99-0.99). 
Presence of educated diabetes 
assistant 
Patients of practices with an assistant present were less likely to receive treatment 
with glucose-lowering drug (OR = 0.72, 95% CI: 0.54-0.95), and more likely to receive 
treatment with statins (OR = 1.54, 95% CI: 0.87-2.71); n.s. RAAS-blockers, BP-lowering 
drugs, lipid-lowering drugs. 
Crosson et 
al.[285]*║ 
50 
practices 
927 
patients 
 
EHR usage Patients in practices with an EHR compared to practice without EHR were more likely 
to have processes of care (3 of 5 guidelines met) performed (AOR = 2.25, 95% CI:1.42-
3.57, p <0.001), meet treatment targets (all treatment target guidelines met)  (AOR = 
1.67, 95% CI:1.07-2.60, p = 0.02), or have 2 of 3 outcomes met (AOR = 1.67, 95% 
CI:1.25-2.24, p <0.001) or all outcomes met (AOR = 2.68, 95% CI: 1.49-4.82, p = 0.001). 
Practice type (solo or other) Solo practices were less likely to have processes of care performed (AOR = 0.38, 95% 
CI: 0.17-0.87, p = 0.02), meet treatment targets (AOR = 0.63, 95% CI: 0.41-0.98, p = 
0.04), n.s. for other measures. 
Ownership (physician-owned or 
other) 
Physician owned practices were more likely to have 2 of 3 outcomes met (AOR = 1.44, 
95% CI: 1.05-1.18, p = 0.02); n.s. for other measures. 
Staff/clinician ratios n.s. 
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Dickinson et 
al.[286]*║ 
40 
practices 
822 
patients 
 
Location (rural or urban) Greater improvement in rural practices (RAP: +0.70 p = 0.006, CQI: +2.44 p <0.001); 
Greater improvement in urban (SD −0.75, p = 0.004) 
Practice size (number of GPs) Greater improvement in process of care scores in smaller practices (RAP: +0.56, p = 
0.02; CQI: +1.96, p <0.001; SD n.s.). 
EHR  n.s. 
% Medicaid patients (<20%; ≥20%) Greater improvement in process of care scores in practices with <20% Medicaid 
patients (SD: + 0.60, p =0.02; RAP n.s.; CQI n.s.). 
Dunn et 
al.[308] 
37 
practices 
Patients 
NR 
Register **each structure criterion only tested for specific processes and outcomes, not all**  
More practices with a register vs. those without register had blood glucose test done 
(89 vs. 73; diff in mean 16 (6, 26) p = 0.004), a HbA1c test done (89 vs. 64, diff in means 
24 (13,36) p<0.001),  cholesterol test (37 vs. 16, 22 (9, 35) p = 0.009), BP test done (88 
vs. 74, 14 (5,24) p = 0.004), urinanalysis (74 vs. 55, 19 (4.34) p = 0.012), weight taken 
(77 vs. 57, 19 (5, 33) p = 0.011). 
Recall system Recall system n.s. for blood glucose tested, mean HbA1c and BP tested. 
One partner sees all patients with 
diabetes 
Practice where one partner sees all diabetics had more patients with urinalysis done 
(72 vs. 56, 16 (0, 32) p = 0.027), n.s. for blood glucose and mean HbA1c. 
Availability of chiropodist Availability of chiropodist n.s. for foot exam. 
Availability of optician Availability of optician n.s. for eye exam or retinopathy present. 
Physician with postgraduate 
training 
n.s. for mean Hba1c, blood glucose test, cholesterol. 
Nurse with postgraduate training n.s. for blood glucose test or mean hba1c 
Ellerbeck et 
al.[287] 
210 
physicians 
Diabetes specific flow sheets **note results of bivariate regression model with proportions weighted by number of 
patients per practice** 
n.s. 
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11,623 
patients 
Use of non-physician personnel to 
identify patients due for 
preventative care 
n.s. 
Practice location (urban or rural)  Lower proportion with lipid measurement among rural (67.0%) vs urban (71.5%) 
practices; n.s. for HbA1c and eye exam. 
Number of patients with diabetes Lower proportion with lipid measurement among practices with 18-35 patients 
(64.4%), compared to those with 5-17 patients (71.6%), 36-58 (70.1%), and 59-1559 
(72.4%); n.s. for HbA1c and eye exam. 
Erickson et 
al.[288]* 
55 dyads  
2,584 
patients 
Physician tenure Longer clinician tenure (p = 0.0319) associated with better diabetes scores (data not 
shown). 
Practice training of “Office nurses” 
or CA training was divided 3 
categories: RN (registered nurse), 
LPN (licensed practical nurses), and 
MA (medical assistants)  
Practices with medical assistant (vs. LPN) less likely to meet (5 metric) quality goal 
(AOR = 0.60, 95% CI: 0.44-0.81, p <0.001) and less likely to receive positive responses 
on patient satisfaction (AOR = 0.65, 95% CI: 0.53-0.80, p <0.001). 
 
Practices with RN (vs. LPN) were more likely to meet quality goal (AOR = 1.37, 95% CI: 
1.01-1.84, p <0.001) and less likely to receive positive responses (AOR = 1.14, 95% CI: 
0.88-1.48, p <0.001). 
Clinician type (Associate provider 
(AP) or MD/Doctor of Osteopathic 
medicine (DO)) 
Practices with MD/DO (vs. AP) more likely to meet goal (AOR = 2.33, 95% CI: 1.23-4.41, 
p = 0.022) and more likely to receive positive responses on patient satisfaction (AOR = 
1.75, 95% CI 1.41-2.17, p <0.001). 
Location (rural or urban) Rural practices (vs. urban) were less likely to receive positive responses (AOR = 0.65, 
95% CI: 0.53-0.81, p = 0.0068). 
Team tenure  n.s. 
Allied staff to clinician ratio Allied health staff-to-clinician ratio was not associated with better scores (p = 0.348) 
(data not shown). 
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Esterman et 
al.[135]║ 
147  
practices  
5455 
patients 
Metropolitan practice n.s. 
Practice size (number of GPs) n.s. 
Practice nurse n.s. 
Chronic disease focused nurse Patient of practice with a nurse was more likely to have Annual Cycle of Care 
completed (AOR = 2.01, 95% CI: 1.07-3.77, p = 0.036). 
Chronic disease planning software 
used 
n.s. 
Corporate practice n.s. 
Co-located AHPs n.s. 
Practice has audit and feedback n.s. 
Practice involved in QI collaboration n.s. 
Practice has dedicated case 
management 
n.s. 
Practice has regular MDT meetings n.s. 
Practice has regular staff education n.s. 
Practice uses shared EHR n.s. 
Practice has patient diabetes 
education events 
Patient of practice with events more likely to have Annual Cycle of Care completed 
(AOR = 1.92, 95% CI: 1.21-3.06, p= 0.004). 
  Practice has self-management 
activities 
n.s. 
Everett et 
al.[304]║ 
261 
practices 
2,576 
patients 
Involvement of the physician 
assistant or nurse practitioner (6 
categories) 
 
[Compared to practices which had no physician assistant (PA)/nurse practitioner(NP)]. 
Patients of practices with supplemental PA/NP who do not Treat High Complexity 
Patients and do not Deliver Chronic Care were less likely to have HbA1c >9% (AOR = 
0.46, 95% CI: 0.22,0.97, p = 0.04), n.s. for remaining outcomes. 
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Patients of practices with supplemental PA/NP who do not Treat High Complexity 
Patients but Deliver Chronic Care were more like to receive at least 2 HbA1c tests 
annually (AOR = 1.4, 95% CI: 1.05,1.82, p = 0.02). 
 
Patients of practices with Supplemental PA/NP Treat High Complexity Patients but do 
not Deliver Chronic Care were more likely to have Mean A1c >9% (AOR= 1.80, 95% CI: 
1.21,2.67, p <0.01). 
 
Patients of practices with Supplemental PA/NP who Treat High Complexity Patients 
and Deliver Chronic Care were less likely to have Mean A1c 7-9% (AOR = 0.70, 95% CI: 
0.59,0.84, p <0.01). 
 
Patients with PA/NP as usual provider n.s. for all outcomes: receipt of HbA1c tests, 
mean HbA1c >9%, mean HbA1c 7-9%. 
Number of diabetes patients n.s. 
% patients female n.s. 
Usual provider (FM or IM/geriatrics) n.s. 
Franks et 
al.[265]║ 
 Deprivation Independent of their own socio-economic status (SES) patients in lower SES practices 
were less likely to receive a HbA1c test (β = 0.09, SE = 0.03, t = 3.09), and eye exam β = 
0.04, SE = 0.03, t = 1.69). 
Friedberg et 
al.[307]β 
305 
practices 
Patients 
NR 
Assistance of patient self-
management 
n.s.  
System for contacting patients for 
preventive services 
Higher performance on nephropathy screening: 2.3, 95% CI: 0.3-4.4, p < 0.007; n.s. for 
HbA1c, eye exams, cholesterol screening. 
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Paper-based physician reminder 
systems 
Lower performance on eye exams: -3.3, 95% CI: -5.9- -0.6, p <0.007; n.s. for HbA1c, eye 
exams, nephropathy screening. 
EHR  Higher performance on eye exams: 3.4, 95% CI: 0.6-6.2, p <0.007 and nephropathy 
screening: 3.1, 95% CI: 0.9-5.3; n.s. for HbA1c, cholesterol screening. 
Language interpreters  n.s. for all 
Providers’ spoken languages  n.s. for all 
Regular appointment hours on 
weekends 
n.s. for all 
Griffiths et al. 
2010[140]* 
 
 
Practices 
to 
between 
7431 and 
7456*** 
 
Patients 
NR 
% physician aged ≥45 years 
 
Greater % ≥45 years associated with lower proportion of patients with HbA1c ≤7.4% (β 
= -0.523, SE = 0.116, p < 0.001), HbA1c ≤10% (β = - 0.250, SE = 0.056, p < 0.001) and 
Total cholesterol ≤5mmol/l (β = -0.315, SE = 0.113, p < 0.01). 
% female physicians 
 
Greater % female associated with better overall performance (β = 0.394, SE = 0.112 p < 
0.001), higher proportion with HbA1c ≤7.4% (β = 0.851, SE = 0.114, p < 0.001), HbA1c 
≤10% (β = 0.537, SE = 0.063, p < 0.001) and total cholesterol ≤5mmol/l (β = 0.546, SE = 
0.111, p <0.001). 
% qualified in the UK  
 
Greater % associated with better overall performance (β = 0.613, SE = 0.130, p < 
0.001), and meeting targets HbA1c ≤7.4% (β = 0.615 , SE = 0.159, p < 0.001) HbA1c 
≤10% (β = 0.703 , SE = 0.095, p < 0.001), BP  ≤145/85mmHg (β = 0.667 , SE = 0.157, p < 
0.001), total cholesterol ≤5mmol/l (β = 0.939 , SE =0.130 , p<0.001). 
List size per FTE practice nurse 
(quintiles) 
Lower list size per FTE nurse associated with greater quality of care score (Q1: β = 
1.935, SE = 0.604, p <0.01; Q2: β = 1.777, SE = 0.618, p <0.05; Q3: β = 1.505, SE = 0.630, 
p <0.05; Q4: β = 1.430, SE = 0.627, p <0.05), more patients with HbA1C ≤7.4% (Q1: β 
=2.249,  SE = 0.713,  p <0.01; Q2: β = 2.046, SE = 0.695,  p <0.01; Q3: β = 1.505, SE = 
0.718, p <0.001) and HbA1C ≤10% (Q1: β = 1.763, SE = 0.449,  p <0.001; Q2: β = 1.639  
SE = 0.440, p <0.001; Q3: β = 1.420, SE = 0.438, p <0.01; Q4: β = 1.499,  SE = 0.460, p 
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<0.01; Q5: β = 0.915,  SE = 0.425, p <0.001), and total cholesterol ≤5mmol/l (Q1: β = 
1.862, SE = 0.632, p <0.01; Q2: β = 1.537, SE = 0.619, p <0.05; Q3: β = 1.335, SE = 0.655, 
p <0.05; Q4: β = 1.754, SE = 0.670, p <0.05; Q5: β = 1.122, SE = 0.648, p <0.01). 
List size per GP Practices with greater list size per GP had more patients HbA1C ≤7.4% (β = 0.15, 95% 
CI: 0.05-0.25, p = 0.007). 
Type (solo or other)  Single-handed practices performed worse: HbA1C ≤10% (β = –0.544, SE = 0.251, p < 
0.05). 
Size (number of patients) Larger practice population associated with poorer performance: HbA1c ≤10% (β = 
0.115, SE = 0.051, p < 0.05) and BP ≤145/85mmHg (β = - 0.282, SE = 0.122, p < 0.05). 
Primary medical services contract n.s. 
Diabetes prevalence (unadjusted) higher prevalence associated with higher performance HbA1c ≤7.4% (β = 
0.689, SE = 0.245, p <0.001); n.s. for other outcomes and better management overall. 
Deprivation Greater deprivation associated with poorer performance HbA1c ≤7.4% (β = -0.460, SE = 
0.155, p < 0.01) and HbA1c ≤10% (β = -0.517, SE =0.069, p < 0.001). 
 
Geographic area density Greater population density associated with poorer performance: HbA1c ≤10% (β = -
0.275, SE =0.076, p < 0.001). 
% patients ≥65 years Greater % patients ≥65 years associated with greater performance: HbA1c ≤7.4% (β = 
1.599, SE = 0.172, p < 0.001); HbA1c ≤10% (β = 0.884, SE = 0.081, p < 0.001); total 
cholesterol ≤5mmol/l (β 0.377, SE = 0.158, p <0.05) but lower performance BP 
≤145/85mmHg (β = -0.552, SE = 0.166, p < 0.001). 
% patients from a racial or ethnic 
minority 
Greater % patients racial or ethnic minority associated with poorer performance: 
HbA1c ≤7.4% (β = -1.529, SE = 0.187, p < 0.001); BP ≤145/85mmHg (β = -0.417, SE = 
0.198, p < 0.05); total cholesterol ≤5mmol/l (β =- 0.508, SE = 0.158, p<0.01). 
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Griffiths et al. 
2011[267]* 
 
N practices  
between 
7431 and 
7456***  
Patients 
NR 
List size per FTE practice nurse 
(quintiles) 
Lower list size per FTE nurse associated with greater quality of care score (Q1: β = 
1.227, SE = 0.166, p <0.001; Q2: β = 1.603, SE = 0.287, p < 0.001; Q3: β = 1.352, SE = 
0.298, p < 0.001; Q4: β = 1.093, SE = 0.300, p < 0.001; Q5: β = 0.990, SE = 0.302, p < 
0.01). 
% physician aged ≥45 years n.s. 
% female physicians n.s. 
% qualified in the UK Increasing % qualified in UK associated with better quality of care score (β = 0.694, SE = 
0.080, p < 0.001). 
Geographic area  Area density (people per hectare 2001) associated with lower score: β = -0.317, SE = 
0.082, p < 0.001. 
Deprivation  n.s. 
Practice size (number of patients) n.s. 
List size per GP n.s. 
Type (solo or other) n.s. 
Primary medical services contract,  n.s. 
Diabetes prevalence (unadjusted) higher prevalence associated with lower quality of care (β = -0.571, SE = 
0.081, p <0.001). 
Organisational factors** Organisational factor - clinical recording (β = 2.632, SE =0.235, p < 0.001) and 
Organisational factor - education & training (β = 0.900, SE =0.144, p < 0.001) associated 
with greater quality of care scores. 
Other organisational factors: patient communication, practice management and 
medicines management n.s. 
% patients from a racial or ethnic 
minority 
n.s. 
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% patients ≥65 years Greater % older associated with lower quality of care (β = -0.372, SE = 0.123, p <0.01) 
Gulliford et 
al. 
2001[290]*║ 
23 health 
centres 
1579 
patients 
 
Number of doctors at each clinic  Compared with practices with 1 doctor per session, those with ≥2 had higher scores: β 
= 1.90, 95% CI: 0.73-3.06. 
Number of trained nurses at each 
clinic  
Compared to practices with 1 nurse per session, practices with 2 nurses per session 
had higher mean score (β = 1.16, 95% CI: 0.032-2.00), as did those with ≥ 3 nurses (β = 
1.18, 95% CI: 0.27-2.09). 
Number of equipment items  Practices with more equipment items had greater mean score: 8-9 items vs. 6-7 (β = 
0.72, 95% CI: -0.51-1.96); 10-11 items vs. 6-7 (β = 2.02, 95% CI: 0.56-3.47). 
Distance from capital  Results were not consistent across categories. 
Number of patients seen during the 
census period  
Compared to those in first quartile, practices in second quartile had lower mean score 
(β = -0.31, 95% CI: -2.01, -1.39), as did practices in highest quartile (β = -1.12, 95% CI: -
3.22-0.99). 
Gulliford et 
al. 2007[289] 
8164 
practices 
Patients 
>50 mil. 
List size per GP  
Mean difference in % between practices in the highest tertile and lowest tertile 
achieving HbA1c ≤7.4%: -0.64, 95% CI: -1.25--0.03, p = 0.04. 
Size (number of GPs)  n.s. 
Training practice status  [Mean difference in % achieving HbA1c ≤7.4% from non-training practices] 
Training practices: -0.60, 95% CI: -1.16--0.04, p = 0.036. 
Type (solo or other)  
 
n.s. 
Practice engaged in postgraduate 
medical training  
 
n.s. 
QOF organisational score  
 
[Mean difference in % achieving HbA1c ≤7.4% from practices in lowest tertile] 
Middle: 3.24, 95% CI: 2.68-3.80, p <0.001;  
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Highest: 5.03, 95% CI: 4.43-5.64, p<0.001 
Diabetes prevalence 
 
[Mean difference in % achieving HbA1c ≤7.4% from practices in lowest tertile] 
Middle: 0.97, 95% CI: 0.41-1.54, p = 0.001 
Highest: 1.97, 95% CI: 1.34-2.59, p <0.001 
% patient ethnic minority [Mean difference in % achieving HbA1c ≤7.4% from practices in lowest tertile] 
Middle n.s. 
Highest: -2.73, 95% CI: -3.61- -1.85, p<0.001 
Deprivation [Mean difference in % achieving HbA1c ≤7.4% from practices in lowest tertile] 
Middle: n.s. 
Highest: -2.96, 95% CI: -3.69--2.23, p <0.001 
Middle tertile compared to highest tertile: -1.03, 95% CI:  -1.63- -0.43, p = 0.001 
 **Similar patterns of association for blood pressure ≤ 145/85 mmHg and cholesterol ≤ 
5.0 mmol/l (data not shown)** 
Harris et 
al.[291] 
614 
physicians 
Patients 
NR 
Use of register Practices with a register had a higher proportion of patients with HbA1c test, 
microalbuminuria test, and across the different study periods (Jan - Jun 1996; Jul - Dec 
1996: Jan-Jun 1997; Jul-Dec 1997 with exception of 1998 which was n.s.; proportion 
with lipid testing only significant in Jul-Dec 1998. 
He et 
al.[254]* 
Practices 
NR 
2912 
patients 
Practice setting (free standing clinic, 
community health centre, other vs. 
private practice)  
Older men: free standing vs. private practice (OR = 2.7, 95 CI: 1.06, 7.07); Other vs. 
private practice (OR = 0.2, 95% CI: 0.05, 0.79); community health centre vs. private 
practice n.s. 
Older women: n.s. 
Physicians (employees or 
contractors vs. owners)  
n.s. 
EHR usage  Older men:  
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Use of EHRs associated with greater likelihood of diagnostic testing (AOR = 2.2, 95% CI: 
1.38-3.58). 
Older women: n.s. 
Laboratory tests (at office or off-
site) 
Older men: 
On-site laboratory tests associated with greater likelihood of diagnostic testing (AOR = 
2.9, 95% CI: 1.99-4.42). 
Older women:  
On-site laboratory tests were associated with a higher likelihood of diagnostic testing 
(AOR = 5.1, 95% CI: 3.20–8.32). 
Juul et al. 
2009[252] 
54 
practices 
226 
patients 
Size (number of GPs) n.s. (association with treatment initiation)  
Number of inhabitants registered in 
the postcode of the practice 
(<10000; ≥10000)  
n.s. (association with treatment initiation) 
Type (solo or group)  n.s. (association with treatment initiation) 
List size per GP  n.s. (association with treatment initiation) 
Average GP age (<50 years; ≥50 
years),  
n.s. (association with treatment initiation) 
Gender (both represented; only 
female; only male) 
n.s. (association with treatment initiation) 
Juul et al. 
2012[292]║ 
193 
practices 
12,960 
patients 
Nurse involvement (1) “No nurses 
employed”, (2) “Nurses employed, 
no nurse-led type 2 diabetes 
consultations”, (3) “Nurses 
employed, nurse-led type 2 
diabetes consultations less 
Compared to practices with no nurse employed, practices with nurse-led consultation 
well-implemented had a greater mean proportion with HbA1c measurement (mean 
diff. = 6.4% points, 95% CI: 1.5-11.4), and had lower proportions HbA1c ≥8% (mean 
diff. = −3.7% points, 95% CI: −6.7- −0.6). 
Differences for cholesterol n.s.  
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implemented”, and, (4) “Nurses 
employed, nurse-led type 2 
diabetes consultations well-
implemented” 
Khunti et 
al.[150] 
169 
practices  
18 642 
patients 
Size (number of patients)  Larger practices have lower compliance with annual assessment of glycated 
haemoglobin and blood pressure (HbA1c check: -1.1, 95% CI: -1.8- -0.38; BP check: -
1.7, 95% CI: -2.6--0.8). 
Fund-holding status Fundholding practices associated with greater annual compliance of some process 
measures (urine check: 9.5, 95% CI: 1.4-17.6); feet check: 9.4, 95% CI: 1.7-17.1); n.s. for 
other measures. 
Deprivation Practices with higher socioeconomic deprivation performed poorly for most process 
measures (HbA1c check: -1.6, 95% CI: -2.6- -0.6); fundi check: -1.3, 95% CI: -2--0.03; 
feet check: -2.0, 95% CI: -3.3- -0.8); BP check: -1.2, 95% CI: -2.3-0.0); n.s. for urine 
check, HbA1c level 
Training practice status n.s. 
Number of practice nurses n.s. 
Size  (number of GPs) Higher number of GPs associated with poorer performance of feet check (-1.9, 95% CI: 
-3.7- -0.2); n.s. for other measures. 
Diabetes mini clinic n.s. 
Recall system Practices with a recall system associated with annual compliance of some process 
measures (fundi check: 25.6, 95% CI: 2.9, 48.9); feet check: 33.9, 95% CI: 10.5-57.2). 
Diabetes prevalence  Increasing prevalence associated with poorer performance of HbA1c check (-6.3, 95% 
CI: -10.7- -1.9) but n.s. for fundi check, feet check, BP check, urine check and HbA1c 
level. 
Practice: % patients under GP care n.s 
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Practice: % patients under hospital 
care 
Practices with greater proportion of patients under hospital care associated with lower 
compliance with process and outcome of care: (HbA1c check -0.3, 95% CI: -0.5 - -0.2); 
fundi check: -0.5, 95% CI: -0.7 - -0.3; urine check: -0.5, 95% CI: -0.7 - -0.3); feet check: -
0.3, 95% CI: -0.5 - -0.1); BP check: -0.4, 95% CI: -0.6 - -0.2); HbA1c normal range: -0.2, 
95% CI: -0.4 - -0.002). 
Personal care (single-handed or 
having a personal list system) 
n.s 
GP interest in diabetes n.s 
Nurse interest in diabetes n.s 
Kontopantelis 
et al.[293]*║ 
148 
practices 
23 780 
patients  
Deprivation Patients attending practices from the most deprived quartile gained less from the 
intervention compared with patients in the most affluent quartile of practices: short 
term (2004/5) score minus predication from pre-QOF trend) = -4.9%, 95% CI: -7.2 - -
2.7) p <0.001; long term (2004/05) score minus prediction from pre-QOF trend) = -
3.8%, 95% CI: -6.8 - -1.1, p = 0.002. 
 
Diabetes prevalence Compared with practices in the first quartile (lowest diabetes prevalence), effect was 
larger for practices in the second and third quartiles: short term (2004/5) score minus 
predication from pre-QOF trend): 2nd Q = 1.4%, 95% CI: -0.7 - 3.5), 3rd Q = 2.1%, 95% 
CI: -0.02 - 4.1,  p = 0.004;  long term (2004/05) score minus prediction from pre-QOF 
trend 2nd Q - 3.2%, 95% CI: 0.7 - 5.4, 3rd Q =  4.8%, 95% CI: 2.5 - 6.8, p <0.001. 
Kuo et 
al.[305]║β  
 Care delivery by nurse practitioner 
(NP) vs. primary care physician 
(PCP) 
Patients with care delivered by NP less likely to receive eye exam (AOR = 0.89, 95% CI = 
0.84–0.93), HbA1c test (AOR = 0.88, 95% CI = 0.79–0.98), and be prescribed statins 
(AOR = 0.94, 95% CI = 0.89–0.99). 
LDL-C test, nephropathy monitoring, and prescription of ACEIs or ARBs n.s. 
Size of service population n.s. 
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Reference N Factors Main results (multivariate analysis unless otherwise stated) 
Matthews et 
al.[262]*║ 
132 health 
centres 
10,674 
patients 
Governance (community-controlled 
or government operated),  
n.s. 
Location (very remote, remote or 
non- remote),  
Increased odds of improvement in delivery of services to patients with type 2 diabetes 
from non-remote (1-2 cycles of participation: AOR = 1.47 (95% CI: 1.06-2.04) p <0.05), 
to remote (1-2 cycles: AOR = 2.91 (95% CI: 1.36,6.22) p <0.01; ≥3 cycles AOR = 3.29 
(1.44-7.54) p < 0.01)) and very remote centres (1-2 cycles: AOR = 4.31 (95% CI: 2.43-
7.67) p <0.001; ≥3 cycles AOR = 5.06 (95% CI: 2.63-9.67) p<0.001)). 
Rates of patient attendance (higher 
or ‘lower regular attendance’ - if 
more than 3% of patients did not 
attend within the previous six 
months) 
Practices with higher attendance more likely to adhere to delivery of type 2 services 
(AOR = 1.40; 95% CI 1.22-1.61) p <0.001). 
McCullough 
et al.[294]* 
557 clinics 
Patients 
NR (≈ 
152,000) 
EHR usage  Compared to paper-based system EHR utilization associated with increase in diabetes 
quality score: β = 0.028, SE = 0.012, p < 0.05. 
Number of diabetes patients n.s. 
Number of clinics within the 
medical group 
Greater number of clinics associated with increase in score: β = 0.004, SE = 0.000, p < 
0.001 
McLean et 
al.[295] 
912  
practices 
Patients 
NR 
 
Location (not remote; remote; very 
remote) 
Care processes: eye exam, peripheral pulses, neuropathy testing, BP recorded, 
cholesterol recorded n.s. 
Outcomes: HbA1c ≤7.4%, HbA1c ≤10%, BP ≤145/85mmHg n.s. 
 
Compared to not remote practices, remote practices had lower mean (IQR) proportion 
with cholesterol ≤5 mmol/l (67.9 (14.4) vs. (68.0 (12.2)).  
Millett et 
al.[144] 
8970 
practices 
Size (number of patients) Larger practices achieved the highest quality of care scores, particularly for process of 
care measures. 
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Reference N Factors Main results (multivariate analysis unless otherwise stated) 
 
1 852 762 
patients 
Process of care: With the exception of retinal screening (0-3000 list size (78.2%) vs 
≥10,000 list size (86.1%)), peripheral pulses (0-3000 list size (73.1%) vs ≥10,000 list size 
(81.1%)) and neuropathy testing (0-3000 list size (71.2%) vs ≥10,000 list size (80.0%)), 
absolute differences in achievement between small and large practices was modest 
(<5%). 
Clinical outcomes: performance of small practices was broadly similar to larger 
practices in achievement of intermediate outcome targets for HbA1c, blood pressure 
and cholesterol. 
 
Clinical outcomes: the trend of higher achievement with increasing practice size was 
less marked in affluent areas e.g. smaller practices were more likely to achieve the 
lower treatment target for HbA1c (47.4%) than larger practices in affluent areas. 
Number of diabetes patients 
(quintiles) 
Similar trends between achievement of indicators and caseload (i.e. achievement 
broadly similar between practices with high and low caseload) (data not shown). 
Deprivation  Process of care: practices located in deprived areas performed less well on quality 
measures than those based in affluent areas e.g. neuropathy testing (deprived = 72.9% 
vs. affluent = 81.4%). Differences in achievement between small practices in deprived 
areas and large practices in affluent areas were considerable on some indicators >10% 
(peripheral pulses; neuropathy testing; retinal screening; microalbuminuria testing). 
Mitchell et 
al.[296]║ 
 
6 practices 
939 
patients 
 
EHR Use of electronic system associated with greater odds of recording: 
BP: Practice Pair 2: AOR = 3.3 (95% CI: 1.2-10.9); Pair 6: AOR = 6.0 (95% CI: 2.1-17.1)) 
Smoking: Pair 1 AOR = 0.2 (95% CI: 0.04-0.7) 
Height: Pair 2 AOR = 7.3 (95% CI: 2.9-18.5); Pair 4 AOR = 0.1 (95% CI: 0.01-0.8); Pair 6 
95% CI: AOR = 4.7 (95% CI: 1.5-14.5) 
Weight: Pair 2 AOR = 3.6 (95% CI: 1.5-8.7); Pair 5 AOR = 6.4 (95% CI: 2.3-56.4), foot 
pulses: Pair 3 AOR = 5.6 (95% CI: 1.8-17.2); Pair 6 AOR = 6.5 (95% CI: 1.8-23.5) 
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Reference N Factors Main results (multivariate analysis unless otherwise stated) 
Foot sensation: Pair 2 AOR = 2.4 (95% CI: 1.1-5.0)  
n.s. HbA1c or fundoscopy 
Ohman et 
al.[143]║β 
46 
practices 
846 
patients 
 
Practices with NPs, practices with 
physician assistants (PA), and 
practices with physician-only 
Practices with NP had higher rate of HbA1c tests than PA (RR = 1.96 ,p = 0.005) and 
physician only (RR = 1.34, p <0.001), higher rates of lipid test than PA (RR = 1.37, p = 
0.004) and physician only practices (RR = 1.17, p  = 0.007), higher rates of 
microalbumin test than PA (RR = 5.26, p < 0.001) and physician only practices (RR = 
1.72,  p  = 0.10). Patients were more likely to meet lipid targets if attending practices 
with PA (RR = 1.37, p = 0.004) or physician only (RR = 1.17, p = 0.03), but less likely to 
be assessed and at target than practices with PA (RR = 1.45, p = 0.001) or Physician 
only (RR = 0.98, p = 0.85). 
 
Compared to practices with physician only, those with PA had lower rates of HbA1c 
tests (RR = 0.68 p = 0.21), lower rates of lipid tests (RR = 0.85 p = 0.29), microalbumin 
test (RR = 0. 33 p = 0.02), patients were less likely to meet lipid targets (RR = 0. 85 p = 
0.20) and less likely to be assessed and at target (RR = 0. 68 p < 0.01). 
 
Receipt of BP check, and meeting targets for HbA1c, microalbuminuria, BP were n.s. 
Orzano et 
al.[297]* ║β 
50 
practices 
883 
patients  
Use of clinical information systems 
in 2 categories: 1) Identification of 
patients  
 2) tracking systems  
Use of identification systems improved achievement of at least 2 of 3 outcome targets 
(AOR = 1.23 (95% CI: 1.06-1.44), p = .007), as did use of tracking systems (AOR = 1.32 
(95% CI: 1.11-1.59) p = 0.002). 
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 Adherence to assessment or treatment guidelines was n.s.  
Poon et 
al.[298]*¶ 
507 
physicians  
150 unique 
medical 
groups 
Patients 
NR 
 
EHR usage n.s. 
Ricci-Cabello 
et al.[299]*β 
7,884 
practices  
54,220,050 
patients 
Diabetes prevalence  Increased prevalence was negatively associated with processes of care measure (back-
transformed effect, −0.31%). For a practice with an average achievement rate, a 
relative increase of 1% in the prevalence of diabetes was associated with a 0.31% 
higher achievement rate across the overall processes of care. 
Outcome of care measure n.s. 
Prevalence of diabetes-concordant 
conditions 
4 /7 conditions were positively associated with achievement rate (%) of process of care 
and outcomes of care measures: obesity (process: 0.33%; outcome: 0.24%), chronic 
kidney disease (process: 0.18%; outcome: 0.30%), atrial fibrillation (process: 0.57%; 
outcome: 0.97%), and heart failure (process: 0.60%; outcome: 0.98%).  
No association was observed for stroke or transient ischemic attack. 
2/7 conditions were negatively associated: hypertension (process: −0.08%; outcome: -
0.22%) and coronary heart disease (process: −0.38%; outcome: -0.31%). 
Prevalence of diabetes-discordant 
conditions 
2/8 conditions were negatively associated: epilepsy (process: −0.80%; outcome: -
0.58%) and severe mental health disorders (process: −0.76%; outcome: -0.95%).  
No associations were observed for 3 other discordant conditions (dementia, 
depression, and hypothyroidism) 
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Reference N Factors Main results (multivariate analysis unless otherwise stated) 
3/8 conditions were positively associated: asthma (process: 0.19%), cancer (process: 
0.59%; outcome: 0.89%), and COPD (process: 0.23%; outcome: 0.95%) 
Spigt et 
al.[141]* 
10 health 
centres 
45 
physicians 
1849 
patients 
Practice protocol  n.s. 
Active measures taken in case a 
patient does not show up (1, 2 or 3 
measures) 
If more active measures in place then more likely to receive optimal care: 1 vs. 3: AOR: 
0.65, 95% CI: 0.47–0.89, p <0.05; 2 vs. 3: AOR: 0.59, 95% CI: 0.50–0.69, p <0.05. 
Registration system  n.s. 
Yearly check-ups (done by GP and 
NP; GP or NP) 
If yearly medical check-ups done by both the GP and NP then patients were more likely 
to receive optimal quality of care (AOR: 5.51; 95% CI: 4.16–7.30, p <0.05). 
Diabetes education programme  Greater odds of receiving optimal quality of care at practices with diabetes education 
programme: AOR: 4.29; 95% CI: 3.40–5.41, p <0.05. 
Practice multidisciplinary 
collaboration  
n.s. 
After visit NP patient discussed with 
GP  
Greater odds of receiving optimal quality of care if after the patient visited the NP the 
patient is discussed with the GP (AOR = 1.80, 95 CI%: 1.62–2.00, p <0.0). 
Use of report cards  n.s. 
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Reference N Factors Main results (multivariate analysis unless otherwise stated) 
Stearn et 
al.[300] 
 
50 
practices  
3550 
patients  
 
Practice nurse training level (not 
involved vs. involved, not trained vs. 
involved, trained and involved)  
(Comparison of % recording; ANOVA) 
In practices where the nurse was not involved compared to involved there was lower 
recording of BP (75% vs 82% (8.9-34.0) p > 0.05), weight (23% vs. 45% (1.2-13.9) p > 
0.05), performance of foot exams (6% vs 28% (9.7-33.2) p > 0.05), visual acuity tests 
(2% vs. 13% (3.0-19.6) p > 0.05). 
 
Smoking status recording n.s. 
 
In practices where nurse was trained but involved compared to practice where nurse 
was trained and involved there was lower proportions with foot exams performed 
(8.9% vs. 38% (5.3-52.9) p > 0.05), visual acuity tests (0.3% vs. 20% (2.9-38.2) p > 0.05). 
 
All other variables, weight, BP, smoking status recording n.s. 
Suleman et 
al.[301] 
629 
practices 
199,485 
patients 
 
Size (number of patients) 
 
n.s. 
Diabetes prevalence  Higher prevalence associated with higher achievement of HbA1c ≤7.5 (β = 1.188, SE = 
0.280, p <0.001) but lower achievement of HbA1c ≤10 (β = -0.342, SE = 0.141, p = 
0.016), and BP ≤145/85 (β = -0.835, SE = 0.272, p = 0.002) and cholesterol ≤5 mmol (β = 
-0.835, SE = 0.272, p = 0.002). 
Obesity prevalence Higher prevalence associated with higher achievement of BP ≤145/85 
(β = 0.432, SE = 0.116, p<0.001), cholesterol ≤5 mmol (β = 0.247, SE = 0.081, p <0.002); 
HbA1c n.s. 
Deprivation Higher deprivation score associated with lower achievement of HbA1c ≤7.5 (β = -0.002, 
SE <0.001, p <0.001) and HbA1c ≤10 (β = -<0.001, SE <0.001, p = 0.002); BP and 
cholesterol n.s. 
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Tahrani et 
al.[142] 
66 
practices 
16 858 
patients  
 
Size (number of patients) 
 
Compared to large practices, smaller practices had a lower mean % (sd) with HbA1c 
≤7.4% (36 (18) vs. 46 (12) p = 0.02, CI for difference -17 to -2), HbA1c ≤10% (64 (16) vs. 
73 (6)  p = 0.003, CI for difference -15 to -3), eye exam (40 (22) vs. 52 (18) p = 0.02; 95% 
CI of difference -22 to -2), prescription of ACE/ARB: small vs. large (96 (7) vs. 90 (9) p = 
0.001, 95 % CI 3 to 11) 
HbA1c ≤7.4%, HbA1c ≤10% n.s. in 2005, 2006, BP ≤145/85, total cholesterol ≤5 n.s., eye 
exam n.s. 2005, 2006, ACE/ARB prescribing n.s. 2004, 2005  
Vamos et 
al.[138]║ 
422 
practices 
154,945 
patients   
Size (number of patients) 
 
No statistically significant variations in achieving BP or HbA1c targets between the 
smallest and largest practices in any year during 1997-2005. 
 
Cholesterol target achievement was lower in the larger practices than in the smallest 
practices in 1998, but there were no statistically significant variations in performance 
between small and large practices for other years during the study period. 
Van Doorn et 
al.[306]║ 
354 
practices 
11 751 
patients  
 
NP per 1000 patients 
 
n.s. 
EHR use (sum score of seven items)µ Greater use (increase of one on a scale of seven) associated with performance within 
the highest quartile of HbA1c level (AOR = 1.80, 95% CI: 1.12-2.88, p = 0.014); n.s. for 
BP or cholesterol. 
GP education (<50 hours per year 
≥50 hours) 
n.s. 
Nurse education (< 15 hours per 
year, ≥ 15 hours) 
Higher nurse education (compared to < 15 hours per year) associated with 
performance within the highest quartile of total cholesterol values (AOR = 2.51, 95% 
CI: 1.02-6.15, p = 0.045); n.s. for others. 
Guidelines  n.s. 
Reminder system n.s. 
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Type (solo or other) Health centre (compared to > 1 GP but not health centre) associated with higher total 
cholesterol values (β = 0.149, 95% CI: 0.037, - 0.262, p = 0.010); HbA1c n.s. 
Diabetes clinic  Higher HbA1c levels in practices with diabetic clinic (β = 0.327, p < 0.000) 
Annual report n.s. 
Patient leaflets Practices with availability of patient leaflets were in SBP (highest quartile) AOR = 2.59, 
95% CI: 1.06-6.15, p = 0.037; HbA1c or cholesterol n.s. 
Composite score of 12 determinants 
related to target areas for 
improvement strategies 
Higher determinant score associated with decrease in SBP:  β = -50, 95% CI:-0.91, -
0.09, p = 0.017; HbA1c or cholesterol levels n.s. 
Wang et 
al.[309]* 
638 
practices 
Patients 
NR (≈ 1 
mil.) 
Practice size (number of GPs) 
 
n.s. 
Wencui et 
al.[302]*║ 
50 
practices 
12 514 
patients 
  
EHR usage Using records for patient reminders increased likelihood of lab testing (composite of 
HbA1c, nephropathy, LDL) (AOR = 1.26, 95% CI: 1.15-1.38, p <0.01) and eye exam (OR = 
1.14, 95% CI: 1.04-1.23, p < 0.01). 
Using registries for quality improvement: n.s. 
Number of diabetes patients Increasing number of patients increased likelihood of lab testing (AOR = 1.03, 95% CI: 
1.02-1.04, p < 0.01, per 100 patients), n.s. for eye exam. 
Wong et 
al.[303]║β 
74 clinics 
87,031 
patients 
Annual patient volume at clinic level 
(quartiles)  
Patients of practices in Q4 vs. Q1 were less likely to have HbA1c test  
 (OR = 0.646, 95% CI: 0.425,0.981, p = 0.040). 
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Q3 vs. Q1 were less likely to have HbA1c test (AOR = 0.655, 95% CI: 0.435,0.986, p = 
0.043), renal function test (AOR = 0.367, 95% CI: 0.172,0.786, p =0.010), full lipid 
profile (AOR = 0.612, 95% CI: 0.384,0.974, p =0.038). 
 
Q2 vs. Q1 were less likely to have renal function test (AOR = 0.357, 95% CI: 0.178, 
0.716, p = 0.004), full lipid profile (AOR = 0.508, 95% CI: 0.333,0.774, p = 0.002). 
 
Prescription of ACEI/ARB for patients with microalbuminuria, urine protein analysis, 
and eye exam, meeting HbA1c, LDL-C and BP targets were n.s.  
Abbreviations: NR, Not Reported; OR, Odds Ratio; EHR, Electronic Health Record; MDT, Multidisciplinary team; WTE, Whole Time Equivalent; GPs, General 
Practitioners; RAP, intervention arm receiving practice facilitation using reflective adaptive process change model based on complexity theory; CQI, 
Continuous quality improvement arm received practice facilitation based on the model for improvement; SD, Self-directed arm received limited feedback on 
their baseline practice culture and level of implementation of the Chronic Care Model based on practice; RN, registered nurse; LPN, licensed practical nurses; 
MA, medical assistants; AP, Associate provider; NP, Nurse Practitioners; FTE, Full Time Equivalent; SES, socio-economic status 
*Composite outcome 
║Patient-level covariates adjusted for in multivariate analysis 
¶Physician-level covariates (additional to explanatory variables) adjusted for in multivariate analysis 
βPractice-level covariates (additional to explanatory variables) adjusted for in multivariate analysis 
**Indicators grouped as ‘Records and information about patients (19), Patient communication’ (8), Education and training (9), Practice management (10), 
Medicines management (10) 
***depending on the condition being studied 
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µ(a) General practitioners (GPs) always use the EHR to create prescriptions, (b) Incoming lab results are processed automatically, (c) Hospital referrals are 
completely created in EHR, (d)Referrals to other disciplines (e.g. physiotherapy) are completely created in EHR, (e) Application forms for diagnostic 
procedures are generated in the EHR,  (f) Contraindications and intolerances are systematically recorded in the EHR, (g) GPs have the support of an electronic 
referral system during visiting hours) 
 
Table 22 Main results for studies which examined both physician and practice factors (n = 12) 
Reference N Factors Main results (multivariate analysis unless otherwise stated) 
Alberti et 
al.[312]*║ 
102 
physicians 
2,160 
patients  
Physician 
Gender 
 
n.s. 
Training (postgraduate, 
diabetes)  
n.s. 
Workload (average number 
of patients per clinic) 
n.s. 
Time commitment n.s. 
Motivation Increased motivation associated with increase in weighted process of care score: β = 0.37 (95% 
CI: 0.22- 1.68) p = 0.013; other scores n.s. 
Practice 
Interest in diabetes 
(presence of regional 
coordinator of the national 
program) 
n.s. 
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Size (number of GPs)  n.s. 
Nutritionist available n.s. 
Number of nurses  n.s. 
Location (urban or rural)  n.s. 
Size (number of patients) n.s. 
Frequency of medical clinics n.s. 
Distance from capital city n.s. 
Affluence of region  Higher affluence associated with increase in weighted process of care score: β = 0.51 (95% CI: 
0.12-0.53) p = 0.003; other scores n.s. 
Motivation of the regional 
director 
n.s. 
Distance from secondary 
care 
n.s. 
Diabetes prevalence  n.s. 
Disease-specific medical 
records 
n.s. 
Register and patient-held 
records 
n.s. 
Availability of medication Four variable outcome of care score:  β = 0.27 (95% CI: 0.00-0.60) p = 0.04; other scores n.s. 
Affluence of the patients  n.s. 
Chronic disease clinics Use of clinics associated with increased in weighted process of care score: β = 0.36 (95% CI: 0.01-
0.70) p = 0.029; other scores n.s. 
Equipment items n.s. 
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Patient education sessions n.s. 
  
Balkau et 
al.[263]║ 
1200 
physicians 
3188 
patients 
Physician 
Age 
 
n.s. 
Gender n.s. 
Practice 
Location 
n.s. 
Number of type 2 patients at 
practice 
n.s. 
Fantini et 
al.[313]*║ 
637 
physicians 
35,912 
patients  
Physician  
Age 
 
 
Younger age (<50 years) favoured good management across several indicators; HbA1c (56-60 vs 
≤ 50 AOR = 0.83, 0.72-0.97; >60 vs ≤ 50 AOR = 0.77, 0.60-0.96), microalbuminuria (56-60 vs  ≤ 50 
AOR = 0.98, 0.81-1.18), creatinine (51-55 vs ≤ 50 AOR = 0.89, 0.80-0.99, 56-60 vs  ≤  50 AOR = 
0.85, 0.75-0.95, >60 vs ≤ 50 AOR = 0.74, 0.61-0.89), lipid profile (>60 vs ≤ 50 AOR = 0.74, 0.61-
0.88). 
Gender 
 
Female gender favoured good management across several indicators; HbA1c (AOR = 0.84, 0.75-
0.95), microalbuminuria (AOR = 0.85, 0.73-0.99), creatinine (AOR = 0.88, 0.80-0.97), eye exam 
(AOR =0.81, 0.79-0.95). 
Panel size  
Practice 
Type (no organisational 
arrangement, association, 
network, group practice) 
[Compared to practice with no organisational arrangement] 
Network practices had greater odds of microalbuminuria test (AOR = 1.404 (95% CI: 1.158-
1.702), creatinine (AOR = 1.195 (95% CI: 1.057-1.351)), lipid profile (AOR = 1.214 (95% CI: 1.076-
1.369)), n.s. for electrocardiogram, eye exam, HbA1c, good management overall. 
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Group practices had greater odds of microalbuminuria test  (OR = 1.413 (95% CI: 1.194-1.672)),  
creatinine (AOR = 1.253 (95% CI: 1.126-1.395)), lipid profile (OR = 1.202 (95% CI: 1.080-1.335)), 
electrocardiogram (AOR = 1.170 (95% CI: 1.055-1.298)), eye exam (AOR = 1.170 (95% CI: 1.055-
1.298)), and good management overall (composite AOR = 1.179 (95% CI: 1.010-1.376)); n.s. 
HbA1c. 
 
Association practices had greater odds of creatinine test (AOR = 1.379 (95% CI: 1.084-1.755)), 
lipid profile (AOR = 1.331 (95% CI: 1.050-1.687)), n.s. for electrocardiogram, eye exam, HbA1c, 
good management overall. 
Location (urban, rural, or 
mountain) 
[Compared to practices in urban areas] 
Location in a rural area was associated with increased prescription of HbA1c test (data not 
shown). 
Location of the ambulatory facility in a mountain area associated with a higher frequency of 
examination of lipid profile (data not shown). 
  
Keating et 
al.[314]*║¶β 
399 
physicians 
652 
patients 
Physician 
Satisfaction with career in 
medicine 
 
Physicians dissatisfied with overall career in medicine less likely to have microalbumin testing (p 
= 0.047) and retinopathy screening (p = 0.03) [data not shown]; n.s. for composite quality 
outcome. 
  % income earned from 
incentives 
n.s. 
Use email for 
communication,  
n.s. 
EHR usage n.s. 
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Practice 
Guidelines  
n.s. 
Flow sheets n.s. 
Type of payment n.s. 
  
Kern et 
al.[311]* 
466 
physicians 
74,618 
patients§ 
Physician 
Age 
 
Patients of older physicians (10-year increase) have lower quality score (β = −0.238 (p = 0.001). 
  Gender Patients of female physician have higher scores (β = 0.422 (p =0.005). 
Credential (MD or Doctor of 
Osteopathic medicine) 
n.s. 
Specialty Family medicine vs. internal medicine: β = -0.640 (p <0.001). 
Panel size 
 
Practice 
n.s. 
EHR EHR vs. paper: β = 0.373 (p = 0.008). 
Location (urban or rural) n.s 
  
McGinn et 
al.[318] 
Physicians 
NR 
31831 
patients 
Physician 
Age 
 
Patients of older physicians were more likely to have poor HbA1c control: OR = 1.037 (95% CI: 
1.010-1.065); n.s. HbA1c test, LDL-C test, LDL-control, eye exam referral, nephropathy screening. 
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  Speciality Physicians with non-primary care subspecialty had lower odds of poor LDL-C control: OR = 0.340 
(95% CI: 0.156-0.738); n.s. HbA1c test, HbA1c control, LDL-C test, eye exam referral, nephropathy 
screening. 
Years since graduation Patients of physician with more years since graduation had lower odds of poor HbA1c control: 
OR = 0.971 (95% CI: 0.945-0.997); n.s. HbA1c test, LDL-C test, LDL-C control, eye exam referral, 
nephropathy screening. 
Credential (MD or DO) n.s. 
Practice 
Type (solo or group) 
 
Group practices had better nephropathy screening rates: OR = 1.441 (95% CI: 1.270-1.721); n.s. 
HbA1c test, HbA1c control, LDL-C test, LDL-C control, eye exam referral. 
  
Parkerton 
et al. 
2004[315]*β 
25 clinics 
182 
physicians 
Patients 
NR 
Physician 
Gender 
 
n.s. 
  Administrative role n.s. 
Years since graduation  n.s. 
Continuity (percentage of a 
panel’s visits that were to 
the primary care physician 
rather than any other 
clinician) 
n.s. 
Practice  
344 
 
Table 22 Main results for studies which examined both physician and practice factors (n = 12) 
Reference N Factors Main results (multivariate analysis unless otherwise stated) 
Usual Provider Continuity 
(specified physician, rather 
than any other clinician in a 
specified time period),  
n.s. 
Shared practice (clarified 
communication structure, 
team roles, and practice 
styles),  
Being in shared practice associated with better management (β = 0.248 p < 0.05). 
Size (number of GPs) Larger medical clinic size associated with better management (β = 0.252 p < 0.05). 
Team tenure  Long tenure associated with better management (β = 1.241 p <.001). 
  
Pham et 
al.[316]║β 
3,660 
physicians  
24 581 
patients 
Physician  
Gender 
n.s. 
  Specialty (internal medicine 
or family medicine) 
Family/GP compared with general internal medicine had lower odds of eye exam: OR = 0.81, 95% 
CI 0.67-0.97, p <0.05; n.s. HbA1c test. 
Training - board certification  n.s. 
Training - whether their 
medical school education 
was completed in the United 
States (including Puerto 
Rico) or Canada, rather than 
another country. 
Physicians qualified in other country than US or Canada had lower odds of eye exam: OR = 0.82, 
95% CI: 0.68-0.99, p <0.05; n.s. for HbA1c test. 
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Table 22 Main results for studies which examined both physician and practice factors (n = 12) 
Reference N Factors Main results (multivariate analysis unless otherwise stated) 
Years in practice n.s. 
Practice 
Type (solo/2 person or 
other) 
 
Compared to solo/2-person practices, small group practices had greater odds of performing 
HbA1c test (OR = 1.90, 95% CI: 1.45-2.48), as did medium/large group practices (OR = 1.91, 95% 
CI: 1.40-2.60); n.s. for eye exam. 
All other practice types: n.s. 
Practice payer mix  Compared to practices with 0-5% revenue from Medicaid those with 6-15% had lower odds of 
HbA1c test: OR = 0.74 (95% CI: 0.60-0.92), as did those with 16-100%: OR = 0.73 (95% CI: 0.57-
0.95); n.s. for eye exam. 
Information technology 
available to generate 
physician reminders about 
preventive services, or to 
obtain information about 
treatment alternatives or 
recommended guidelines  
Practices using information technology for guidelines or reminders were more likely to perform 
eye exams (OR = 1.21, 95% CI: 1.08-1.35); n.s. HbA1c test. 
  
Spann et 
al.[256]║ 
95 
physicians 
822 
patients 
Physician  
Gender 
 
n.s. 
  Number of patients with 
diabetes seen in month 
n.s. 
Years in practice n.s. 
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Table 22 Main results for studies which examined both physician and practice factors (n = 12) 
Reference N Factors Main results (multivariate analysis unless otherwise stated) 
Practice 
Type (single speciality, 
academic setting, solo 
practices, multispecialty 
group, combo of settings) 
 
[Compared to single-specialty practices] 
Patients of practices in an academic setting had greater HbA1c values (β = 0.61 (95% CI: 0.25-
0.97)) and greater odds of HbA1c >7% (poor control) (OR = 2.90 (95% CI 1.56-5.38)); n.s. BP > 
130/85mmHg, poor LDL-C control >100mg/dl. 
 
Patients of solo practices had greater HbA1c (β = 0.40 (95% CI: 0.03-0.77)), higher odds of poor 
HbA1c control (OR = 1.88 (95% CI: 1.01-3.50)), and higher odds of BP > 130/85mmHg (OR = 2.12 
(95% CI: 1.14-3.94)); n.s. for poor LDL-C control >100mg/dl. 
 
Multispecialty practices had greater HbA1c β = 0.39 (95% CI: 0.03-0.75); n.s. for other outcomes. 
Flow sheets n.s. 
EHR n.s. 
Involvement of nurse 
practitioner (NP) or 
physician assistant (PA)  
Involvement associated with lower HbA1c values: β = -0.37 (95% CI: -0.67 - -0.08); n.s. for other 
outcomes. 
Patient registries n.s. 
Dietician n.s. 
Diabetes educators n.s. 
Endocrinologists n.s. 
  
Van 
Bruggen et 
al.[259]¶ 
30 
practices 
Physician  
Age 
n.s. 
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Table 22 Main results for studies which examined both physician and practice factors (n = 12) 
Reference N Factors Main results (multivariate analysis unless otherwise stated) 
1283 
patients 
 
  Gender n.s. 
Time in practice n.s. 
Involvement in diabetes care n.s. 
Practice 
% GPs working part time 
 
n.s. 
Size (number of patients) n.s. 
% patients > 55 years n.s. 
Diabetes prevalence n.s. 
Location  n.s. 
Type (solo, duo or group 
practice) 
n.s. 
Presence of a practice nurse Nurses were more often involved in diabetes care in practices which intensified anti-
hypertensive treatment in >60% of their poorly controlled patients vs. practices that did not 
made these changes adequately (77.8% versus 67.9%, p = 0.016).  
All other differences between inert and non-inert practices n.s. 
 
[in all practices (intervention & control)] Clinical inertia in response to poor BP control was less 
common if a practice nurse was actively involved in diabetes care (AOR = 0.12, 95% CI: 0.02–
0.91). 
Role of the practice assistant 
(participating vs. non-
n.s. 
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Table 22 Main results for studies which examined both physician and practice factors (n = 12) 
Reference N Factors Main results (multivariate analysis unless otherwise stated) 
participating in diabetes 
care) 
  
Vinker et 
al.[317]* 
161 
physicians 
Patients 
NR 
Physician  
Age 
 
n.s. 
  Gender n.s. 
Training - board certification  Patients of board certified physician had greater diabetic care score (β = 0.185, p < 0.05) in 2003, 
greater diabetic control score in 2003 (β = 0.196, p < 0.05) and 2005 (β = 0.348, p < 0.05).  
Managerial position held in 
clinic  
n.s. 
Years in practice n.s. 
Panel size n.s. 
Practice  
Location (urban or rural) 
 
n.s. 
  
Visca et 
al.[268]*║ 
1678 
physicians 
73,920 
patients 
Physician 
Age 
Older physicians had lower adherence to guidelines (effect x 10 years): β = - 0.092 (95% CI: -
0.123 - -0.061). 
  Gender Female GPs had greater adherence to guidelines: β = 0.058 (95% CI: 0.022-0.094). 
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Table 22 Main results for studies which examined both physician and practice factors (n = 12) 
Reference N Factors Main results (multivariate analysis unless otherwise stated) 
Team membership (“solo”, 
base group, network group 
or group practice) 
 
n.s. 
Panel size Physician with greater list size (effect x 100) had greater adherence: β = 0.009 (95% CI: 0.004,-
0.014). 
Number of diabetes patients 
on panel 
n.s. 
% patients aged 85+ on 
panel 
Physicians with greater number of patients 85+ had lower adherence β = -0.004 (95% CI: -0.007, -
0.001). 
% patients dx > 4 years on 
panel 
Physicians with greater number of patients with dx >4 years had higher adherence: β = 0.003 
(95% CI: 0.001,0.005). 
Average Charlson index of 
panel 
n.s. 
Practice  
District mean of diabetes 
prevalence,   
n.s. 
District mean of % patients 
aged 85+  
Practices with greater proportion of patients 85+ had higher adherence: β = 0.073 (95% CI: 
0.010-0.137). 
District mean of charlson 
index 
n.s. 
District mean of % dx >4 
years 
Practices with greater proportion of patients dx >5 had higher adherence: β = 0.043 (95% CI: 
0.009-0.077). 
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Table 22 Main results for studies which examined both physician and practice factors (n = 12) 
Reference N Factors Main results (multivariate analysis unless otherwise stated) 
Size (number of GPs) Greater adherence in practices with greater number of GPs on team: β = 0.016 (95% CI: 0.006-
0.026) 
Financial incentives Practices with financial incentives had greater adherence: β = 0.085 (95% CI: 0.022-0.147) 
  
Weiner et 
al.[253] β 
 
2980 
practices 
10,000 
physicians 
97,388 
patients 
Physician 
Specialty (GP, internal 
medicine), multispecialty or 
single specialty (solo, 
partnership, single specialty 
group) 
 
A greater (adjusted) proportion of patients of family medicine vs. internal medicine physicians 
had blood glucose measured during the study period: 84.0% vs. 79.9%, p = 0.001 
 
A lower (adjusted) proportion of patients of general practice vs. internal medicine had an eye 
exam:  45.1% vs. 47.8%, p =.01, HbA1c test 10.8% vs. 16.7%, p =0.001, and cholesterol 49.8% vs. 
57.5%, p =0.001 
 
A lower (adjusted) proportion of patients of multidisciplinary physicians vs. internal medicine had 
an eye exam: 44.1% vs 47.8, p =.001, and cholesterol tested: 51.9% vs. 57.5%, p =0.001 
Practice  
Location (urban or rural) 
 
Practices in an urban location had a higher (adjusted) proportion of patients with HbA1c test 
17.2% vs. 14.5%, p = 0.001, cholesterol test 58.1% vs. 48.4%, p=0.001, and blood glucose 81.6% 
vs. 78.1%, p=0.001 
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Abbreviations: NR, Not Reported; OR, Odds Ratio; EHR, Electronic Health Record; GPs, General Practitioners 
*Composite outcome 
║Patient-level covariates adjusted for in multivariate analysis 
¶Physician-level covariates (additional to explanatory variables) adjusted for in multivariate analysis 
βPractice-level covariates (additional to explanatory variables) adjusted for in multivariate analysis 
§also includes patients for breast cancer screening; chlamydia screening; colorectal cancer screening; appropriate medications for people with asthma; 
testing for children with pharyngitis; and treatment for children with upper respiratory infection 
 
 
 
Table 23 Quality assessment  
Study  Were the 
criteria for 
inclusion in 
the sample 
clearly 
defined? 
Were the study 
subjects and 
the setting 
described in 
detail?* 
Was the 
exposure 
measured in a 
valid and 
reliable way?║ 
Were objective, 
standard 
criteria used for 
measurement 
of the 
condition?§ 
Were 
confounding 
factors 
identified? 
Were strategies 
to deal with 
confounding 
factors stated? 
Were the 
outcomes 
measured in a 
valid and reliable 
way?α 
Was 
appropriate 
statistical 
analysis 
used? 
Alberti et al. No Partial Yes Unclear Yes Yes Yes Yes 
Angstman et al. Yes Partial Unclear Unclear Yes Yes Unclear Yes 
Balkau et al. Yes Yes Unclear Unclear Yes Yes Unclear Yes 
Berthold et al. Yes Partial Unclear No Yes Yes Unclear Yes 
Bower et al. Yes Partial Yes Unclear Yesβ Yes Yes Yes 
Bralic-Lang et al. Yes Partial Yes  Unclear Yes Yes Yes Yes 
Bredfelt et al. Yes Yes Yes  Yes Yesβ Yes Yes Yes 
Brody et al. Yes Yes Unclear Yes Yes Yes Yes Yes 
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Campbell et al. Yes Partial Unclear Yes Yesβ Yes* Yes  Yes* 
Cebul et al. Yes Yes Yes Unclear Yes Yes Yes Yes 
Cheung et al. Yes Partial Yes Yes Yes Yes Yes Yes 
Cho et al. Yes Partial Unclear Yes Yes Yes Yes Yes 
Crosson et al. Yes Partial Yes Yes Yes Yes Yes Yes 
Dahrouge et al. Yes Yes Yes Yes Yes Yes Yes Yes 
Dahrouge et al. (2016) Yes Partial Yes Yes Yes Yes Yes Yes 
Dunn et al. Yes Partial Yes Yes No No Yes No 
Ellerbeck et al. Yes Partial Yes Unclear No No  Yes Yes 
Erickson et al. Unclear Yes Unclear Unclear Yesβ Yes Unclear Yes 
Esterman et al. Yes Yes Yes Unclear Yes Yes Yes Yes 
Everett et al. Yes Yes Yes Yes Yes Yes Yes Yes 
Fantini et al. Yes Partial Yes Yes Yes Yes Unclear Yes 
Ferroni et al. Yes Yes Yes Yes Yes Yes Yes Yes 
Franks et al. Yes Yes Yes Yes Yes Yes Yes Yes 
Friedberg et al. Yes Partial Yes Unclear Yesβ Yes Yes Yes 
Griffiths et al. (2010) Yes Partial Yes Unclear Yesβ Yes Yes Yes 
Griffiths et al. (2011) Yes Partial Yes Unclear Yesβ Yes Yes Yes 
Gulliford et al. (2001) Yes Yes Yes Yes Yes Yes Yes Yes 
Gulliford et al. (2007) Unclear Partial Yes Unclear Yesβ Yes Yes Yes 
Harris et al. Unclear Partial Yes Yes No No Yes No 
He et al. Yes  Yes Yes No Yesβ Yes Yes Yes 
Holmboe et al.  (2008) Yes Yes Unclear Yes Yes Yes Yes Yes 
Holmboe et al. (2006) Yes Yes Yes Yes Yes Yes Yes Yes 
Juul et al. (2009) Yes Yes Yes Yes Yesβ No Yes Yes 
Juul et al. (2012) Unclear Yes Yes Unclear Yes Yes Yes Yes 
Kamien et al. Yes  Partial Yes  Unclear No No Yes  No 
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Keating et al. Yes Partial Yes Yes Yes Yes Yes Yes 
Kern et al. Yes Partial Yes Unclear Yesβ Yes Yes Yes 
Khunti et al. Unclear Partial Yes Unclear Yesβ Yes Yes Yes 
Kim et al. Yes Partial Yes Unclear Yes Yes Yes Yes 
Kontopantelis et al. Yes Yes Yes Yes Yes Yes Yes Yes 
Kuo et al. Yes Yes Yes Yes Yesβ Yes  Yes  Yes 
Leblanc et al. Yes Partial Unclear Yes Yes Yes Yes Yes 
Linder et al. Unclear Partial Yes Yes Yes Yes Yes Yes 
Matthews et al. Yes Partial Partial Unclear Yes Yes Yes Yes 
McCullough et al. Unclear Yes Yes Unclear Yesβ Yes Yes Yes 
McGinn et al. Unclear Partial Yes Unclear Yesβ Yes Yes Yes 
McLean et al. Unclear Partial Yes  Unclear No No Yes Yes 
Millett et al. Yes Partial Yes   Unclear No No Yes Yes**  
Mitchell et al. Yes Partial Yes Yes Yes Yes Yes Yes 
Ohman et al. Yes Partial Yes Yes Yes Yes Yes Yes 
Orzano et al. Unclear Partial Yes Yes Yes Yes Yes Yes 
Parkerton et al. (2003) Yes Partial Yes Unclear Yesβ Yes Yes Yes 
Parkerton et al. (2004) Unclear Partial Yes Unclear Yesβ Yes Yes Yes 
Pham et al. Yes Partial Yes Yes Yes Yes Yes Yes 
Poon et al. Yes Partial Yes Unclear Yesβ Yes Yes Yes 
Ricci-Cabello et al. Yes Partial Yes Unclear Yesβ Yes Yes Yes 
Shuval et al. Yes Partial Yes Unclear Yesβ Yes Yes Yes 
Spann et al. Yes Partial Yes No Yes Yes Yes Yes 
Spigt et al. Yes Partial Yes Yes Yesβ Yes Unclear Yes 
Stearn et al. Unclear Partial Partial Unclear No No Yes No 
Streja et al. Yes Partial Yes Yes Yes Yes Yes Yes 
Suleman et al. Yes Yes Yes Unclear Yesβ Yes Yes Yes 
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Tabenkin et al. Yes Yes Yes Yes Yes Yes Yes Yes 
Tahrani et al. Unclear Partial Unclear Unclear No No Yes Yes 
Turchin et al.  (2007) Yes  Partial Yes  Yes  Yes Yes Yes  Yes 
Turchin et al. (2008)  Yes Partial Yes Yes Yes Yes Yes Yes 
Vamos et al. Yes Yes Yes Yes Yes Yes Yes Yes 
Van Bruggen et al. Yes Partial Yes Unclear Yesβ Yes Yes Yes 
Van Doorn et al. Yes Partial Yes Unclear Yes Yes Yes Yes 
Vinker et al. Yes Partial Yes Unclear Yesβ Yes Yes Yes 
Visca et al. Yes Yes Yes Yes Yes Yes Yes Yes 
 Wang et al. Unclear Partial Yes Unclear No No Yes No 
Weiner et al. Yes Yes Yes Yes Yesβ Yes Yes Yes 
Wencui et al. Yes Yes Yes  Unclear Yesβ Yes Yes Yes 
Wong et al. Yes Partial Yes Yes Yes Yes Yes Yes  
Was true 
randomizati
on used for 
assignment 
of 
participants 
to treatment 
groups? 
Were 
treatment 
groups treated 
identically 
other than the 
intervention of 
interest? 
Was follow up 
complete and 
if not, were 
differences 
between 
groups in 
terms of their 
follow up 
adequately 
described and 
analyzed? 
Were 
participants 
analyzed in the 
groups to which 
they were 
randomized? 
Were 
outcomes 
measured in 
the same 
way for 
treatment 
groups? 
Were outcomes 
measured in a 
reliable way? 
Was appropriate 
statistical 
analysis used? 
Was the trial 
design 
appropriate, 
and any 
deviations 
from the 
standard RCT 
design 
(individual 
randomizatio
n, parallel 
groups) 
accounted 
for in the 
conduct and 
355 
 
analysis of 
the trial? 
Dickinson et al.*** Unclear No Yes Yes Yes Yes Yes Yes 
*Partial if location and time period reported but no information (e.g. demographics) on population sampled from 
║Most studies used self-report survey to derive information on practice or physician factors so marked as 'yes' if this approach was used 
§Most studies only stated that people with diabetes were included; some referred to ICD codes or diagnostic criteria. Marked as 'Unclear' where limited 
information was provided (e.g. QOF data), 'No' if diagnosis on basis of clinical judgement or patient self-report 
βPatient-level confounders not identified 
αGenerally this was determined from medical records, claims data, or data submitted to QOF (all taken as valid for this QA). Few studies mention the 
abstraction process or whether abstracters were trained, and whether quality assessment done. 
**no detailed analysis because of large sample size 
***The following questions were not applicable: Was allocation to treatment groups concealed? Were participants blind to treatment assignment? Were 
those delivering treatment blind to treatment assignment? 
 
356 
 
 
Figure 14 Gender and quality 
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  Figure 15 Physician experience and quality 
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  Figure 16 Diabetes volume and quality 
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   Figure 17 Type and quality 
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Figure 18 Electronic Health Record (HER) use and quality 
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10.3 Appendix 3 Supplementary files for Chapter 4 
 
 
 
 
 
 
 
 
 
 
Figure 19 Sampling flow chart 
*Participants were sampled by sorting alphabetically first by name and selecting every third person. 
**After ordering randomly, every third person was sampled .
1999 
Census sample 
N = 336 
2003 
Census sample 
N = 843 
2008 
Systematic sample* 
N = 988 Systematic sample* 
Census sample 
Random sample** 
N = 1029 
2016 
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Table 24 Processes recorded among participants aged <75 years and ≥75 years with type 2 diabetes 1999 – 2016 
 <75 years ≥75 years 
 1998/1999 
N = 257 
2003 
N = 655 
2008 
N = 745 
2016 
N = 741 
1999 
N = 79 
2003 
N = 187 
2008 
N = 243 
2016 
N = 287 
 N (%) N (%) N (%) N (%) N (%) N (%) N (%) N (%) 
BMI*¶µβα 165 (64) 380 (58) 560 (75) 517 (70) 38 (48) 90 (48) 164 (67) 219 (76) 
         
Smoking status¶ 181 (70) 493 (75) 572 (77) 578 (78) 49 (62) 136 (73) 186 (77) 234 (82) 
         
HbA1c*¶α 216 (84) 625 (95) 735 (99) 734 (99) 68 (86) 173 (93) 231 (95) 286 (100) 
         
Blood pressure¶α 242 (94) 649 (99) 740 (99) 725 (98) 69 (87) 186 (99) 238 (98) 282 (98) 
         
Cholesterolβ*¶ 219 (85) 638 (97) 735 (99) 733 (99) 48 (61) 176 (94) 237 (98) 284 (99) 
         
Triglyceridesµβα 186 (72) 607 (93) 733 (99) 731 (99) 40 (51) 163 (87) 234 (96) 280 (98) 
         
Creatinine*¶   175 (68) 541 (83) 732 (98) 730 (99) 59 (75) 154 (82) 238 (98) 285 (99) 
         
ACR*¶α║ NA NA 549 (74) 628 (85) NA NA 162 (67) 214 (75) 
         
Foot assessment NA 363 (55) 523 (77) 398 (54) NA 110 (59) 170 (78) 141 (49) 
 Abbreviations: ACR, Albumin Creatinine Ratio; BMI, Body Mass Index; NA, not available, data on this variable were not collected at this time point 
*significant trend in <75 age group p < 0.05 
¶significant trend in ≥75 age group p <0.05 
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µsignificant difference in recording between <75 and ≥75 in 1999 p < 0.05 
βsignificant difference in recording between <75 and  ≥75 in 2003 p < 0.05 
αsignificant difference in recording between <75 and  ≥75 in 2008 p < 0.05 
║significant difference in recording between <75 and ≥75 in 2016 p < 0.05 
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Table 25 BMI and smoking status recording among participants with type 2 
diabetes 1999 – 2016 attending 10 general practices enrolled in programme 
since 1999 
Practice Process 1998/1999 2003 2008 2016 
  N (%) N (%) N (%) N (%) 
1  N = 34 N = 61 N = 46 N = 47 
 BMI* 9 (26) 32 (52) 46 (100) 47 (100) 
 Smoking status 33 (97) 59 (97) 44 (96) 46 (98) 
2  N = 29 N =29 N = 27 N = 14 
 BMI 27 (93) 17 (59) 23 (85) 14 (100) 
 Smoking status 22 (76) 12 (41) 24 (89) 12 (86) 
3  N = 58 N = 116 N = 63 N = 49 
 BMI* 42 (71) 90 (78) 48 (76) 48 (98) 
 Smoking status 52 (88) 109 (94) 53 (84) 47 (96) 
4  N = 53 N = 39 N = 31 N = 40 
 BMI* 15 (27) 4 (10) 4 (13) 17 (43) 
 Smoking status 14 (26) 20 (51) 7 (23) 18 (45) 
5  N = 26 N =24 N =24 N = 29 
 BMI 20 (74) 5 (21) 17 (71) 20 (70) 
 Smoking status** 21 (78) 22 (92) 14 (58) 16 (55) 
6  N = 16 N = 30 N =16 N = 17 
 BMI** 16 (100) 18 (60) 12 (75) 1 (5.9) 
 Smoking status** 15 (94) 29 (97) 15 (94) 7 (41) 
7  N = 29 N = 28 N = 20 N = 27 
 BMI* 19 (66) 19 (68) 19 (95) 27 (100) 
 Smoking status 16 (55) 15 (54) 16 (80) 18 (67) 
8  N = 30 N = 62 N = 56 N = 50 
 BMI** 28 (88) 31 (50) 33 (60) 2 (4) 
 Smoking status** 28 (87) 50 (81) 50 (91) 30 (60) 
9  N = 39 N = 62 N = 54 N = 47 
 BMI* 15 (38) 23 (37) 49 (91) 45 (96) 
 Smoking status* 16 (41) 26 (42) 48 (89) 46 (98) 
10  N = 17 N = 37 N = 20 N = 52 
 BMI* 12 (71) 14 (38) 20 (100) 51 (98) 
 Smoking status 13 (76) 27 (73) 20 (100) 39 (75) 
Abbreviations: BMI, Body Mass Index 
*significant p < 0.05 
**significant decline in recording p < 0.05 
Proportions were analysed using chi-squared test for trend and logistic regression adjusted 
for age and gender 
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Table 26 Demographics, duration and diabetes control among participants with 
type 2 diabetes in 2016 (n = 1,029) 
 HbA1c ≤58mmol/mol (7.5%) 
N = 770 
HbA1c >58mmol/mol (7.5%) 
N = 251 
Age 
Median (IQR) 
69 (61-76) 
 
65 (56-73) 
   
Male 453 (59) 145 (58) 
   
Diabetes duration 
(years)* 
Median (IQR) 
 
 
8 (5-11) 
 
11 (7-14) 
   
Diabetes control*   
Diet only 167 (22) 6 (2.4) 
OHA only 512 (67) 138 (49) 
Insulin only 10 (1.3) 10 (3.9) 
Insulin and OHA 54 (7.0) 84 (33) 
Injectables and OHA 24 (3.1) 25 (10) 
OHA or injectable║ 600 (78) 245 (98) 
Abbreviation: OHA, oral hypoglycaemic agent; IQR, interquartile range 
*significant p<0.001; difference in people with HbA1c ≤58mmol/mol and HbA1c > 
58mmol/mol were analysed using Students t test or Wilcoxon-Mann-Whitney test for 
continuous data and Pearson’s chi squared for categorical data 
║OHA, insulin or other injectable 
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Table 27 Data collected 1999 - 2016 
Variable 1999 2003 2008 2016 
Demographics     
  Age √ √ √ √ 
  Sex √ √ √ √ 
  Diabetes type √ √ √ √ 
Lifestyle     
  BMI √ √ √ √ 
  Smoking status √ √ √ √ 
Clinical     
  HbA1c √ √ √ √ 
  Cholesterol √ √ √ √ 
  BP √ √ √ √ 
  Serum creatinine √ √ √ √ 
  eGFR (calculated using   √ √ √ √ 
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  CKD-EPI equation*) 
Complications     
  Retinopathy √ √ √ √ 
  Foot ulcer  √ √ √ √ 
  Macrovascular complication 
  (new in past 12 months) 
√ - - - 
  Attendance at renal clinic √ √ √ √ 
  Minor amputation √ √ √ √ 
Death - - - √ 
Abbreviations: eGFR, estimated glomerular filtration rate; BP, blood pressure 
*Females: eGFR = 141 X min(creatinine/0.7, 1)-0.329  X max(creatinine/0.7, 1)-1.209 X 0.993age  
X  1.018; Males:  eGFR = 141 X min(creatinine/0.9, 1)-0.411  X  max(creatinine/0.9, 1)-1.209 X 
0.993age 
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Table 28 Clinical profile of participants 1999 – 2016 
 1999  
N = 376 
2003  
N = 337 
2008  
N = 271 
2016 
N = 192 
Ptrend* 
 Mean (95% CI) Mean (95% CI) Mean (95% CI)  Mean (95% CI)   
      
BMI (kg/m2) 29.3 (28.6-30.0) 29.2 (28.3-30.2) 30.2 (27.9-32.4) 29.9 (28.0-31.8) 0.100 
      
HbA1c (mmol/mol [%]) 55 (54-57)  
[7.2 (7.1-7.4)] 
 
63 (60-66)  
[7.9 (7.6-8.2)] 
 
56 (53-61)  
[7.3 (7.0-7.7)] 
 
58 (55-62)  
[7.5 (7.2-7.8)] 
 
0.03 
      
Systolic BP (mmHg)† 144.3 (142.1-146.5)  141.1 (138.1-144.2) 135.3 (131.4-139.1) 133.7 (130.2-137.3) <0.0001 
      
Cholesterol (mmol/l)† 5.4 (5.2-5.5)  4.8 (4.7-4.9) 3.9 (3.7-4.1)  3.9 (3.8-4.2)  <0.0001 
      
Triglycerides (mmol/l)† 2.4 (2.2-2.6)  2.0 (1.8-2.2) 1.5 (1.3-1.7) 1.4 (1.3-1.7) <0.0001 
      
eGFR (mL/min/1.73 m²)† 77.1 (74.3-80.0) 73.3 (70.7-75.9) 74.0 (68.4-79.6) 64.3 (58.5-70.1) 0.59 
Abbreviations: eGFR, estimated glomerular filtration rate; BP, blood pressure  
Adjusted for clustering by participant 
*significant based on linear regression models adjusted for age and sex; 
†significant p<0.05 unadjusted for age and sex 
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Table 29 Multivariable Cox survival analysis (n = 356)* 
 Males (n = 179) Females (n = 176) 
 Model 1 Model 2 Model 1 Model 2 
 HR 95% CI P  HR 95% CI P HR 95% CI P HR 95% CI P 
Age (per 10-year 
increase) 
2.66 [2.19,3.24] <0.001 2.66 [2.11,3.34] <0.001 2.14 [1.69,2.72] <0.001 1.83 [1.40,2.40] <0.001 
             
BMI 1.01 [0.94,1.08] 0.82 1.02 [0.95,1.09] 0.65 0.98 [0.93,1.02] 0.51 0.98 [0.92,1.04] 0.47 
             
Smoking             
No (ref)             
Yes 1.04 [0.61,1.79] 0.88 1.19 [0.63,2.24] 0.59 1.07 [0.64,1.79] 0.80 1.10 [0.63,1.91] 0.76 
             
Clinical             
Systolic BP (per 
10mmHg increase) 
0.96 [0.81,1.13] 0.61 0.96 [0.82,1.14] 0.67 1.00 [0.86,1.16] 0.97 1.00 [0.85,1.17] 0.97 
Cholesterol (mmol/l) 1.11 [0.83,1.47] 0.48 1.17 [0.89,1.60] 0.26 1.07 [0.83,1.38] 0.60 1.06 [0.80,1.40] 0.71 
HbA1c (%) 1.16 [0.98,1.37] 0.08 1.18 [1.00,1.40] 0.06 1.09 [0.93,1.28] 0.29 1.09 [0.92,1.30] 0.32 
eGFR (per 15 
mL/min/1·73 m² 
increase) 
0.83 [0.63,1.10] 0.19 0.83 [0.62,1.12] 0.22 0.76 [0.60,0.95] 0.02 0.75 [0.58,0.96] 0.03 
Triglycerides (mmol/l) 0.92 [0.72,1.16] 0.46 0.82 [0.62,1.09] 0.17 1.02 [0.80,1.32] 0.85 0.97 [0.71,1.28] 0.74 
             
Macrovascular 
complication  
            
No (ref)             
Yes 1·94 [1·35,2·79] <0·001 2·06 [1·08,3·92] 0·03 1·92 [0·54,6·89,] 0·32 1·78 [0.49,6.48] 0.38 
Abbreviations: eGFR, estimated glomerular filtration rate; BP, blood pressure; HR, hazard ratio 
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Model 1 adjusted for age and sex; Model 2 adjusted for all covariates 
*imputed dataset; 164 with date of death; 79 men, 85 women; 18 excluded as no date of death derived from national records; 2 excluded as date of 
death preceded first data collection point 
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10.5 Appendix 5 Supplementary files for Chapter 6 
   
10.5.1 Main modifications made to the questionnaire 
• Questions on who employs and manages DNS were modified. 
• The response to the question on the grade of their current position was 
changed.  
• The direct question on research involvement (yes/no) was changed to 
instead ask the amount of time spent on research.  
• There was no question on the content or topics covered in patient education 
sessions, or on the frequency or location of these sessions.  
• DNS were asked about liaison not only with practice nurses but also with 
other professionals, GPs, hospital or community DNS, consultants, and the 
nature of this role. 
• DNS were not asked specifically about involved in paediatric nursing.  
• There was no open-ended question on reasons for not using nurse 
prescribing. 
 
 
371 
 
10.5.2 Recruitment response  
 
10.5.3 Other patients seen reported in open-ended comments 
 
Other patients attending DNS services 
Other patients attending DNS services mentioned by participants were patients 
with cystic fibrosis-related diabetes (n = 10) or steroid induced diabetes (n = 6), 
neonatal (n = 4), Maturity Onset Diabetes of the Young (MODY) (n = 4), post-
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transplant (n = 2), post pancreatic surgery (n = 3) patients, or with patients 
pancreatitis (n = 3), and those using insulin pumps (n = 3). 
 
Other roles in patient care 
Other roles in patient care were mentioned by hospital and community nurses (n = 
35) and included, Diabetic Ketoacidosis (DKA) management (n = 2), endocrine 
patients with conditions involving the pituitary, thyroid, adrenal and other 
endocrine glands (n = 1), preparation for transition to adult services (n = 1), health 
screening for traveller groups (n = 1), primary and secondary school education (n = 
1) and involvement in social care work (n = 1).  
 
Types of clinics 
Forty-four respondents reported the type of clinic they run. Most reported they ran 
clinics run for patients with T2DM (n = 15) or T1DM (n=11) needing review.  
Specialist clinics reported were pump training clinics (n = 5), clinics for GDM (n=8), 
pre-pregnancy/pre-conception (n = 5), transition clinics for young adults (n = 5), and 
paediatric clinics (n = 5). 
 
Non-diabetic roles2 
Fourteen respondents reported the roles they perform unrelated to diabetes, 
which included endocrine work (n = 4), management duties (n = 3), administration 
(n = 2)3, patient advice (n =2), and teaching (n = 1). 
                                                     
2A closed question asked respondents “Do you cover roles not solely related to diabetes?” Fifteen 
responded “Yes” to this question, 14 of whom expanded on this in the open-ended comments. 
3Administrative work relating to diabetes may have been seen by respondents as being different to 
general administrative work.  When asked about time spent in administration, 58 respondents 
reported they spent time on this type of work, however, just 2 respondents indicated administration 
was work unrelated to diabetes 
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Table 30 Clinic activity, location and support by hospital (n = 59) and community (n = 23) nurses within each region 
 Overall (n = 82) Region 1 (n = 18) Region 2 (n = 21) Region 3 (n = 22) Region 4 (n = 21) 
 
Hospital 
(n = 59) 
Community 
(n = 23) 
Hospital 
(n = 11) 
Community 
(n = 7) 
Hospital 
(n = 17) 
Community 
(n =4) 
Hospital 
(n =17) 
Community 
(n = 5) 
Hospital 
(n =14) 
Community  
(n= 7) 
 N (%) N (%) N (%) N (%) N (%) N (%) N (%) N (%) N (%) N (%) 
Run nurse-led clinic         
Both 23 (39.0) 1 (4.3) 3 (27.3) 0 (0) 9 (52.9) 0 (0) 5 (29.4) 0 (0) 6 (42.9) 1 (14.3) 
Generalised clinics only 19 (32.2) 12 (52.2) 5 (45.5) 4 (57.1) 3 (17.6) 2 (50.0) 9 (52.9) 3 (60) 2 (14.3) 3 (42.9) 
Specialised clinics only 17 (28.8) 10 (43.3) 3 (27.3) 3 (42.9) 5 (29.4) 2 (50.0) 3 (17.6) 2 (40) 6 (42.9) 3 (42.9) 
           
Number of nurse-led clinics per week        
1 9 (15.3) 3 (13.0) 2 (18.2) 1 (14.3) 3 (17.6) 0 (0) 1 (5.9) 0 (0) 3 (21.4) 2 (28.6) 
2 17 (28.8) 5 (21.7) 3 (27.3) 1 (14.3) 3 (17.6) 2 (50.0) 5 (29.4) 0 (0) 6 (42.9) 2 (28.6) 
3 5 (8.5) 3 (13.0) 0 (0) 1 (14.3) 0 (0) 0 (0) 3 (17.6) 1 (20) 2 (14.3) 1 (14.3) 
≥4  27 (47.5) 12 (52.2) 6 (54.5) 4 (57.1) 11 (64.7) 2 (50.0) 8 (47.1) 4 (80) 3 (21.4) 2 (28.6) 
           
Number of patients per clinic         
< 5 14 (23.7) 1 (4.3) 7 (63.6) 1 (14.3) 2 (11.8) 0 (0) 4 (23.5) 0 (0) 1 (7.1) 0 (0) 
5 17 (28.8) 15 (65.2) 3(27.3) 4 (57.1) 4 (23.5) 3 (75.0) 4 (23.5) 4 (80) 6 (42.9) 4 (57.1) 
10 17 (28.8) 7 (30.4) 0 (0) 2 (28.6) 6(35.3) 1 (25.0) 6 (35.3) 1 (20) 5 (35.7) 3 (42.9) 
≥15  10 (16.9) 0 (0) 0 (0) 0 (0) 5 (29.4) 0 (0) 3 (17.6) 0 (0) 2 (14.3) 0 (0) 
NA 1 (1.7) 0 (0) 1 (9.1) 0 (0) 0 (0) 0 (0) 0 (0) 0 (0) 0 (0)  0 (0) 
           
Patients also see a consultant/GP         
No 8 (13.6) 7 (30.4) 0 (0) 1 (14.3) 3 (17.6) 1 (25.0) 4 (23.5) 2 (40) 1 (7.1) 3 (42.9) 
At a later date 44 (74.6) 13 (56.5) 9 (90.9) 4 (57.1) 10 (58.8) 3 (75.0) 13 (76.5) 2 (40) 11 (78.6) 4 (57.1) 
During the same visit 7 (11.9) 2 (8.7) 1 (9.1) 2 (28.6) 4 (23.5) 0 (0) 0 (0) 0 (0) 2 (14.3) 0 (0) 
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Table 30 Clinic activity, location and support by hospital (n = 59) and community (n = 23) nurses within each region 
 Overall (n = 82) Region 1 (n = 18) Region 2 (n = 21) Region 3 (n = 22) Region 4 (n = 21) 
 
Hospital 
(n = 59) 
Community 
(n = 23) 
Hospital 
(n = 11) 
Community 
(n = 7) 
Hospital 
(n = 17) 
Community 
(n =4) 
Hospital 
(n =17) 
Community 
(n = 5) 
Hospital 
(n =14) 
Community  
(n= 7) 
 N (%) N (%) N (%) N (%) N (%) N (%) N (%) N (%) N (%) N (%) 
NA 0 (0) 1 (4.3) 0 (0) 0 (0) 0 (0) 0 (0) 0 (0) 1 (20) 0 (0) 0 (0) 
           
Clinic location           
GP surgery 1 (1.7) 18 (78.3) 1 (9.1) 5 (71.4) 0 (0) 3 (75.0) 0 (0) 5 (100) 0 (0) 4 (57.1) 
Primary care centre 0 (0) 7 (30.4) 0 (0) 1 (14.3) 0 (0) 1 (25.0) 0 (0) 4 (80) 0 (0) 1 (14.3) 
Community outreach clinic 0 (0) 3 (13.0) 0 (0) 0 (0) 0 (0) 0 (0) 0 (0) 1 (20) 0 (0) 2 (28.6) 
Hospital 47 (79.7) 10 (43.5) 6(54.5) 2 (28.6) 14 (82.4) 2 (50.0) 14 (82.4) 2 (40) 13 (92.9) 4 (57.1) 
Outpatients Dept. 27 (45.8) 7 (30.4) 8 (72.7) 1 (14.3) 8 (47.1) 1 (25.0) 5 (29.4) 3 (60) 6 (42.9) 2 (28.6) 
           
Clinic support           
Consultant 50 (84.7) 10 (43.5) 11 (100) 2 (28.6) 12 (70.6) 1 (25.0) 14 (82.4) 2 (40) 13 (92.9) 5 (71.4) 
Specialist Registrars  34 (57.6) 4 (17.4) 3 (27.3) 1 (14.3) 14 (82.4) 1 (25.0) 9 (52.9) 0 (0) 8 (57.1) 2 (28.6) 
Senior House Officer 21 (35.6) 2 (8.7) 6 (54.5) 0 (0) 5 (29.4) 0 (0) 4 (23.5) 0 (0) 6 (42.9) 2 (28.6) 
Intern 14 (23.7) 0 (0) 5 (45.5) 0 (0) 3 (17.6) 0 (0) 1 (5.9) 0 (0) 5 (35.7) 0 (0) 
Practice nurse 2 (3.4) 17 (73.9) 1 (9.1) 4 (57.1) 1 (5.9) 2 (50.0) 0 (0) 4 (80) 0 (0) 7 (100) 
GP 4 (6.8) 19 (82.8) 2 (18.2) 5 (71.4) 2 (11.8) 3(75.0) 0 (0) 4 (80) 0 (0) 7 (100) 
Hospital DNS 31 (52.5) 11 (47.8) 8 (72.7) 2 (28.6) 9 (52.9 2 (50.0) 6 (35.3) 2 (40) 8 (57.1) 5 (71.4) 
Community DNS 11 (18.6) 3 (13.0) 4 (36.4) 1 (14.3) 3 (17.6) 0 (0) 0 (0) 0 (0) 4 (28.6) 2 (28.6) 
Podiatrist 21 (35.6) 9 (39.19) 6 (54.5) 3 (42.9) 7 (41.2) 1 (25.0) 3 (17.6) 1 (20) 5 (35.7) 4 (57.1) 
Dietician 35 (59.3) 9 (39.19) 8 (72.7) 4 (57.1) 12 (70.6) 0 (0) 8 (47.1) 2 (40) 7 (50) 3 (42.9) 
Psychologist 6 (10.2) 0 (0) 2 (18.2) 0 (0) 3 (17.6) 0 (0) 0 (0) 0 (0) 1 (7.1) 0 (0) 
Healthcare Assistant 10 (16.9) 1 (4.3) 3 (27.3) 0 (0) 3 (17.0) 0 (0) 0 (0) 0 (0) 4 (28.6) 1 (14.3) 
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Figure 20 Hospital services, new and existing ‘integrated’ community posts (n = 
26) across the four administrative regions of the health service 
Initiatives: Diabetes in General Practice (69 practices in Cork and Kerry); HSE Midland 
Diabetes Structured Care Programme (30 practices in Laois, Offaly, Longford and 
Westmeath); HSE West (19 practices in Sligo and Leitrim); East Coast Area Diabetes Shared 
Care (25 practices in Dublin South and Wicklow) 
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10.6.1 Topic Guides  
Topic guides exclude sections which focused specifically to other aspects of the 
National Programme for Diabetes (i.e. RetinaScreen, Model of Care for the Diabetic 
Foot) being explored as part of the broader study.  
 
National Clinical Programme for Diabetes  
Rationale: 
The role of the Diabetes Nurse Specialist is central to diabetes care and continues to evolve in 
response to the policies and practices within the health system. The number of Diabetes 
Nurse Specialists working in Ireland has increased in recent times, due in part to the changes 
introduced by the National Clinical Programme in Diabetes (NCPD). We want to know what 
you think about these changes, and how the national programme has impacted on your local 
service. As you know, we recently conducted a national survey of Diabetes Nurse Specialists 
in Ireland to assess the availability of specialist services in Ireland. We now want to hear 
about your experience providing diabetes care to understand in more detail, the challenges 
and opportunities for integrated care.  
 
We did some preliminary interviews about how services implemented as part of the NCPD 
are working so I would like to ask you about some of the theories that have come up and 
what your experience has been 
 
The interview should last about 30 minutes 
Just some general house-keeping before we start (Briefly go through consent form) 
- If it is ok with you I will audio record the interview so I can give you my full attention and 
don’t have to take any notes. This way I can be sure I don’t miss anything.  
- Anything we discuss will be confidential and your identity will remain anonymous 
on any reports or publications. We may use direct quotes from this interview but 
again I stress that your name will not appear anywhere. Your identity and position 
will be kept completely anonymous.  
- Finally you can stop the interview at any point, if you wish. And you are free to 
withdraw from the study at any time.  
- Do you have any questions for me before we get started? 
- Sign consent and give copy.  
377 
 
 
NCPD outline  
The National Clinical Care Programme for Diabetes was set up a couple of years ago. It 
brought together representatives from all the different disciplines involved in diabetes care 
to try and improve the way services are delivered. They do this in a number of different 
ways, for example designing models of care for patients or trying to secure additional 
resources and posts for diabetes. The National Programme was instrumental in developing 
the new model of integrated care (including the recruitment of integrated care nurses), the 
national retinopathy screening programme, RetinaScreen, and developing a standard 
Model of Care for the Diabetic Foot (including the recruitment of additional podiatrists etc). 
TOPIC GUIDE (Community DNS)  
Service provision/ DNS role 
Can you tell me a bit about the 
diabetes service you provide here in 
XX? (i.e. Type of patients, referrals, 
where are you based, how does 
governance work) 
 
What is your role in the community? 
 
 
How did you set up the service in this 
area? 
 
 
 
 
 
 
 
Working with other professionals 
/across settings 
How has your service received in your 
area? 
By GPs, PNs, In the hospital by 
consultants, by other DNS, patients? 
 
How has your role been received in 
secondary care? 
 
 
Do you have a liaison role with other 
professionals in the 
hospital/community? 
 
 
 
 
 
 
 
 
Has this changed over time? How? 
What is your role for the 1 day in the hospital? 
 
 
What was your approach to contacting GPs (day 
1)? List of GPs? 
What was your approach to GPs who may not 
link in? 
What happens with those who do not engage 
with the service? 
Are all GPs able to access the service? Why 
(not)? 
 
 
 
 
 
Why do you think this is?  
How have you responded? 
 
 
 
 
 
 
With who? What does this involve/look like? 
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Anything which could be done 
differently in terms of the DNS role to 
facilitate working with other 
services/professionals? 
 
How do you find being based in both 
primary and secondary care? 
Is there an agreement for how your service 
should work (primary & secondary care? What 
does this cover? How does it work? 
 
Between primary & secondary; within secondary 
care or the community? 
 
 
 
 
 
 
 
What are the challenges?  
Service changes 
Have you seen any recent changes in 
how patients are managed between 
primary & secondary care here? 
 
Would you describe care as 
integrated4? (Why/Why not?) 
Do you follow the national model of 
care5 in this area? 
 
Are you familiar with the National 
Clinical Programme for Diabetes?  
 
What was this change? What do you think the 
impact of this is on patient care? On your own 
work? 
 
 
GP engagement with DNS 
GP engagement with the new 
integrated DNS service has been 
varied (by which we mean in some 
areas DNS couldn’t ‘get in the door’ in 
other areas they were ‘welcomed’). 
 
Would this fit with your experience?  
 
 
 
 
 
 
 
 
Why do you think that is? 
                                                     
4What we mean by integrated care is that patients are managed by primary and secondary care 
services depending on the complexity of their diabetes. There are good links between primary and 
secondary care (e.g. better access to hospital services for integrated care patients) and professionals 
in both sectors have an understanding of where different patients should be cared for. So, this 
would mean joint management of more complex patients, with less complex Type 2s mainly 
managed in primary care. 
5The national model of care aims to standardise management of patients with diabetes, including 
management across primary and secondary care. It outlines the different roles of those involved in 
care i.e. GP, PNs, DNS, dieticians, their roles and responsibilities, along with the types of patients to 
be cared for across the two sectors, and those to be cared in secondary care 
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Role of DNS 
It has been suggested in previous 
interviews that there is variation in 
the nurse role in different areas. So 
the nurses have different roles6 in 
practices (e.g. see different patient 
types of patients)  
 
What does your role involve in the 
practices you work with? 
 
Would you say your role varies - are 
there any parts you feel don’t happen 
in certain places?  
 
 
 
 
 
 
 
 
 
 
 
Why do you think that is? 
Integrated care in secondary care 
We are trying to find out how the 
integrated role and the model of care 
is being implemented in secondary 
care. 
 
What has your experience been? 
 
 
Clear how the model of care is meant to work in 
secondary care?  
(e.g. discharge back to community)  
 
Anything you think needs to be done in 
secondary care services for the MOC to work? 
(e.g. standardisation of GP referrals forms to 
facilitate discharge; discharge + advice to GPs) 
-MOC been seen as a positive or negative 
change? If so, why? 
 
- Is it clear how your role is meant to work in the 
hospital? How does governance work? 
Final questions 
What parts of the DNS role work well 
and what don’t? 
 
What facilitates or impedes you in 
delivering your role?  
 
Is there anything that I haven’t 
touched on that you think is 
important? 
 
Any way the role could be changed or 
improved? 
 
 
TOPIC GUIDE (Hospital DNS) 
Service provision/ DNS role 
Can you tell me a bit about the 
diabetes service you provide here 
in XX? (i.e. Type of patients, 
 
Has this changed over time? How? 
 
 
                                                     
6The intended role of the ICN was that they would act as a link between primary & secondary care, 
run clinics in primary care, provide training and support to practice nurses, serve as specialist 
support for GPs/practice nurses for complex patients & support GP/practice nurses in management 
of uncomplicated type 2 diabetes, be involved in structured education 
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referrals, where are you based, 
how does governance work) 
 
Working with other professionals / 
across settings 
How is your service received in your 
area? 
By GPs, PNs, In the hospital by 
consultants, by other DNS, 
patients? 
 
 
 
 
Why do you think this is?  
How have you responded? 
 
 
 
 
How are patients managed 
between primary & secondary care 
here? 
 
 
 
 
 
 
Would you describe care as 
integrated7? (Why/Why not?) 
 
 
Do you follow the national model of 
care8 in this area? 
 
Are you familiar with the National 
Clinical Programme for Diabetes?  
-Always been the case? 
 
-Any change in how they are managed? (Why 
(not)? 
 
-If change in secondary care…What was this 
change? Why? Impact of this is on patient care? 
On your own work? 
 
GP engagement with DNS 
GP engagement with the new 
integrated DNS service has been 
varied (by which we mean in some 
areas DNS couldn’t ‘get in the door’ 
in other areas they were 
‘welcomed’). 
 
 
 
 
 
 
Why do you think that is? 
                                                     
7What we mean by integrated care is that patients are managed by primary and secondary care 
services depending on the complexity of their diabetes. There are good links between primary and 
secondary care (e.g. better access to hospital services for integrated care patients) and professionals 
in both sectors have an understanding of where different patients should be cared for. So this would 
mean joint management of more complex patients, with less complex Type 2s mainly managed in 
primary care. 
8The national model of care aims to standardise management of patients with diabetes, including 
management across primary and secondary care. It outlines the different roles of those involved in 
care i.e. GP, PNs, DNS, dieticians, their roles and responsibilities, along with the types of patients to 
be cared for across the two sectors, and those to be cared in secondary care. 
381 
 
Would this fit with your 
experience? Why do you think that 
is? 
Integrated care in secondary care 
We are trying to find out how the 
integrated role and the model of 
care is implemented in secondary 
care. 
 
What has your experience been? 
 
 
Clear how the model is meant to work in 
secondary care?  
 
- Anything you think needs to be done in 
secondary care services for the MOC to work? (e.g. 
standardisation of GP referrals forms to facilitate 
discharge; discharge + advice to GPs) 
 
-Has the model of care been seen as a positive or 
negative change? If so, why? 
 
-How has the ICN service/role been received in the 
hospital by consultants and other DNS? Seen 
positively or negatively? Why? 
 
-Clear how this role is meant to work in the 
hospital? How does governance work? 
Final questions  
What parts of the DNS role work 
well and what don’t? 
 
What facilitates or impedes you in 
delivering your role?  
Is there anything that I haven’t 
touched on that you think is 
important?  
 
Any way the role could be changed or improved? 
 
-At level of nurse (e.g. support networks; own 
experience) 
-Wider infrastructure (e.g. space, staffing, ICT) 
 
 
Table 31 DNS behaviours in relation to public health nurses which facilitate 
delivery of the DNS service and support public health nurses in their role 
Contact public health nurses to arrange for patients to receive insulin in the 
community 
 
Liaise with public health nurses to follow-up discharged patients in community 
 
Facilitate a faster turnaround for public health nurses on prescribing or adjusting 
insulin 
“They [public health nurses] know that we adjust the insulin…then the other thing is that 
it’s done that day, it’s a time turnaround. It’s fast. It’s not waiting for a week or maybe 
calling the GP out to adjust insulin when it can be done from here” (HDNS17) 
 
Facilitate or advise public health nurses to link with the GP to get the “patient sorted” 
(CDNS5) 
 
Facilitate public health nurse access to bloods or appropriate equipment 
 
Provide public health nurses with informal advice and education: 
382 
 
“They [public health nurses] were astounded to think that they would have to check a 
patient's glucose level before they would leave a dressing clinic, if they were a diabetic or 
on sulphonylureas. Because they didn't see it as being part of, a. the overall care and b. 
part of their role” (CDNS7) 
 
“Because I’m in the open plan office they’ll come by to run something by me. So they’ll 
have learned a lot about diabetes” (CDNS5) 
 
Benefit from public health nurse knowledge: 
“They have direct links, they know the family dynamics and everything, they're on the 
ground” (CDNS1) 
 
10.7 Appendix 7 Research output and dissemination 
10.7.1 Reports 
• Riordan F., McHugh S., Marsden P., Kearney P., Harkins V. Audit Report of the HSE 
Midland Diabetes Structured Care Programme. Department of Public Health, 
Health Service Executive Dublin Mid-Leinster. 2017. Available from: 
http://www.lenus.ie/hse/handle/10147/621484  
 
• Overview of Activity Data in Primary Care from Clinical Nurse Specialist (CNSp) 
Diabetes Integrated Care Group. Available from: 
https://www.hse.ie/eng/about/who/cspd/ncps/diabetes/resources/an-overview-
of-activity-data-from-clinical-nurse-specialist-report.pdf  
 
10.7.2 Additional non-thesis related research published during the PhD 
• Riordan F, McGann R, Kingston C, Perry I. Schulze M, Andersen L, et al (2018) A 
systematic review of methods to assess intake of saturated fat among healthy 
European adults and children: A DEDIPAC (Determinants of Diet and Physical 
Activity) study. BMC Nutrition, 4(21) 
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healthy European adults and children: A DEDIPAC study. Public Health 
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and improve services: a realist evaluation protocol. Implementation Science, 11:107 
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Clinical handover practices in maternity services in Ireland: A qualitative descriptive 
study. Midwifery, 2016 39: 20-26 
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10.7.3 Policy briefs 
Health Policy Brief. Supporting Community Diabetes Nurse Specialists to integrate care in 
the Irish health service: Qualitative findings from the National Study of Diabetes Nurse 
Specialists. Prepared by F Riordan, SM McHugh, PM Kearney. December 2017 
 
10.7.4 Research dissemination  
 
Table 32 Conferences attended by the author 
Paper Conference proceedings  
384 
 
Diabetes Nurse Specialist services in Ireland: 
A cross-sectional survey. Riordan F, McHugh 
SM, Murphy K, Barrett J, Kearney PM. 
 
Oral presentation 
 
Society for Social Medicine Annual Scientific 
Meeting, York, Sept. 2016. 
 
National Health Services Research Institute 
Research day, Cork, Nov. 2016 
 
 
Poster presentation 
 
UCC School of Nursing and Midwifery Annual 
Research Conference, Nov. 2016 
 
UCC New Horizons conference, Dec. 2016 
Trends in the Quality of Structured Diabetes 
Care in Primary Care. Riordan F, McHugh 
SM, Marsden P, Harkins V, Kearney PM. 
 
Oral presentation 
 
Jacqueline Horgan Bronze Medal Meeting, Dublin, 
Nov. 2016 
 
International Conference on Integrated Care, 
Dublin, May 2017 
 
International Society of Quality in Healthcare 
(ISQua) Conference, London, Oct. 2017 
 
Poster presentation 
 
Society for Social Medicine Annual Scientific 
Meeting, York, Sept. 2016. 
 
National Health Services Research Institute 
Research day, Cork, Nov. 2016 
 
Association of University Department of General 
Practice in Ireland Scientific meeting, Limerick, 
March 2017 
Long term outcomes and mortality among 
patients enrolled in a structured primary 
care-led diabetes programme. Riordan F, 
McHugh SM, Marsden P, Harkins V, Kearney 
PM. 
 
Oral presentation 
 
Association of University Department of General 
Practice in Ireland Scientific meeting, Limerick, 
March 2017 
 
Elevator pitch 
 
Society for Academic Primary Care Annual 
Scientific Meeting, Coventry, July 2017 
 
Poster presentation 
 
385 
 
International Conference on Integrated Care, 
Dublin, May 2017 
Challenges experienced by community-
based clinical nurse specialists in supporting 
the delivery of integrated diabetes care: a 
qualitative study. Riordan F, McHugh SM, 
McGrath NM, Kearney PM. 
 
Oral presentation 
 
Society for Social Medicine Annual Scientific 
Meeting, Manchester, Sept. 2017 
 
Jacqueline Horgan Bronze Medal Meeting, Dublin, 
Nov. 2017 
 
School of Nursing and Midwifery Annual Research 
Conference, Cork, Nov. 2017 
 
Structured Population and Health Services 
Research Education (SPHeRE) conference, Dublin, 
Jan. 2018 
 
Poster (not presented) 
 
International Conference on Integrated Care, 
Utrecht, May 2018 
 
10.8  Appendix 8 PhD education and training 
10.8.1 Awards 
• Short-listed for the Jacqueline Horgan Bronze Medal Prize for Epidemiology, 2016 
and 2017 
• Awarded student travel bursary by the College of Medicine and Health to attend a 
course on focus groups at the University of Oxford (March 2016) 
• Awarded student bursary by Society of Social Medicine to cover registration fees, 
travel and accommodation for Society for Social Medicine Annual Conference, 
University of York (September 2016) 
 
Table 33 Training and workshops attended during PhD 
Year Course Facilitator 
 Modules for credit  
 PG 7021 The Ethics of Healthcare Research Module Dr Kieran Doran 
 PG 6003 Teaching and Learning for Graduate Studies Dr Marian McCarthy 
 Other courses  
2016 PG7016 Systematic reviews for the health sciences Prof. John Browne 
2016 Introduction to Focus Groups Oxford Health Experiences 
Research Group (HERG) 
Dr Jenny Hislop 
2016 PG6008 Qualitative Data Analysis and  
Computer Assisted Qualitative Data Analysis (CAQDA) 
Software for the Social Sciences and Humanities, Day 1 
and 2 
Mr Ben Meehan 
2017 Analysing Qualitative Interviews, Oxford HERG Dr Jenny Hislop 
2017 Mixed Methods Research Training, RCSI Prof. Alicia O’Cathain 
386 
 
2017 Cochrane Ireland, Cochrane Systematic Review course  
 Workshop  
2016 Symposium on Evidence Synthesis in Health Professions 
Education Workshop 3: Introduction to Realist Reviews.   
Dr Geoff Wong 
2016 Health Economics Masterclass NUIG Multiple speakers 
 
10.9 Appendix 9 Department contribution 
Table 34 Teaching and supervision contributions 
Teaching    
Year Course Module Role 
2016-2017 BSc Public Health EH3012 Tutor 
2017-2018 BSc Public Health EH3012 Tutor 
2017-2018 BSc Public Health EH2007 Tutor (substitute) 
2017 Masters Occ. Health EH6080 Guest lecturer 
(Introduction to Survey 
Design) 
2018 BSc Public Health EH2007 Tutor 
Supervision    
Year Course Lead supervisor(s)  
2015 MPH student Dr Eoin Coughlan  
2015 MPH student Dr Janas Harrington  
2016 MPH student Dr Martin Davoran  
2016 MPH student Dr Sheena McHugh  
2017 MPH student Dr Eilis O’Reilly  
2018 MPH student Prof. Patricia Kearney  
 
Department seminars 
Organised for 2016/2017 academic year (30 seminars in total)
387 
 
10.10 Appendix 10 Published papers, ethical approval for the studies included in 
the thesis, and the national DNS survey (Chapter 6) 
 
 1Riordan F, et al. BMJ Open 2017;7:e015049. doi:10.1136/bmjopen-2016-015049
Open Access 
AbstrAct
Objectives International evidence suggests the diabetes 
nurse specialist (DNS) has a key role in supporting 
integrated management of diabetes. We examine whether 
hospital and community DNS currently support the 
integration of care, examine regional variation in aspects 
of the service relevant to the delivery of integrated care 
and identify barriers to service delivery and areas for 
improvement.
Design A cross-sectional survey of hospital and 
community-based DNS in Ireland.
Methods Between September 2015 and April 2016, a 67-
item online survey, comprising closed and open questions 
on their clinical role, diabetes clinics, multidisciplinary 
working, and barriers and facilitators to service delivery, 
was administered to all eligible DNS (n=152) in Ireland. 
DNS were excluded if they were retired or on maternity 
leave or extended leave.
results The response rate was 66.4% (n=101): 60.6% 
(n=74) and 89.3% (n=25) among hospital and community 
DNS, respectively. Most DNS had patients with stable 
(81.8%) and complicated type 2 diabetes mellitus (89.9%) 
attending their service. The majority were delivering nurse-
led clinics (81.1%). Almost all DNS had a role liaising with 
(91%), and providing support and education to (95%), 
other professionals. However, only a third reported that 
there was local agreement on how their service should 
operate between the hospital and primary care. Barriers 
to service delivery that were experienced by DNS included 
deficits in the availability of specialist staff (allied health 
professionals, endocrinologists and DNS), insufficient 
space for clinics, structured education and issues with 
integration.
conclusions Delivering integrated diabetes care through 
a nurse specialist-led approach requires that wider service 
issues, including regional disparities in access to specialist 
resources and formalising agreements and protocols on 
multidisciplinary working between settings, be explicitly 
addressed.
bAckgrOunD
In recent years, internationally and in 
Ireland, there has been increased interest 
in how to deliver integrated care for people 
with chronic diseases such as type 2 diabetes 
mellitus (T2DM),1 2 coordinating manage-
ment so that patients receive the ‘right 
services’ in the ‘right place’.3 The complex 
nature of diabetes necessitates the involve-
ment of healthcare professionals from 
different disciplines and settings to achieve 
effective management.2 Integrated diabetes 
management across community-based and 
specialist services has been shown to improve 
quality of care4 5 and reduce preventable 
hospitalisations for diabetes-related compli-
cations.6
International evidence suggests the nurse 
specialist has a key role in supporting the 
integrated management of chronic disease7 
through delivering nurse-led clinics in primary 
care,8 9 liaising between care providers5 9–11 and 
providing specialist education and support 
to other professionals,5 10 including those 
in primary care.9 12 13 The shift towards 
primary care management of T2DM has 
meant the role has been increasingly moved 
into community settings.14 The UK13 and the 
The role of nurse specialists in the 
delivery of integrated diabetes care: a 
cross-sectional survey of diabetes nurse 
specialist services
Fiona Riordan,1 Sheena M McHugh,1 Katie Murphy,2 Julie Barrett,1 
Patricia M Kearney1
To cite: Riordan F, McHugh SM, 
Murphy K, et al.  The role 
of nurse specialists in the 
delivery of integrated diabetes 
care: a cross-sectional 
survey of diabetes nurse 
specialist services. BMJ Open 
2017;7:e015049. doi:10.1136/
bmjopen-2016-015049
 ► Prepublication history and 
additional material for this 
paper are available online. To 
view these files please visit the 
journal online (http:// dx. doi. 
org/ 10. 1136/ bmjopen- 2016- 
015049).
Received 7 November 2016
Revised 26 January 2017
Accepted 2 February 2017
1Department of Epidemiology 
and Public Health, University 
College Cork National University 
of Ireland, Cork, Ireland
2Department of General Practice, 
University College Cork, Cork, 
Ireland
correspondence to
Fiona Riordan;  
 fiona. riordan@ ucc. ie and 
Professor Patricia M Kearney;  
 patricia. kearney@ ucc. ie
Research
strengths and limitations of this study
 ► This study is the first to examine the provision of 
diabetes nurse specialist (DNS) services nationally 
in Ireland.
 ► A comprehensive questionnaire that was employed 
in a previous UK study and adapted for the Irish 
context was used for the study.
 ► Although the support of the Irish Diabetes Nurse 
Specialist Association and other sources was 
enlisted to generate the sampling frame, there is no 
definitive list of all DNS in Ireland.
 ► Only a small number of nurses work in both 
hospital and community roles; therefore, we did 
not distinguish between DNS who are solely based 
in the community and those in new posts working 
between hospital and community.
group.bmj.com on February 22, 2018 - Published by http://bmjopen.bmj.com/Downloaded from 
2 Riordan F, et al. BMJ Open 2017;7:e015049. doi:10.1136/bmjopen-2016-015049
Open Access 
Netherlands5 8 have seen the introduction of models of 
care where the diabetes nurse specialist (DNS) supports 
general practitioners (GPs) or practice nurses (PNs) in 
diabetes management8 13 (eg, intermediate care clinics for 
diabetes (ICCD), which accept referrals of more complex 
patients to reduce the burden to the hospital system15), or 
performs tasks previously conducted by the GP, including 
coordination and organisation of care (vertical task substi-
tution).8 These models have been found to improve clinical 
outcomes,5 8 reduce inappropriate referrals to secondary 
care,13 and may reduce outpatient attendances.15 16 
However, the role and work setting of DNS differ between 
countries.17–19 For example, in Sweden and the Netherlands, 
half or more of DNS may work in integrated or community 
settings and have prescribing rights.11 17 In contrast, most 
DNS in Ireland are hospital-based, and although nurse 
prescribing has been introduced since 2008, not all nurses 
perform this role. Given these differences, it is important to 
establish how the DNS role within the specific health system 
supports an integrated and sustainable model of diabetes 
care.
In Ireland, the importance of nurse specialists in chronic 
disease management and facilitating integrated care 
between settings has been recognised.20–22 The National 
Clinical Programme for Diabetes (NCPD), established in 
2010 to improve care for people with diabetes in Ireland, is 
developing the DNS service by introducing more commu-
nity-based DNS to facilitate the delivery of a new model 
of integrated diabetes care.23 These changes are taking 
place within a traditionally hospital-centric healthcare 
system where there is a disconnect between secondary and 
primary care services in how they are funded, managed and 
resourced. Diabetes services have historically been unstruc-
tured and characterised by pockets of good provision and a 
mix of care arrangements.20 In some areas diabetes care is 
primarily hospital-led; in others, care is delivered in general 
practice, sometimes on an opportunistic and ad-hoc basis. 
Chronic disease management in secondary care is also 
not well integrated with general practice,22 not all areas 
have a local diabetes service, and within general practice 
the delivery of diabetes care may be variable. In many 
areas, there are deficiencies in terms of access to specialist 
resources, including DNS.24–26 This has driven the develop-
ment of formal diabetes initiatives (10 nationally) that seek 
to improve the quality and organisation of care at a local 
level. These include models of structured or shared care 
with local clinical guidelines and support from a community 
DNS to facilitate communication between these practices 
and the hospital,9 or enhanced access to specialist commu-
nity resources, including dietetics, podiatry and DNS.27
The purpose of the new integrated care model is to stan-
dardise management of diabetes. It aims to ensure patients 
are cared for in the most appropriate setting and by the 
most appropriate healthcare professionals. As outlined in 
the latest guidance on diabetes management,28 patients 
with uncomplicated T2DM are managed in primary care, 
patients with complicated T2DM are managed between 
primary and secondary care, and management of type 1 
diabetes mellitus (T1DM) and gestational diabetes mellitus 
(GDM) takes place in secondary care. Implementation of 
the new model may vary depending on local circumstances 
and context, including existing models of care. Newly intro-
duced DNS have, in some areas, been linked to existing 
initiatives, whereas in other areas the service was entirely 
new. The current study may identify some of these regional 
variations and forms part of a programme of work evalu-
ating the implementation of the NCPD.29
The new reforms can be understood as evidence-based 
strategies to integrate care at the level of service organ-
isation and delivery (eg, promoting multidisciplinary 
teamwork through establishing the DNS as a ‘link’ between 
services; providing dedicated support by nurse specialists 
to primary care professionals) and at the clinical level (eg, 
introduction of guidelines on practice management).28 
Similar to the ICCDs established in the UK, these new DNS 
will provide necessary intermediary specialist support in the 
community in the management of more complex patients. 
They provide education and support for GPs and PNs, 
and work between community (80%) and hospital settings 
(20%), facilitating integration between the two settings.28 
DNS may deliver clinics in general practice, independently, 
or in some cases initially jointly with the PN or GP, to build 
capacity, confidence and skills in the management of more 
uncomplicated patients.
Although DNS support for patients and health profes-
sionals is a pillar of the national strategy for delivering 
integrated diabetes care, unlike other countries,5 10 11 19 30 
there is a dearth of information on how DNS services are 
delivered in Ireland. Our aim is to examine the way and 
extent to which DNS services currently support the inte-
gration of care and identify areas for improvement. We 
expect hospital and community DNS to differ in terms 
of the patients they provide care to and the professionals 
they support and are supported by. Therefore we describe 
the role of these DNS separately. Given the current vari-
ation in how diabetes services are delivered in Ireland, 
some aspects of the DNS role that are important in the 
integration of care (nurse-led clinics, agreements on 
working across primary and secondary care, access to 
other professionals) may differ across the country. There-
fore, we examine these by region. Finally, we identify 
barriers and facilitators to delivering diabetes care from 
the DNS perspective. The study will provide an insight 
into how the DNS role works in the context of a tradition-
ally fragmented health system characterised by regional 
variation and ongoing efforts to standardise and improve 
how diabetes care is delivered.23
MethODs
Participants
The eligible study population comprised all currently 
employed DNS (n=152), excluding retired DNS, those on 
maternity or extended leave. Registration with the Irish 
Diabetes Nurse Specialist Association (IDNSA) is not 
mandatory, and there is no national register of DNS posts 
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Table 1 Characteristics of the sample population (n=101)
N (%)
Based
  Hospital 74 (73.3)*
  Community 25 (24.8)†
  Other 2 (2.0)
Service area
  Adult 66 (65.4)
  Paediatric only 14 (13.9)
  Maternity only 5 (5.0)
  All three service areas 9 (8.9)
  Adult and paediatrics 3 (3.0)
  Adult and maternity 2 (2.0)
  Other 2 (2.0)
Region
  1 23 (22.8)
  2 25 (24.8)
  3 27 (26.7)
  4 26 (25.7)
Age
  25–34 9 (8.9)
  35–44 36 (35.6)
  45–54 38 (37.6)
  55–64 18 (17.8)
Education
  Masters in diabetes 11 (10.9)
  Diabetes counselling course 7 (6.9)
  PGDip in diabetes nursing 81 (80.2)
  Certificate in diabetes nursing (including 
e-learning) 22 (21.8)
  Masters in primary care 1 (1.0)
  Registered nurse prescriber 37 (36.6)
Employer‡
  Health Service Executive 84 (83.1)
  Private 9 (8.9)
  Other 6 (5.9)
Employment Mean (SD)
  Years working as a DNS§ 11.2 (7.4)
  Years in current position¶ 8.1 (6.8)
*Includes six advanced nurse practitioner or advanced midwife 
practitioner grade nurses, two clinical nurse managers, and three 
diabetes nurses not graded as DNS but qualified and performing 
role of DNS.
†Includes 16 integrated care nurses recruited as part of the 
national programme.
‡Missing data for two respondents.
§Missing data for three respondents.
¶Missing data for one respondent.
DNS, diabetes nurse specialist.
in Ireland. Therefore, we compiled a list through regional 
primary care initiatives, IDNSA, Diabetes Ireland, the 
national diabetes charity which funds the provision of 
some DNS posts, and the NCPD, which highlighted the 
survey at national and local conferences and meetings. 
The IDNSA asked their members to register their details 
with the study researchers.
Questionnaire
Participants were invited by e-mail to complete the 
self-administered, 67-item questionnaire electronically 
(SurveyMonkey) between September 2015 and April 
2016. The survey was based on a questionnaire devel-
oped by Diabetes UK and Association of British Clinical 
Diabetologists (ABCD) Specialist Services Study Group,19 
modified for the Irish health system in collaboration with 
a local nurse network, and piloted with two DNS, both 
of whom worked across hospital and community settings. 
Adaptations related to the questionnaire are included as 
online supplementary material. The survey comprised 
closed and open-ended questions addressing the DNS’ 
role in diabetes, clinic activity, links with other services, 
the nature of service agreements and their liaison 
role, and barriers and facilitators to service delivery 
(online supplementary material). Three reminders were 
sent, the final in conjunction with an e-mail notification 
from the IDNSA (online supplementary material).
Data management and analysis
Data were cleaned in Excel before importing into Stata 
(SE V.12) for analysis. Fisher’s exact tests were used to test 
differences in the role performed between hospital and 
community, and to examine service provision (clinics, 
referrals, local agreements) across the four regions 
defined according to the Diabetes Services Implemen-
tation Groups (DSIG), which are clinically led regional 
networks responsible for local implementation of the 
national programme. A p value of <0.05 was considered 
statistically significant. The Bonferroni correction was 
used to adjust for multiple comparisons. Complete case 
analysis was used and missing data are highlighted as 
applicable. NVivo (V.11) was used to manage and cate-
gorise open-ended responses. FR conducted a thematic 
analysis of responses to the questions on barriers and 
facilitators. The grouping of codes to generate overar-
ching themes was reviewed by JB.
results
The response rate was 66.4% (n=101): 60.6% (n=74) 
of hospital and 89.3% (n=25) of community DNS. This 
included six advanced nurse practitioner or advanced 
midwife practitioner grade nurses, two clinical nurse 
managers, and three diabetes nurses not graded as 
DNS but who were qualified and performing the role 
of DNS. Two DNS in non-clinical roles were classified as 
‘Other’. DNS from all four DSIGs and all counties in the 
Ireland participated. Most were hospital-based (table 1). 
group.bmj.com on February 22, 2018 - Published by http://bmjopen.bmj.com/Downloaded from 
4 Riordan F, et al. BMJ Open 2017;7:e015049. doi:10.1136/bmjopen-2016-015049
Open Access 
Respondents were working as a DNS for an average of 
11 years. Although most had completed a postgraduate 
diploma in diabetes, few (10.9%) had a master’s-level 
qualification, and just over a third (36.6%) were nurse 
prescribers.
Dns role
Most DNS had a written job description (n=89, 88.1%). 
All DNS were involved in some aspect of patient manage-
ment (table 2), but this differed by setting. More hospital 
than community DNS were involved in inpatient care, and 
specific elements of care for patients with T1DM (refer-
rals, glucose monitoring, insulin initiation or education, 
checking injection sites) (p<0.001) and provision of 
specialist clinics (non-significant) (table 2). While most 
hospital and community DNS reported that patients with 
complicated T2DM attended their service, the majority 
also saw patients with stable T2DM (figure 1). In two 
regions a greater proportion of nurses reported seeing 
stable T2DM (R1: 95.7%; R2: 70.8%; R3: 88.9%; R4: 
72%). Other patients seen were reported in open-ended 
comments (online supplementary material).
Of the 58 (59.2%) DNS who spent time on adminis-
trative work, the mean hours per week were 4.8±2.5 and 
5.7±2.8 among hospital and community DNS, respec-
tively. Few spent time on research or audit (n=36, 35.6%); 
on average, hospital DNS spent 1.5±0.8 hours per week 
while community DNS spent 2.3±1.6 hours. Few DNS 
had a dedicated budget (n=16, 16.3%) or protected time 
(n=27, 27.5%) for continuing professional development 
(CPD).
clinics
Nurse-led clinics can be understood as clinics where DNS 
may work without immediate supervision and are respon-
sible for case management. Overall, 81.1% (n=82) of 
DNS delivered nurse-led clinics, including generalised 
clinics (n=31, 37.8%), specialised (n=27, 32.9%) or both 
(n=24, 29.3%).
The greatest proportion of DNS provided ≥4 clinics 
per week (48.8%). While similar across most regions (R1: 
55.6%; R2: 61.9%; R3: 54.6%; R4: 23.8%), frequency in 
R4 was consistently lower. This was true among both DNS 
types: overall 52% community DNS provided ≥4 clinics 
(R1: 57.1%; R2: 50%; R3:8 0% R4: 28.6%) and 47.5% of 
hospital DNS provided ≥4 clinics (R1: 54.5%, R2: 64.7%, 
R3: 47.1%, R4: 21.4%) (online supplementary material).
Some DNS were supported in clinics by other members 
of the multidisciplinary team, for example a podiatrist 
(n=30, 36.6%) or dietician (n=44, 53.7%). Most commu-
nity DNS were supported in clinic by a PN (73.9%). 
According to hospital and community DNS, patients 
generally saw a consultant (74.6%) or GP (56.5%) at a 
later date rather than on the day of the clinic.
Half reported a waiting list for their clinic service. Where 
reported (n=41), the waiting time was commonly 1–3 
months (n=20), ranging from >1 month (n=5) to a year or 
more (n=4). The main reasons reported in open-ended 
comments (n=51) were the referral volume (n=24) and 
shortage of clinical staff (n=12). Of 24 respondents who 
provided clinics in the community, 12 reported that GPs 
were eligible to access those clinics, and in open-ended 
comments (n=11) indicated the service was available to 
GPs who were enrolled in a shared or structured care 
scheme (n=6), interested in diabetes care or willing 
to engage with the integrated care programme (n=3), 
or those practices employing a PN (n=2). Respondents 
reported that clinics were currently inaccessible where 
the service was at capacity or the catchment area was too 
large for the DNS to cover (n=4).
links with other professionals
Most DNS (n=94, 95%) were educating other profes-
sionals, primarily hospital-based nursing staff by hospital 
DNS (81.2%), and PNs (92%) and GPs (88%) by commu-
nity DNS. Community DNS were involved in education 
of allied health professionals (52%) and staff in nursing 
homes (21.6%) (table 2).
Most DNS liaised with other healthcare professionals 
(n=92, 91.1%) (table 2). As outlined in open-ended 
responses (n=83), this role involved patient case discus-
sion (n=40) and follow-up (n=8), referrals (advising 
but also being able to facilitate fast-track into hospital) 
(n=18), providing advice (n=13) and education (n=7) to 
other staff, seeking advice from consultants (n=6), and 
being a coordinator or ‘link’ between services (n=10).
Over one third of DNS (n=37, 36.6%) reported there 
was no discharge pathway to primary care for ward 
discharges (R1: 30.4%; R2: 40%; R3: 44.4%; R4: 30.8%), 
and a third (n=36, 36.7%) reported there was an agree-
ment between the hospital and primary care outlining 
how their service operates (R1: 50%; R2: 16.7%; R3: 
33.3%; R4: 48%). As outlined in open-ended comments 
(n=29) local agreements included following a shared care 
model (n=6) or integrated model (regular GP review 
with annual secondary care review) (n=5), working 80/20 
between community/hospital (n=5), rapid referral path-
ways from primary care into hospital (n=3) or being able 
to discharge patients to primary care (n=2).
While almost all DNS reported referral access to 
other professionals (n=92, 91.1%), there were regional 
differences in access to social workers (p=0.01) and 
psychologists (p=0.01) (figure 2) (non-significant after 
adjustment).
barriers and facilitators to delivering diabetes care
Most participants outlined barriers and facilitators to 
delivering their service in open-ended comments (n=89, 
88%). DNS suggested it was not feasible to conduct audit, 
research and quality improvement (n=14), citing time 
constraints (n=7), and poor IT systems (n=4) as the main 
reasons. They identified limited opportunities for profes-
sional development (n=9), which was not supported by 
managers (n=3) or allocated protected time (n=3).
Being supported by the multidisciplinary team facil-
itated service delivery (n=15), and DNS identified a 
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Table 2 Specific roles performed by DNS
Overall (n=99)* Hospital (n=74) Community (n=25)
Type 1, N 
(%)
Type 2, N 
(%)
Type 1, N 
(%)
Type 2, N 
(%) Type 1, N (%)
Type 2, N 
(%)
Core role
  Patient management† 88 (88.9) 90 (90.9) 73 (98.6) 67 (90.5) 15 (60.0) 23 (92.0)
  Medical review 54 (54.5) 57 (57.6) 46 (62.2) 44 (59.5) 8 (32.0) 13 (52)
  Telephone advice† 89 (89.9) 89 (89.9) 72 (97.3) 66 (89.2) 17 (68.0) 23 (92.0)
  Referrals 73 (73.7) 74 (74.7) 62 (83.8) 57 (77.0) 11 (44.0) 17 (68.0)
  Dose adjustment 73 (73.7) 72 (72.7) 58 (78.4) 51 (68.9) 15 (60.0) 21 (84.0)
  Insulin/GLP (glucagon-like 
peptide) initiation/education† 81 (81.8) 89 (89.9) 68 (91.9) 66 (89.2) 13 (52) 23 (92.0)
  Checking injection sites† 90 (90.9) 89 (89.9) 73 (98.6) 66 (89.2) 17 (68) 23 (92.0)
  Glucose monitoring† 89 (89.9) 91 (91.9) 73 (98.6) 67 (90.5) 16 (64.0) 24 (96.0)
  Inpatient care‡ 77 (77.8) 71 (71.7) 69 (93.2) 61 (82.4) 8 (32) 10 (40.0)
  Hypo management† 89 (89.9) 90 (90.9) 73 (98.6) 67 (90.5) 16 (64) 23 (92.0)
Specialist roles
  Hypertension clinics 5 (5.1) 6 (6.1) 5 (6.8) 5 (6.8) 0 (0) 1 (4.0)
  Renal clinics 10 (10.1) 13 (13.1) 10 (13.5) 12 (16.2) 0 (0) 1 (4.0)
  Assessment clinics prior to 
surgery 25 (25.3) 23 (23.2) 23 (31.1) 21 (28.4) 2 (8.0) 2 (8.0)
  Preconception discussion 52 (52.5) 48 (48.5) 41 (55.4) 36 (48.6) 11 (44.0) 12 (48.0)
  Prescribing 31 (31.3) 34 (34.3) 27 (36.5) 29 (39.4) 4 (16.0) 5 (20.0)
Other
  Providing foot care 76 (76.7) 52 (70.3) 24 (96.0)
  RetinaScreen registration 62 (62.3) 43 (58.1) 19 (76.0)
Liaison
  Consultant 81 (81.8) 60 (81.1) 21 (84)
  Hospital DNS§ 43 (43.4) 22 (29.7) 21 (84)
  Community DNS 48 (48.5) 40 (54.1) 8 (32)
  GP§ 70 (70.7) 46 (62.2) 24 (96)
  PN§ 58 (58.6) 35 (47.3) 23 (92)
Overall
(n=101)
Hospital
(n=74)
Community 
(n=25)
Other
(n=2)
Professional education
  GP§ 48 (47.5) 25 (33.8) 22 (88.0) 1 (50)
  PN§ 60 (59.4) 35 (47.3) 23 (92.0) 2 (100)
  Nursing staff in hospitals§ 82 (81.2) 71 (95.9) 11 (44.0) 0 (0)
  Medical staff in hospitals§ 49 (48.5) 47 (63.5) 2 (8.0) 0 (0)
  Allied health professionals 41 (40.6) 27 (36.5) 13 (52) 1 (50)
  Medical staff in nursing homes§ 35 (34.7) 16 (21.6) 17 (68.0) 2 (100)
Patient education 101 (100) 74 (100) 25 (100) 2 (100)
*Two respondents were excluded as they did not perform a clinical role.
†Significant difference in role performed for patients with type 1 diabetes mellitus after adjustment for multiple comparisons (Bonferroni 
corrected, p<0.002).
‡Significant difference in role performed for patients with type 2 diabetes mellitus after adjustment for multiple comparisons (Bonferroni 
corrected, p<0.002).
§Significant difference in role performed after adjustment for multiple comparisons (Bonferroni corrected, p<0.002).
DNS, diabetes nurse specialist; GP, general practitioner; PN, practice nurse. 
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Figure 1 Patient types seen by nurse type: hospital (n=74) or community (n=25).
Figure 2 Referral access by region.
shortage of specialist staff (allied health professionals, 
endocrinologists, DNS) as a main barrier to providing 
care (n=48). Other barriers were a lack of clerical 
support (n=19), poor ICT (information and commu-
nication technology) (n=8) and space limitations 
(n=19), which affected clinic (n=10) and structured 
education (n=8) provision. Barriers to integration 
included inappropriate referrals of stable T2DM to 
secondary care (n=7), GP reluctance to engage with 
the new community DNS service (n=7) and the lack of 
ICT to facilitate information-sharing between primary 
and secondary care (n=6).
DiscussiOn
Main findings
Our study indicates that most hospital and community 
DNS supported integrated care through management 
of complicated T2DM, liaising with and educating 
other professionals, and working independently to 
deliver nurse-led clinics. The latter is consistent with 
the move towards greater autonomy in the role. In the 
UK, nurse-led clinics were identified as a new devel-
opment in 2008, with 90% of DNS services providing 
this service.19 However, we also identified specific 
areas for attention, in terms of the types of patients 
being managed by DNS, access to other professionals, 
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the provision of clinics, and support for CPD, research 
and audit.
Although the role of the DNS is to support manage-
ment of complex patients, most reported that patients 
with stable T2DM attend their service. DNS also high-
lighted ongoing issues with inappropriate referrals to 
secondary care. Many lacked a formal agreement on how 
their service operates between primary and secondary 
care, and a protocol to guide discharge from secondary 
to community care. Although most DNS had a liaison 
role with other care providers, referral access to specialist 
staff varied regionally. Space limitations, a shortfall in 
specialist staff and the lack of shared ICT between primary 
and secondary care were highlighted by DNS as barriers 
to service delivery. Half of DNS reported a waiting list 
for clinics, and the frequency varied, as did the support 
available in clinics from multidisciplinary professionals. 
These differences in clinic delivery may reflect the avail-
ability of space and staff at a given hospital or GP practice. 
Although most community DNS delivered community 
clinics, access to this service was not universal. In some 
areas it depended on GP willingness to engage with the 
integrated service, practice participation in an existing 
diabetes care scheme, PN availability or DNS service 
capacity.
Research and audit is considered a key component of 
the nurse specialist role nationally21 31 and internation-
ally.32 However, as in the UK and Sweden,17 19 33 we found 
that few DNS spend time on research or audit, lacking 
opportunity or support to do so. Although DNS were 
highly trained and experienced, as in the UK, few (11%) 
had completed a master’s qualification.34 Lack of support 
for CPD was identified as an issue in the UK19 34 and was 
also highlighted by the current survey.
strengths and limitations
This study is the first to examine the provision of DNS 
services nationally in Ireland. One strength is the use of a 
comprehensive questionnaire employed in a previous UK 
study,19 which was adapted for the Irish context. Although 
there is no definitive list of all DNS in Ireland, we enlisted 
the support of the IDNSA, and this increases the likelihood 
that all potential participants were aware of the study. All 
four DSIG regions and counties were well represented, 
and we are confident the results capture the national situ-
ation in terms of DNS services. The balance of hospital to 
community DNS in the study reflects the national profile 
of DNS. Due to the small number of nurses working 
in both roles, our results did not distinguish between 
DNS solely based in the community and those in new 
posts working between hospital and community. The 
latter group spend 80% of their time in the community 
and their role is likely to be very similar to community 
DNS. Our question on patients who attend DNS services 
provides some insight into whether the role aligns with the 
national model. However it does assume that DNS have 
the same understanding of what is meant by complicated 
and uncomplicated (stable) T2DM. A further limitation 
is that this question does not capture why certain patients 
are being seen by the DNS. For example, we do not know 
whether there is a process by which DNS can discharge 
patients who become stable, given that patients may tran-
sition from complicated to stable and vice versa. While 
we are lacking routinely collected administrative data 
on the number and nature of referrals, community DNS 
have begun to collect data on their activity (number of 
complex/stable patients seen, practices visited, GPs 
interested in engaging, patients were discussed with 
the multidisciplinary team (MDT), formal professional 
education sessions). These data may also be harnessed to 
further assess the implementation of the model.
implications
Our study has implications for the implementation of 
integrated care models that rely substantially on the 
role of the DNS. First, the findings suggest the need for 
organisational and professional changes — that is, better 
resourcing of specialist staff, provision of dedicated space 
and changes in the receptiveness to the DNS role — to 
better enable DNS to support the integration of care 
as intended. Specific barriers that affect DNS service 
delivery (space and staff resources, inappropriate refer-
rals to secondary care) may also not be unique to Ireland, 
and their implications for integrated care may be relevant 
for the delivery of DNS services internationally.
Second, DNS continued to manage stable T2DM and 
mentioned the volume of inappropriate referrals in open-
ended comments. This appears to suggest that the model 
of care, where DNS primarily see complex patients, has 
not been fully realised. Variation in diabetes services and 
the capacity of primary care may mean that moving to 
a scenario where DNS only see complicated patients will 
be a gradual process. There were also regional differ-
ences in terms of patients with stable T2DM attending 
DNS services, which may reflect the structure of primary 
care locally, access to secondary care services and other 
specialists.
Third, while nurse-led community clinics have been 
implemented effectively in parts of the Netherlands as 
a strategy to integrate care,5 8 our findings suggest that 
local arrangements and resourcing may affect delivery. 
There were issues at a local level in terms of accessing 
DNS support through community-based clinics that have 
reached capacity or operate outside their catchment. 
Where GPs did have access, other factors (eg, being part 
of an existing initiative) affected eligibility. Although 
more work is required to fully understand how nurse-led 
clinics can operate effectively in this context, formal 
agreements and protocols to guide patient manage-
ment across settings and healthcare providers are likely 
important.35 Without a formal structure and adequate 
resourcing in place, as the DNS services become oversub-
scribed, they may contribute to, rather than address, any 
existing regional variation in diabetes care.
Finally, discharge pathways to community care and 
formal agreements on how DNS services operate between 
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the hospital and primary care did not always appear to 
be in place; this may be one reason why existing arrange-
ments continue to dictate patient management across the 
two settings. We show that the liaison role described by 
DNS in this study did align with elements of international 
models, that is, patient case discussion5 12 36 and care 
planning,8 and provision of advice, support5 13 and educa-
tion10 13 to other care providers. However, without formal 
guidance in place, DNS availability for advice and support 
could vary nationally. This is something that needs to be 
further explored.
Our study was carried out at a time of ongoing policy 
reform; in 2015 a new diabetes ‘cycle of care’ funding 
initiative, known as the ‘cycle of care’, was introduced. 
This scheme will for the first time nationally remunerate 
GPs for care of patients with stable T2DM (two structured 
visits of per year) who hold a general medical services 
card. The initiative will establish formal requirements 
for registering, recording and reporting processes of 
care (clinical parameters, routine foot screening and 
referral, lifestyle review).37 Payment will be made on the 
basis of registering eligible patients and delivering two 
review visits, and data will be reported/collected as per 
a standard proforma. While this may translate to more 
appropriate referrals and structured patient manage-
ment, enhanced access to community resources does not 
form part of the initiative, and it is likely to further stretch 
already limited specialist resources and the demand for 
community DNS. Almost one-fifth of DNS surveyed will 
be eligible to retire in the next 10 years or fewer, which 
may place an additional strain on services. Our survey 
respondents identified the lack of DNS as a barrier to 
providing care. The shortfall in nurses has also been 
highlighted as a concern in the UK where DNS posts are 
stagnating.38 It is concerning that the shift of patient care 
to the community may continue in areas unsupported by 
a well-resourced multidisciplinary team. Such deficien-
cies will influence how successfully DNS can coordinate 
care and support the delivery of an integrated service.
cOnclusiOn
Our results suggest that hospital and community DNS, 
working in a traditionally fragmented health system and 
against a backdrop of service variation, perform key roles 
to support the integration of care. Yet our findings suggest 
there is some regional variation in how the new model 
of care is being implemented, in terms of management 
of uncomplicated T2DM, clinic delivery and available 
support from multidisciplinary professionals. There are 
areas for improvement if the DNS role is to be used to 
its full potential and if a standardised model of care is to 
be achieved. Changes to the wider service infrastructure 
(resourcing, space allocation, ICT, attitudes of profes-
sionals involved) are required in order to align the health 
system towards the delivery of integrated care. Expanding 
the DNS service into the community to support primary 
care as an isolated strategy may be limited in its potential 
to fully integrate care on a national level. While this study 
provides a useful ‘snapshot’ into DNS service delivery, 
future qualitative work is required to explore and under-
stand how the role supports integration and changing 
requirements of the service as reforms continue.
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Abstract
Aim To examine the quality of care delivered by a structured primary care-led programme for people with Type 2
diabetes mellitus in 1999–2016.
Methods The Midland Diabetes Structured Care Programme provides structured primary care-led management.
Trends over time in care processes were examined (using a chi-squared trend test and age- and gender-adjusted logistic
regression). Screening and annual review attendance were reviewed. A composite of eight National Institute for Health
and Care Excellence-recommended processes was used as a quality indicator. Participants who were referred to diabetes
nurse specialists were compared with those not referred (Student’s t-test, Pearson’s chi-squared test, Wilcoxon–Mann–
Whitney test). Proportions achieving outcome targets [HbA1c ≤58 mmol/mol (7.5%), blood pressure ≤140/80 mmHg,
cholesterol <5.0 mmol/l] were calculated.
Results Data were available for people with diabetes aged ≥18 years: 1998/1999 (n=336); 2003 (n=843); 2008 (n=988);
and 2016 (n=1029). Recording of some processes improved significantly over time (HbA1c, cholesterol, blood pressure,
creatinine), and in 2016 exceeded 97%. Foot assessment and annual review attendance declined. In 2016, only 29% of
participants had all eight National Institute for Health and Care Excellence processes recorded. A higher proportion of
people with diabetes who were referred to a diabetes nurse specialist had poor glycaemic control compared with those
not referred. The proportions meeting blood pressure and lipid targets increased over time.
Conclusions Structured primary care led to improvements in the quality of care over time. Poorer recording of some
processes, a decline in annual review attendance, and participants remaining at high risk suggest limits to what
structured care alone can achieve. Engagement in continuous quality improvement to target other factors, including
attendance and self-management, may deliver further improvements.
Diabet. Med. 00: 000–000 (2018)
Introduction
Diabetes mellitus is a complex chronic condition requiring
structured management, including a focus on treatment goals
for blood pressure, glucose control and lipids, regular review
and recall, screening for complications, and input from a
multidisciplinary professional team [1]. Primary care, as a
first point of contact and source of continuous, comprehen-
sive and coordinated care, is often seen as a starting point for
the delivery and organization of diabetes care [2]. Evidence
suggests that primary care management can be as effective as
hospital-led care if well supported and organized [2]. Efforts
to optimize care across different health systems have led
disease management programmes to better organize man-
agement in primary care and improve coordination between
the community, outpatient/ambulatory and inpatient settings
[3–5].
Disease management programmes in primary care incor-
porate different components: multidisciplinary cooperation;
registration systems; audit and feedback; clinician reminders;
patient and professional education; and/or the establishment
of a specific communication system and ongoing collabora-
tion between specialities and primary care (shared care).
Structured approaches to diabetes care, combining some or
all of these elements, demonstrate improvements in gly-
caemic control and cardiovascular risk factors [4,6],Correspondence to: Fiona Riordan. E-mail: fiona.riordan@ucc.ie
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although the evidence for the effectiveness of shared care is
less certain [7,8]. Specific components delivering significant
improvements in clinical outcomes [6,8,9] and care processes
[6], include access to a multidisciplinary team [8], case
management [8], partial replacement of physicians by nurses
[9], self-management promotion [8], and interventions to
prompt recall and review of patients, including electronic
registries, reminders and tracking systems [6]. Interventions
operating at all levels of the health system (system, provider
and patient), however, have demonstrated a greater effect on
glycaemic control than interventions targeting a single level
[8].
Despite growing evidence regarding ways to improve the
quality of diabetes care, some uncertainties remain, including
whether the effects achieved by evaluative quality improve-
ment studies can be replicated in ‘real-life’ practice. Despite
international consensus on optimal diabetes management, a
gap persists between recommendations and actual practice
[10]. With increasing pressure on primary care, growing
patient numbers and workforce shortages [2,11], demon-
strating the long-term sustainability of structured primary
care management is a challenge. Internationally, high-quality
service evaluations to address this evidence gap are lacking
[11]. Most studies examining diabetes management in
primary care have a relatively short follow-up [4,6,7], cannot
provide an insight into the sustainability of these pro-
grammes over time, and may not be able to demonstrate
effectiveness [7]. Few studies evaluate enhanced models of
primary care management over a longer period, of 10 years
or more [12–14].
In Ireland [15], as elsewhere in Europe [5], national policy
in recent years has focused on moving from hospital-led
management to delivering care in the community. Diabetes
care is historically unstructured, but formal primary care
initiatives have been developed across the country to improve
the quality of care and service delivery at a local level. The
longest running is the HSE Midland Diabetes Structured
Care Programme (Midland Programme), established in 1997/
1998. We aimed to examine the quality of care delivered by
the Midland Programme over a long follow-up period
(1999–2016) through a series of cross-sections. We reviewed
the delivery of the programme by examining trends in the
processes of care performed for people with Type 2 diabetes
mellitus and benchmarked the programme against interna-
tional standards [16,17].
Methods
Setting
In Ireland, the national prevalence of doctor-diagnosed
diabetes among adults aged ≥18 years is 5.2%, an increase
from 2.2% in 1998 [18]. Over one-third of adults (37%) are
overweight and 23% are obese. The prevalence of smoking is
23% [19].
Midland Diabetes Structured Care Programme
The Midland Programme, based in four counties in Ireland
(Longford, Westmeath, Laois and Offaly), includes several
evidence-based intervention components: adoption of clinical
guidelines; patient register and recall and protected time for
review (three 30-min visits per year); organization and
coordination of care by practice nurses; structured multidis-
ciplinary support; and professional and patient education
[8,9]. Practices are remunerated for patients’ visits through
an existing chronic disease programme, Heartwatch, or
reimbursed for practice nurse time. Practices receive clinical
(diabetes nurse specialists, podiatry/chiropody, dietetic),
educational, and administrative support, which has changed
since the programme was first established; for example, there
has been a loss of dietetic support (Fig. 1).
Data collection
Diabetes nurse specialists extracted data from practice
records on people with Type 1 and Type 2 diabetes (aged
≥18 years) enrolled at four time points: 1998/1999; 2003;
2008; and 2016. A census sample was selected in 1998/1999
and 2003, and a random sample in 2008 and 2016. In 2008,
participants were sampled by sorting alphabetically first by
name, and selecting every third person. In 2016, all partic-
ipants who were still alive and were part of the census sample
in 1998/1999 were selected. After ordering randomly, every
third person was sampled from these participants. The
remainder of the participants in 2016 were sampled by
sorting alphabetically first by name, then sampling every
third person. This approach was taken to approximate a
random sample overall in 2016. Sample size was calculated
What’s new?
• Most studies on the impact of multifaceted, structured,
primary care programmes on the quality of diabetes
care have a short follow-up time; studies demonstrating
long-term sustainability are lacking.
• We found significant improvements in quality of care
(care processes delivered) among practices enrolled in a
primary care programme over a 16-year period.
• Lifestyle processes were less well recorded, and there
were declines in foot assessment and attendance at
annual review, and participants continued to have poor
risk factor control.
• Programmes may be limited when operating within the
constraints of primary care and the wider service
context.
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based on precision of HbA1c estimates. In 2003, the mean
HbA1c for the total sample was 60 mmol/mol (7.6%) and the
95% CI was  1 mmol/mol (0.11%), which equates to
~1.5%; therefore, a confidence level of 95% and CI of 2%
was chosen to calculate the sample size for 2008 and 2016.
Based on the total population of 2275 participants in 2008,
the sample size was 1168. Based on the total population of
participants in 2016 of 3797, the sample size was 1471. Only
data on participants with Type 2 diabetes are reported here.
Data sources included clinical notes (electronic and paper),
outpatient appointments letters and referrals to chiropody/
podiatry, retinopathy and dietetics. Data were collected on
demographics: age, gender and general medical services
status (a means-tested method of public health insurance;
general medical services cardholders have free access to
general practitioner services and medications) [20]. Data
were also collected on diabetes type, duration, annual review
attendance, use of diabetes-related services (retinopathy
screening, specialist eye services (any service in community
or hospital, private or public), diabetes nurse specialist or
podiatrist/chiropodist), prescription of diabetes medications
(oral hypoglycaemic agents, insulin, injectables) and other
medications (statins, angiotensin-converting enzyme inhib-
iters, aspirin). Data were collected on care processes carried
out in the previous 12 months: foot assessment carried out by
any healthcare professional (i.e. general practitioner, practice
nurse, diabetes nurse specialist, consultant, podiatrist), mea-
surement of glycated haemoglobin (HbA1c), cholesterol,
blood pressure, creatinine, albumin creatinine ratio, BMI,
smoking status) and intermediate clinical outcomes (HbA1c,
cholesterol, triglycerides, blood pressure, creatinine). Smok-
ing status (yes/no) in the past 12 months was determined on
the basis of participants’ response to a question about
whether they smoke now. Data on complications were also
collected: retinopathy, macrovascular [heart attack (myocar-
dial infarction), heart failure (congestive cardiac failure),
stroke (cerebrovascular accident), and mini stroke (transient
ischemic attack)], peripheral neuropathy, autonomic neu-
ropathy, foot risk category, and ulcer. Both eyes are checked
during assessments and people were classified as having
retinopathy if it was recorded in at least one eye. Both feet
are also checked and classification of foot risk (low/moder-
ate/high) was recorded on the basis of the highest risk in
either foot. Ulcer was recorded as ‘yes’ if the person had an
ulcer in at least one foot.
Analysis
Practice addresses were mapped to Electoral Divisions and
assigned a deprivation score and decile using the 2011
National Deprivation Index for Health and Health Services
Research developed by the Small Area Health Research Unit
[21]. Data were represented as means  SD or median
(interquartile range; continuous data) or numbers and
proportions (categorical data). Quality of care was defined
using a composite of eight care processes recommended by
the National Institute for Health and Care Excellence
(NICE): HbA1c, blood pressure, cholesterol, smoking status,
BMI, creatinine, albumin creatinine ratio and foot examina-
tion [22]. Although recording of triglycerides was reported,
this process was excluded from the composite. Trends over
time in the proportion with processes recorded were exam-
ined using the chi-squared test for trend, and logistic
regression models adjusted for age and gender. Trends in
FIGURE 1 National reforms, resources available to the programme, and participating general practitioners and people with diabetes enrolled 1999–
2016. Information on numbers of resources (diabetes nurse specialists and podiatrists/chiropodists) were unavailable at time points between data
collection. DNS, diabetes nurse specialist.
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recording were examined for selected processes collected
across all 4 years (HbA1c, blood pressure, cholesterol,
smoking status, BMI, creatinine) across practices. Differ-
ences in the proportion with processes recorded between
participants aged <75 years and ≥75 years were examined
using Pearson’s chi-squared test. The proportions attending
annual review and diabetes-related services were reported at
different time points. Differences in the demographic and
clinical profile of participants referred and those not referred
to a diabetes nurse specialist were tested using Student’s t-test
or Wilcoxon–Mann–Whitney test (continuous data), and
Pearson’s chi-squared test (categorical data). Guidelines
recommend people with complicated Type 2 diabetes mel-
litus attend a diabetes nurse specialist [23]. People with
complicated Type 2 diabetes are defined as those requiring
insulin, those with HbA1c >58 mmol/mol (7.5%) on two or
more glucose-lowering agents (not insulin), and those with
complications or graded as having a high-risk foot [23].
Continuous outcome data were categorized according to
international standards: blood pressure ≤140/80 mmHg,
triglycerides <2.0 mmol/l, cholesterol 5.0 mmol/l and HbA1c
≤58 mmol/mol (7.5%) [16,17,24], and proportions of
participants meeting clinical outcome targets were calcu-
lated. All analysis was carried out in STATA v.12 for windows
(StataCorp, College Station, TX, USA).
Results
Profile of the sample population
Data on 336 people with Type 2 diabetes in 1998/1999 (10
practices), 843 in 2003 (20 practices), 988 in 2008 (30
practices), and 1029 (30 practices) in 2016 were available for
analysis. Overall <10% of data were missing, with some
exceptions depending on time points: creatinine (1–31%),
BMI (27–44%), smoking status (21–32%), podiatrist/chi-
ropodist attendance (0–17%) and dietitian attendance
(0–40%). Where missing data occur, the figures represent
the recorded data. Over 85% of general practitioners were
based in practices within the lowest deprivation deciles: 9
(n=14, 41%) or 10 (n=15, 44%). In 2016, the median
(interquartile range) age of the cohort was 68 (60–76) years,
most were men (n = 603, 59%) and most had a general
medical services card (n = 823, 80%). The median duration
of diabetes was 9 years. The profile of people with Type 2
diabetes was similar across time points (Table 1).
Process measures
In 2016, recording for most care processes was >97%.
Recording improved significantly since 1998/1999, with
change more evident between earlier time points (Fig. 2).
Recording of BMI and smoking status remained consistently
lower than other processes. Although there was a significant
improvement between 1998/1999 and 2008 (BMI: 60% vs
73%; smoking status: 68% vs 77%) recording remained
below 80% from 2008 to 2016. The proportion of partic-
ipants with a foot assessment in the past 12 months declined
from 2008 to 2016 (77% vs 53%). In 2016, only 29% (n =
296) of participants had all eight NICE-recommended
processes recorded.
Trends in recording were similar when stratified by age
(<75 years and ≥75 years) with the exception of smoking
status and blood pressure recording among participants <75
years (Table S1). At individual time points certain processes
were consistently less well recorded (P< 0.05) among
participants aged ≥75 years: 1999 (BMI: 64% vs 48%;
triglycerides: 72% vs 51%), 2003 (BMI: 58% vs 48%;
triglycerides: 93% vs 87%), 2008 (BMI: 75% vs 67%;
triglycerides: 99% vs 96%; albumin creatinine ratio: 74% vs
67%), and 2016 (albumin creatinine ratio: 85% vs 75%).
Consistent improvements in recording were seen across all
practices for HbA1c, systolic blood pressure, cholesterol,
triglycerides and creatinine. There was some variation in
proportions recorded in 1999 among the 10 originally
enrolled practices (HbA1c 0–100%; blood pressure 69–
100%; cholesterol 0–100%; triglycerides 0–100%; crea-
tinine 0–97%). BMI and smoking status recording did not
improve consistently, with some practices showing a decline
in recording over time. Data for the 10 original practices are
shown in Table S2.
Attendance at annual review and diabetes-related services
Annual diabetes review attendance increased between 1998/
1999 (18%, n = 46/261) and 2008 (91%, n = 895/980), but
dropped in 2016 (77%, n = 788/1025). In 2016, clinical
characteristics were recorded for most participants who
attended and did not attend annual review (HbA1c: 100%
vs 97%; blood pressure: 99% vs 93%; cholesterol: 100% vs
96%; creatinine: 100% vs 95%); however, there were
differences in recording of foot assessment (57% vs 38%),
BMI (79% vs 47%) and smoking status (86% vs 56%). A
similar pattern was observed in 2008. In 2008, 58% of
participants (n = 548/949) had seen a chiropodist or
podiatrist in the past 12 months, which declined further
by 2016 (51%, n = 439/863). In 2008, only 51% (n = 507/
988) had attended specialist eye services, but in 2016, 80%
(n = 800/1006) of participants had attended either the
national screening programme (RetinaScreen) or specialist
eye services. The proportion who had seen a hospital or
community dietitian dropped from 50% (n = 167/336) in
1998/1999 to 7.1% (n = 42/610) in 2016, but recording
quality also declined; 41% (n = 419/1029) were missing
data in 2016 compared with 0.3% (n = 1/336) in 1998/
1999.
Attendance at a diabetes nurse specialist increased between
2008 and 2016 (11% vs 15%). Participants who were
referred had diabetes for longer and were younger than those
who were not referred (Table 2). A greater proportion of
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people referred had poor glycaemic control [HbA1c >58
mmol/mol (7.5%); 50% vs 20%; P<0.001], were on oral
hypoglycaemic agents or injectables (98% vs 81%;
P<0.001), and had retinopathy (41% vs 30%; P<0.01);
however, a lower proportion were classified as having a high
risk of foot disease (1.9% vs 4.4%; P<0.05).
Table 1 Characteristics and clinical profile of participants with Type 2 diabetes 1998/1999–2016*
1998/1999
n = 336
2003
n = 843
2008
n = 988
2016
n = 1029
Median (IQR) age, years 65 (56–74) 65 (56–73) 66 (59–74) 68 (60–76)
Male, n (%) 168 (50) 438 (52) 562 (57) 603 (59)
Median (IQR) diabetes duration, years NA NA 6 (3–9) 9 (5–12)
General medical services NA NA NA 823 (80)
Mean (SD) BMI, kg/m2 29.3 (4.7) 30.6 (4.8) 30.6 (4.8) 31.2 (5.9)
BMI <25 kg/m2, n (%) 33 (16) 42 (9) 94 (13) 81 (11)
Smokers, n (%) 58 (25) 123 (20) 146 (19) 121 (15)
Diabetes treatment, n (%)
Diet only 60 (18) 187 (22) 131 (13) 173 (17)
OHA only 262 (80) 532 (70) 685 (70) 643 (63)
Insulin + OHA 0 (0) 39 (4.6) 131 (13) 140 (14)
Insulin only 10 (3.0) 25 (3.0) 38 (3.9) 21 (2.0)
Statins, n (%) NA NA 799 (81) 854 (83)
ACE inhibitors, n (%) NA NA 734 (74) 680 (67)
Aspirin, n (%) NA NA 740 (75) 611 (59)
Mean (SD) HbA1c
mmol/mol 55 (18) 58 (18) 53 (13) 54 (14)
% 7.2 (1.7) 7.5 (1.6) 7.0 (1.2) 7.1 (1.3)
HbA1c concentration, n (%)
<48 mmol/mol (6.5%) 104 (37) 229 (29) 351 (36) 364 (36)
≤53 mmol/mol (7.0%) 156 (55) 382 (48) 589 (61) 607 (59)
≤58 mmol/mol (7.5%) 191 (67) 481 (60) 720 (74) 770 (75)
Mean (SD) systolic blood pressure, mmHg 144.4 (19.9) 140.5 (18.7) 135.9 (16.3) 135.1 (16.0)
Systolic blood pressure, n (%)
<130/80 mmHg 25 (8.0) 96 (12) 212 (22) 212 (21)
≤140/80 mmHg 112 (36) 405 (48) 560 (57) 597 (59)
Mean (SD) cholesterol, mmol/l 5.3 (1.2) 4.9 (1.0) 4.1 (1.1) 4.1 (1.0)
Cholesterol concentration, n (%)
<4.5 mmol/l 60 (23) 268 (33) 647 (67) 711 (70)
<5.0 mmol/l 102 (38) 450 (55) 785 (81) 846 (83)
Mean (SD) triglycerides, mmol/l 2.4 (1.5) 2.1 (1.9) 1.8 (1.2) 1.7 (1.5)
Triglycerides <2.0 mmol/l, n (%) 103 (46) 460 (60) 684 (71) 760 (75)
Mean (SD) creatinine, lmol/l 86.5 (30.1) 84.8 (20.7) 87.8 (46.0) 86.5 (34.0)
NA, not available (data on this variable were not collected at this time point); ACE, angiotensin-converting-enzyme; IQR, interquartile range;
OHA, oral hypoglycaemic agent.
*Based on available data: age: 1999 (336), 2003 (842), 2008 (987), 2016 (1,028). Diabetes duration: 2008 (848), 2016 (1005). GMS: 2016
(1027). BMI: 1999 (203), 2003 (470), 2008 (725), 2016 (736). Smoking status: 1999 (230), 2003 (629), 2008 (759), 2016 (813). Diabetes
treatment: 1999 (332), 2003 (843), 2008 (985), 2016 (1026). Statins: 2008 (987), 2016 (1028). Aspirin: 2008 (986), 2016 (1027). ACE
inhibitor: 2008 (984), 2016 (1017). HbA1c: 1999 (284), 2003 (799), 2008 (967), 2016 (1021). Blood pressure: 1999 (311), 2003 (836), 2008
(979), 2016 (1008). Cholesterol: 1999 (267), 2003 (815), 2008 (973), 2016 (1018). Triglycerides: 1999 (226), 2003 (771), 2008 (968), 2016
(1012). Creatinine: 1999 (234), 2003 (695), 2008 (971), 2016 (1016).
FIGURE 2 Participants with nine care processes recorded 1999–2016. *P < 0.05. Albumin: creatinine ratio was not recorded in 1999 and 2003; foot
assessment was not recorded in 1999. Proportions were analysed using a chi-squared test for trend and logistic regression adjusted for age and
gender. ACR, albumin:creatinine ratio.
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Outcome targets
Over time, the proportion meeting blood pressure and lipid
targets increased, whereas the proportion with HbA1c ≤58
mmol/mol (7.5%) was similar (Table 1). Across time points,
the proportion meeting all three outcome targets (HbA1c,
blood pressure and cholesterol) ranged from 12% (1999) to
39% (2016). Those at high risk [HbA1c >58 mmol/mol
(7.5%)] had diabetes for longer. The proportion on oral
hypoglycaemic agents only was similar among high- and
low-risk groups. A greater proportion at low risk were on
oral hypoglycaemic agents or injectables (Table S3).
Discussion
We examined the quality of care delivered by a structured
primary care management programme for people with Type
2 diabetes. We found significant improvements in process of
care recording. These are consistent with changes in record-
ing [3,6,13,14] reported by multifaceted international pro-
grammes with similar components: registration [6,13,14],
practice guidelines [3,14], incentives [3], ongoing profes-
sional education [6,14], nurse case management [13], and
structured multidisciplinary support [3]. Our findings suggest
these changes can be sustained over time in a real-life setting;
however, despite evidence of ongoing improvement, there
may be limits to what structured programmes can achieve in
the long term. BMI and smoking status were consistently less
well recorded, and performance of foot assessment and
attendance at dietetic and annual review declined in the later
years of the programme, and some participants remained at
high risk.
Unlike the Quality and Outcomes Framework in the UK,
payment as part of the Midland Programme is not based on
process recording. Smoking status and BMI recording
remained lower than other processes, comparing poorly with
the recent National Diabetes Audit [22], based on Quality
and Outcomes Framework data, and with other European
countries [25]. BMI and smoking status recording in the
National Diabetes Audit, however, was also lower than
recording of other processes. While incentivizing individual
indicators can improve recording to a degree, poor docu-
mentation of certain processes may persist. Some may be
given lower priority than other clinical measurements during
review visits. BMI recording, for example, may only occur if
a general practitioner or practice nurse recognizes the person
Table 2 Profile of participants who were referred to a diabetes nurse specialist* in 2016
Referred to diabetes nurse specialist
Yes
n = 153
No
n = 866
Yes, but did not attend
n = 9
Median (IQR) age†, years 65 (56–71) 69 (61–76) 58 (53–63)
Men, n (%) 88 (58) 511 (59) 4 (44)
Median (IQR) diabetes duration†, years 10 (6–14) 9 (5–12) 9.5 (9–12)
Mean (SD) BMI, kg/m2 32.1 (6.1) 31.0 (5.9) 32.6 (4.4)
Smoker, n (%) 21 (18) 99 (14) 1 (13)
Diabetes control†, n (%)
Diet only 3 (2.0) 168 (19) 1 (11)
OHA only 71 (47) 569 (66) 3 (33)
Insulin only 5 (3.3) 15 (1.7) 1 (11)
Insulin and OHA 57 (38) 81 (9.3) 2 (22)
Injectables and OHA 16 (11) 31 (3.6) 2 (22)
OHA or injectable†‡ 149 (98) 696 (81) 8 (89)
HbA1c > 58 mmol/mol (7.5%), n (%) 80 (50) 172 (20) 4 (50)
Median (IQR) HbA1c
†
mmol/mol 60 (50–69) 50 (44–57) 64 (52–69)
% 7.6 (6.7–8.5) 6.7 (6.2–7.4) 8.0 (6.9–8.5)
Mean (SD) systolic blood pressure, mmHg 133.7 (14.2) 135.4 (16.3) 127.2 (12.2)
Complications, n (%)
Retinopathy† 54 (41) 197 (30) 3 (50)
Macrovascular 8 (5.2) 89 (10) 2 (22)
Peripheral neuropathy 7 (4.6) 29 (3.4) 0 (0)
Autonomic neuropathy 5 (3.3) 28 (3.2) 0 (0)
High-risk foot† 2 (1.9) 14 (4.4) 1 (17)
Ulcer 4 (2.7) 20 (2.3) 0 (0)
IQR, interquartile range; OHA, oral hypoglycaemic agent.
*People with complicated Type 2 diabetes should attend a diabetes nurse specialist. This includes people requiring insulin, people with HbA1c
>58 mmol/mol (7.5%) on two or more glucose-lowering agents (not insulin), and people with complications or graded as having a high-risk
foot [23].
†P < 0.05; difference in people attending and not attending diabetes nurse specialist visit were analysed using Student’s t-test or Wilcoxon–
Mann–Whitney test for continuous data and Pearson’s chi-squared for categorical data.
‡OHA, insulin or other injectable.
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with diabetes as overweight/obese, intends to offer manage-
ment, or feels willing or able to engage in discussions about
weight [26]. We found variation across practices in recording
of BMI and smoking status, with some practices showing a
decline in recording over time. With the exception of 2016,
BMI was consistently less well recorded among older
participants (aged ≥75 years). Foot assessments, also poorly
recorded, have been more frequently performed among
people with low income, poorer metabolic control, or
complications, and less frequently by general practitioners
compared with specialists [27]. Assessments may be time-
consuming and unfeasible as part of regular review, or only
prioritized when the general practitioner is aware of an
increased risk of amputation.
We found a significant, improving trend over time in
recording of care processes; however, this was driven by
more substantial improvements between earlier time points.
There was minimal change between 2008 and 2016 once
recording >97% had been achieved; however, a similar
pattern was observed for BMI and smoking status, although
these were less well recorded. This suggests that recording
may plateau irrespective of whether near maximal recording
has been achieved or not. A plateau was also observed in the
UK 1 year after the introduction of the Quality and
Outcomes Framework [28], suggesting limits to what can
be achieved through incentives, regardless of the reimburse-
ment method. This raises the question of whether the Quality
and Outcomes Framework should be replaced with a model
to deliver more sustained improvements [29]. This has
implications for the new Diabetes Cycle of Care initiative
introduced in Ireland in 2015, which remunerates general
practitioners for care of people with stable Type 2 diabetes
who hold a general medical services card. Practices are paid
on the basis of registering eligible people with diabetes,
delivering two review visits per year, recording and reporting
on care processes (clinical characteristics, routine foot
screening/referral, lifestyle review), not on the basis of
meeting clinical targets. The initiative may improve the
delivery of care processes, but only up to a point. Scotland
has recently replaced the Quality and Outcomes Framework,
establishing general practitioner quality clusters, small
groups of practices which engage in local, peer-led quality
improvement activities [29]. While they may see an initial
decline in care processes, there is scope for improvement
beyond what is achievable through payments.
Although we did not track clinical outcomes in a fixed
population, by reviewing outcomes in separate cross-
sections, we gained some insight into the profile of people
with diabetes receiving structured care. In Ireland, 40% of
older adults (≥55 years) are reported to have high blood
pressure (systolic blood pressure ≥140 mmHg), and 41%
have cholesterol >5 mmol/l [30]. Although recording of most
processes in the Midland Programme was >97%, many
participants were in high risk categories in terms of
glycaemic control and their cardiovascular profile. Between
2003 and 2016, 26–40% had HbA1c >58 mmol/mol (7.5%),
41–52% had blood pressure >140/80 mmHg, and 15–42%
had cholesterol >5 mmol/l, consistent with research showing
recording does not necessarily translate to better outcomes
[31].
Recording clinical values is a quality measure in itself
which may indicate the need to intensify treatment; however,
achieving outcome targets requires appropriate action by
professionals and people with diabetes. Emphasizing pro-
cesses alone, as with the Cycle of Care, may not deliver
improved outcomes. Motivation of the person with diabetes,
adherence to treatment and the efficacy of self-management,
influence risk factor management [10], but were not captured
in the present study. We found the proportion of people with
HbA1c ≤58 mmol/mol (7.5%) was similar across time points,
which could reflect the long disease duration among partic-
ipants or the declining effect of oral hypoglycaemic agents
[32]. While treatment goals provide a benchmark for quality,
Lipska et al. [33] have recently questioned the use of
‘surrogate’ outcome targets, such as HbA1c, as quality
indicators. They may not be appropriate for certain sub-
groups (e.g. the elderly or those with comorbidities) and
should be individualized according to complication risk,
preferences and control strategy. Greater emphasis has been
placed on involving people with diabetes in the decision
about their individual HbA1c target [16,17]. Future moni-
toring of the Midland Programme should consider incorpo-
rating this information; that is, recording whether a target
has been agreed, documenting the agreed target, and using
this as a basis for evaluating the quality of care.
Although retinopathy screening attendance improved, in
2016, 20% had not attended specialist eye services or
RetinaScreen, the new national screening and treatment
programme introduced in 2013. National guidelines recom-
mend that people with complicated Type 2 diabetes should
attend a diabetes nurse specialist, including people requiring
insulin, people with HbA1c >58 mmol/mol (7.5%) on two or
more glucose-lowering agents (not insulin), or people with
complications or graded as having a high-risk foot [23]. In
line with this recommendation, we found participants with
more complicated diabetes were referred to a diabetes nurse
specialist. While the rate of non-attendance was low overall,
those who did not attend had a higher median HbA1c than
attenders. Further work is necessary to understand barriers to
attendance among these participants, ways to improve
attendance, and facilitate risk management. Although most
participants attended for annual review, this declined
between 2009 and 2016 (91% vs 77%). Transport, work
and family commitments, and lack of motivation have been
cited as reasons for non-attendance at annual review [34];
however, practice-level resource constraints could also
account for this decline. An official annual review may not
be performed at a single visit but instead components spread
over several visits to lessen practice nurse workload. The
increasing complexity of management may require longer
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reviews that cannot be incorporated into one visit [35]. Unlike
clinical measurements, BMI, smoking status and foot assess-
ment were less well recorded among those who did not attend
annual review. These processes may not be a priority during
regular visits, particularly for people with poor attendance.
Ireland is moving towards the delivery of structured,
integrated diabetes management in primary care, with the
establishment of the National Clinical Programme for
Diabetes, the resourcing of community-based ‘integrated’
diabetes nurse specialists to facilitate delivery of the new
model of integrated care that manages people with diabetes
according to their complexity, and the Cycle of Care (Fig. 1)
[23]; however, as a multi-component programme with good
specialist support, the Midland Programme provides an
insight into the impact of providing structured care in the
community that predates these national changes (Fig. 1). As
enhanced access to community-based specialist resources
does not form part of the Cycle of Care initiative, care may
be moved to the community in areas with less access to a
well-resourced multidisciplinary team. Programmes such as
the Midland Programme may also be influenced by health
service changes. We observed a drop in dietetic screening
alongside a loss of resources, further indicating the impor-
tance of sustained resources to deliver care in the community.
A strength of the present study is that it examines, over a
long follow-up period, the impact of structured primary care-
led service model, delivered in routine practice rather than as
part of a quality improvement trial; however, participants
were not the same at each time point (although some were
represented at each). We also took different approaches to
sampling at each time point. In 2008 and 2016, as the
number enrolled in the programme exceeded 2000, it was
not feasible to collect data manually on every participant,
therefore, an appropriate random sample was taken. In
2016, as part of the larger sample taken at this time point,
data were collected on all participants who had been enrolled
in 1998/1999 and were still alive in 2016. This was done in
order to facilitate a separate analysis which examines
survival in the original cohort enrolled in the programme
since its initiation. We can judge the overall delivery of the
programme, but cannot infer the impact on individual
participants since enrolment. Although different individuals
were represented across different time points, it is encourag-
ing that participants enrolled in this structured care pro-
gramme were meeting outcome targets; however, we lacked
control practices to determine whether changes in clinical
outcomes reflected overall improvements in medication (e.g.
new oral hypoglycaemic agents) and management in the time
period, or in the organization and delivery of the pro-
gramme. Most participants enrolled were on lipid-lowering
or blood pressure medication. The programme is multi-
faceted so we cannot prove that one component was more
effective than others. Data were extracted from general
practice records, and we depended on the reliability of data
from this source.
Our findings illustrate sustained improvements in the care
delivered by practices in a multifaceted, primary-care led
programme over time, suggesting this approach is feasible in
real-life primary care; however, our findings also identify limits
to what can be achieved by structured care programmes,
particularly when operating within the resource constraints of
primary care and the wider health service context. We need to
better understand general practitioner management decisions,
patient attendance, adherence and self-management, and
whether these factors moderate the impact of these pro-
grammes. Programmes such as theMidland Programme should
move beyond monitoring and engage in a continuous cycle of
quality improvement to respond to the challenges of delivering
optimal primary care-led diabetes care in everyday practice.
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Consent Form
Survey of Diabetes Nurse Specialists in Ireland (Wave 2)
1. We want to gain a greater understanding of your role in diabetes care.This study is going to improve
our understanding of how services are currently organised in Ireland. This information is important to
inform plans for changes in diabetes management in the future. 
Before proceeding with the survey, we ask that you please read the following and indicate your consent
below.
The purpose and nature of the study has been explained to me in writing. 
I am participating voluntarily.
I understand that I can withdraw from the study, without repercussions, at any time.
I understand that I can withdraw permission to use the data, in which case the material will be deleted.
I understand that anonymity will be ensured in the write-up of results.
I understand that anonymised data will be used in the report and any subsequent publications.
I consent to participate in the National Survey of Diabetes Nurse Specialists in Ireland.
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Contact Information
Survey of Diabetes Nurse Specialists in Ireland (Wave 2)
Name:  
Address 1:  
Address 2:  
City/Town:  
Email Address:  
Mobile Number:  
2. Please provide the following information:
3. The survey will be followed by a qualitative study exploring Diabetes Nurse Specialists' experiences
providing care in the Irish health system. If you do not wish to be contacted about this follow-up study
please tick this box:
Do not contact me
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Education & Employment
Survey of Diabetes Nurse Specialists in Ireland (Wave 2)
4. What is your job title?
5. Are you a:
Community DNS
Hospital DNS
Both community and hospital DNS
ANP (Primary Care)
CNS (General Practice)
Other (please specify below)
6. Where are you based? (Tick all that apply)
Community
General Practice
Hospital
Other (please specify below)
7. Do you work in:
Adult services
Paediatric services
Maternity services
Other (please specify below)
8. What is your catchment area?
3
    
9. What age group are you in?
25-34 35-44 45-54 55-64 65 or older
10. Post basic qualification (please tick all that apply)
Masters in Diabetes
Masters in Nursing Studies
PhD (completed or undertaking)
Diabetes counselling course
Higher Diploma (HDip) in Diabetes Nursing
Post Graduate Diploma in Diabetes
Certificate in Diabetes Nursing
Certificate in Diabetes through E-learning (ICGP module)
Diabetes in Primary Care (NUIG/UCC module)
Masters in Primary Care
Other (please specify below)
11. Are you a Registered Nurse Prescriber (RNP)?
Yes
No
12. How many years experience do you have working as a DNS?
13. How many years experience do you have working in your current position?
14. What is the grade of your current position?
Staff nurse
Senior staff nurse
Clinical Nurse Specialist
Advanced Nurse Practitioner
Clinical Nurse Manager
Other (please specify below)
15. Do you know the whole time equivalent (WTE) of your position?
Yes
No
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16. If yes, please estimate the WTE.
 Employed by Funded by
HSE
Diabetes Ireland
Pharmaceutical company
Diabetes initiative
Other (please specify)
17. Who are you employed and funded by?
Community
General Practice
Hospital
Total hours per week
18. How many hours per week do you spend working in each setting(s)?
Adult services
Paediatric services
Young person's clinic
Diabetes in pregnancy
In-patient services
Out-patient services
Community clinics
GP practices
Research/audit
Administration
19. How many hours per week do you spend working in each of these services?
5
If yes, which hospital(s)?
20. Are you linked to a specific hospital?
Yes
No
21. Is there a clinical governance lead for your service?
Yes
No
22. If yes, who is responsible for clinical governance?
Consultant
GP
Other (please specify below)
23. Who is your manager?
Hospital
GP
General manager for community
Transformation Development Officer
Director of Nursing
Director of Public Health Nursing
Other (please specify below)
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Providing Diabetes Care
Survey of Diabetes Nurse Specialists in Ireland (Wave 2)
24. Is there a written job description for your role?
Yes
No
25. What type of patients attend your service? (Tick all that apply)
Type 1 diabetes
Stable Type 2 diabetes
Complicated Type 2 diabetes
Gestational Diabetes
Young adults with diabetes
Pre-diabetes
Other patient groups (please specify below)
 Type 1 diabetes Type 2 diabetes Other patient groups
Patient management
Prescribing
Dose adjustment only
Insulin/GLP1 initiation/education
Checking injection sites
Glucose Monitoring
Hypo Management
Medical review
Other (please specify)
26. Regarding diabetes, what are your specific roles in patient care? (tick all that apply)
7
 Type 1 diabetes Type 2 diabetes Other patient groups
Hypertension clinics
Renal clinics
Pre-conception discussion
In-patient diabetes care
Referrals
Telephone advice
Assessment clinics prior to surgery
Other (please specify)
27. Are you involved in any of the following? (Tick all that apply)
 Type 1 diabetes Type 2 diabetes Other patient groups
Patient education
Family education
Pump Training
Other (please specify)
28. What are your specific roles in education? (Tick all that apply)
 Type 1 diabetes Type 2 diabetes Other patient group
Smoking cessation advice
Dietary advice
Physical activity advice
Weight management
Other (please specify)
29. Are you involved in any of the following aspects of lifestyle management? (Tick all that apply)
8
30. Are care plans developed with patients?
Yes
No
If yes, which screening tool do you use?
31. Are you involved in providing foot care?
Yes
No
If no, who is responsible for this?
32. Do you register patients for RetinaScreen?
Yes
No
33. Do you have referral access to other services? (Tick all that apply)
No
Podiatrist
Dietician
Ophthalmologist
Psychologist
Social Worker
Other (please specify below)
If yes, which patients are advised to self-monitor?
34. Do you advise patients with diabetes to self-monitor blood glucose levels?
Yes
No
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If yes, please outline what has been agreed locally.
35. Is there a local agreement between the hospital and primary care regarding how your DNS service
operates?
Yes
No
36. Do you have a liaison role with any of the following colleagues? (Tick all that apply)
No
GP
Practice Nurse
Hospital DNS (if applicable)
Community DNS (if applicable)
Consultant
Other (please specify)
37. What does this liaison role involve?
If yes, please specify
38. Do you cover other roles not solely related to diabetes?
Yes
No
10
39. Are there other nurses engaged in the diabetes service in your area? (Tick all that apply)
No
Diabetes Nurse Facilitator
Staff Nurses
Practice Nurses
Public Health Nurses
Other (please specify below)
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Clinics
Survey of Diabetes Nurse Specialists in Ireland (Wave 2)
What type of specialist clinic you do you lead?
40. Do you run a nurse-led diabetes clinic?
No
Yes, generalised clinics only
Yes, specialised clinics only
Both
41. How many nurse-led clinics do you run each week?
None
1
2
3
4 or more
42. On average, how many patients do you see per clinic?
Less than 5
5
10
15
15 or more
Not applicable
43. Do patients also see a consultant/GP?
Yes, during the same visit
Yes, at a later date
No
Not applicable
12
44. Where are these clinics held? (Tick all that apply)
General Practice
Primary care centre
Community outreach clinic
Hospital
Out-patients clinic
Not applicable
Other (please specify below)
If no, who is the service available to?
45. If you provide clinics in the community, are all GP practices eligible to access your service?
Yes
No
Not applicable
46. Who is generally available to support you in the diabetes clinic? (Tick all that apply)
Consultant
SpRs or equivalent
Senior House Officer
Intern
Practice Nurse
GP
Hospital DNS
Community DNS
Podiatrist
Dietician
Psychologist
Health care assistant
Not applicable
Other (please specify below)
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If yes, please estimate how long people wait to attend the service
47. Is there a waiting list for your service?
Yes
No
48. In your opinion, what are the main reasons for the waiting list in your area?
49. Do you provide out-of-hours diabetes consultations?
Yes
No
50. If 'yes', when are the out-of-hours sessions held in your area? (please tick all that apply)
At weekends
In the evenings
Other (please specify below)
51. Do you provide a drop-in service for patients?
Yes
No
 Telephone support service Messaging service
Yes, universal access for all patients
Urgent only
Specialist patient groups
Pregnancy
Paediatric
None available
52. Are any of the following telephone services available to patients? (Tick all that apply)
14
53. When is the telephone support service available? (Tick all that apply)
Weekday office hours
Weekend office hours
Weekday evenings
24hours- 7 days a week
Not applicable
54. Which members of staff operate the telephone support service? (Tick all that apply)
DNS
Secretaries
Medical staff
Consultant
Podiatrist
Dietician
Practice Nurse
GP
Not applicable
Other (please specify below)
55. How quickly do patients get a response to messages?
56. Is there a discharge follow-up pathway from wards to diabetes out-patient care?
Yes
No
Not known
57. Is there a discharge follow-up pathway to primary care for ward discharges?
Yes
No
Not known
58. Do all people with diabetes admitted to hospital in your area have ready access to specialist
diabetes team support?
Yes
No
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Education
Survey of Diabetes Nurse Specialists in Ireland (Wave 2)
59. Is a structured patient education programme available in your area for the following patient groups ?
(Tick all that apply)
Type 1
Type 2
Paediatric
Gestational Diabetes
Prevention
None available
Other (please specify below)
60. If yes, which programmes are available in your area?(Tick all that apply)
DESMOND
XPERT
CODE
DAPHNE
Walk Away from Diabetes
Not applicable
Other (please specify below)
If yes, how is this education provided? (e.g. information only, one-to-one sessions, groups sessions)
61. Are you involved in providing education to any of the following professional groups?
GP
Practice Nurse
Nursing staff in hospitals
Medical staff in hospitals
Allied health professionals
Medical staff in nursing homes
None of these groups
16
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Recording Activity
Survey of Diabetes Nurse Specialists in Ireland (Wave 2)
62. Are any of the following records used? (Tick all that apply)
Paper record
Electronic patient health record
Patient passport
Shared care book
None of the above
63. If yes, who completes the record? (Tick all that apply)
Me
Another DNS
Patient
Consultant
GP
Practice Nurse
Not applicable
Other (please specify below)
Telephone advice
Informal patient drop-in activity
In-patient contact
Running clinics
Multidisciplinary team activity/meetings
GP/Practice liaison
64. Please estimate the percentage of time (%) per month spent on each of these additional activities.
18
65. Are these activities recorded? (Please tick all that apply)
Telephone advice
Informal patient drop-in activity
In-patient contact
Number of clinics
Multidisciplinary team meetings
GP/Practice liaison
None recorded
19
Survey of Diabetes Nurse Specialists in Ireland (Wave 2)
 
66. Do you have protected time for continuing professional development?
Yes No
 
67. Is there a protected budget for diabetes continuing professional development?
Yes No
20
Opportunities & obstacles for diabetes care in Ireland
Survey of Diabetes Nurse Specialists in Ireland (Wave 2)
68. We value your insight into diabetes care. Please use the space provided to describe the main
barriers and facilitators to delivering the diabetes service in your area.
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